<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d11" for="edge" attr.name="created_at" attr.type="long" />
  <key id="d10" for="edge" attr.name="file_path" attr.type="string" />
  <key id="d9" for="edge" attr.name="source_id" attr.type="string" />
  <key id="d8" for="edge" attr.name="keywords" attr.type="string" />
  <key id="d7" for="edge" attr.name="description" attr.type="string" />
  <key id="d6" for="edge" attr.name="weight" attr.type="double" />
  <key id="d5" for="node" attr.name="created_at" attr.type="long" />
  <key id="d4" for="node" attr.name="file_path" attr.type="string" />
  <key id="d3" for="node" attr.name="source_id" attr.type="string" />
  <key id="d2" for="node" attr.name="description" attr.type="string" />
  <key id="d1" for="node" attr.name="entity_type" attr.type="string" />
  <key id="d0" for="node" attr.name="entity_id" attr.type="string" />
  <graph edgedefault="undirected">
    <node id="South African managed healthcare organization">
      <data key="d0">South African managed healthcare organization</data>
      <data key="d1">organization</data>
      <data key="d2">A healthcare organization in South Africa where a study on Type 2 Diabetes Mellitus (T2DM) patients with comorbidities was conducted.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391358</data>
    </node>
    <node id="University of the Witwatersrand">
      <data key="d0">University of the Witwatersrand</data>
      <data key="d1">organization</data>
      <data key="d2">An academic institution in Johannesburg, South Africa, associated with the authors of the study.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391358</data>
    </node>
    <node id="Lovina Asha Naidoo">
      <data key="d0">Lovina Asha Naidoo</data>
      <data key="d1">person</data>
      <data key="d2">A co-author of the study on T2DM patients with comorbidities in a South African managed healthcare organization.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391358</data>
    </node>
    <node id="Neil Butkow">
      <data key="d0">Neil Butkow</data>
      <data key="d1">person</data>
      <data key="d2">A co-author of the study on T2DM patients with comorbidities in a South African managed healthcare organization.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391358</data>
    </node>
    <node id="Paula Barnard">
      <data key="d0">Paula Barnard</data>
      <data key="d1">person</data>
      <data key="d2">A co-author of the study on T2DM patients with comorbidities in a South African managed healthcare organization.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391358</data>
    </node>
    <node id="Elena Libhaber">
      <data key="d0">Elena Libhaber</data>
      <data key="d1">person</data>
      <data key="d2">A co-author of the study on T2DM patients with comorbidities in a South African managed healthcare organization.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391358</data>
    </node>
    <node id="South Africa">
      <data key="d0">South Africa</data>
      <data key="d1">geo</data>
      <data key="d2">South Africa is a country located in Africa, renowned for hosting significant institutions such as the South African managed healthcare organization and the University of the Witwatersrand. It is deeply involved in national programs aimed at implementing collaborative activities for the management of tuberculosis and diabetes, as highlighted in various studies and guidelines. South Africa has been the focus of research on the burden of disease attributable to diabetes, with specific attention to disparities in diabetes prevalence and management strategies among different population groups. The country is also referenced in the context of South African Corporate Social Responsibility (CSR) targets related to cataract surgery rates and the Road Traffic Act of 1996, which outlines legislation regarding diabetes and driving fitness. Notably, South Africa was the location for the South Africa Demographic and Health Survey of 2003, and it is associated with the development and implementation of diabetes management guidelines, including those for maternity care. The country has been noted for higher mortality rates from diabetic ketoacidosis (DKA) compared to developed nations, although data on diabetes-related hospital admissions for foot complications remain unavailable. Additionally, conservative estimates of diabetes prevalence among adults aged 20–79 years have been documented, with the South African Medical Association (SEMDSA) playing a role in shaping diabetes-related guidelines and initiatives.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e&lt;SEP&gt;chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78&lt;SEP&gt;chunk-b752ce36b859046d9641b5096d445e7c&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6&lt;SEP&gt;chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-358680bfd64f7682f010caf1db56168e&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-3d51f582eadeb6057c2d495ca70b761b&lt;SEP&gt;chunk-d6b09b4b09529f8f51aa7d3eb8384af7&lt;SEP&gt;chunk-76dcee1ddb22a2d709c06cd143cc277a&lt;SEP&gt;chunk-8a3fa9809e33f235ebfe9c0204d7fbfb&lt;SEP&gt;chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391360</data>
    </node>
    <node id="Johannesburg">
      <data key="d0">Johannesburg</data>
      <data key="d1">geo</data>
      <data key="d2">A city in South Africa where the University of the Witwatersrand is located.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391358</data>
    </node>
    <node id="Annual Meeting of The Japanese Pharmacological Society">
      <data key="d0">Annual Meeting of The Japanese Pharmacological Society</data>
      <data key="d1">event</data>
      <data key="d2">An academic event where the study on T2DM patients with comorbidities was presented as part of the proceedings.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Type 2 Diabetes Mellitus">
      <data key="d0">Type 2 Diabetes Mellitus</data>
      <data key="d1">category</data>
      <data key="d2">A medical condition studied in the context of comorbidities within a South African managed healthcare organization.&lt;SEP&gt;Type 2 Diabetes Mellitus is linked to Hyperglycaemic Hyperosmolar State (HHS) in cases of new-onset diabetes, as stated in the text.</data>
      <data key="d3">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb&lt;SEP&gt;chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391421</data>
    </node>
    <node id="Major Depressive Disorder">
      <data key="d0">Major Depressive Disorder</data>
      <data key="d1">category</data>
      <data key="d2">A mental health condition studied in the context of comorbidities with Type 2 Diabetes Mellitus.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Cardiovascular diseases">
      <data key="d0">Cardiovascular diseases</data>
      <data key="d1">category</data>
      <data key="d2">A category of comorbidities associated with Type 2 Diabetes Mellitus in the study.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Cancer">
      <data key="d0">Cancer</data>
      <data key="d1">category</data>
      <data key="d2">A category of comorbidities mentioned in the study as a discordant condition with Type 2 Diabetes Mellitus.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Coronary Artery Disease">
      <data key="d0">Coronary Artery Disease</data>
      <data key="d1">category</data>
      <data key="d2">A specific type of cardiovascular disease mentioned in the context of comorbidity with Major Depressive Disorder (MDD) and its impact on patient outcomes.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Dr A Motsoaledi">
      <data key="d0">Dr A Motsoaledi</data>
      <data key="d1">person</data>
      <data key="d2">Dr A Motsoaledi is the Minister of Health who wrote the foreword for the diabetes management guideline.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Dr G Ramokgopa">
      <data key="d0">Dr G Ramokgopa</data>
      <data key="d1">person</data>
      <data key="d2">Dr G Ramokgopa is the Deputy Minister of Health who provided a statement supporting the diabetes guideline.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Ms MP Matsoso">
      <data key="d0">Ms MP Matsoso</data>
      <data key="d1">person</data>
      <data key="d2">Ms MP Matsoso is the Director-General of Health who acknowledged the contributions to the guideline development.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Department of Health">
      <data key="d0">Department of Health</data>
      <data key="d1">organization</data>
      <data key="d2">The Department of Health is the government entity responsible for the diabetes management guideline in South Africa.&lt;SEP&gt;The Department of Health was a member of the SEMDSA Steering Committee and participated in guideline development.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a&lt;SEP&gt;chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Society for Endocrinology, Metabolism and Diabetes for South Africa (SEMDSA)">
      <data key="d0">Society for Endocrinology, Metabolism and Diabetes for South Africa (SEMDSA)</data>
      <data key="d1">organization</data>
      <data key="d2">SEMDSA is an organization that provided leadership in developing the diabetes management guideline.&lt;SEP&gt;The SEMDSA is a South African organization involved in diabetes management and guideline development.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Diabetes Implementation Strategy for South Africa">
      <data key="d0">Diabetes Implementation Strategy for South Africa</data>
      <data key="d1">category</data>
      <data key="d2">The Diabetes Implementation Strategy for South Africa is a national plan to manage diabetes, aligned with the African Diabetes Declaration and Strategy.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Non-Communicable Diseases Summit (2011)">
      <data key="d0">Non-Communicable Diseases Summit (2011)</data>
      <data key="d1">event</data>
      <data key="d2">The Non-Communicable Diseases Summit in September 2011 set targets for reducing the burden of non-communicable diseases in South Africa.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391359</data>
    </node>
    <node id="Healthcare Resource Utilization">
      <data key="d0">Healthcare Resource Utilization</data>
      <data key="d1">category</data>
      <data key="d2">A concept referring to the extraction of hospital admissions, length of stay, and costs per admission as part of the study's methods.</data>
      <data key="d3">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391360</data>
    </node>
    <node id="Healthcare Organization">
      <data key="d0">Healthcare Organization</data>
      <data key="d1">organization</data>
      <data key="d2">The healthcare organization is an institution where 902 T2DM patients were registered and studied for MDD-related hospital utilization patterns.</data>
      <data key="d3">chunk-8fc89353659871857f4a2f36b706fc19</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391361</data>
    </node>
    <node id="T2DM">
      <data key="d0">T2DM</data>
      <data key="d1">category</data>
      <data key="d2">T2DM (Type 2 Diabetes Mellitus) is a medical condition studied in relation to MDD (Major Depressive Disorder) and hospitalization rates.</data>
      <data key="d3">chunk-8fc89353659871857f4a2f36b706fc19</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391361</data>
    </node>
    <node id="MDD">
      <data key="d0">MDD</data>
      <data key="d1">category</data>
      <data key="d2">MDD (Major Depressive Disorder) is a mental health condition analyzed alongside T2DM in the study, with significant hospitalization implications.</data>
      <data key="d3">chunk-8fc89353659871857f4a2f36b706fc19</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391362</data>
    </node>
    <node id="T2DM without MDD">
      <data key="d0">T2DM without MDD</data>
      <data key="d1">category</data>
      <data key="d2">A patient group with T2DM but without MDD, characterized by predominantly male patients (62%) and an average age of 58 years.</data>
      <data key="d3">chunk-8fc89353659871857f4a2f36b706fc19</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391362</data>
    </node>
    <node id="T2DM with MDD">
      <data key="d0">T2DM with MDD</data>
      <data key="d1">category</data>
      <data key="d2">A patient group with both T2DM and MDD, characterized by predominantly female patients (64%) and an average age of 60 years.</data>
      <data key="d3">chunk-8fc89353659871857f4a2f36b706fc19</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391362</data>
    </node>
    <node id="Negotiated Service Delivery Agreement">
      <data key="d0">Negotiated Service Delivery Agreement</data>
      <data key="d1">category</data>
      <data key="d2">The Negotiated Service Delivery Agreement is a policy framework aiming to increase life expectancy and reduce maternal mortality in South Africa.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391362</data>
    </node>
    <node id="African Diabetes Declaration and Strategy">
      <data key="d0">African Diabetes Declaration and Strategy</data>
      <data key="d1">event</data>
      <data key="d2">The African Diabetes Declaration and Strategy provided the basis for South Africa's Diabetes Implementation Strategy.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391362</data>
    </node>
    <node id="Directorate: Chronic Diseases, Disabilities and Geriatrics">
      <data key="d0">Directorate: Chronic Diseases, Disabilities and Geriatrics</data>
      <data key="d1">organization</data>
      <data key="d2">A sub-unit of the National Department of Health focused on chronic diseases and geriatrics.&lt;SEP&gt;This Directorate is part of the National Department of Health and compiled the diabetes management guideline.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391362</data>
    </node>
    <node id="Type 2 Diabetes">
      <data key="d0">Type 2 Diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Type 2 Diabetes is a chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency, primarily affecting adults and high-risk individuals. It is a prevalent condition with rising global incidence, marked by impaired glucose regulation, lipid disturbances (elevated triglycerides, reduced HDL cholesterol), and an increased risk of vascular disease and diabetic nephropathy, necessitating regular screening for chronic kidney disease (CKD). The condition is associated with significant health challenges, including 30–85% of cases remaining undiagnosed at the time of diagnosis, and is a focus of prevention strategies, lifestyle modifications (e.g., dietary changes, physical activity, weight management), and management protocols at the primary care level. Risk factors include obesity, hereditary predisposition (particularly in offspring of diabetic parents), and co-morbidities such as HIV co-infection, hepatitis C, and dyslipidaemia, with specific emphasis on screening and management in HIV-positive patients. Physical activity recommendations highlight the importance of resistance and aerobic exercises for metabolic control. While one description erroneously notes Type 2 Diabetes as a condition diagnosed before pregnancy, this likely refers to pre-existing Type 2 Diabetes in pregnant individuals, not gestational diabetes. The 2012 SEMDSA Guideline and referenced publications underscore its significance, emphasizing early detection through diagnostic criteria and screening protocols. Overall, Type 2 Diabetes is a complex, multifactorial disorder requiring integrated medical, lifestyle, and public health interventions.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e&lt;SEP&gt;chunk-1427a4f3a37a8bc9105d9dc8f4a4b755&lt;SEP&gt;chunk-87e7e545e69a570dc134ec02d336fb1d&lt;SEP&gt;chunk-7328f1285f97b5e01ee98cc53f8391b9&lt;SEP&gt;chunk-2747f5a8e50f80ecb003d82a6236b5de&lt;SEP&gt;chunk-48019451fb64599a32100497e8728c0d&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-79bcdf813ecc9a1a30cad14ddfd21884&lt;SEP&gt;chunk-13c6d53292dee777497019b48adc774c&lt;SEP&gt;chunk-76dcee1ddb22a2d709c06cd143cc277a&lt;SEP&gt;chunk-e40dd1b6f667a901a4ea2e77d6f8087a&lt;SEP&gt;chunk-03650d0126e6b49e45077884bfc6007b&lt;SEP&gt;chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391362</data>
    </node>
    <node id="Non-Communicable Diseases">
      <data key="d0">Non-Communicable Diseases</data>
      <data key="d1">category</data>
      <data key="d2">Non-Communicable Diseases are a group of health conditions, including diabetes, targeted by the 2020 reduction goals.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391363</data>
    </node>
    <node id="Screening, Diagnosis, and Management of Complications">
      <data key="d0">Screening, Diagnosis, and Management of Complications</data>
      <data key="d1">category</data>
      <data key="d2">Key components of the guideline's scope, covering prevention, diagnosis, and treatment strategies for type 2 diabetes.</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391363</data>
    </node>
    <node id="Screening for early detection">
      <data key="d0">Screening for early detection</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391363</data>
    </node>
    <node id="Organization of diabetes care">
      <data key="d0">Organization of diabetes care</data>
      <data key="d1">organization</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391363</data>
    </node>
    <node id="Requirements at Clinic level for a diabetes service">
      <data key="d0">Requirements at Clinic level for a diabetes service</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391365</data>
    </node>
    <node id="Schedule of visits to a diabetes clinic">
      <data key="d0">Schedule of visits to a diabetes clinic</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391365</data>
    </node>
    <node id="Targets for glycaemic control">
      <data key="d0">Targets for glycaemic control</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391365</data>
    </node>
    <node id="Glycaemic management">
      <data key="d0">Glycaemic management</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391365</data>
    </node>
    <node id="Self monitoring of blood glucose (SMBG)">
      <data key="d0">Self monitoring of blood glucose (SMBG)</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391365</data>
    </node>
    <node id="Sick days">
      <data key="d0">Sick days</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391365</data>
    </node>
    <node id="Follow-up">
      <data key="d0">Follow-up</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Follow-up refers to the process of monitoring and managing patient health after initial treatment, focusing on glycaemic control, lifestyle modification, and complication detection.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391365</data>
    </node>
    <node id="Referrals">
      <data key="d0">Referrals</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391365</data>
    </node>
    <node id="Hypoglycaemia">
      <data key="d0">Hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Hypoglycaemia is a serious medical condition characterized by abnormally low blood glucose levels, commonly associated with diabetes and its treatment, particularly insulin therapy or other therapeutic interventions. It is identified as an acute complication of diabetes, often arising from improper medication management, carbohydrate intake, or physical activity without adequate adjustments. Hypoglycaemia may cause transient cognitive dysfunction, loss of consciousness, or impaired driving ability, necessitating drivers to monitor blood glucose levels and avoid driving when levels fall below 4.0 mmol/L. The condition can be masked by beta-blockers in diabetic patients, complicating its detection. Additionally, it poses a risk during physical activity if medication or carbohydrate intake is not appropriately balanced. Hypoglycaemia is a potential consequence of diabetes management, emphasizing the need for careful monitoring and adjustment of treatment regimens to prevent severe complications.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78&lt;SEP&gt;chunk-b752ce36b859046d9641b5096d445e7c&lt;SEP&gt;chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-2747f5a8e50f80ecb003d82a6236b5de&lt;SEP&gt;chunk-a7f14fa25c0f0f6b50f4346d68fa7305&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391367</data>
    </node>
    <node id="Hyperglycaemic emergencies">
      <data key="d0">Hyperglycaemic emergencies</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391367</data>
    </node>
    <node id="DKA">
      <data key="d0">DKA</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391367</data>
    </node>
    <node id="HHS">
      <data key="d0">HHS</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391367</data>
    </node>
    <node id="Obesity">
      <data key="d0">Obesity</data>
      <data key="d1">category</data>
      <data key="d2">Obesity is a medical condition associated with insulin resistance, increased risk of cardiovascular complications, and weight gain in type 2 diabetic patients, particularly linked to abdominal fat. It is a significant risk factor for cardiovascular disease (CVD) and metabolic syndrome in type 2 diabetes, with particular relevance when body mass index (BMI) is ≥25 or waist circumference is elevated. Studies in South Africa indicate varying correlations between obesity and diabetes across population groups, with notable associations observed in Coloured and African females. These findings underscore the complex interplay between obesity, metabolic health, and demographic-specific risk profiles.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-72284fe3e2da042b4841a91a96c6513d&lt;SEP&gt;chunk-358680bfd64f7682f010caf1db56168e&lt;SEP&gt;chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391367</data>
    </node>
    <node id="Cardiovascular risk and dyslipidaemia">
      <data key="d0">Cardiovascular risk and dyslipidaemia</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391367</data>
    </node>
    <node id="Aspirin therapy">
      <data key="d0">Aspirin therapy</data>
      <data key="d1">category</data>
      <data key="d2">Aspirin therapy is a treatment mentioned in the context of cardiovascular risk management for diabetes patients.&lt;SEP&gt;Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391367</data>
    </node>
    <node id="Hypertension">
      <data key="d0">Hypertension</data>
      <data key="d1">category</data>
      <data key="d2">Hypertension, a medical condition characterized by elevated blood pressure, is a common comorbidity in type 2 diabetes and a critical cardiovascular disease (CVD) risk factor in individuals with diabetes. It is strongly associated with increased risks during pregnancy and diabetes management, as well as the progression of diabetic complications such as macro- and microvascular damage. Effective management of Hypertension in diabetes requires strict blood pressure control, with recommended targets of systolic blood pressure &lt;140 mmHg and diastolic blood pressure &lt;80 mmHg, to mitigate cardiovascular complications and reduce the progression of diabetes-related health issues. Hypertension is also recognized as a key driver of adverse outcomes in both diabetic and non-diabetic populations, underscoring the need for tailored guidelines and interventions to address its multifaceted impact on health.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d&lt;SEP&gt;chunk-87e7e545e69a570dc134ec02d336fb1d&lt;SEP&gt;chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-358680bfd64f7682f010caf1db56168e&lt;SEP&gt;chunk-3d51f582eadeb6057c2d495ca70b761b&lt;SEP&gt;chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391367</data>
    </node>
    <node id="Chronic Kidney Disease (CKD)">
      <data key="d0">Chronic Kidney Disease (CKD)</data>
      <data key="d1">category</data>
      <data key="d2">CKD is a long-term complication of diabetes mellitus, characterized by progressive kidney damage. It requires regular screening, including monitoring of albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR).&lt;SEP&gt;Chronic Kidney Disease (CKD) is listed as an abbreviation in the text, though its specific context in the document is not elaborated.&lt;SEP&gt;Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391368</data>
    </node>
    <node id="Retinopathy">
      <data key="d0">Retinopathy</data>
      <data key="d1">category</data>
      <data key="d2">Retinopathy is a chronic eye disease commonly associated with diabetes, characterized by damage to the blood vessels in the retina. This condition can lead to significant visual impairment and may affect driving performance, highlighting its impact on daily functioning. Retinopathy is a well-documented complication of diabetes, frequently studied and addressed in medical guidelines due to its prevalence and potential severity. The disease underscores the importance of regular eye examinations and diabetes management to mitigate its progression and complications.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78&lt;SEP&gt;chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391369</data>
    </node>
    <node id="Feet">
      <data key="d0">Feet</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391369</data>
    </node>
    <node id="Pregnancy">
      <data key="d0">Pregnancy</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Pregnancy is a condition that requires increased glucose testing in diabetic patients due to its impact on glycaemic control.&lt;SEP&gt;Pregnancy is a critical consideration in hypertension management, requiring discontinuation of ACE inhibitors and diuretics and switching to methyldopa.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b&lt;SEP&gt;chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391369</data>
    </node>
    <node id="Family planning and pre-conception care">
      <data key="d0">Family planning and pre-conception care</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391369</data>
    </node>
    <node id="Older Persons">
      <data key="d0">Older Persons</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Older Persons refers to the geriatric population with a high prevalence of diabetes mellitus, requiring tailored management approaches.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391369</data>
    </node>
    <node id="High risk ethnic groups">
      <data key="d0">High risk ethnic groups</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391370</data>
    </node>
    <node id="HIV">
      <data key="d0">HIV</data>
      <data key="d1">category</data>
      <data key="d2">HIV (Human Immunodeficiency Virus) is a medical condition linked to significant health complications, including metabolic disorders such as dysglycaemia, dyslipidaemia, and lipodystrophy, which increase the risk of developing diabetes mellitus. In South Africa, patients undergoing HAART (Highly Active Antiretroviral Therapy) are particularly at risk for diabetes, necessitating regular screening to monitor and manage this comorbidity. HIV is also categorized under BIOCHEMISTRY in certain contexts, specifically as part of screening protocols for HIV infection. Furthermore, HIV requires careful consideration in diabetes care, particularly in high-risk populations, due to its complex interplay with metabolic health. These associations highlight the importance of integrated approaches to managing HIV and diabetes, ensuring timely interventions and monitoring for patients on antiretroviral therapy.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d&lt;SEP&gt;chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-98786d9fc0c669ea92f47d22f68e9730&lt;SEP&gt;chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391370</data>
    </node>
    <node id="Fasting">
      <data key="d0">Fasting</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Fasting is a practice undertaken for religious or personal reasons by some individuals with diabetes, requiring medical planning and adjustments to minimize risks such as hypoglycaemia and dehydration.&lt;SEP&gt;Fasting refers to the practice of abstaining from food, requiring SMBG monitoring and hydration management in individuals with diabetes.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-13c6d53292dee777497019b48adc774c&lt;SEP&gt;chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391370</data>
    </node>
    <node id="High risk individuals – prevention and delay of type 2 diabetes">
      <data key="d0">High risk individuals – prevention and delay of type 2 diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391370</data>
    </node>
    <node id="Driving">
      <data key="d0">Driving</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391370</data>
    </node>
    <node id="Tuberculosis">
      <data key="d0">Tuberculosis</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Tuberculosis is a disease that intersects with diabetes care, requiring management in specific populations.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391371</data>
    </node>
    <node id="Periodontal (gum) disease">
      <data key="d0">Periodontal (gum) disease</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391371</data>
    </node>
    <node id="Rehabilitation">
      <data key="d0">Rehabilitation</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Rehabilitation is a component of care for visually impaired individuals, focusing on improving quality of life and functional independence.&lt;SEP&gt;Rehabilitation is a process integrated into diabetes care for specific populations and settings.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-87e7e545e69a570dc134ec02d336fb1d&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391371</data>
    </node>
    <node id="Management of comorbidities and complications">
      <data key="d0">Management of comorbidities and complications</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391371</data>
    </node>
    <node id="Management of blood glucose">
      <data key="d0">Management of blood glucose</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391371</data>
    </node>
    <node id="Non-pharmacological">
      <data key="d0">Non-pharmacological</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391372</data>
    </node>
    <node id="Pharmacological">
      <data key="d0">Pharmacological</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391372</data>
    </node>
    <node id="Algorithms">
      <data key="d0">Algorithms</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391373</data>
    </node>
    <node id="Statin therapy">
      <data key="d0">Statin therapy</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391373</data>
    </node>
    <node id="Progression of classic diabetic nephropathy">
      <data key="d0">Progression of classic diabetic nephropathy</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391373</data>
    </node>
    <node id="Criteria for the diagnosis of diabetes">
      <data key="d0">Criteria for the diagnosis of diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391373</data>
    </node>
    <node id="Use of HbA1c in the diagnosis of diabetes mellitus">
      <data key="d0">Use of HbA1c in the diagnosis of diabetes mellitus</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391374</data>
    </node>
    <node id="Screening for type 2 diabetes in asymptomatic adults">
      <data key="d0">Screening for type 2 diabetes in asymptomatic adults</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391374</data>
    </node>
    <node id="Patient history, physical examination, biochemistry and other activities recommended for visits to a diabetes clinic">
      <data key="d0">Patient history, physical examination, biochemistry and other activities recommended for visits to a diabetes clinic</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391374</data>
    </node>
    <node id="Monitoring of patients with diabetes and frequency of tests">
      <data key="d0">Monitoring of patients with diabetes and frequency of tests</data>
      <data key="d1">category</data>
      <data key="d2">A category representing the monitoring framework for diabetes patients, including frequency of tests and procedures.&lt;SEP&gt;Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391374</data>
    </node>
    <node id="Targets for fasting plasma glucose, post-prandial glucose, HbA1c in different patient types">
      <data key="d0">Targets for fasting plasma glucose, post-prandial glucose, HbA1c in different patient types</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391374</data>
    </node>
    <node id="Differentiation between the types of hyperglycaemic coma">
      <data key="d0">Differentiation between the types of hyperglycaemic coma</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391375</data>
    </node>
    <node id="CVD risk factors and targets for patients with type 2 diabetes">
      <data key="d0">CVD risk factors and targets for patients with type 2 diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391375</data>
    </node>
    <node id="Harmonised criteria for the clinical diagnosis of the metabolic syndrome">
      <data key="d0">Harmonised criteria for the clinical diagnosis of the metabolic syndrome</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391375</data>
    </node>
    <node id="Ideal lipid profile for a patient with diabetes">
      <data key="d0">Ideal lipid profile for a patient with diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391375</data>
    </node>
    <node id="Risk categorisation system for diabetic feet">
      <data key="d0">Risk categorisation system for diabetic feet</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391375</data>
    </node>
    <node id="Targets for control in older persons">
      <data key="d0">Targets for control in older persons</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391376</data>
    </node>
    <node id="Diabetes Education">
      <data key="d0">Diabetes Education</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Diabetes Education refers to the structured, evidence-based patient education programs outlined in the guideline.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391376</data>
    </node>
    <node id="Lifestyle Modification">
      <data key="d0">Lifestyle Modification</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Lifestyle modification focuses on dietary changes, physical activity, and behavioral adjustments to manage diabetes.&lt;SEP&gt;Lifestyle modification refers to changes in diet, exercise, and behavior aimed at improving diabetes management.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-a7f14fa25c0f0f6b50f4346d68fa7305&lt;SEP&gt;chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391376</data>
    </node>
    <node id="Foot Care">
      <data key="d0">Foot Care</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Foot care is a category emphasizing the importance of maintaining foot health to prevent ulcers, gangrene, and amputations in diabetes management.&lt;SEP&gt;Foot care refers to daily hygiene practices, inspection, and proper footwear recommendations for individuals with diabetes to prevent complications.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3&lt;SEP&gt;chunk-03650d0126e6b49e45077884bfc6007b&lt;SEP&gt;chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391376</data>
    </node>
    <node id="Foot Screening Assessment Form">
      <data key="d0">Foot Screening Assessment Form</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391376</data>
    </node>
    <node id="Rapid screening for diabetic neuropathy">
      <data key="d0">Rapid screening for diabetic neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391376</data>
    </node>
    <node id="Clinic structure">
      <data key="d0">Clinic structure</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391376</data>
    </node>
    <node id="Glycated haemoglobin">
      <data key="d0">Glycated haemoglobin</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391376</data>
    </node>
    <node id="Patient adherence in chronic conditions">
      <data key="d0">Patient adherence in chronic conditions</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391376</data>
    </node>
    <node id="Diabetes Care in Specific Populations">
      <data key="d0">Diabetes Care in Specific Populations</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391377</data>
    </node>
    <node id="List of Algorithms, Figure and Tables">
      <data key="d0">List of Algorithms, Figure and Tables</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391377</data>
    </node>
    <node id="World Health Organization">
      <data key="d0">World Health Organization</data>
      <data key="d1">organization</data>
      <data key="d2">The World Health Organization (WHO) is referenced in the text as an abbreviation, though its specific role or activities in the context of diabetes management are not explicitly detailed.&lt;SEP&gt;The World Health Organization is cited in the guidelines for diabetes diagnosis and management protocols.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391377</data>
    </node>
    <node id="Diabetes Mellitus">
      <data key="d0">Diabetes Mellitus</data>
      <data key="d1">category</data>
      <data key="d2">Diabetes Mellitus is identified as a major public health problem, with Type 2 diabetes accounting for over 90% of cases.&lt;SEP&gt;Diabetes mellitus is a medical condition with increasing incidence in the HIV population on antiretroviral therapy (ARVs), requiring regular screening for signs of diabetes.&lt;SEP&gt;Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycaemia and disturbances of carbohydrate, fat, and protein metabolism due to defects in insulin secretion, insulin action, or both.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391377</data>
    </node>
    <node id="Metabolic Syndrome">
      <data key="d0">Metabolic Syndrome</data>
      <data key="d1">category</data>
      <data key="d2">Metabolic Syndrome is described as a cluster of conditions (abdominal obesity, elevated triglycerides, low HDL-cholesterol, hypertension, elevated fasting glucose) that increase the risk of diabetes and cardiovascular disease.&lt;SEP&gt;The Metabolic Syndrome, or insulin resistance syndrome, is a major public-health challenge linked to 5-fold increased diabetes risk and doubled CVD risk.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391378</data>
    </node>
    <node id="Impaired Fasting Glucose (IFG)">
      <data key="d0">Impaired Fasting Glucose (IFG)</data>
      <data key="d1">category</data>
      <data key="d2">Impaired Fasting Glucose (IFG) is a pre-diabetic condition associated with a 25–50% lifetime risk of developing type 2 diabetes.&lt;SEP&gt;Impaired Fasting Glucose (IFG) is categorized as a high-risk state for developing diabetes, part of the spectrum of glucose tolerance.&lt;SEP&gt;Impaired Fasting Glucose is a category of intermediate hyperglycaemia defined by fasting plasma glucose levels between 6.1–7.0 mmol/L.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391378</data>
    </node>
    <node id="Impaired Glucose Tolerance (IGT)">
      <data key="d0">Impaired Glucose Tolerance (IGT)</data>
      <data key="d1">category</data>
      <data key="d2">Impaired Glucose Tolerance (IGT) is a medical condition characterized by elevated blood glucose levels following a glucose load, without meeting the diagnostic criteria for diabetes. It is classified as a pre-diabetic state, associated with a 25–50% lifetime risk of developing type 2 diabetes, and is identified as a high-risk stage within the spectrum of glucose tolerance disorders. IGT falls under the category of intermediate hyperglycaemia, typically diagnosed through an oral glucose tolerance test (OGTT) that measures specific plasma glucose thresholds. This condition highlights an increased susceptibility to diabetes while remaining distinct from the full-blown disease, serving as a critical intermediate phase in the progression of glucose metabolism abnormalities.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-13c6d53292dee777497019b48adc774c&lt;SEP&gt;chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391378</data>
    </node>
    <node id="Non-Communicable Diseases (NCDs)">
      <data key="d0">Non-Communicable Diseases (NCDs)</data>
      <data key="d1">category</data>
      <data key="d2">Non-Communicable Diseases (NCDs) are referenced as conditions for which health professionals should promote healthy living and recognize risk factors.&lt;SEP&gt;Non-communicable diseases are a group of conditions, including diabetes, that are not transmitted from person to person and are often chronic.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391378</data>
    </node>
    <node id="Cardiovascular Disease (CVD)">
      <data key="d0">Cardiovascular Disease (CVD)</data>
      <data key="d1">category</data>
      <data key="d2">A condition with significant risk factors for patients with type 2 diabetes, influencing aspirin therapy recommendations and hypertension management.&lt;SEP&gt;Cardiovascular Disease (CVD) is referenced as an abbreviation and is noted as a condition to which people with diabetes are at increased risk.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391378</data>
    </node>
    <node id="Peripheral Artery Disease (PAD)">
      <data key="d0">Peripheral Artery Disease (PAD)</data>
      <data key="d1">category</data>
      <data key="d2">Peripheral Artery Disease (PAD) is listed as an abbreviation in the text, though its specific context is not elaborated.&lt;SEP&gt;Peripheral artery disease is a condition involving reduced blood flow to the limbs, often assessed through pulse palpation.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391379</data>
    </node>
    <node id="Gestational Diabetes Mellitus (GDM)">
      <data key="d0">Gestational Diabetes Mellitus (GDM)</data>
      <data key="d1">category</data>
      <data key="d2">Gestational Diabetes Mellitus (GDM) is a category of diabetes diagnosed during pregnancy, requiring specific screening and management protocols.&lt;SEP&gt;Gestational Diabetes Mellitus (GDM) is referenced as an abbreviation in the text, though its specific context is not elaborated.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391379</data>
    </node>
    <node id="Chronic Conditions">
      <data key="d0">Chronic Conditions</data>
      <data key="d1">category</data>
      <data key="d2">Chronic Conditions are mentioned in the context of patient adherence, particularly in the annexure titled 'A guide to patient adherence in chronic conditions.'&lt;SEP&gt;Chronic Conditions refer to long-term health issues such as diabetes, hypertension, and mental health disorders that require ongoing management.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e&lt;SEP&gt;chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391379</data>
    </node>
    <node id="Annexure E">
      <data key="d0">Annexure E</data>
      <data key="d1">event</data>
      <data key="d2">Annexure E is a document section discussing Glycated haemoglobin (HbA1c) in the context of diabetes management.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391379</data>
    </node>
    <node id="Annexure F">
      <data key="d0">Annexure F</data>
      <data key="d1">event</data>
      <data key="d2">Annexure F is a document referenced for checking patient adherence to treatment instructions in diabetes management.&lt;SEP&gt;Annexure F is a document section providing a guide to patient adherence in chronic conditions.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391380</data>
    </node>
    <node id="SA Diabetes Declaration Implementation Strategy">
      <data key="d0">SA Diabetes Declaration Implementation Strategy</data>
      <data key="d1">organization</data>
      <data key="d2">The SA Diabetes Declaration Implementation Strategy is a framework referenced for organizing diabetes care and improving quality of care.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391380</data>
    </node>
    <node id="Long-term care model Implementation Plan">
      <data key="d0">Long-term care model Implementation Plan</data>
      <data key="d1">organization</data>
      <data key="d2">The Long-term care model Implementation Plan is a strategy mentioned for structured diabetes management and clinic organization.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391380</data>
    </node>
    <node id="National Guideline: Non-Communicable Diseases">
      <data key="d0">National Guideline: Non-Communicable Diseases</data>
      <data key="d1">organization</data>
      <data key="d2">The National Guideline: Non-Communicable Diseases is referenced as a strategic resource for chronic disease prevention and management.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391380</data>
    </node>
    <node id="Health Promoters">
      <data key="d0">Health Promoters</data>
      <data key="d1">person</data>
      <data key="d2">Health Promoters are mentioned as health professionals involved in promoting healthy living and diabetes risk factor awareness.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391380</data>
    </node>
    <node id="Community Health Workers">
      <data key="d0">Community Health Workers</data>
      <data key="d1">person</data>
      <data key="d2">Community Health Workers are identified as lay health workers contributing to diabetes education and chronic disease prevention.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391380</data>
    </node>
    <node id="Self Monitoring of Blood Glucose (SMBG)">
      <data key="d0">Self Monitoring of Blood Glucose (SMBG)</data>
      <data key="d1">category</data>
      <data key="d2">SMBG is described as a tool for regular blood glucose monitoring in diabetes management.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391381</data>
    </node>
    <node id="Random Plasma Glucose (RPG)">
      <data key="d0">Random Plasma Glucose (RPG)</data>
      <data key="d1">category</data>
      <data key="d2">RPG is referenced as a method for assessing blood glucose levels in diabetes diagnosis and monitoring.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391381</data>
    </node>
    <node id="Uncontrolled Hyperglycaemia">
      <data key="d0">Uncontrolled Hyperglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Uncontrolled Hyperglycaemia is described as a complication stemming from improper diabetes management or patient non-adherence.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391381</data>
    </node>
    <node id="Microvascular Complications">
      <data key="d0">Microvascular Complications</data>
      <data key="d1">category</data>
      <data key="d2">Microvascular Complications are noted as long-term effects of diabetes, including retinopathy, nephropathy, and neuropathy.&lt;SEP&gt;Microvascular complications, such as retinopathy and nephropathy, are associated with an increased risk of foot ulceration.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391381</data>
    </node>
    <node id="Macrovascular Complications">
      <data key="d0">Macrovascular Complications</data>
      <data key="d1">category</data>
      <data key="d2">Macrovascular Complications are described as diabetes-related conditions affecting the heart, peripheral arteries, and cerebrovascular system.</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391381</data>
    </node>
    <node id="Primary Health Care Level">
      <data key="d0">Primary Health Care Level</data>
      <data key="d1">category</data>
      <data key="d2">Primary Health Care Level refers to the initial tier of healthcare services focused on education, screening, and management of diabetes and other chronic conditions.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391381</data>
    </node>
    <node id="Health Professionals">
      <data key="d0">Health Professionals</data>
      <data key="d1">category</data>
      <data key="d2">Health Professionals include Health Promoters, Community Health Workers, lay health workers, and traditional healers responsible for diabetes education and referral pathways.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391381</data>
    </node>
    <node id="Patients">
      <data key="d0">Patients</data>
      <data key="d1">category</data>
      <data key="d2">Patients are individuals with diabetes or at high risk, who have obligations to maintain health through lifestyle modifications and adherence to management plans.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391381</data>
    </node>
    <node id="Health System">
      <data key="d0">Health System</data>
      <data key="d1">category</data>
      <data key="d2">The Health System encompasses all healthcare providers, facilities, and policies aimed at managing chronic illnesses like diabetes through coordinated care.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391382</data>
    </node>
    <node id="Oral Health Promotion">
      <data key="d0">Oral Health Promotion</data>
      <data key="d1">category</data>
      <data key="d2">Oral Health Promotion involves routine screening and preventive treatments to manage oral diseases among diabetic patients.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391382</data>
    </node>
    <node id="Health Facility">
      <data key="d0">Health Facility</data>
      <data key="d1">geo</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391382</data>
    </node>
    <node id="Oral Hygienists">
      <data key="d0">Oral Hygienists</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391382</data>
    </node>
    <node id="Dentists">
      <data key="d0">Dentists</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391383</data>
    </node>
    <node id="National Glycohemoglobin Standardization Program (NGSP)">
      <data key="d0">National Glycohemoglobin Standardization Program (NGSP)</data>
      <data key="d1">organization</data>
      <data key="d2">NGSP is a program that provides standardized testing criteria for HbA1c measurements, ensuring alignment with international reference values.</data>
      <data key="d3">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391383</data>
    </node>
    <node id="Diabetes Control and Complications Trial (DCCT)">
      <data key="d0">Diabetes Control and Complications Trial (DCCT)</data>
      <data key="d1">organization</data>
      <data key="d2">DCCT is a trial that established criteria for standardizing HbA1c assays, which are used in diabetes diagnosis.</data>
      <data key="d3">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391383</data>
    </node>
    <node id="Diabetes">
      <data key="d0">Diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Diabetes is a chronic metabolic disorder characterized by persistent hyperglycaemia, diagnosed through various blood glucose tests. It encompasses multiple forms, including gestational diabetes, and necessitates screening for high-risk patients. The condition is associated with an increased risk of complications such as tuberculosis, hypoglycaemia, periodontal disease, retinopathy, and cataracts, which may impair driving performance due to visual and neurological effects. Clinical management and monitoring are essential to address these complications and maintain quality of life. Diabetes requires ongoing medical care to manage its diverse impacts on health and daily functioning.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78&lt;SEP&gt;chunk-b752ce36b859046d9641b5096d445e7c&lt;SEP&gt;chunk-1ad658d71c2cfb7b36bed8ed79dcb30e&lt;SEP&gt;chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391383</data>
    </node>
    <node id="Hyperglycaemic crisis">
      <data key="d0">Hyperglycaemic crisis</data>
      <data key="d1">category</data>
      <data key="d2">Hyperglycaemic crisis refers to severe hyperglycaemia, including diabetic ketoacidosis and hyperosmolar non-ketotic hyperglycaemia, requiring immediate medical attention.</data>
      <data key="d3">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391383</data>
    </node>
    <node id="Fasting Plasma Glucose (FPG)">
      <data key="d0">Fasting Plasma Glucose (FPG)</data>
      <data key="d1">category</data>
      <data key="d2">FPG is a diagnostic test measuring blood glucose levels after an 8-hour fast, used to identify diabetes and impaired glucose tolerance.&lt;SEP&gt;FPG is a test measuring blood glucose levels after an overnight fast, used to assess diabetes management.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391384</data>
    </node>
    <node id="Two-hour Plasma Glucose (2-h PG) during Oral Glucose Tolerance Test (OGTT)">
      <data key="d0">Two-hour Plasma Glucose (2-h PG) during Oral Glucose Tolerance Test (OGTT)</data>
      <data key="d1">category</data>
      <data key="d2">2-h PG is a test measuring blood glucose levels 2 hours after a 75g glucose load, used in diagnosing diabetes and IGT.</data>
      <data key="d3">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391384</data>
    </node>
    <node id="Glycated Haemoglobin A1c (HbA1c)">
      <data key="d0">Glycated Haemoglobin A1c (HbA1c)</data>
      <data key="d1">category</data>
      <data key="d2">HbA1c is a blood test reflecting average blood glucose levels over 2-3 months, used in diabetes diagnosis when standardized criteria are met.</data>
      <data key="d3">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391384</data>
    </node>
    <node id="World Health Organization (WHO)">
      <data key="d0">World Health Organization (WHO)</data>
      <data key="d1">organization</data>
      <data key="d2">The World Health Organization (WHO) is an international organization deeply involved in health-related consultations and the development of global health frameworks. It collaborates with the International Union Against Tuberculosis and Lung Disease to create guidelines for the care and control of tuberculosis and diabetes. Additionally, the WHO serves as the authoritative source for current diagnostic criteria for Gestational Diabetes Mellitus (GDM) and is recognized as the authority recommending the use of a 75g glucose load for the Oral Glucose Tolerance Test (OGTT). These contributions highlight the WHO's pivotal role in shaping both general health policies and specific medical standards, ensuring alignment with global health needs and scientific advancements.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e&lt;SEP&gt;chunk-b752ce36b859046d9641b5096d445e7c&lt;SEP&gt;chunk-22ea9604ec397a3a7efc9e587557e950&lt;SEP&gt;chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391384</data>
    </node>
    <node id="High-risk individuals">
      <data key="d0">High-risk individuals</data>
      <data key="d1">category</data>
      <data key="d2">High-risk individuals are a group for whom a 75g OGTT is indicated, based on specific criteria outlined in the text.&lt;SEP&gt;High-risk individuals include those with a family history of type 2 diabetes, high-risk ethnic groups, obesity (BMI &gt;35 kg/m2), increased waist circumference, history of gestational diabetes, metabolic syndrome, cardiovascular disease, polycystic ovarian syndrome, and impaired glucose tolerance (IGT) or impaired fasting glucose (IFG).</data>
      <data key="d3">chunk-13c6d53292dee777497019b48adc774c&lt;SEP&gt;chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391384</data>
    </node>
    <node id="Malaria">
      <data key="d0">Malaria</data>
      <data key="d1">category</data>
      <data key="d2">Malaria is mentioned as a population characteristic that may influence the choice between HbA1c and plasma glucose testing for diabetes diagnosis.</data>
      <data key="d3">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391385</data>
    </node>
    <node id="Haemoglobinopathies">
      <data key="d0">Haemoglobinopathies</data>
      <data key="d1">category</data>
      <data key="d2">Haemoglobinopathies are listed as population characteristics that may affect the use of HbA1c in diabetes diagnosis.</data>
      <data key="d3">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391385</data>
    </node>
    <node id="Symptomatic individuals">
      <data key="d0">Symptomatic individuals</data>
      <data key="d1">category</data>
      <data key="d2">Symptomatic individuals are those exhibiting symptoms of diabetes, such as polyuria, polydipsia, and weight loss, and are discussed in the context of diabetes diagnosis.</data>
      <data key="d3">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391385</data>
    </node>
    <node id="Asymptomatic individuals">
      <data key="d0">Asymptomatic individuals</data>
      <data key="d1">category</data>
      <data key="d2">Asymptomatic individuals are those without clear symptoms of diabetes, requiring repeated testing for diagnosis.</data>
      <data key="d3">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391385</data>
    </node>
    <node id="High-Risk Individuals">
      <data key="d0">High-Risk Individuals</data>
      <data key="d1">category</data>
      <data key="d2">High-Risk Individuals are defined as adults with a BMI &gt;25 kg/m2, additional risk factors like hypertension, family history of diabetes, or high-risk ethnic groups (e.g., South Asian descent), who require targeted screening.</data>
      <data key="d3">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391385</data>
    </node>
    <node id="Low-Risk Individuals">
      <data key="d0">Low-Risk Individuals</data>
      <data key="d1">category</data>
      <data key="d2">Low-Risk Individuals are those without significant risk factors for diabetes, with screening recommended only after the age of 45 years.</data>
      <data key="d3">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391385</data>
    </node>
    <node id="Screening for Early Detection of Type 2 Diabetes in Adults">
      <data key="d0">Screening for Early Detection of Type 2 Diabetes in Adults</data>
      <data key="d1">category</data>
      <data key="d2">Screening for Early Detection of Type 2 Diabetes in Adults is a process conducted within healthcare settings to identify individuals at risk of developing diabetes, emphasizing follow-up and targeted approaches.</data>
      <data key="d3">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391385</data>
    </node>
    <node id="Health Care Setting">
      <data key="d0">Health Care Setting</data>
      <data key="d1">category</data>
      <data key="d2">Health Care Setting refers to the environment where diabetes screening is conducted, ensuring access to follow-up testing and care, as opposed to community-based screening.</data>
      <data key="d3">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391385</data>
    </node>
    <node id="Organization of Diabetes Care">
      <data key="d0">Organization of Diabetes Care</data>
      <data key="d1">organization</data>
      <data key="d2">Organization of Diabetes Care refers to the systematic approach required for managing diabetes, including well-trained personnel, calibrated equipment, management protocols, and regular audit processes to ensure quality care.</data>
      <data key="d3">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391386</data>
    </node>
    <node id="Community Screening">
      <data key="d0">Community Screening</data>
      <data key="d1">category</data>
      <data key="d2">Community Screening refers to diabetes screening conducted outside a healthcare setting (e.g., at fun days or shopping centres), which is not recommended due to inadequate follow-up and care access.</data>
      <data key="d3">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391386</data>
    </node>
    <node id="Regular Audit">
      <data key="d0">Regular Audit</data>
      <data key="d1">category</data>
      <data key="d2">Regular Audit is a process instituted within diabetes care to review intervention implementation, improve service delivery standards, and ensure adherence to care protocols.</data>
      <data key="d3">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391386</data>
    </node>
    <node id="Requirements at Clinic Level for a Diabetes Service">
      <data key="d0">Requirements at Clinic Level for a Diabetes Service</data>
      <data key="d1">category</data>
      <data key="d2">Requirements at Clinic Level for a Diabetes Service include calibrated equipment, dedicated staff, patient registers, legible records, and management protocols to support effective diabetes care delivery.</data>
      <data key="d3">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391386</data>
    </node>
    <node id="Diabetes Service">
      <data key="d0">Diabetes Service</data>
      <data key="d1">category</data>
      <data key="d2">A structured healthcare service focused on managing chronic diabetes, including requirements for personnel, equipment, protocols, and patient care processes.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391386</data>
    </node>
    <node id="Clinic Level Requirements">
      <data key="d0">Clinic Level Requirements</data>
      <data key="d1">category</data>
      <data key="d2">A set of standards and protocols for diabetes clinics, including trained personnel, adequate space, protocols, equipment, and audit processes.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391387</data>
    </node>
    <node id="Protocols and Guidelines">
      <data key="d0">Protocols and Guidelines</data>
      <data key="d1">category</data>
      <data key="d2">Comprehensive procedures covering screening, regular care, referrals, and other diabetes management processes.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391387</data>
    </node>
    <node id="Basic PHC Equipment">
      <data key="d0">Basic PHC Equipment</data>
      <data key="d1">category</data>
      <data key="d2">Essential medical equipment for primary healthcare, including BP machines, blood glucose meters, HbA1c testing devices, and other diagnostic tools.&lt;SEP&gt;Medical equipment essential for primary healthcare, including tools for neuropathy screening.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743&lt;SEP&gt;chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391387</data>
    </node>
    <node id="Annual Audit">
      <data key="d0">Annual Audit</data>
      <data key="d1">event</data>
      <data key="d2">A scheduled process to evaluate the implementation of diabetes care interventions and assess the quality of service delivery.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391387</data>
    </node>
    <node id="Patient Recall System">
      <data key="d0">Patient Recall System</data>
      <data key="d1">category</data>
      <data key="d2">A patient recall system is a structured approach to ensure regular follow-up and adherence to diabetes management protocols.&lt;SEP&gt;A system for tracking and contacting patients who miss appointments or require follow-up for specific care aspects.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b&lt;SEP&gt;chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391388</data>
    </node>
    <node id="Education Material">
      <data key="d0">Education Material</data>
      <data key="d1">category</data>
      <data key="d2">Resources provided to patients for diabetes management, including information on lifestyle, medication, and monitoring.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391388</data>
    </node>
    <node id="Support Groups">
      <data key="d0">Support Groups</data>
      <data key="d1">category</data>
      <data key="d2">Community-based initiatives to assist patients with diabetes through peer support and education.&lt;SEP&gt;Support Groups are mentioned as existing structures to be utilized for facilitating health education and peer support.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e&lt;SEP&gt;chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391388</data>
    </node>
    <node id="Register of All Patients">
      <data key="d0">Register of All Patients</data>
      <data key="d1">category</data>
      <data key="d2">A system for maintaining a comprehensive list of patients to facilitate recall for nonattendance and specific care aspects.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391388</data>
    </node>
    <node id="Legible Patient Records">
      <data key="d0">Legible Patient Records</data>
      <data key="d1">category</data>
      <data key="d2">Documentation standards requiring clear and readable patient records for effective care management.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391388</data>
    </node>
    <node id="Flow Charts and Annual Review Charts">
      <data key="d0">Flow Charts and Annual Review Charts</data>
      <data key="d1">category</data>
      <data key="d2">Visual tools used for tracking patient progress and annual assessments within the diabetes service.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391388</data>
    </node>
    <node id="Adequate Space">
      <data key="d0">Adequate Space</data>
      <data key="d1">category</data>
      <data key="d2">Requirement for sufficient physical space in clinics for individual consultations, patient privacy, and group education.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391389</data>
    </node>
    <node id="Trained Personnel for Chronic Disease Management">
      <data key="d0">Trained Personnel for Chronic Disease Management</data>
      <data key="d1">category</data>
      <data key="d2">Requirement for healthcare staff appropriately trained in managing chronic diseases like diabetes.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391389</data>
    </node>
    <node id="Controlled Glycaemia, Blood Pressure and Lipids">
      <data key="d0">Controlled Glycaemia, Blood Pressure and Lipids</data>
      <data key="d1">category</data>
      <data key="d2">Health indicators monitored during the annual audit to assess patient outcomes and care quality.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391389</data>
    </node>
    <node id="Annexure D - Clinic Structure">
      <data key="d0">Annexure D - Clinic Structure</data>
      <data key="d1">document</data>
      <data key="d2">A document outlining the structural requirements and layout of a diabetes clinic.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391389</data>
    </node>
    <node id="Schedule of Visits to a Diabetes Clinic">
      <data key="d0">Schedule of Visits to a Diabetes Clinic</data>
      <data key="d1">event</data>
      <data key="d2">A structured plan detailing the frequency and components of patient examinations and tests in a diabetes clinic.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391389</data>
    </node>
    <node id="Initial Visit">
      <data key="d0">Initial Visit</data>
      <data key="d1">event</data>
      <data key="d2">The first appointment for a patient in a diabetes clinic, involving comprehensive history, physical examination, and biochemistry assessments.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391389</data>
    </node>
    <node id="History, Physical Examination, Biochemistry">
      <data key="d0">History, Physical Examination, Biochemistry</data>
      <data key="d1">category</data>
      <data key="d2">Key components of the initial visit, including patient history, physical checks, and laboratory tests.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391389</data>
    </node>
    <node id="Specific Procedures: BP Checked, HbA1c Done, Foot Exam, Retinopathy Assessed">
      <data key="d0">Specific Procedures: BP Checked, HbA1c Done, Foot Exam, Retinopathy Assessed</data>
      <data key="d1">category</data>
      <data key="d2">Designated care processes to be tracked during audits, including blood pressure checks, HbA1c testing, foot examinations, and retinopathy assessments.</data>
      <data key="d3">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391389</data>
    </node>
    <node id="HISTORY">
      <data key="d0">HISTORY</data>
      <data key="d1">category</data>
      <data key="d2">A category in the monitoring framework that includes patient symptoms, medication, and lifestyle information.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391390</data>
    </node>
    <node id="PHYSICAL EXAMINATION">
      <data key="d0">PHYSICAL EXAMINATION</data>
      <data key="d1">category</data>
      <data key="d2">A category in the monitoring framework that includes physical assessments such as weight, blood pressure, and foot inspection.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391390</data>
    </node>
    <node id="BIOCHEMISTRY">
      <data key="d0">BIOCHEMISTRY</data>
      <data key="d1">category</data>
      <data key="d2">A category in the monitoring framework that includes biochemical tests like blood glucose, HbA1c, and lipid profile.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391390</data>
    </node>
    <node id="OTHER ACTIVITIES">
      <data key="d0">OTHER ACTIVITIES</data>
      <data key="d1">category</data>
      <data key="d2">A category in the monitoring framework that includes educational activities, goal setting, and medication reviews.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391390</data>
    </node>
    <node id="ANNUAL VISIT">
      <data key="d0">ANNUAL VISIT</data>
      <data key="d1">category</data>
      <data key="d2">A category representing the annual medical check-up for diabetes patients, including screening for retinopathy.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391391</data>
    </node>
    <node id="Symptoms of hyperglycaemia">
      <data key="d0">Symptoms of hyperglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under HISTORY that includes patient symptoms related to high blood sugar levels.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391391</data>
    </node>
    <node id="Medication">
      <data key="d0">Medication</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under HISTORY that includes assessment of medication adherence and side effects.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391391</data>
    </node>
    <node id="Symptoms of hypoglycaemia">
      <data key="d0">Symptoms of hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under HISTORY that includes patient symptoms related to low blood sugar levels.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391391</data>
    </node>
    <node id="Depression">
      <data key="d0">Depression</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under HISTORY that includes assessment of depression in diabetes patients.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391391</data>
    </node>
    <node id="Review home monitoring chart">
      <data key="d0">Review home monitoring chart</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under HISTORY that includes review of patient home glucose monitoring data.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391392</data>
    </node>
    <node id="Weight &amp; BMI">
      <data key="d0">Weight &amp; BMI</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under PHYSICAL EXAMINATION that includes measurement of weight and body mass index.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391392</data>
    </node>
    <node id="Waist circumference">
      <data key="d0">Waist circumference</data>
      <data key="d1">category</data>
      <data key="d2">A measurement used in diabetes risk assessment, with specific thresholds (women ≥ 80 cm, men ≥ 90 cm) for Asian/Indian descent individuals.&lt;SEP&gt;A sub-category under PHYSICAL EXAMINATION that includes measurement of waist circumference.&lt;SEP&gt;Waist circumference is a critical measure for metabolic syndrome and diabetes, with targets varying by gender and ethnicity (e.g., &lt;94 cm for men, &lt;80 cm for women).</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d&lt;SEP&gt;chunk-98786d9fc0c669ea92f47d22f68e9730&lt;SEP&gt;chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391392</data>
    </node>
    <node id="Blood pressure">
      <data key="d0">Blood pressure</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under PHYSICAL EXAMINATION that includes measurement of blood pressure.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391392</data>
    </node>
    <node id="Feet inspection">
      <data key="d0">Feet inspection</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under PHYSICAL EXAMINATION that includes assessment of foot injuries, ulcers, and deformities.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391392</data>
    </node>
    <node id="Injection sites">
      <data key="d0">Injection sites</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under PHYSICAL EXAMINATION that includes inspection of injection sites for complications.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391393</data>
    </node>
    <node id="Blood glucose">
      <data key="d0">Blood glucose</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under BIOCHEMISTRY that includes measurement of blood glucose levels.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391393</data>
    </node>
    <node id="HbA1c">
      <data key="d0">HbA1c</data>
      <data key="d1">category</data>
      <data key="d2">HbA1c is a sub-category under BIOCHEMISTRY and a medical test that measures glycated hemoglobin, reflecting average blood glucose levels over the past 2–3 months. It is primarily used to monitor long-term blood glucose control in individuals with diabetes, with general target ranges of &lt;7% in step 1 and &lt;8.5% in step 2, though these targets may be individualized based on patient-specific factors. The test is also relevant for assessing diabetes management in drivers and those at risk of hypoglycaemia. However, HbA1c is not recommended for HIV-positive patients due to potential inaccuracies caused by viral effects on haemoglobin, comorbid conditions, and drug interactions with antiretroviral medications. It serves as a diagnostic and monitoring tool, providing critical insights into glucose regulation over time.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e&lt;SEP&gt;chunk-b752ce36b859046d9641b5096d445e7c&lt;SEP&gt;chunk-2d53ce416d979deb26807ffd3d639467&lt;SEP&gt;chunk-ede226b3a0ceacb1cf58a1a70ebfe39d&lt;SEP&gt;chunk-98786d9fc0c669ea92f47d22f68e9730&lt;SEP&gt;chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391393</data>
    </node>
    <node id="Lipids (TC, HDLC, LDLC, TG)">
      <data key="d0">Lipids (TC, HDLC, LDLC, TG)</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under BIOCHEMISTRY that includes measurement of lipid profile parameters.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391393</data>
    </node>
    <node id="Creatinine; calculate eGFR">
      <data key="d0">Creatinine; calculate eGFR</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under BIOCHEMISTRY that includes measurement of kidney function via creatinine and eGFR.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391393</data>
    </node>
    <node id="Potassium">
      <data key="d0">Potassium</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under BIOCHEMISTRY that includes measurement of potassium levels.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391393</data>
    </node>
    <node id="Urine protein: (albumin/creatinine ratio)">
      <data key="d0">Urine protein: (albumin/creatinine ratio)</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under BIOCHEMISTRY that includes measurement of urine protein and albumin/creatinine ratio.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391393</data>
    </node>
    <node id="Education">
      <data key="d0">Education</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under OTHER ACTIVITIES that includes patient education on lifestyle and disease management.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391393</data>
    </node>
    <node id="Goal setting">
      <data key="d0">Goal setting</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under OTHER ACTIVITIES that includes setting medical and lifestyle goals for patients.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391394</data>
    </node>
    <node id="Pre-conception counselling/family planning">
      <data key="d0">Pre-conception counselling/family planning</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under OTHER ACTIVITIES that includes guidance for patients planning pregnancy.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391394</data>
    </node>
    <node id="Medication revision/adjustment">
      <data key="d0">Medication revision/adjustment</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under OTHER ACTIVITIES that includes adjustment of medication regimens.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391394</data>
    </node>
    <node id="Immunisations">
      <data key="d0">Immunisations</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under OTHER ACTIVITIES that includes administration of vaccines.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391394</data>
    </node>
    <node id="Screening for retinopathy">
      <data key="d0">Screening for retinopathy</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under ANNUAL VISIT that includes assessment of eye health for diabetic retinopathy.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391394</data>
    </node>
    <node id="Lifestyle and behavioural changes including smoking cessation">
      <data key="d0">Lifestyle and behavioural changes including smoking cessation</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under Education that includes lifestyle modifications for diabetes management.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391395</data>
    </node>
    <node id="Self-management">
      <data key="d0">Self-management</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under Education that includes patient strategies for self-care.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391395</data>
    </node>
    <node id="Nutrition advice, eating habits and meal planning">
      <data key="d0">Nutrition advice, eating habits and meal planning</data>
      <data key="d1">category</data>
      <data key="d2">A sub-category under Education that includes dietary recommendations for diabetes patients.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391395</data>
    </node>
    <node id="monofilament assessment">
      <data key="d0">monofilament assessment</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391395</data>
    </node>
    <node id="vibration sense using tuning fork">
      <data key="d0">vibration sense using tuning fork</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391396</data>
    </node>
    <node id="Ankle jerk">
      <data key="d0">Ankle jerk</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391396</data>
    </node>
    <node id="peripheral neuropathy">
      <data key="d0">peripheral neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391396</data>
    </node>
    <node id="foot pulses">
      <data key="d0">foot pulses</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391396</data>
    </node>
    <node id="Blood Pressure">
      <data key="d0">Blood Pressure</data>
      <data key="d1">category</data>
      <data key="d2">Blood Pressure is a medical parameter monitored in diabetic patients for assessment and management.&lt;SEP&gt;Blood pressure monitoring is a key component of diabetes follow-up to manage cardiovascular risks.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305&lt;SEP&gt;chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391396</data>
    </node>
    <node id="Lipid profile">
      <data key="d0">Lipid profile</data>
      <data key="d1">category</data>
      <data key="d2">Lipid profile is a set of tests assessing cholesterol and other lipids in the blood, relevant for diabetic patients.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391396</data>
    </node>
    <node id="Foot examination">
      <data key="d0">Foot examination</data>
      <data key="d1">category</data>
      <data key="d2">Foot examination is a procedure conducted to assess foot health in diabetic patients, including inspection of feet and shoes.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391397</data>
    </node>
    <node id="Albumin/creatinine ratio">
      <data key="d0">Albumin/creatinine ratio</data>
      <data key="d1">category</data>
      <data key="d2">Albumin/creatinine ratio is a test used to screen for chronic kidney disease (CKD) in diabetic patients, with specific normal ranges for men and women.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391397</data>
    </node>
    <node id="eGFR">
      <data key="d0">eGFR</data>
      <data key="d1">category</data>
      <data key="d2">eGFR is a measure derived from serum creatinine to assess kidney function, with a normal value above 60 ml/minute.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391397</data>
    </node>
    <node id="Glycosuria">
      <data key="d0">Glycosuria</data>
      <data key="d1">category</data>
      <data key="d2">Glycosuria is the presence of glucose in urine, which is a poor measure of glycaemic control but may be used if other tools are unavailable.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391397</data>
    </node>
    <node id="ECG">
      <data key="d0">ECG</data>
      <data key="d1">category</data>
      <data key="d2">ECG is a diagnostic test used to assess heart function, particularly in patients with ischaemic heart disease or other cardiovascular disease risk factors.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391397</data>
    </node>
    <node id="Fasting Plasma Glucose">
      <data key="d0">Fasting Plasma Glucose</data>
      <data key="d1">category</data>
      <data key="d2">Fasting Plasma Glucose is a blood test measuring glucose levels after an overnight fast, with target ranges specified for diabetic patients.&lt;SEP&gt;Fasting plasma glucose is the preferred screening test for diabetes in HIV-positive patients, to be conducted every 6 months.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d&lt;SEP&gt;chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391397</data>
    </node>
    <node id="Post-prandial Glucose">
      <data key="d0">Post-prandial Glucose</data>
      <data key="d1">category</data>
      <data key="d2">Post-prandial Glucose is a blood test measuring glucose levels after a meal, with target ranges dependent on HbA1c targets.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391397</data>
    </node>
    <node id="Glycaemic Control Targets">
      <data key="d0">Glycaemic Control Targets</data>
      <data key="d1">category</data>
      <data key="d2">Glycaemic Control Targets include specific ranges for fasting plasma glucose, post-prandial glucose, and HbA1c levels, tailored to different patient types.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391397</data>
    </node>
    <node id="Self-monitoring technique">
      <data key="d0">Self-monitoring technique</data>
      <data key="d1">category</data>
      <data key="d2">Self-monitoring technique refers to methods used by patients to monitor their own health parameters, such as blood glucose levels, as indicated in the text.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391398</data>
    </node>
    <node id="Weight and waist">
      <data key="d0">Weight and waist</data>
      <data key="d1">category</data>
      <data key="d2">Weight and waist measurements are part of the assessment for diabetic patients, likely related to obesity and metabolic health monitoring.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391398</data>
    </node>
    <node id="BMI">
      <data key="d0">BMI</data>
      <data key="d1">category</data>
      <data key="d2">A metric used in diabetes screening, with lower thresholds recommended for Asian/Indian descent individuals due to their increased diabetes risk at lower BMI levels.&lt;SEP&gt;BMI (Body Mass Index) is a metric used to assess body fat based on weight and height, mentioned in the context of diabetic patient monitoring.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391398</data>
    </node>
    <node id="Foot and shoe inspection">
      <data key="d0">Foot and shoe inspection</data>
      <data key="d1">category</data>
      <data key="d2">Foot and shoe inspection is a procedure for diabetic patients to check for foot-related complications, ensuring proper footwear and early detection of issues.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391398</data>
    </node>
    <node id="Eye examination for retinopathy">
      <data key="d0">Eye examination for retinopathy</data>
      <data key="d1">category</data>
      <data key="d2">Eye examination for retinopathy is a diagnostic procedure to detect diabetic retinopathy, a complication of diabetes affecting the eyes.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391399</data>
    </node>
    <node id="Protein">
      <data key="d0">Protein</data>
      <data key="d1">category</data>
      <data key="d2">Protein is a component of urine tests (e.g., proteinuria) used in screening for kidney disease in diabetic patients.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391399</data>
    </node>
    <node id="Serum creatinine concentration">
      <data key="d0">Serum creatinine concentration</data>
      <data key="d1">category</data>
      <data key="d2">Serum creatinine concentration is a blood test used to assess kidney function, as part of chronic kidney disease (CKD) screening in diabetic patients.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391399</data>
    </node>
    <node id="Referral to health educator and/or dietician">
      <data key="d0">Referral to health educator and/or dietician</data>
      <data key="d1">category</data>
      <data key="d2">Referral to health educator and/or dietician is a recommended action for diabetic patients, particularly those who are overweight or out-of-control, to manage their condition.</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391399</data>
    </node>
    <node id="Majority of patients">
      <data key="d0">Majority of patients</data>
      <data key="d1">category</data>
      <data key="d2">A category of patients for whom the target fasting plasma glucose (FPG) is 4.0 – 7.0 mmol/L, post-prandial glucose (PPG) is 5.0 – 10.0 mmol/L, and HbA1c is &lt;7%."</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391399</data>
    </node>
    <node id="Young, Low risk, Newly diagnosed, No cardiovascular disease">
      <data key="d0">Young, Low risk, Newly diagnosed, No cardiovascular disease</data>
      <data key="d1">category</data>
      <data key="d2">A category of patients (young individuals with low risk, newly diagnosed, and no cardiovascular disease) with target FPG 4.0 – 7.0 mmol/L, PPG 4.4 -7.8 mmol/L, and HbA1c &lt;6.5%."</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391400</data>
    </node>
    <node id="Older persons, High risk, Hypoglycaemic unaware, Poor short-term prognosis">
      <data key="d0">Older persons, High risk, Hypoglycaemic unaware, Poor short-term prognosis</data>
      <data key="d1">category</data>
      <data key="d2">A category of patients (older individuals with high risk, hypoglycaemic unawareness, and poor short-term prognosis) with target FPG 4.0 – 7.0 mmol/L, PPG &lt;12 mmol/L, and HbA1c &lt;7.5%."</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391400</data>
    </node>
    <node id="Biguanides">
      <data key="d0">Biguanides</data>
      <data key="d1">category</data>
      <data key="d2">A category of hypoglycaemic agents, with metformin as the only available product, used as the 'anchor' oral anti-diabetic agent in type 2 diabetes management."&lt;SEP&gt;Biguanides is a class of oral antidiabetic drugs that includes metformin, used to lower blood glucose levels by reducing hepatic glucose production and improving insulin sensitivity.</data>
      <data key="d3">chunk-2d53ce416d979deb26807ffd3d639467&lt;SEP&gt;chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391400</data>
    </node>
    <node id="Sulphonylureas">
      <data key="d0">Sulphonylureas</data>
      <data key="d1">category</data>
      <data key="d2">Sulphonylureas are a class of oral antidiabetic drugs primarily used to manage type 2 diabetes by reducing HbA1c levels by 1.5–2%, though they are associated with hypoglycaemia as a major adverse effect, particularly in older patients. These medications require careful dose timing adjustments during fasting to mitigate hypoglycaemic risks. Specific agents within this class, such as glibenclamide, are contraindicated in elderly patients due to heightened hypoglycaemia risks, whereas gliclazide and glimepiride are preferred alternatives. Additionally, sulphonylureas are linked to weight gain in type 2 diabetic patients, a consideration in long-term management. Their use necessitates individualized assessment, especially in vulnerable populations, to balance glycaemic control with potential side effects.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-ebdd9159e939274d247a78b6acac88a4&lt;SEP&gt;chunk-358680bfd64f7682f010caf1db56168e&lt;SEP&gt;chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391400</data>
    </node>
    <node id="Insulin">
      <data key="d0">Insulin</data>
      <data key="d1">category</data>
      <data key="d2">Insulin is a hormone produced in the body, primarily by the pancreas, and plays a critical role in managing blood glucose levels in diabetes. It is a class of medications used in the management of type 2 diabetes, typically serving as second- or third-line therapy when other treatments, such as oral hypoglycaemic agents or combination oral therapies, fail to achieve adequate glycaemic control. Insulin is administered subcutaneously and is particularly indicated in step 3 of diabetes management for patients who do not respond to combination oral therapy. Its use requires tailored adjustments during fasting and specific dosing recommendations for elderly patients, which range from 0.25–0.35 units/kg/day, depending on physical and cognitive assessments. However, its effectiveness can be compromised in poorly controlled diabetes due to inflammation caused by periodontal disease or periodontitis, as systemic inflammation from these conditions may reduce insulin's efficacy. Insulin is available in various types and regimens, offering flexibility in treatment approaches.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c&lt;SEP&gt;chunk-2d53ce416d979deb26807ffd3d639467&lt;SEP&gt;chunk-3b872e8f4507f0b517d813175b50e40d&lt;SEP&gt;chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-ebdd9159e939274d247a78b6acac88a4&lt;SEP&gt;chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391400</data>
    </node>
    <node id="Metformin">
      <data key="d0">Metformin</data>
      <data key="d1">category</data>
      <data key="d2">Metformin is a biguanide class medication and the only available product in its category, primarily used as a first-line treatment for type 2 diabetes. It is typically prescribed in oral doses of 500mg or 850mg, with a maximum daily dose of 2550mg. Metformin is effective in reducing HbA1c levels by 1–2% and is often used as monotherapy, though it may also be combined with other antidiabetic therapies depending on clinical needs. Dosage adjustments are required in patients with severe renal impairment, during fasting, and in individuals with age-related contraindications dependent on serum creatinine levels. It is recommended for patients with a BMI &gt;35 kg/m², those younger than 60 years, and individuals with a family history of diabetes, hypertension, poor lipid profiles, or HbA1c &gt;6%. However, the medication must be discontinued immediately if a patient is vomiting or dehydrated, requiring urgent medical attention. Its use is contraindicated in certain populations based on renal function and age, highlighting the importance of careful patient selection and monitoring.</data>
      <data key="d3">chunk-2d53ce416d979deb26807ffd3d639467&lt;SEP&gt;chunk-3b872e8f4507f0b517d813175b50e40d&lt;SEP&gt;chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b&lt;SEP&gt;chunk-13c6d53292dee777497019b48adc774c&lt;SEP&gt;chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391401</data>
    </node>
    <node id="Lifestyle modification">
      <data key="d0">Lifestyle modification</data>
      <data key="d1">category</data>
      <data key="d2">A non-pharmacological management category emphasizing long-term changes in diet, weight loss, and monthly assessments to achieve HbA1c &lt;7% and body weight reduction of 5–10%."&lt;SEP&gt;Lifestyle modification includes low-calorie diets, low-refined carbohydrates, low-saturated fat, low-salt intake, regular exercise (150 minutes/week of moderate-intensity activity), and 5–10% body weight reduction.&lt;SEP&gt;Lifestyle modification is a strategy emphasized in diabetes management to prevent weight gain and improve health outcomes.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e&lt;SEP&gt;chunk-13c6d53292dee777497019b48adc774c&lt;SEP&gt;chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391401</data>
    </node>
    <node id="Steps 1–3">
      <data key="d0">Steps 1–3</data>
      <data key="d1">category</data>
      <data key="d2">A structured glycaemic management framework involving lifestyle modification, metformin, and other therapies over time to achieve HbA1c targets."</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391401</data>
    </node>
    <node id="Young diabetics &lt;30 years">
      <data key="d0">Young diabetics &lt;30 years</data>
      <data key="d1">category</data>
      <data key="d2">A category of patients (young individuals with diabetes under 30 years of age) who require hospital-level assessment at least once per year due to specific clinical needs.</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391401</data>
    </node>
    <node id="Sulphonylurea">
      <data key="d0">Sulphonylurea</data>
      <data key="d1">category</data>
      <data key="d2">A class of antidiabetic drugs used in managing type 2 diabetes, requiring dose adjustments during fasting.&lt;SEP&gt;Sulphonylurea is a class of oral antidiabetic drugs used in the management of type 2 diabetes, often prescribed in combination with metformin.&lt;SEP&gt;Sulphonylurea is a class of oral antidiabetic drugs used to lower blood glucose levels.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4&lt;SEP&gt;chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391401</data>
    </node>
    <node id="Gliclazide">
      <data key="d0">Gliclazide</data>
      <data key="d1">category</data>
      <data key="d2">A sulphonylurea medication preferred for elderly patients due to lower hypoglycaemic and cardiovascular event risks compared to glibenclamide.&lt;SEP&gt;A sulphonylurea medication, potentially requiring dose timing changes during fasting.&lt;SEP&gt;Gliclazide is a sulphonylurea medication used to manage type 2 diabetes, typically starting at 40mg daily with breakfast and increasing in 40mg increments.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-ebdd9159e939274d247a78b6acac88a4&lt;SEP&gt;chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391401</data>
    </node>
    <node id="Glibenclamide">
      <data key="d0">Glibenclamide</data>
      <data key="d1">category</data>
      <data key="d2">A specific sulphonylurea medication, for which timing adjustments may be needed during fasting.&lt;SEP&gt;A sulphonylurea medication associated with increased hypoglycaemia risk in elderly patients, thus not recommended for use in this population.&lt;SEP&gt;Glibenclamide is a sulphonylurea medication used for type 2 diabetes, starting at 2.5mg daily with breakfast and increasing in 2.5mg increments.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-ebdd9159e939274d247a78b6acac88a4&lt;SEP&gt;chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391401</data>
    </node>
    <node id="FPG">
      <data key="d0">FPG</data>
      <data key="d1">category</data>
      <data key="d2">FPG (Fasting Plasma Glucose) is a blood test measuring glucose levels after an 8-hour fast, with thresholds of &gt;8 mmol/L indicating treatment failure.</data>
      <data key="d3">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391401</data>
    </node>
    <node id="Step 1">
      <data key="d0">Step 1</data>
      <data key="d1">event</data>
      <data key="d2">Step 1 refers to initial diabetes management involving lifestyle modification and metformin monotherapy, with failure defined as HbA1c &gt;7% and &lt;8.5% after 2-3 months.</data>
      <data key="d3">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391402</data>
    </node>
    <node id="Step 2">
      <data key="d0">Step 2</data>
      <data key="d1">event</data>
      <data key="d2">Step 2 involves adding sulphonylurea (gliclazide/glibenclamide) to metformin and lifestyle modification for patients who fail step 1.</data>
      <data key="d3">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391402</data>
    </node>
    <node id="Step 3">
      <data key="d0">Step 3</data>
      <data key="d1">event</data>
      <data key="d2">Step 3 entails initiating insulin therapy alongside metformin for patients who fail step 2, with discontinuation of sulphonylurea if biphasic insulin is used.</data>
      <data key="d3">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391402</data>
    </node>
    <node id="Severe Renal Impairment">
      <data key="d0">Severe Renal Impairment</data>
      <data key="d1">category</data>
      <data key="d2">Severe renal impairment (eGFR &lt;60 ml/minute) is a contraindication for sulphonylurea use and requires specialist management.</data>
      <data key="d3">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391402</data>
    </node>
    <node id="Congestive Heart Failure">
      <data key="d0">Congestive Heart Failure</data>
      <data key="d1">category</data>
      <data key="d2">Congestive heart failure is a contraindication for metformin use due to risks of lactic acidosis and reduced renal perfusion.</data>
      <data key="d3">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391402</data>
    </node>
    <node id="Intermediate-acting Insulin">
      <data key="d0">Intermediate-acting Insulin</data>
      <data key="d1">category</data>
      <data key="d2">Intermediate-acting insulin (e.g., NPH) is a type of insulin used in diabetes management, typically administered at bedtime.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391403</data>
    </node>
    <node id="Long-acting Insulin">
      <data key="d0">Long-acting Insulin</data>
      <data key="d1">category</data>
      <data key="d2">Long-acting insulin is a type of insulin used for sustained blood glucose control, often combined with oral medications.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391403</data>
    </node>
    <node id="Biphasic Insulin">
      <data key="d0">Biphasic Insulin</data>
      <data key="d1">category</data>
      <data key="d2">Biphasic insulin is a type of insulin regimen that combines rapid-acting and intermediate-acting insulin, used when oral medications are discontinued.&lt;SEP&gt;Biphasic insulin necessitates glucose monitoring before breakfast and supper, with a focus on maintaining stable glycaemic control.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391403</data>
    </node>
    <node id="Ketoacidosis">
      <data key="d0">Ketoacidosis</data>
      <data key="d1">category</data>
      <data key="d2">A serious metabolic complication of diabetes characterized by high blood ketone levels, contraindicating fasting if present within 3 months.&lt;SEP&gt;Ketoacidosis is a serious complication of diabetes characterized by high blood glucose and ketone levels, requiring immediate medical attention.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4&lt;SEP&gt;chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391403</data>
    </node>
    <node id="Self-Monitoring of Blood Glucose (SMBG)">
      <data key="d0">Self-Monitoring of Blood Glucose (SMBG)</data>
      <data key="d1">category</data>
      <data key="d2">SMBG involves regular blood glucose testing to monitor and manage diabetes, ensuring targets are met.&lt;SEP&gt;SMBG is a technique that encourages patients to take responsibility for glycaemic control, improving confidence and self-management, with testing frequency depending on insulin regimen.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391404</data>
    </node>
    <node id="Fasting Glucose">
      <data key="d0">Fasting Glucose</data>
      <data key="d1">category</data>
      <data key="d2">Fasting glucose refers to blood glucose levels measured after an overnight fast, used as a target for diabetes management.&lt;SEP&gt;Fasting glucose refers to blood glucose levels measured upon waking, which must be monitored daily for patients on intermediate- or long-acting insulin.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391404</data>
    </node>
    <node id="Polyuria">
      <data key="d0">Polyuria</data>
      <data key="d1">category</data>
      <data key="d2">Polyuria is a symptom of uncontrolled diabetes, characterized by excessive urine production, mentioned as part of severe decompensation criteria.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391404</data>
    </node>
    <node id="Polydipsia">
      <data key="d0">Polydipsia</data>
      <data key="d1">category</data>
      <data key="d2">Polydipsia is a symptom of uncontrolled diabetes, characterized by excessive thirst, mentioned as part of severe decompensation criteria.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391404</data>
    </node>
    <node id="Weight Loss">
      <data key="d0">Weight Loss</data>
      <data key="d1">category</data>
      <data key="d2">Weight loss is a sign of severe diabetes decompensation, noted as a criterion for hospital-level care in the text.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391404</data>
    </node>
    <node id="Severe Decompensation">
      <data key="d0">Severe Decompensation</data>
      <data key="d1">category</data>
      <data key="d2">Severe decompensation refers to a critical state in diabetes management, defined by criteria like FPG &gt;15mmol/L, HbA1c &gt;11%, or ketoacidosis.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391404</data>
    </node>
    <node id="Severe Hyperglycaemia">
      <data key="d0">Severe Hyperglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Severe hyperglycaemia is a condition marked by extremely high fasting plasma glucose levels (&gt;20mmol/L), requiring hospital-level intervention.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391405</data>
    </node>
    <node id="Diabetic Ketoacidosis (DKA)">
      <data key="d0">Diabetic Ketoacidosis (DKA)</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic Ketoacidosis (DKA) is a life-threatening metabolic complication of diabetes, most commonly associated with type 1 diabetes, and characterized by uncontrolled hyperglycaemia, metabolic acidosis, and elevated total body ketones. It is marked by the presence of strongly positive urine and serum ketones, decreased blood pH, and low serum bicarbonate levels. DKA is classified as a hyperglycaemic emergency requiring immediate treatment with intravenous fluids and insulin to address significant morbidity and mortality risks. While it can occur in patients of any age, it is more frequently observed in young individuals. Notably, DKA is mentioned as part of severe decompensation criteria in diabetes management and carries a higher mortality rate in South Africa compared to developed countries, underscoring regional disparities in outcomes. The condition arises from severe insulin deficiency, leading to excessive ketone production and systemic metabolic imbalance, emphasizing its role as a critical acute complication of diabetes.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e&lt;SEP&gt;chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-a7f14fa25c0f0f6b50f4346d68fa7305&lt;SEP&gt;chunk-8a3fa9809e33f235ebfe9c0204d7fbfb&lt;SEP&gt;chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391405</data>
    </node>
    <node id="Structured Education">
      <data key="d0">Structured Education</data>
      <data key="d1">category</data>
      <data key="d2">Structured education involves teaching patients about insulin types, injection techniques, and storage, emphasized in insulin therapy guidelines.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391405</data>
    </node>
    <node id="Injection Technique">
      <data key="d0">Injection Technique</data>
      <data key="d1">category</data>
      <data key="d2">Injection technique refers to proper methods for administering insulin, covered in patient education protocols.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391405</data>
    </node>
    <node id="Insulin Storage">
      <data key="d0">Insulin Storage</data>
      <data key="d1">category</data>
      <data key="d2">Insulin storage involves guidelines for keeping insulin at appropriate temperatures to maintain efficacy, part of patient education.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391405</data>
    </node>
    <node id="Risk of Weight Gain">
      <data key="d0">Risk of Weight Gain</data>
      <data key="d1">category</data>
      <data key="d2">Risk of weight gain is a potential side effect of insulin therapy, highlighted in patient counseling notes.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391405</data>
    </node>
    <node id="Insulin Regimen">
      <data key="d0">Insulin Regimen</data>
      <data key="d1">category</data>
      <data key="d2">Insulin regimen refers to the specific schedule and type of insulin injections (e.g., 2–4 times daily, once daily, or biphasic) that dictate the frequency of SMBG.&lt;SEP&gt;Insulin regimen refers to the specific schedule and types of insulin used, tailored to patient lifestyle and numeracy skills.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391405</data>
    </node>
    <node id="Numeracy Skills">
      <data key="d0">Numeracy Skills</data>
      <data key="d1">category</data>
      <data key="d2">Numeracy skills refer to a patient's ability to understand and manage numerical information, relevant to insulin dose titration.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391405</data>
    </node>
    <node id="Written Instructions">
      <data key="d0">Written Instructions</data>
      <data key="d1">category</data>
      <data key="d2">Written instructions are provided to patients for self-managing insulin dose adjustments, ensuring adherence to protocols.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391406</data>
    </node>
    <node id="Glucometer Strips">
      <data key="d0">Glucometer Strips</data>
      <data key="d1">category</data>
      <data key="d2">Glucometer strips are essential for self-monitoring of blood glucose (SMBG), ensuring patients can track their levels effectively.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391406</data>
    </node>
    <node id="Sharps Disposal">
      <data key="d0">Sharps Disposal</data>
      <data key="d1">category</data>
      <data key="d2">Sharps disposal involves safe handling and disposal of used needles, emphasized as part of patient education and safety protocols.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391406</data>
    </node>
    <node id="Meals and Snacks">
      <data key="d0">Meals and Snacks</data>
      <data key="d1">category</data>
      <data key="d2">Meals and snacks are dietary considerations aligned with individual insulin regimens, ensuring proper glycemic control.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391406</data>
    </node>
    <node id="Acute Complications">
      <data key="d0">Acute Complications</data>
      <data key="d1">category</data>
      <data key="d2">Acute complications include hypoglycaemia and hyperglycaemia, which patients are educated to recognize and manage during insulin therapy.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391407</data>
    </node>
    <node id="Intensive Insulin Therapy">
      <data key="d0">Intensive Insulin Therapy</data>
      <data key="d1">category</data>
      <data key="d2">Intensive insulin therapy involves multiple daily injections and is considered when glycaemic targets remain unmet despite basal or biphasic insulin use.&lt;SEP&gt;Intensive insulin therapy involves multiple daily injections, considered when standard regimens fail to meet glycaemic targets.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391407</data>
    </node>
    <node id="Specialist Referral">
      <data key="d0">Specialist Referral</data>
      <data key="d1">category</data>
      <data key="d2">Specialist referral is a medical action taken at any stage if glycaemic targets remain unmet, indicating the need for expert intervention.&lt;SEP&gt;Specialist referral is a step in diabetes management when glycaemic targets remain unmet, requiring expert medical evaluation.</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391407</data>
    </node>
    <node id="Glycaemic Targets">
      <data key="d0">Glycaemic Targets</data>
      <data key="d1">category</data>
      <data key="d2">Glycaemic targets refer to the blood glucose levels that diabetic patients aim to achieve, which are not met in some cases, prompting the need for intensified insulin therapy.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391407</data>
    </node>
    <node id="Acute Illness">
      <data key="d0">Acute Illness</data>
      <data key="d1">category</data>
      <data key="d2">Acute illness is a condition that requires increased glucose testing in diabetic patients due to its impact on glycaemic control.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391407</data>
    </node>
    <node id="Poor Glycaemic Control">
      <data key="d0">Poor Glycaemic Control</data>
      <data key="d1">category</data>
      <data key="d2">Poor glycaemic control is a state where blood glucose levels are not adequately managed, necessitating more frequent self-monitoring and potential specialist intervention.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391408</data>
    </node>
    <node id="Hypoglycaemic Episodes">
      <data key="d0">Hypoglycaemic Episodes</data>
      <data key="d1">category</data>
      <data key="d2">Hypoglycaemic episodes are instances of abnormally low blood glucose levels that require increased monitoring and adjustments to therapy.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391408</data>
    </node>
    <node id="Adjustments to Therapy">
      <data key="d0">Adjustments to Therapy</data>
      <data key="d1">category</data>
      <data key="d2">Adjustments to therapy refer to modifications in treatment regimens, such as insulin doses, required during periods of poor glycaemic control or illness.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391408</data>
    </node>
    <node id="Oral Agents">
      <data key="d0">Oral Agents</data>
      <data key="d1">category</data>
      <data key="d2">Oral agents are medications used in diabetes management, but their use with self-monitoring via glucose test strips lacks evidence-based support.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391408</data>
    </node>
    <node id="Intermediate- or Long-Acting Insulin">
      <data key="d0">Intermediate- or Long-Acting Insulin</data>
      <data key="d1">category</data>
      <data key="d2">Intermediate- or long-acting insulin requires daily fasting glucose monitoring and periodic calculation of average fasting glucose levels.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391408</data>
    </node>
    <node id="Sick Days">
      <data key="d0">Sick Days</data>
      <data key="d1">category</data>
      <data key="d2">Sick days refer to periods of illness or stress that may require additional insulin, escalation of therapy, or urgent medical attention due to hyperglycaemia.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391409</data>
    </node>
    <node id="Short-Acting Insulin">
      <data key="d0">Short-Acting Insulin</data>
      <data key="d1">category</data>
      <data key="d2">Short-acting insulin is used during sick days to manage hyperglycaemia, administered before meals in increased doses as per specific guidelines.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391409</data>
    </node>
    <node id="Follow-Up Appointments">
      <data key="d0">Follow-Up Appointments</data>
      <data key="d1">category</data>
      <data key="d2">Follow-up appointments are essential for monitoring glycaemic control, blood pressure, blood lipids, and providing therapeutic education to achieve therapeutic objectives.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391409</data>
    </node>
    <node id="Therapeutic Education">
      <data key="d0">Therapeutic Education</data>
      <data key="d1">category</data>
      <data key="d2">Therapeutic education involves providing patients with knowledge and skills to manage their diabetes effectively.&lt;SEP&gt;Therapeutic education involves teaching patients about self-care, lifestyle modifications, and proper injection techniques for effective diabetes management.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391409</data>
    </node>
    <node id="Doctor">
      <data key="d0">Doctor</data>
      <data key="d1">person</data>
      <data key="d2">Doctor refers to the medical professional responsible for considering intensive insulin therapy and specialist referrals when glycaemic targets are unmet.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391409</data>
    </node>
    <node id="Clinic">
      <data key="d0">Clinic</data>
      <data key="d1">organization</data>
      <data key="d2">Clinic is a healthcare facility where protocols for patient screening, visits, and monitoring are established.&lt;SEP&gt;Clinic is a medical facility where patients can seek urgent assistance during periods of illness or hyperglycaemia.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391409</data>
    </node>
    <node id="Hospital">
      <data key="d0">Hospital</data>
      <data key="d1">organization</data>
      <data key="d2">Hospital is a medical facility where patients are admitted for treatment of severe hypoglycaemia and hyperglycaemic emergencies, as per the protocol.&lt;SEP&gt;Hospital is a medical institution where patients are advised to seek urgent medical care during hyperglycaemia or other critical conditions.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b&lt;SEP&gt;chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391409</data>
    </node>
    <node id="Hyperglycaemia">
      <data key="d0">Hyperglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">A condition of elevated blood glucose levels, potentially caused by TB treatment and requiring monitoring.&lt;SEP&gt;Hyperglycaemia refers to abnormally high blood glucose levels requiring urgent medical review or intervention, as outlined in the text.&lt;SEP&gt;Hyperglycaemia refers to elevated blood glucose levels (&gt;14 mmol/L), which is a contraindication for strenuous exercise in diabetes management.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c&lt;SEP&gt;chunk-cc794a96abc6fea4b99860aedd47da8b&lt;SEP&gt;chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391409</data>
    </node>
    <node id="Average Fasting Glucose">
      <data key="d0">Average Fasting Glucose</data>
      <data key="d1">category</data>
      <data key="d2">Average fasting glucose is calculated every 3–7 days for patients on intermediate- or long-acting insulin to assess glycaemic control.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391410</data>
    </node>
    <node id="Diet">
      <data key="d0">Diet</data>
      <data key="d1">category</data>
      <data key="d2">Diet refers to the nutritional guidelines provided to patients during illness or stress, emphasizing carbohydrate-containing foods and fluids for glycaemic stability.</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391410</data>
    </node>
    <node id="Urgent Referrals">
      <data key="d0">Urgent Referrals</data>
      <data key="d1">category</data>
      <data key="d2">Urgent Referrals refers to medical referrals that require immediate attention, including conditions like dehydration, hypoglycaemic coma, and severe complications.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391410</data>
    </node>
    <node id="Standard Referrals">
      <data key="d0">Standard Referrals</data>
      <data key="d1">category</data>
      <data key="d2">Standard Referrals are medical referrals made according to guidelines, covering patients with specific conditions such as thin patients, severe infections, and type 1 diabetics.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391410</data>
    </node>
    <node id="Back-referrals">
      <data key="d0">Back-referrals</data>
      <data key="d1">category</data>
      <data key="d2">Back-referrals denote the process of referring patients back to primary care for comprehensive follow-up after specialist intervention.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391410</data>
    </node>
    <node id="Glycaemic Control">
      <data key="d0">Glycaemic Control</data>
      <data key="d1">category</data>
      <data key="d2">Glycaemic control refers to the monitoring and optimization of blood glucose levels in diabetes management.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391411</data>
    </node>
    <node id="Blood Lipids">
      <data key="d0">Blood Lipids</data>
      <data key="d1">category</data>
      <data key="d2">Blood lipids refer to the management of cholesterol and triglyceride levels to prevent cardiovascular complications.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391411</data>
    </node>
    <node id="Weight Monitoring">
      <data key="d0">Weight Monitoring</data>
      <data key="d1">category</data>
      <data key="d2">Weight monitoring is part of diabetes care to address obesity-related complications and improve metabolic outcomes.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391411</data>
    </node>
    <node id="Self-Care">
      <data key="d0">Self-Care</data>
      <data key="d1">category</data>
      <data key="d2">Self-care involves patient education and support to manage diabetes independently through lifestyle modifications.&lt;SEP&gt;Self-care is a category encompassing practices like identification disc usage, family involvement, weight management, dietary interventions, and regular self-monitoring for diabetes management.&lt;SEP&gt;Self-care is a key component of foot care management, emphasizing patient education and proactive measures.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305&lt;SEP&gt;chunk-03650d0126e6b49e45077884bfc6007b&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391411</data>
    </node>
    <node id="Self-Monitoring Techniques">
      <data key="d0">Self-Monitoring Techniques</data>
      <data key="d1">category</data>
      <data key="d2">Self-monitoring techniques include methods for patients to track blood glucose levels and injection practices.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391412</data>
    </node>
    <node id="Injection Techniques">
      <data key="d0">Injection Techniques</data>
      <data key="d1">category</data>
      <data key="d2">Injection techniques refer to proper administration of insulin and other injectable diabetes medications.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391412</data>
    </node>
    <node id="Long-Term Complications">
      <data key="d0">Long-Term Complications</data>
      <data key="d1">category</data>
      <data key="d2">Long-term complications include monitoring and managing diabetes-related issues such as neuropathy, retinopathy, and kidney disease.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391412</data>
    </node>
    <node id="Compliance">
      <data key="d0">Compliance</data>
      <data key="d1">category</data>
      <data key="d2">Compliance refers to the patient's adherence to prescribed treatment regimens and lifestyle recommendations.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391412</data>
    </node>
    <node id="Drug Side Effects">
      <data key="d0">Drug Side Effects</data>
      <data key="d1">category</data>
      <data key="d2">Drug side effects involve monitoring adverse reactions to diabetes medications, such as insulin or sulphonylureas.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391412</data>
    </node>
    <node id="Social Factors">
      <data key="d0">Social Factors</data>
      <data key="d1">category</data>
      <data key="d2">Social factors include assessing how diabetes and its treatment interact with a patient's socioeconomic and environmental context.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391413</data>
    </node>
    <node id="Metabolic Conditions">
      <data key="d0">Metabolic Conditions</data>
      <data key="d1">category</data>
      <data key="d2">Metabolic conditions encompass disorders related to glucose metabolism, such as hyperglycaemia and hypoglycaemia.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391413</data>
    </node>
    <node id="Hyperglycaemia (&gt;25 mmol/L)">
      <data key="d0">Hyperglycaemia (&gt;25 mmol/L)</data>
      <data key="d1">category</data>
      <data key="d2">Hyperglycaemia exceeding 25 mmol/L is a critical condition requiring urgent medical intervention.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391413</data>
    </node>
    <node id="Hypoglycaemic Coma">
      <data key="d0">Hypoglycaemic Coma</data>
      <data key="d1">category</data>
      <data key="d2">Hypoglycaemic coma is a severe complication of diabetes treatment, requiring immediate management to prevent brain damage.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391413</data>
    </node>
    <node id="Severe Complications">
      <data key="d0">Severe Complications</data>
      <data key="d1">category</data>
      <data key="d2">Severe complications refer to critical medical issues that may arise in diabetes, such as sepsis, gangrene, or sudden vision loss.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391413</data>
    </node>
    <node id="Sepsis">
      <data key="d0">Sepsis</data>
      <data key="d1">category</data>
      <data key="d2">Sepsis is a severe infection that can lead to systemic inflammation and organ failure, requiring urgent referral.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391413</data>
    </node>
    <node id="Gangrene">
      <data key="d0">Gangrene</data>
      <data key="d1">category</data>
      <data key="d2">Gangrene is a severe complication of foot ulcers and peripheral arterial disease, often leading to amputation.&lt;SEP&gt;Gangrene is the death of body tissue due to lack of blood supply, often requiring urgent medical attention.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391413</data>
    </node>
    <node id="Vision Deterioration">
      <data key="d0">Vision Deterioration</data>
      <data key="d1">category</data>
      <data key="d2">Vision deterioration refers to sudden or progressive loss of visual acuity, potentially linked to diabetes complications.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391413</data>
    </node>
    <node id="Serious Infections">
      <data key="d0">Serious Infections</data>
      <data key="d1">category</data>
      <data key="d2">Serious infections include conditions like tuberculosis, urinary tract infections, and abscesses that require specialist intervention.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391413</data>
    </node>
    <node id="Oral Health Complications">
      <data key="d0">Oral Health Complications</data>
      <data key="d1">category</data>
      <data key="d2">Oral health complications involve dental and gum issues that may arise in patients with diabetes.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391414</data>
    </node>
    <node id="Thin Patients">
      <data key="d0">Thin Patients</data>
      <data key="d1">category</data>
      <data key="d2">Thin patients refer to individuals with low body mass index (BMI) who may require tailored diabetes management.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391414</data>
    </node>
    <node id="Major Surgery">
      <data key="d0">Major Surgery</data>
      <data key="d1">category</data>
      <data key="d2">Major surgery refers to complex procedures requiring preoperative and postoperative diabetes management.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391414</data>
    </node>
    <node id="Pregnant Women">
      <data key="d0">Pregnant Women</data>
      <data key="d1">category</data>
      <data key="d2">Pregnant women with diabetes require specialized care to manage risks to both mother and fetus.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391414</data>
    </node>
    <node id="HbA1c &gt;7.0%">
      <data key="d0">HbA1c &gt;7.0%</data>
      <data key="d1">category</data>
      <data key="d2">HbA1c &gt;7.0% indicates poor long-term glycemic control and may necessitate referral for optimized management.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391415</data>
    </node>
    <node id="Type 1 Diabetics">
      <data key="d0">Type 1 Diabetics</data>
      <data key="d1">category</data>
      <data key="d2">Type 1 diabetics require specific care due to the autoimmune nature of the disease and dependence on insulin therapy.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391415</data>
    </node>
    <node id="Pregnancy with Glycosuria">
      <data key="d0">Pregnancy with Glycosuria</data>
      <data key="d1">category</data>
      <data key="d2">Pregnancy with glycosuria involves monitoring for gestational diabetes and related complications.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391415</data>
    </node>
    <node id="High-Risk Feet">
      <data key="d0">High-Risk Feet</data>
      <data key="d1">category</data>
      <data key="d2">High-risk feet refer to diabetic foot ulcers or deformities that may lead to amputation if not managed properly.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391415</data>
    </node>
    <node id="Persistent Proteinuria">
      <data key="d0">Persistent Proteinuria</data>
      <data key="d1">category</data>
      <data key="d2">Persistent proteinuria indicates kidney damage, a common complication in diabetes that requires specialist care.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391415</data>
    </node>
    <node id="Undiagnosed Visual Difficulties">
      <data key="d0">Undiagnosed Visual Difficulties</data>
      <data key="d1">category</data>
      <data key="d2">Undiagnosed visual difficulties may signal diabetic retinopathy, a leading cause of blindness in diabetics.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391416</data>
    </node>
    <node id="Hepatic and Renal Dysfunction">
      <data key="d0">Hepatic and Renal Dysfunction</data>
      <data key="d1">category</data>
      <data key="d2">Hepatic and renal dysfunction refers to liver and kidney impairment in diabetes, requiring specialist management.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391416</data>
    </node>
    <node id="Increased Exercise">
      <data key="d0">Increased Exercise</data>
      <data key="d1">category</data>
      <data key="d2">Increased exercise is a potential cause of hypoglycaemia in diabetics, requiring careful monitoring.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391416</data>
    </node>
    <node id="Decreased Food Intake">
      <data key="d0">Decreased Food Intake</data>
      <data key="d1">category</data>
      <data key="d2">Decreased food intake can lead to hypoglycaemia, necessitating adjustments in diabetes management.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391416</data>
    </node>
    <node id="Inappropriate Insulin Dose">
      <data key="d0">Inappropriate Insulin Dose</data>
      <data key="d1">category</data>
      <data key="d2">Inappropriate insulin dose is a common cause of hypoglycaemia, requiring careful titration.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391417</data>
    </node>
    <node id="Inappropriate Sulphonylurea Dose">
      <data key="d0">Inappropriate Sulphonylurea Dose</data>
      <data key="d1">category</data>
      <data key="d2">Inappropriate sulphonylurea dose can cause hypoglycaemia, necessitating dose adjustments.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391417</data>
    </node>
    <node id="Progressive Renal Failure">
      <data key="d0">Progressive Renal Failure</data>
      <data key="d1">category</data>
      <data key="d2">Progressive renal failure is a complication of diabetes that may contribute to hypoglycaemia through altered drug metabolism.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391417</data>
    </node>
    <node id="Alcohol Intake">
      <data key="d0">Alcohol Intake</data>
      <data key="d1">category</data>
      <data key="d2">Alcohol intake can exacerbate hypoglycaemia in diabetics, requiring patient education and monitoring.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391417</data>
    </node>
    <node id="Symptoms of Hypoglycaemia">
      <data key="d0">Symptoms of Hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Symptoms of hypoglycaemia include hunger, sweating, confusion, and dizziness, requiring prompt treatment.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391417</data>
    </node>
    <node id="Treatment of Mild Hypoglycaemia">
      <data key="d0">Treatment of Mild Hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Treatment of mild hypoglycaemia involves rapid-acting carbohydrate intake to restore blood glucose levels.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391417</data>
    </node>
    <node id="Treatment of Severe Hypoglycaemia">
      <data key="d0">Treatment of Severe Hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Treatment of severe hypoglycaemia requires immediate administration of glucagon or intravenous glucose.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391418</data>
    </node>
    <node id="Sodium Chloride 0.9% Infusion">
      <data key="d0">Sodium Chloride 0.9% Infusion</data>
      <data key="d1">category</data>
      <data key="d2">Sodium chloride 0.9% infusion is a medical intervention administered before transferring ill patients to manage dehydration and prevent hypoglycaemia during transport.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391418</data>
    </node>
    <node id="Signs of Hypoglycaemia">
      <data key="d0">Signs of Hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Signs of hypoglycaemia include behavioural changes, confusion, seizures, and coma, which are critical indicators requiring immediate medical attention.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391418</data>
    </node>
    <node id="Primary Care">
      <data key="d0">Primary Care</data>
      <data key="d1">category</data>
      <data key="d2">Primary care refers to the initial level of healthcare provided by general practitioners or community health services, to which patients are referred back for ongoing management.</data>
      <data key="d3">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391418</data>
    </node>
    <node id="Severe Hypoglycaemia">
      <data key="d0">Severe Hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Severe Hypoglycaemia is a condition requiring immediate intervention by another person, involving intravenous dextrose administration and hospital referral.</data>
      <data key="d3">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391418</data>
    </node>
    <node id="Hyperglycaemic Hyperosmolar State (HHS)">
      <data key="d0">Hyperglycaemic Hyperosmolar State (HHS)</data>
      <data key="d1">category</data>
      <data key="d2">Hyperglycaemic Hyperosmolar State is a condition marked by marked hyperglycaemia (&gt;50 mmol/L), hyperosmolality, and severe dehydration. It typically affects middle-aged or older patients and has a high mortality rate.&lt;SEP&gt;Hyperglycaemic hyperosmolar state is a hyperglycaemic emergency associated with severe hyperglycaemia, requiring urgent intravenous treatment.</data>
      <data key="d3">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb&lt;SEP&gt;chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391418</data>
    </node>
    <node id="Recurrent Hypoglycaemia">
      <data key="d0">Recurrent Hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Recurrent Hypoglycaemia refers to repeated severe hypoglycaemic episodes, often requiring hospital assessment and intensive monitoring.</data>
      <data key="d3">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391418</data>
    </node>
    <node id="Hypoglycaemic Unawareness">
      <data key="d0">Hypoglycaemic Unawareness</data>
      <data key="d1">category</data>
      <data key="d2">Hypoglycaemic Unawareness is a complication of long-term diabetes where patients fail to recognize early hypoglycaemic symptoms, leading to neuroglycopenia.</data>
      <data key="d3">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391418</data>
    </node>
    <node id="Diabetic Patient Education">
      <data key="d0">Diabetic Patient Education</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic Patient Education involves teaching patients to recognize and manage hypoglycaemia, and to identify causes of hypoglycaemic episodes.</data>
      <data key="d3">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391419</data>
    </node>
    <node id="Hypoglycaemic Awareness">
      <data key="d0">Hypoglycaemic Awareness</data>
      <data key="d1">category</data>
      <data key="d2">Hypoglycaemic Awareness refers to the ability to detect early symptoms of hypoglycaemia, which may be impaired in some patients due to autonomic failure.</data>
      <data key="d3">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391419</data>
    </node>
    <node id="Dextrose Solution">
      <data key="d0">Dextrose Solution</data>
      <data key="d1">category</data>
      <data key="d2">Dextrose Solution refers to medical substances like 50% Dextrose solution and 5% Dextrose in Water, used in intravenous treatment for hypoglycaemia.</data>
      <data key="d3">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391419</data>
    </node>
    <node id="Thiamine 100mg IMI">
      <data key="d0">Thiamine 100mg IMI</data>
      <data key="d1">category</data>
      <data key="d2">Thiamine 100mg IMI is a medication administered to specific patients (e.g., alcoholic, malnourished) during IV infusion for hypoglycaemia management.</data>
      <data key="d3">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391419</data>
    </node>
    <node id="Alcohol Abuse">
      <data key="d0">Alcohol Abuse</data>
      <data key="d1">category</data>
      <data key="d2">Alcohol Abuse is a contributing factor to recurrent hypoglycaemia, as noted in the text.&lt;SEP&gt;Alcohol abuse is a secondary cause of hyperlipidaemia that must be excluded in diabetic patients, as mentioned in the text.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884&lt;SEP&gt;chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391420</data>
    </node>
    <node id="Self-induced Hypoglycaemia">
      <data key="d0">Self-induced Hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Self-induced Hypoglycaemia is a cause of recurrent hypoglycaemic episodes, as identified in the text.</data>
      <data key="d3">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391420</data>
    </node>
    <node id="Myocardial Infarction (MI)">
      <data key="d0">Myocardial Infarction (MI)</data>
      <data key="d1">category</data>
      <data key="d2">Myocardial Infarction is a precipitating factor for both Diabetic Ketoacidosis (DKA) and Hyperglycaemic Hyperosmolar State (HHS), as mentioned in the text.</data>
      <data key="d3">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391420</data>
    </node>
    <node id="Cerebrovascular Accident (CVA)">
      <data key="d0">Cerebrovascular Accident (CVA)</data>
      <data key="d1">category</data>
      <data key="d2">Cerebrovascular Accident is another precipitating factor for DKA and HHS, as noted in the text.</data>
      <data key="d3">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391420</data>
    </node>
    <node id="Type 1 Diabetes">
      <data key="d0">Type 1 Diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Type 1 Diabetes is a category of diabetes diagnosed before pregnancy, with or without complications.&lt;SEP&gt;Type 1 Diabetes is associated with Diabetic Ketoacidosis (DKA) in cases of new-onset diabetes, according to the text.&lt;SEP&gt;Type 1 diabetes is an autoimmune condition with a hereditary risk, particularly in offspring of diabetic parents.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e&lt;SEP&gt;chunk-8a3fa9809e33f235ebfe9c0204d7fbfb&lt;SEP&gt;chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391420</data>
    </node>
    <node id="Hyperglycaemic Coma">
      <data key="d0">Hyperglycaemic Coma</data>
      <data key="d1">category</data>
      <data key="d2">Hyperglycaemic Coma is a condition requiring urgent treatment at the primary care level, differentiated into DKA and HHS in clinical practice.</data>
      <data key="d3">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391421</data>
    </node>
    <node id="Hyperglycaemic Hyperosmolar Coma (HHS)">
      <data key="d0">Hyperglycaemic Hyperosmolar Coma (HHS)</data>
      <data key="d1">category</data>
      <data key="d2">Hyperglycaemic Hyperosmolar Coma is a medical condition marked by markedly raised blood glucose levels, severe dehydration, mental status changes, and potential focal neurological signs, typically associated with type 2 diabetes.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391421</data>
    </node>
    <node id="Cardiovascular risk">
      <data key="d0">Cardiovascular risk</data>
      <data key="d1">category</data>
      <data key="d2">Cardiovascular risk refers to the increased likelihood of heart disease or stroke in individuals with type 2 diabetes, exacerbated by factors like dyslipidaemia and obesity.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391421</data>
    </node>
    <node id="Dyslipidaemia">
      <data key="d0">Dyslipidaemia</data>
      <data key="d1">category</data>
      <data key="d2">Dyslipidaemia is a metabolic disorder characterized by abnormal lipid levels, encompassing elevated triglycerides and low high-density lipoprotein (HDL) cholesterol, which are major risk factors for cardiovascular disease (CVD) in diabetic patients. It is closely associated with HIV infection and antiretroviral therapy (ART), including highly active antiretroviral therapy (HAART), and contributes to macrovascular disease and atherosclerosis in individuals with diabetes. Dyslipidaemia may be exacerbated by certain medications such as beta-blockers and diuretics. Furthermore, it is identified as a risk factor for the development of diabetes, underscoring its complex role in metabolic health. The condition involves abnormal levels of cholesterol and triglycerides, linking it to both the progression of diabetes and the increased cardiovascular risks observed in affected populations.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d&lt;SEP&gt;chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-358680bfd64f7682f010caf1db56168e&lt;SEP&gt;chunk-2747f5a8e50f80ecb003d82a6236b5de&lt;SEP&gt;chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391421</data>
    </node>
    <node id="Chronic kidney disease">
      <data key="d0">Chronic kidney disease</data>
      <data key="d1">category</data>
      <data key="d2">Chronic kidney disease is a long-term condition where the kidneys lose their ability to filter waste from the blood, often associated with diabetes as a leading cause.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391422</data>
    </node>
    <node id="Neuropathy">
      <data key="d0">Neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">A condition assessed in the foot screening form, indicating nerve damage that may affect sensation in the feet.&lt;SEP&gt;Neuropathy refers to nerve damage often caused by diabetes, leading to symptoms like numbness, pain, and foot problems.&lt;SEP&gt;Neuropathy refers to nerve damage, particularly loss of protective sensation, which increases the risk of foot ulcers.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e&lt;SEP&gt;chunk-64e5a3cde95aa21d4710ea279f09b919&lt;SEP&gt;chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391422</data>
    </node>
    <node id="South Africa Demographic and Health Survey, 2003">
      <data key="d0">South Africa Demographic and Health Survey, 2003</data>
      <data key="d1">event</data>
      <data key="d2">The South Africa Demographic and Health Survey, 2003 is a study that reported percentages of overweight and obese adult persons in South Africa.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391422</data>
    </node>
    <node id="Myocardial infarction">
      <data key="d0">Myocardial infarction</data>
      <data key="d1">category</data>
      <data key="d2">Myocardial infarction (heart attack) in diabetic patients is more severe and rapidly fatal than in non-diabetics, linked to accelerated atherosclerosis.&lt;SEP&gt;Myocardial infarction is a medical condition listed as a precipitant for hyperglycaemic hyperosmolar coma (HHS) in the text.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d&lt;SEP&gt;chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391422</data>
    </node>
    <node id="Cerebrovascular accident">
      <data key="d0">Cerebrovascular accident</data>
      <data key="d1">category</data>
      <data key="d2">Cerebrovascular accident is a medical condition listed as a precipitant for hyperglycaemic hyperosmolar coma (HHS) in the text.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391422</data>
    </node>
    <node id="Insulin therapy">
      <data key="d0">Insulin therapy</data>
      <data key="d1">category</data>
      <data key="d2">Insulin therapy is a treatment for diabetes that is associated with weight gain in type 2 diabetic patients.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391422</data>
    </node>
    <node id="Kussmaul respiration">
      <data key="d0">Kussmaul respiration</data>
      <data key="d1">category</data>
      <data key="d2">Kussmaul respiration is a sign of diabetic ketoacidosis (DKA), characterized by deep, sighing breathing.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391422</data>
    </node>
    <node id="Focal neurological signs">
      <data key="d0">Focal neurological signs</data>
      <data key="d1">category</data>
      <data key="d2">Focal neurological signs are symptoms associated with hyperglycaemic hyperosmolar coma (HHS), indicating neurological complications.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391422</data>
    </node>
    <node id="Seizures">
      <data key="d0">Seizures</data>
      <data key="d1">category</data>
      <data key="d2">Seizures are neurological complications listed as signs of hyperglycaemic hyperosmolar coma (HHS).</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391423</data>
    </node>
    <node id="Behavioural therapy">
      <data key="d0">Behavioural therapy</data>
      <data key="d1">category</data>
      <data key="d2">Behavioural therapy is a method recommended to support weight loss in obese type 2 diabetic patients.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391423</data>
    </node>
    <node id="National Guideline: Prevention and Management of Overweight and Obesity in South Africa">
      <data key="d0">National Guideline: Prevention and Management of Overweight and Obesity in South Africa</data>
      <data key="d1">category</data>
      <data key="d2">The National Guideline is a document referenced in the text for managing overweight and obesity in South Africa.</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391423</data>
    </node>
    <node id="Macrovascular disease">
      <data key="d0">Macrovascular disease</data>
      <data key="d1">category</data>
      <data key="d2">Macrovascular disease refers to cardiovascular complications in individuals with type 2 diabetes, increasing CVD risk 2- to 3-fold in men and 3- to 5-fold in women compared to non-diabetics.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391423</data>
    </node>
    <node id="Stroke">
      <data key="d0">Stroke</data>
      <data key="d1">category</data>
      <data key="d2">Stroke in diabetic patients is more extensive and likely to be rapidly fatal compared to non-diabetics, associated with atherosclerosis.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391423</data>
    </node>
    <node id="Atherosclerosis">
      <data key="d0">Atherosclerosis</data>
      <data key="d1">category</data>
      <data key="d2">Atherosclerosis is accelerated and severe in diabetes, influenced by risk factors like hyperglycaemia, hypertension, dyslipidaemia, and obesity.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391424</data>
    </node>
    <node id="Chronic hyperglycaemia">
      <data key="d0">Chronic hyperglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Chronic hyperglycaemia (high blood sugar) is a key risk factor for accelerated atherosclerosis in diabetes, distinct from other risk factors affecting non-diabetics.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391424</data>
    </node>
    <node id="Diabetic dyslipidaemia">
      <data key="d0">Diabetic dyslipidaemia</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic dyslipidaemia refers to lipid disturbances in type 2 diabetes, including elevated triglycerides and reduced HDL cholesterol, contributing to vascular disease.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391424</data>
    </node>
    <node id="Cigarette smoking">
      <data key="d0">Cigarette smoking</data>
      <data key="d1">category</data>
      <data key="d2">Cigarette smoking is a modifiable CVD risk factor in diabetes, with cessation recommended as a target for management.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391424</data>
    </node>
    <node id="Total Cholesterol">
      <data key="d0">Total Cholesterol</data>
      <data key="d1">category</data>
      <data key="d2">Total Cholesterol is a CVD risk factor in diabetes, with a target of &lt;4.5 mmol/L.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391425</data>
    </node>
    <node id="LDL-Cholesterol">
      <data key="d0">LDL-Cholesterol</data>
      <data key="d1">category</data>
      <data key="d2">LDL-Cholesterol (bad cholesterol) is a key CVD risk factor in diabetes, with targets of &lt;1.8 mmol/L (or &lt;2.5 mmol/L under specific criteria).</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391425</data>
    </node>
    <node id="HDL-Cholesterol">
      <data key="d0">HDL-Cholesterol</data>
      <data key="d1">category</data>
      <data key="d2">HDL-Cholesterol (good cholesterol) is a protective factor against CVD in diabetes, with targets of &gt;1.0 mmol/L in men and &gt;1.2 mmol/L in women.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391425</data>
    </node>
    <node id="Triglycerides">
      <data key="d0">Triglycerides</data>
      <data key="d1">category</data>
      <data key="d2">Triglycerides are a type of lipid that is often elevated in patients with type 2 diabetes, contributing to metabolic complications.&lt;SEP&gt;Triglycerides are elevated in diabetic dyslipidaemia, with a target of &lt;1.7 mmol/L for CVD risk reduction.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d&lt;SEP&gt;chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391425</data>
    </node>
    <node id="Body Mass Index (BMI)">
      <data key="d0">Body Mass Index (BMI)</data>
      <data key="d1">category</data>
      <data key="d2">BMI is a key indicator of obesity in diabetes, with a target of &lt;25 kg/m² for CVD risk management.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391425</data>
    </node>
    <node id="Fasting glucose">
      <data key="d0">Fasting glucose</data>
      <data key="d1">category</data>
      <data key="d2">Elevated fasting glucose is a defining feature of the metabolic syndrome and a risk factor for diabetes and CVD.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391426</data>
    </node>
    <node id="Polycystic Ovarian Syndrome (PCOS)">
      <data key="d0">Polycystic Ovarian Syndrome (PCOS)</data>
      <data key="d1">category</data>
      <data key="d2">Polycystic Ovarian Syndrome is an ancillary feature of the Metabolic Syndrome, often associated with insulin resistance and hormonal imbalances.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391426</data>
    </node>
    <node id="Non-Alcoholic Fatty Liver Disease (NAFLD)">
      <data key="d0">Non-Alcoholic Fatty Liver Disease (NAFLD)</data>
      <data key="d1">category</data>
      <data key="d2">Non-Alcoholic Fatty Liver Disease is an ancillary feature of the Metabolic Syndrome, linked to metabolic dysfunction and insulin resistance.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391426</data>
    </node>
    <node id="Sleep Apnoea">
      <data key="d0">Sleep Apnoea</data>
      <data key="d1">category</data>
      <data key="d2">Sleep Apnoea is an ancillary feature of the Metabolic Syndrome, characterized by disrupted breathing during sleep and associated with obesity and metabolic disturbances.&lt;SEP&gt;Sleep apnoea is a condition mentioned in the text as a situation with higher relative risks compared to diabetes-related driving risks.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d&lt;SEP&gt;chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391426</data>
    </node>
    <node id="Abdominal Obesity">
      <data key="d0">Abdominal Obesity</data>
      <data key="d1">category</data>
      <data key="d2">Abdominal Obesity is a characteristic feature of the Metabolic Syndrome, defined by excess fat accumulation in the abdominal region.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391426</data>
    </node>
    <node id="Atherogenic Dyslipidaemia">
      <data key="d0">Atherogenic Dyslipidaemia</data>
      <data key="d1">category</data>
      <data key="d2">Atherogenic Dyslipidaemia is a defining feature of the Metabolic Syndrome, characterized by elevated triglycerides and reduced HDL cholesterol levels.</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391426</data>
    </node>
    <node id="Lipid Disturbances">
      <data key="d0">Lipid Disturbances</data>
      <data key="d1">category</data>
      <data key="d2">Lipid disturbances refer to abnormal levels of lipids in the blood, such as increased triglycerides and decreased HDL cholesterol, commonly observed in patients with diabetes.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391426</data>
    </node>
    <node id="Vascular Disease">
      <data key="d0">Vascular Disease</data>
      <data key="d1">category</data>
      <data key="d2">Vascular disease is a condition associated with high incidence in diabetic patients, likely linked to lipid disturbances.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391426</data>
    </node>
    <node id="HDL Cholesterol">
      <data key="d0">HDL Cholesterol</data>
      <data key="d1">category</data>
      <data key="d2">HDL cholesterol is a type of cholesterol that is typically decreased in patients with type 2 diabetes, contributing to cardiovascular risks.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391426</data>
    </node>
    <node id="LDL Cholesterol">
      <data key="d0">LDL Cholesterol</data>
      <data key="d1">category</data>
      <data key="d2">LDL cholesterol is a lipid that should be kept below 1.8 mmol/L in diabetic patients, with stricter goals for those with cardiovascular risk factors.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391427</data>
    </node>
    <node id="Ideal Lipid Profile">
      <data key="d0">Ideal Lipid Profile</data>
      <data key="d1">category</data>
      <data key="d2">The Ideal Lipid Profile is a therapeutic target for diabetic patients, specifying maximum levels for total cholesterol, LDL cholesterol, and triglycerides, and minimum levels for HDL cholesterol.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391427</data>
    </node>
    <node id="Statins">
      <data key="d0">Statins</data>
      <data key="d1">category</data>
      <data key="d2">Statins are first-line medications for lowering LDL cholesterol in diabetic patients, regardless of baseline lipid levels.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391427</data>
    </node>
    <node id="Diabetic Mortality">
      <data key="d0">Diabetic Mortality</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic mortality refers to deaths caused by complications of diabetes, particularly prevalent in White, Coloured, and Asian patients, with increasing incidence in Black patients.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391427</data>
    </node>
    <node id="White">
      <data key="d0">White</data>
      <data key="d1">category</data>
      <data key="d2">White is an ethnic group for whom diabetic mortality is a significant concern, as indicated in the text.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391428</data>
    </node>
    <node id="Coloured">
      <data key="d0">Coloured</data>
      <data key="d1">category</data>
      <data key="d2">Coloured is an ethnic group for whom diabetic mortality is a significant concern, as indicated in the text.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391428</data>
    </node>
    <node id="Asian">
      <data key="d0">Asian</data>
      <data key="d1">category</data>
      <data key="d2">Asian is an ethnic group for whom diabetic mortality is a significant concern, as indicated in the text.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391428</data>
    </node>
    <node id="Black">
      <data key="d0">Black</data>
      <data key="d1">category</data>
      <data key="d2">Black is an ethnic group for whom diabetic mortality is uncommon but increasing, as indicated in the text.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391428</data>
    </node>
    <node id="Fasting Lipid Profile">
      <data key="d0">Fasting Lipid Profile</data>
      <data key="d1">category</data>
      <data key="d2">Fasting lipid profile is a diagnostic test requiring a 10-hour fast, used to evaluate lipid levels in diabetic patients.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391428</data>
    </node>
    <node id="Metabolic Control">
      <data key="d0">Metabolic Control</data>
      <data key="d1">category</data>
      <data key="d2">Metabolic control refers to the management of diabetes to prevent complications, including dyslipidaemia, and is emphasized as critical in the text.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391429</data>
    </node>
    <node id="Diabetic Dyslipidaemia">
      <data key="d0">Diabetic Dyslipidaemia</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic dyslipidaemia refers to abnormal lipid profiles in diabetic patients, characterized by elevated triglycerides and reduced HDL cholesterol.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391429</data>
    </node>
    <node id="Hypothyroidism">
      <data key="d0">Hypothyroidism</data>
      <data key="d1">category</data>
      <data key="d2">Hypothyroidism is a secondary cause of hyperlipidaemia that must be excluded in diabetic patients, as mentioned in the text.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391429</data>
    </node>
    <node id="Renal Disease">
      <data key="d0">Renal Disease</data>
      <data key="d1">category</data>
      <data key="d2">Renal disease is a secondary cause of hyperlipidaemia that must be excluded in diabetic patients, as mentioned in the text.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391429</data>
    </node>
    <node id="Group 1">
      <data key="d0">Group 1</data>
      <data key="d1">category</data>
      <data key="d2">Group 1 refers to a category of type 2 diabetic patients with existing cardiovascular disease or chronic kidney disease, requiring statin therapy.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391430</data>
    </node>
    <node id="Group 2">
      <data key="d0">Group 2</data>
      <data key="d1">category</data>
      <data key="d2">Group 2 refers to a category of type 2 diabetic patients without cardiovascular disease or chronic kidney disease, requiring risk assessment for statin therapy.</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391430</data>
    </node>
    <node id="Type 2 Diabetic Patients">
      <data key="d0">Type 2 Diabetic Patients</data>
      <data key="d1">category</data>
      <data key="d2">Patients with type 2 diabetes, focusing on those without cardiovascular disease or chronic kidney disease, under 40 years of age, and with diabetes duration &lt;10 years.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391430</data>
    </node>
    <node id="Aspirin Therapy">
      <data key="d0">Aspirin Therapy</data>
      <data key="d1">category</data>
      <data key="d2">Aspirin therapy is recommended for patients with diabetes and a history of cardiovascular disease, but not for younger patients without significant risk factors.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391430</data>
    </node>
    <node id="ACE Inhibitors (ACEi)">
      <data key="d0">ACE Inhibitors (ACEi)</data>
      <data key="d1">category</data>
      <data key="d2">The recommended first-line treatment for hypertension in type 2 diabetes, with specific monitoring requirements for eGFR and potential side effects.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391430</data>
    </node>
    <node id="Dihydropyridine Calcium-Channel Blockers (DHP CCB)">
      <data key="d0">Dihydropyridine Calcium-Channel Blockers (DHP CCB)</data>
      <data key="d1">category</data>
      <data key="d2">A class of antihypertensive medications used as an adjunct to ACEi if blood pressure targets are not met.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391430</data>
    </node>
    <node id="Microalbuminuria/Proteinuria">
      <data key="d0">Microalbuminuria/Proteinuria</data>
      <data key="d1">category</data>
      <data key="d2">A marker of kidney damage in type 2 diabetes, influencing the choice of antihypertensive medications.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391431</data>
    </node>
    <node id="Blood Pressure (BP) Targets">
      <data key="d0">Blood Pressure (BP) Targets</data>
      <data key="d1">category</data>
      <data key="d2">The revised target BP range for type 2 diabetes patients is 120/70–140/80 mmHg, with specific monitoring protocols.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391431</data>
    </node>
    <node id="Random Cholesterol &gt; 7.5 mmol/L">
      <data key="d0">Random Cholesterol &gt; 7.5 mmol/L</data>
      <data key="d1">category</data>
      <data key="d2">A medical criterion for referral in type 2 diabetic patients, indicating elevated cholesterol levels that require attention.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391431</data>
    </node>
    <node id="Fasting Triglycerides &gt; 10 mmol/L">
      <data key="d0">Fasting Triglycerides &gt; 10 mmol/L</data>
      <data key="d1">category</data>
      <data key="d2">A medical criterion for referral in type 2 diabetic patients, indicating severely elevated triglyceride levels.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391431</data>
    </node>
    <node id="White-Coat Hypertension">
      <data key="d0">White-Coat Hypertension</data>
      <data key="d1">category</data>
      <data key="d2">A condition where blood pressure readings are elevated in a clinical setting but normal at home, requiring ambulatory BP measurement for accurate diagnosis.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391431</data>
    </node>
    <node id="Ambulatory BP Measurement (ABPM)">
      <data key="d0">Ambulatory BP Measurement (ABPM)</data>
      <data key="d1">category</data>
      <data key="d2">A diagnostic method used to assess blood pressure over a 24-hour period, particularly for identifying white-coat hypertension.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391431</data>
    </node>
    <node id="Gastrointestinal (GIT) Bleeds">
      <data key="d0">Gastrointestinal (GIT) Bleeds</data>
      <data key="d1">category</data>
      <data key="d2">A potential complication associated with aspirin therapy in diabetic patients, increasing in risk with long-term use.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391431</data>
    </node>
    <node id="Intracranial Bleeds">
      <data key="d0">Intracranial Bleeds</data>
      <data key="d1">category</data>
      <data key="d2">A potential complication associated with aspirin therapy in diabetic patients, though less common than GIT bleeds.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391431</data>
    </node>
    <node id="Microvascular Disease">
      <data key="d0">Microvascular Disease</data>
      <data key="d1">category</data>
      <data key="d2">A complication of diabetes and hypertension, involving damage to small blood vessels, particularly in the eyes, kidneys, and nerves.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391432</data>
    </node>
    <node id="Macrovascular Disease">
      <data key="d0">Macrovascular Disease</data>
      <data key="d1">category</data>
      <data key="d2">A complication of diabetes and hypertension, involving damage to large blood vessels, leading to conditions like heart disease and stroke.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391432</data>
    </node>
    <node id="Estimated Glomerular Filtration Rate (eGFR)">
      <data key="d0">Estimated Glomerular Filtration Rate (eGFR)</data>
      <data key="d1">category</data>
      <data key="d2">A key metric monitored during ACE inhibitor therapy to assess kidney function and guide treatment adjustments.&lt;SEP&gt;eGFR is a measure of kidney function calculated from serum creatinine levels and is used to monitor CKD progression.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead&lt;SEP&gt;chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391432</data>
    </node>
    <node id="Ischaemic Heart Disease">
      <data key="d0">Ischaemic Heart Disease</data>
      <data key="d1">category</data>
      <data key="d2">A cardiovascular condition that is an indication for aspirin therapy in diabetic patients, as it increases risk of further complications.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391432</data>
    </node>
    <node id="Peripheral Vascular Disease">
      <data key="d0">Peripheral Vascular Disease</data>
      <data key="d1">category</data>
      <data key="d2">A cardiovascular condition that is an indication for aspirin therapy in diabetic patients, as it increases risk of further complications.&lt;SEP&gt;Peripheral vascular disease is a condition associated with reduced blood flow to the limbs, increasing the risk of foot ulceration and delayed healing.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391433</data>
    </node>
    <node id="Previous Thrombotic Stroke">
      <data key="d0">Previous Thrombotic Stroke</data>
      <data key="d1">category</data>
      <data key="d2">A cardiovascular condition that is an indication for aspirin therapy in diabetic patients, as it increases risk of further complications.</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391433</data>
    </node>
    <node id="ACE Inhibitors">
      <data key="d0">ACE Inhibitors</data>
      <data key="d1">category</data>
      <data key="d2">ACE inhibitors are a class of medications used in the management of hypertension and chronic kidney disease (CKD), but they may cause side effects such as hyperkalemia, renal failure, persistent cough, and lower glucose levels. They should be avoided during pregnancy.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391433</data>
    </node>
    <node id="Diuretics">
      <data key="d0">Diuretics</data>
      <data key="d1">category</data>
      <data key="d2">Diuretics are medications that may inhibit insulin release when used in large doses. They are also associated with worsening dyslipidaemia and are contraindicated during pregnancy.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391433</data>
    </node>
    <node id="Beta-Blockers">
      <data key="d0">Beta-Blockers</data>
      <data key="d1">category</data>
      <data key="d2">Beta-blockers are medications that may mask symptoms of hypoglycaemia and exacerbate peripheral vascular disease. They are also linked to worsening dyslipidaemia.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391433</data>
    </node>
    <node id="Methyldopa">
      <data key="d0">Methyldopa</data>
      <data key="d1">category</data>
      <data key="d2">Methyldopa is a medication prescribed for hypertension management in pregnant patients, as it is considered safer than ACE inhibitors and diuretics during pregnancy.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391434</data>
    </node>
    <node id="Diabetic Nephropathy">
      <data key="d0">Diabetic Nephropathy</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic nephropathy is a frequent complication of diabetes mellitus, leading to significant morbidity and mortality. It progresses through stages of proteinuria and requires intensive diabetes and blood pressure management.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391434</data>
    </node>
    <node id="Hyperkalemia">
      <data key="d0">Hyperkalemia</data>
      <data key="d1">category</data>
      <data key="d2">Hyperkalemia (elevated serum potassium) is a concern in diabetes management, particularly with the use of ACE-inhibitors and potassium-restricted diets.&lt;SEP&gt;Hyperkalemia is a potential side effect of ACE inhibitors, characterized by elevated potassium levels. It requires immediate medical attention and may necessitate discontinuation of ACE inhibitors.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b&lt;SEP&gt;chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391434</data>
    </node>
    <node id="Persistent Cough">
      <data key="d0">Persistent Cough</data>
      <data key="d1">category</data>
      <data key="d2">Persistent cough is a common side effect of ACE inhibitors, which may resolve spontaneously or require dose adjustment.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391434</data>
    </node>
    <node id="Lower Glucose Levels">
      <data key="d0">Lower Glucose Levels</data>
      <data key="d1">category</data>
      <data key="d2">Lower glucose levels are a potential side effect of ACE inhibitors, necessitating caution in diabetic patients.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391434</data>
    </node>
    <node id="Angioedema">
      <data key="d0">Angioedema</data>
      <data key="d1">category</data>
      <data key="d2">Angioedema is a rare but serious adverse reaction to ACE inhibitors, characterized by swelling around the eyes and lips, and potentially life-threatening airway obstruction.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391435</data>
    </node>
    <node id="Insulin Release Inhibition">
      <data key="d0">Insulin Release Inhibition</data>
      <data key="d1">category</data>
      <data key="d2">Insulin release inhibition is a side effect of diuretics when used in large doses, potentially affecting glucose regulation.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391435</data>
    </node>
    <node id="Hypoglycaemia Masking">
      <data key="d0">Hypoglycaemia Masking</data>
      <data key="d1">category</data>
      <data key="d2">Hypoglycaemia masking is a risk associated with beta-blockers, as they may obscure the symptoms of low blood sugar.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391435</data>
    </node>
    <node id="Antenatal Unit">
      <data key="d0">Antenatal Unit</data>
      <data key="d1">category</data>
      <data key="d2">An antenatal unit is a specialized healthcare facility equipped to manage high-risk pregnancies, particularly those involving hypertension and renal complications.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391435</data>
    </node>
    <node id="Renal Medicine Physician">
      <data key="d0">Renal Medicine Physician</data>
      <data key="d1">category</data>
      <data key="d2">A renal medicine physician is a specialist in managing kidney-related conditions, including CKD and renovascular hypertension.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391435</data>
    </node>
    <node id="Screening">
      <data key="d0">Screening</data>
      <data key="d1">event</data>
      <data key="d2">Screening is a critical process in CKD management, involving annual monitoring of albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR).</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391435</data>
    </node>
    <node id="Monitoring">
      <data key="d0">Monitoring</data>
      <data key="d1">event</data>
      <data key="d2">Monitoring involves regular follow-up of serum creatinine and potassium levels after initiating ACE inhibitors or adjusting their doses.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391435</data>
    </node>
    <node id="Treatment Adjustment">
      <data key="d0">Treatment Adjustment</data>
      <data key="d1">event</data>
      <data key="d2">Treatment adjustment is necessary when blood pressure targets are not met, requiring changes in medication and management strategies.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391435</data>
    </node>
    <node id="Albumin-to-Creatinine Ratio (ACR)">
      <data key="d0">Albumin-to-Creatinine Ratio (ACR)</data>
      <data key="d1">category</data>
      <data key="d2">ACR is a key diagnostic tool in screening for CKD, measured via a random urine sample to assess proteinuria.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391436</data>
    </node>
    <node id="Renovascular Hypertension">
      <data key="d0">Renovascular Hypertension</data>
      <data key="d1">category</data>
      <data key="d2">Renovascular hypertension is a type of hypertension caused by kidney artery narrowing, requiring referral to a renal medicine physician for management.</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391436</data>
    </node>
    <node id="Diabetic Retinopathy">
      <data key="d0">Diabetic Retinopathy</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic Retinopathy refers to the focus of studies on the prevalence of retinopathy in the United States.&lt;SEP&gt;Diabetic retinopathy is a leading cause of visual impairment in working-age populations, primarily caused by diabetes, and is preventable/treatable.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391436</data>
    </node>
    <node id="Renal Care">
      <data key="d0">Renal Care</data>
      <data key="d1">category</data>
      <data key="d2">Renal care refers to specialized medical care for patients with chronic kidney disease (CKD), including referral criteria and management strategies.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391436</data>
    </node>
    <node id="Proteinuria">
      <data key="d0">Proteinuria</data>
      <data key="d1">category</data>
      <data key="d2">Proteinuria (excess urinary protein) is a marker of kidney damage in diabetes and a criterion for referral to specialized renal care.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391436</data>
    </node>
    <node id="South African CSR Targets">
      <data key="d0">South African CSR Targets</data>
      <data key="d1">category</data>
      <data key="d2">South African CSR targets relate to cataract surgery rates, which have not been met since 2005 despite available treatment options.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391437</data>
    </node>
    <node id="Fundus Examination">
      <data key="d0">Fundus Examination</data>
      <data key="d1">category</data>
      <data key="d2">Fundus examination is a key screening method for diabetic retinopathy, performed by trained eye care professionals at diagnosis and annually.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391437</data>
    </node>
    <node id="Fundus Photography">
      <data key="d0">Fundus Photography</data>
      <data key="d1">category</data>
      <data key="d2">Fundus photography is a screening method for diabetic retinopathy, involving retinal imaging for diagnosis and monitoring.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391437</data>
    </node>
    <node id="Mobile Fundus Camera">
      <data key="d0">Mobile Fundus Camera</data>
      <data key="d1">category</data>
      <data key="d2">A mobile fundus camera is a device used for screening diabetic retinopathy in primary care settings, improving the quality of patient care.&lt;SEP&gt;Mobile fundus camera is a tool used in primary care settings for retinal imaging, improving accessibility to diabetic retinopathy screening.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391437</data>
    </node>
    <node id="HIV Population on ARVs">
      <data key="d0">HIV Population on ARVs</data>
      <data key="d1">category</data>
      <data key="d2">HIV population on antiretroviral therapy (ARVs) requires regular screening for diabetes-related eye complications due to increased diabetes prevalence.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391438</data>
    </node>
    <node id="Pregnant Women with Pre-Existing Diabetes">
      <data key="d0">Pregnant Women with Pre-Existing Diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Pregnant women with pre-existing diabetes are a high-risk group for diabetic retinopathy, requiring specialized screening protocols.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391438</data>
    </node>
    <node id="Known Duration of Diabetes ≤ 5 Years">
      <data key="d0">Known Duration of Diabetes ≤ 5 Years</data>
      <data key="d1">category</data>
      <data key="d2">A category of patients with diabetes for ≤ 5 years, where non-diabetic renal disease should be considered as a potential cause of CKD.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391438</data>
    </node>
    <node id="Family History of Non-Diabetic Renal Disease">
      <data key="d0">Family History of Non-Diabetic Renal Disease</data>
      <data key="d1">category</data>
      <data key="d2">A category of patients with a family history of non-diabetic renal disease, such as polycystic kidney disease, requiring further investigation.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391438</data>
    </node>
    <node id="Systemic Disease">
      <data key="d0">Systemic Disease</data>
      <data key="d1">category</data>
      <data key="d2">Systemic disease refers to conditions affecting multiple body systems, which may contribute to CKD in diabetic patients.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391438</data>
    </node>
    <node id="District Level">
      <data key="d0">District Level</data>
      <data key="d1">geo</data>
      <data key="d2">District level refers to the administrative tier where fundus examination services should be available for diabetic patients.</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391439</data>
    </node>
    <node id="Diabetic Retinopathy (DR)">
      <data key="d0">Diabetic Retinopathy (DR)</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic Retinopathy (DR) is a complication of diabetes that affects the retina and requires specialized management, including referral to secondary care for laser therapy or surgery.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391439</data>
    </node>
    <node id="Foot Problems in Diabetes">
      <data key="d0">Foot Problems in Diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Foot problems in diabetes are major causes of morbidity and mortality, leading to ulceration, amputation, and increased healthcare costs.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391439</data>
    </node>
    <node id="Peripheral Sensory Diabetic Neuropathy">
      <data key="d0">Peripheral Sensory Diabetic Neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">Peripheral sensory diabetic neuropathy is a condition that increases the risk of foot ulceration due to loss of protective sensation and vulnerability to trauma.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391439</data>
    </node>
    <node id="Ulceration">
      <data key="d0">Ulceration</data>
      <data key="d1">category</data>
      <data key="d2">Ulceration is a preventable complication of diabetes, often resulting from neuropathy, trauma, and peripheral arterial disease.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391439</data>
    </node>
    <node id="Amputation">
      <data key="d0">Amputation</data>
      <data key="d1">category</data>
      <data key="d2">Amputation is a severe complication of diabetes, often linked to foot ulcers and peripheral arterial disease, with poor prognosis for the contralateral limb.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391439</data>
    </node>
    <node id="Retinal Photography">
      <data key="d0">Retinal Photography</data>
      <data key="d1">category</data>
      <data key="d2">Retinal photography is a feasible and cost-effective method for screening diabetic retinopathy in primary care settings.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391439</data>
    </node>
    <node id="Laser Therapy">
      <data key="d0">Laser Therapy</data>
      <data key="d1">category</data>
      <data key="d2">Laser therapy is an effective treatment for preserving sight in proliferative retinopathy and macula oedema.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391439</data>
    </node>
    <node id="Vitrectomy Surgery">
      <data key="d0">Vitrectomy Surgery</data>
      <data key="d1">category</data>
      <data key="d2">Vitrectomy surgery is used in advanced retinopathy to manage complications of diabetic retinopathy.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391439</data>
    </node>
    <node id="Pharmacological Intervention">
      <data key="d0">Pharmacological Intervention</data>
      <data key="d1">category</data>
      <data key="d2">Pharmacological intervention is one of the management options for sight-threatening diabetic retinopathy.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391440</data>
    </node>
    <node id="Low-Vision Evaluation">
      <data key="d0">Low-Vision Evaluation</data>
      <data key="d1">category</data>
      <data key="d2">Low-vision evaluation is recommended for visually impaired individuals to aid in rehabilitation.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391440</data>
    </node>
    <node id="Peripheral Arterial Disease (PAD)">
      <data key="d0">Peripheral Arterial Disease (PAD)</data>
      <data key="d1">category</data>
      <data key="d2">Peripheral arterial disease (PAD) is a risk factor for foot ulceration, delayed healing, and increased mortality in people with diabetes.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391440</data>
    </node>
    <node id="Plantar Pressure">
      <data key="d0">Plantar Pressure</data>
      <data key="d1">category</data>
      <data key="d2">Excessive plantar pressure is a contributing factor to foot ulceration in individuals with diabetes.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391440</data>
    </node>
    <node id="Trauma">
      <data key="d0">Trauma</data>
      <data key="d1">category</data>
      <data key="d2">Trauma, particularly repetitive, is a causative factor in foot ulceration among people with diabetes.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391441</data>
    </node>
    <node id="Ischaemia">
      <data key="d0">Ischaemia</data>
      <data key="d1">category</data>
      <data key="d2">Ischaemia, a symptom of PAD, is a critical factor in delayed healing of foot ulcers in diabetic patients.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391441</data>
    </node>
    <node id="Claudication">
      <data key="d0">Claudication</data>
      <data key="d1">category</data>
      <data key="d2">Claudication is a symptom of peripheral arterial disease, commonly associated with diabetes.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391441</data>
    </node>
    <node id="Rest Pain">
      <data key="d0">Rest Pain</data>
      <data key="d1">category</data>
      <data key="d2">Rest pain is a symptom of ischaemia in peripheral arterial disease, often seen in diabetic patients.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391441</data>
    </node>
    <node id="Risk Categorisation System for Diabetic Feet">
      <data key="d0">Risk Categorisation System for Diabetic Feet</data>
      <data key="d1">category</data>
      <data key="d2">The risk categorisation system for diabetic feet is used to determine the frequency of foot examinations and manage ulceration risks.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391441</data>
    </node>
    <node id="Foot Care Management">
      <data key="d0">Foot Care Management</data>
      <data key="d1">category</data>
      <data key="d2">Foot care management involves collaboration between patients and healthcare providers to prevent ulcers and amputations.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391442</data>
    </node>
    <node id="North America">
      <data key="d0">North America</data>
      <data key="d1">geo</data>
      <data key="d2">North America is a region where foot complications account for 20% of diabetes-related hospital admissions.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391442</data>
    </node>
    <node id="Ophthalmologist">
      <data key="d0">Ophthalmologist</data>
      <data key="d1">organization</data>
      <data key="d2">An ophthalmologist is a medical specialist who assesses and treats sight-threatening diabetic retinopathy through interventions like laser therapy.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391442</data>
    </node>
    <node id="Podiatrist">
      <data key="d0">Podiatrist</data>
      <data key="d1">organization</data>
      <data key="d2">A podiatrist is a healthcare professional specializing in foot care for patients with diabetes, focusing on ulcer prevention and management.&lt;SEP&gt;Podiatrist is a specialist who provides treatment for non-ulcerative and ulcerative foot pathology, as part of the management plan.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391442</data>
    </node>
    <node id="Vascular Unit">
      <data key="d0">Vascular Unit</data>
      <data key="d1">organization</data>
      <data key="d2">A vascular unit is a medical department that provides care for patients with peripheral arterial disease and related complications.&lt;SEP&gt;Vascular unit is a medical department involved in the treatment of peripheral artery disease (PAD) and related conditions.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391443</data>
    </node>
    <node id="Orthotist">
      <data key="d0">Orthotist</data>
      <data key="d1">organization</data>
      <data key="d2">An orthotist is a healthcare professional who designs and provides orthotic devices to support foot function in diabetic patients.&lt;SEP&gt;Orthotist is a specialist who provides orthotic devices or interventions to support foot care and mobility.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391443</data>
    </node>
    <node id="Surgeon">
      <data key="d0">Surgeon</data>
      <data key="d1">organization</data>
      <data key="d2">A surgeon is a medical professional who performs surgical interventions such as vitrectomy for advanced retinopathy.&lt;SEP&gt;Surgeon is a medical professional involved in surgical interventions related to foot pathology.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391443</data>
    </node>
    <node id="Wound Care Unit">
      <data key="d0">Wound Care Unit</data>
      <data key="d1">organization</data>
      <data key="d2">A wound care unit is a specialized healthcare team that manages and treats foot ulcers in diabetic patients.&lt;SEP&gt;Wound care unit is a specialized medical team responsible for managing and treating foot ulcers.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453&lt;SEP&gt;chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391443</data>
    </node>
    <node id="Annexure C1">
      <data key="d0">Annexure C1</data>
      <data key="d1">event</data>
      <data key="d2">Annexure C1 is a referenced document or section in the text that provides guidelines for foot care management.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391443</data>
    </node>
    <node id="Foot Examination">
      <data key="d0">Foot Examination</data>
      <data key="d1">category</data>
      <data key="d2">A foot examination is a clinical assessment performed on diabetes diagnosis to detect risk factors for ulceration.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391443</data>
    </node>
    <node id="Foot Assessment Forms">
      <data key="d0">Foot Assessment Forms</data>
      <data key="d1">category</data>
      <data key="d2">Foot assessment forms are tools used to document foot history and examination results for diabetes patients.</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391444</data>
    </node>
    <node id="risk categorisation system for diabetic feet">
      <data key="d0">risk categorisation system for diabetic feet</data>
      <data key="d1">category</data>
      <data key="d2">A system used to classify patients based on their risk of foot ulceration, with categories 0 to 3, each defined by specific risk profiles and checkup frequencies.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391444</data>
    </node>
    <node id="Category 0">
      <data key="d0">Category 0</data>
      <data key="d1">category</data>
      <data key="d2">A risk category for diabetic feet with no sensory neuropathy and no peripheral artery disease (PAD), requiring checkups once a year.&lt;SEP&gt;Category 0 refers to individuals with no sensory neuropathy and no peripheral artery disease (PAD), requiring check-ups once a year.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919&lt;SEP&gt;chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391444</data>
    </node>
    <node id="Category 1">
      <data key="d0">Category 1</data>
      <data key="d1">category</data>
      <data key="d2">A risk category for diabetic feet with sensory neuropathy present but no foot deformity or PAD, requiring checkups once every 6 months.&lt;SEP&gt;Category 1 refers to individuals with sensory neuropathy but no foot deformity or PAD, requiring check-ups once every 6 months.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919&lt;SEP&gt;chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391444</data>
    </node>
    <node id="Category 2">
      <data key="d0">Category 2</data>
      <data key="d1">category</data>
      <data key="d2">A risk category for diabetic feet with sensory neuropathy and signs of foot deformity and PAD present, requiring checkups once every 3 months.&lt;SEP&gt;Category 2 refers to individuals with sensory neuropathy and signs of foot deformity and PAD, requiring check-ups as specified in the table.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919&lt;SEP&gt;chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391444</data>
    </node>
    <node id="Category 3">
      <data key="d0">Category 3</data>
      <data key="d1">category</data>
      <data key="d2">A risk category for diabetic feet with previous ulceration or amputation, requiring checkups once every 1–3 months.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391444</data>
    </node>
    <node id="Health Care Personnel">
      <data key="d0">Health Care Personnel</data>
      <data key="d1">organization</data>
      <data key="d2">Health care personnel refers to the professionals involved in providing foot care advice and management, working in partnership with patients and caregivers.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391444</data>
    </node>
    <node id="Patient">
      <data key="d0">Patient</data>
      <data key="d1">person</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Patient is an individual requiring foot care management, often in collaboration with health care personnel and caregivers.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5&lt;SEP&gt;chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391444</data>
    </node>
    <node id="Care Giver">
      <data key="d0">Care Giver</data>
      <data key="d1">person</data>
      <data key="d2">Care giver is a family member or individual responsible for assisting the patient in foot care management.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391445</data>
    </node>
    <node id="Semmes Weinstein Monofilament">
      <data key="d0">Semmes Weinstein Monofilament</data>
      <data key="d1">equipment</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391445</data>
    </node>
    <node id="128 Hz Tuning Fork">
      <data key="d0">128 Hz Tuning Fork</data>
      <data key="d1">equipment</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391445</data>
    </node>
    <node id="Cotton Wool Ball">
      <data key="d0">Cotton Wool Ball</data>
      <data key="d1">equipment</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391445</data>
    </node>
    <node id="Charcot Foot">
      <data key="d0">Charcot Foot</data>
      <data key="d1">category</data>
      <data key="d2">Charcot foot is a condition characterized by bone deformities and instability in the foot, often associated with neuropathy.&lt;SEP&gt;Charcot foot is a severe foot condition requiring referral to hospitals with orthopaedic and podiatrist services.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d&lt;SEP&gt;chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391446</data>
    </node>
    <node id="Loss of Protective Sensation">
      <data key="d0">Loss of Protective Sensation</data>
      <data key="d1">category</data>
      <data key="d2">Loss of protective sensation is a condition where the patient cannot feel pain or pressure, increasing the risk of foot injuries.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391446</data>
    </node>
    <node id="Intermittent Claudication">
      <data key="d0">Intermittent Claudication</data>
      <data key="d1">category</data>
      <data key="d2">Intermittent claudication is a symptom of PAD characterized by pain in the legs during walking, relieved by rest.</data>
      <data key="d3">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391446</data>
    </node>
    <node id="Foot Ulceration">
      <data key="d0">Foot Ulceration</data>
      <data key="d1">category</data>
      <data key="d2">Foot ulceration is a medical condition that requires prevention through patient education, referral, and frequent examination.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391446</data>
    </node>
    <node id="Painful Peripheral Neuropathy">
      <data key="d0">Painful Peripheral Neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">Painful peripheral neuropathy is a condition treated by health care providers with medications like amitriptyline and paracetamol.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391446</data>
    </node>
    <node id="Non-Ulcerative Foot Pathology">
      <data key="d0">Non-Ulcerative Foot Pathology</data>
      <data key="d1">category</data>
      <data key="d2">Non-ulcerative foot pathology includes conditions like corns, calluses, nail deformities, and foot deformities requiring podiatric or orthopaedic care.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391447</data>
    </node>
    <node id="Peripheral Artery Disease">
      <data key="d0">Peripheral Artery Disease</data>
      <data key="d1">category</data>
      <data key="d2">Peripheral artery disease is a condition requiring referral to vascular surgery centers if pedal pulses are absent.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391447</data>
    </node>
    <node id="Ulcerative Foot Pathology">
      <data key="d0">Ulcerative Foot Pathology</data>
      <data key="d1">category</data>
      <data key="d2">Ulcerative foot pathology necessitates specialist management at secondary or tertiary care levels.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391447</data>
    </node>
    <node id="Diabetes in Pregnancy">
      <data key="d0">Diabetes in Pregnancy</data>
      <data key="d1">category</data>
      <data key="d2">Diabetes in pregnancy poses risks for mothers and fetuses, including hypertension, hydramnios, and macrosomia.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391447</data>
    </node>
    <node id="Gestational Diabetes (GDM)">
      <data key="d0">Gestational Diabetes (GDM)</data>
      <data key="d1">category</data>
      <data key="d2">Gestational diabetes is diabetes first diagnosed during pregnancy, requiring screening via oral glucose tolerance tests.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391447</data>
    </node>
    <node id="Pregestational Diabetes">
      <data key="d0">Pregestational Diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Pregestational diabetes refers to Type 1 or Type 2 diabetes diagnosed before pregnancy, with or without complications.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391448</data>
    </node>
    <node id="Hydramnios">
      <data key="d0">Hydramnios</data>
      <data key="d1">category</data>
      <data key="d2">Hydramnios is an excessive accumulation of amniotic fluid, a complication of diabetes during pregnancy.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391448</data>
    </node>
    <node id="Macrosomia">
      <data key="d0">Macrosomia</data>
      <data key="d1">category</data>
      <data key="d2">Macrosomia refers to a large-for-gestational-age baby, a complication associated with gestational diabetes.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391448</data>
    </node>
    <node id="Perinatal Morbidity and Mortality">
      <data key="d0">Perinatal Morbidity and Mortality</data>
      <data key="d1">category</data>
      <data key="d2">Perinatal morbidity and mortality are adverse outcomes for mothers and fetuses in pregnancies with diabetes.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391448</data>
    </node>
    <node id="Periodontal Disease">
      <data key="d0">Periodontal Disease</data>
      <data key="d1">category</data>
      <data key="d2">A condition linked to diabetes, involving inflammation of the gums and tooth roots, and requiring dental referral for management.&lt;SEP&gt;Periodontal disease is a gum condition requiring attention in diabetes care, particularly for high-risk individuals.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d&lt;SEP&gt;chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391448</data>
    </node>
    <node id="Annexure B: General Principles for Foot Care">
      <data key="d0">Annexure B: General Principles for Foot Care</data>
      <data key="d1">category</data>
      <data key="d2">A document referenced in the text outlining general principles for foot care in diabetes management.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391448</data>
    </node>
    <node id="Annexure C1: Foot Screening Assessment Form">
      <data key="d0">Annexure C1: Foot Screening Assessment Form</data>
      <data key="d1">category</data>
      <data key="d2">A document referenced in the text describing a form for foot screening assessment in diabetes care.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391448</data>
    </node>
    <node id="Annexure C2: Rapid Screening for Diabetic Neuropathy">
      <data key="d0">Annexure C2: Rapid Screening for Diabetic Neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">A document referenced in the text detailing a rapid screening method for diabetic neuropathy.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391448</data>
    </node>
    <node id="Inheritance of Diabetes">
      <data key="d0">Inheritance of Diabetes</data>
      <data key="d1">category</data>
      <data key="d2">A table in the text discussing the inheritance patterns of diabetes based on parental status and associated risks.</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391449</data>
    </node>
    <node id="South Asian Descent">
      <data key="d0">South Asian Descent</data>
      <data key="d1">category</data>
      <data key="d2">South Asian Descent is a category of individuals identified as having an increased risk for gestational diabetes.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391449</data>
    </node>
    <node id="Family Planning">
      <data key="d0">Family Planning</data>
      <data key="d1">category</data>
      <data key="d2">Family Planning is a category of pre-conception care emphasizing contraception and reproductive health for women with diabetes.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391449</data>
    </node>
    <node id="Pre-Conception Care">
      <data key="d0">Pre-Conception Care</data>
      <data key="d1">category</data>
      <data key="d2">Pre-Conception Care is a category of medical guidance for women with diabetes to optimize health before pregnancy.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391449</data>
    </node>
    <node id="Lifestyle Interventions">
      <data key="d0">Lifestyle Interventions</data>
      <data key="d1">category</data>
      <data key="d2">Lifestyle Interventions are strategies, such as weight loss and physical activity, aimed at reducing diabetes risk in older adults.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391449</data>
    </node>
    <node id="Diabetic Complications">
      <data key="d0">Diabetic Complications</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic Complications refers to complications arising from diabetes, which are screened for in pre-conception care to assess risk and manage health outcomes.&lt;SEP&gt;Diabetic complications, such as periodontitis and microvascular/macrovascular issues, are central to the rehabilitation and management discussions.</data>
      <data key="d3">chunk-75ca22fbc387195da8d2321ec5c32e2e&lt;SEP&gt;chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391450</data>
    </node>
    <node id="Asian/Indian descent">
      <data key="d0">Asian/Indian descent</data>
      <data key="d1">category</data>
      <data key="d2">A population group in South Africa with a higher prevalence of type 2 diabetes, requiring earlier screening due to increased risk at lower BMI levels.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391450</data>
    </node>
    <node id="Urbanised Black people">
      <data key="d0">Urbanised Black people</data>
      <data key="d1">category</data>
      <data key="d2">A population group in South Africa with a 6.4% diabetes prevalence, where urbanised Black females over 60 years are at particular risk.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391450</data>
    </node>
    <node id="White and Coloured people">
      <data key="d0">White and Coloured people</data>
      <data key="d1">category</data>
      <data key="d2">A population group in South Africa with a 6.2% diabetes prevalence, where Coloured individuals over 60 years, especially females, are at higher risk.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391450</data>
    </node>
    <node id="Coloured individuals">
      <data key="d0">Coloured individuals</data>
      <data key="d1">category</data>
      <data key="d2">A population group in South Africa with significant obesity prevalence (26.3%) and a correlation between obesity and diabetes, particularly in females.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391451</data>
    </node>
    <node id="African women">
      <data key="d0">African women</data>
      <data key="d1">category</data>
      <data key="d2">A subgroup in South Africa with a 31.8% obesity prevalence and a strong link between obesity and diabetes, contributing to higher diabetes risk.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391451</data>
    </node>
    <node id="White women">
      <data key="d0">White women</data>
      <data key="d1">category</data>
      <data key="d2">A subgroup in South Africa with a 21.1% obesity prevalence, lower than other groups, but still relevant in diabetes risk assessment.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391451</data>
    </node>
    <node id="Diabetes mellitus">
      <data key="d0">Diabetes mellitus</data>
      <data key="d1">category</data>
      <data key="d2">A chronic metabolic disorder discussed in the text, with increasing prevalence in South Africa's HIV-positive population on ARVs and among high-risk ethnic groups.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391451</data>
    </node>
    <node id="HAART">
      <data key="d0">HAART</data>
      <data key="d1">category</data>
      <data key="d2">A treatment regimen for HIV that contributes to metabolic complications, including dysglycaemia, dyslipidaemia, lipodystrophy, and accelerated atherosclerosis.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391451</data>
    </node>
    <node id="Dysglycaemia">
      <data key="d0">Dysglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">A metabolic complication linked to HIV and HAART, characterized by impaired glucose regulation and increased insulin resistance.&lt;SEP&gt;Dysglycaemia refers to impaired glucose regulation, which is linked to HIV infection, particularly due to chronic inflammation and insulin resistance.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391451</data>
    </node>
    <node id="Insulin resistance">
      <data key="d0">Insulin resistance</data>
      <data key="d1">category</data>
      <data key="d2">A metabolic abnormality associated with HIV and HAART, contributing to the development of diabetes mellitus in affected populations.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391452</data>
    </node>
    <node id="Lipodystrophy">
      <data key="d0">Lipodystrophy</data>
      <data key="d1">category</data>
      <data key="d2">A metabolic complication of HAART, characterized by abnormal fat distribution, and associated with increased diabetes risk in HIV-positive individuals.&lt;SEP&gt;Lipodystrophy is a condition involving abnormal fat distribution, often seen in HIV patients, and is a risk factor for diabetes mellitus.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391452</data>
    </node>
    <node id="Accelerated atherosclerosis">
      <data key="d0">Accelerated atherosclerosis</data>
      <data key="d1">category</data>
      <data key="d2">A cardiovascular complication linked to HIV and HAART, exacerbating diabetes-related risks in affected patients.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391452</data>
    </node>
    <node id="Type 2 diabetes">
      <data key="d0">Type 2 diabetes</data>
      <data key="d1">category</data>
      <data key="d2">A form of diabetes discussed in the text, with varying prevalence rates across South African population groups and increased screening recommendations for high-risk ethnic groups.&lt;SEP&gt;A medical condition characterized by insulin resistance and relative insulin deficiency, for which fasting may be considered under specific conditions.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391452</data>
    </node>
    <node id="Micro- and macrovascular complications">
      <data key="d0">Micro- and macrovascular complications</data>
      <data key="d1">category</data>
      <data key="d2">Complications of diabetes mellitus, requiring vigilance by healthcare providers in managing high-risk ethnic groups and HIV-positive patients.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391452</data>
    </node>
    <node id="C3 Aspirin Therapy in Diabetes">
      <data key="d0">C3 Aspirin Therapy in Diabetes</data>
      <data key="d1">category</data>
      <data key="d2">A guideline referenced in the text for aspirin use as secondary prevention of cardiovascular events in diabetic patients.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391452</data>
    </node>
    <node id="D4. HIGH-RISK ETHNIC GROUPS AND DIABETES">
      <data key="d0">D4. HIGH-RISK ETHNIC GROUPS AND DIABETES</data>
      <data key="d1">category</data>
      <data key="d2">A section discussing disparities in diabetes prevalence and complications among South African population groups, emphasizing targeted screening and management strategies.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391452</data>
    </node>
    <node id="D5. HIV AND DIABETES">
      <data key="d0">D5. HIV AND DIABETES</data>
      <data key="d1">category</data>
      <data key="d2">A section highlighting the intersection of HIV and diabetes in South Africa, emphasizing the need for regular screening and management of metabolic complications in HIV-positive patients.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391452</data>
    </node>
    <node id="Aspirin">
      <data key="d0">Aspirin</data>
      <data key="d1">category</data>
      <data key="d2">A medication recommended for secondary prevention of cardiovascular events in older diabetic patients and those with diastolic hypertension.&lt;SEP&gt;Aspirin refers to a medication discussed in a 2009 meta-analysis on vascular disease prevention.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391453</data>
    </node>
    <node id="Glimepiride">
      <data key="d0">Glimepiride</data>
      <data key="d1">category</data>
      <data key="d2">A sulphonylurea medication preferred for elderly patients, associated with fewer hypoglycaemic and cardiovascular events compared to glibenclamide.&lt;SEP&gt;A sulphonylurea medication, for which timing adjustments may be necessary during fasting.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442&lt;SEP&gt;chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391453</data>
    </node>
    <node id="Glitazones">
      <data key="d0">Glitazones</data>
      <data key="d1">category</data>
      <data key="d2">A class of antidiabetic drugs avoided in the elderly due to risks of fluid retention, cardiac failure, and osteoporotic fractures.</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391453</data>
    </node>
    <node id="CD4 cut off point">
      <data key="d0">CD4 cut off point</data>
      <data key="d1">category</data>
      <data key="d2">"A medical parameter related to HIV treatment, specifically referencing the threshold (350 cells/mm³</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391453</data>
    </node>
    <node id="Accelerated Atherosclerosis">
      <data key="d0">Accelerated Atherosclerosis</data>
      <data key="d1">category</data>
      <data key="d2">Accelerated atherosclerosis is a cardiovascular complication associated with HIV and metabolic abnormalities, contributing to increased health risks in affected individuals.</data>
      <data key="d3">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391454</data>
    </node>
    <node id="Hepatitis C">
      <data key="d0">Hepatitis C</data>
      <data key="d1">category</data>
      <data key="d2">Hepatitis C is a viral infection that acts as a non-traditional risk factor for type 2 diabetes, primarily through liver-related insulin resistance.</data>
      <data key="d3">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391454</data>
    </node>
    <node id="Antiretroviral Therapy (ART)">
      <data key="d0">Antiretroviral Therapy (ART)</data>
      <data key="d1">category</data>
      <data key="d2">Antiretroviral therapy (ART) is a treatment for HIV that is associated with metabolic complications such as dysglycaemia and is a significant risk factor for diabetes mellitus in HIV-positive patients.</data>
      <data key="d3">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391454</data>
    </node>
    <node id="Zidovudine">
      <data key="d0">Zidovudine</data>
      <data key="d1">category</data>
      <data key="d2">Zidovudine is an antiretroviral drug that suppresses bone marrow and affects the reliability of HbA1c as a diagnostic test in HIV-positive patients.</data>
      <data key="d3">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391454</data>
    </node>
    <node id="Oral Glucose Tolerance Test (OGTT)">
      <data key="d0">Oral Glucose Tolerance Test (OGTT)</data>
      <data key="d1">category</data>
      <data key="d2">Oral glucose tolerance test (OGTT) is the preferred diagnostic method for diabetes in HIV-positive patients, as opposed to HbA1c.</data>
      <data key="d3">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391454</data>
    </node>
    <node id="Structured Education Programme">
      <data key="d0">Structured Education Programme</data>
      <data key="d1">category</data>
      <data key="d2">Structured education programme is a therapeutic intervention for individuals with diabetes planning to fast, focusing on meal planning, glucose monitoring, and medication management.</data>
      <data key="d3">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391455</data>
    </node>
    <node id="Type 1 diabetes">
      <data key="d0">Type 1 diabetes</data>
      <data key="d1">category</data>
      <data key="d2">A medical condition characterized by absolute insulin deficiency, for which fasting is contraindicated.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391455</data>
    </node>
    <node id="Severe and recurrent episodes of hypoglycaemia with unawareness">
      <data key="d0">Severe and recurrent episodes of hypoglycaemia with unawareness</data>
      <data key="d1">category</data>
      <data key="d2">A condition involving frequent, severe hypoglycaemic episodes with a lack of awareness, making fasting contraindicated.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391455</data>
    </node>
    <node id="Poor glycaemic control">
      <data key="d0">Poor glycaemic control</data>
      <data key="d1">category</data>
      <data key="d2">A state of suboptimal blood glucose management, which is a contraindication for fasting.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391455</data>
    </node>
    <node id="Hyperosmolar hyperglycaemic state">
      <data key="d0">Hyperosmolar hyperglycaemic state</data>
      <data key="d1">category</data>
      <data key="d2">A life-threatening condition involving severe hyperglycaemia and dehydration, contraindicating fasting if present within 3 months.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391455</data>
    </node>
    <node id="Severe acute illness">
      <data key="d0">Severe acute illness</data>
      <data key="d1">category</data>
      <data key="d2">A critical health condition that makes fasting contraindicated.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391456</data>
    </node>
    <node id="Occupations that require intense physical labour">
      <data key="d0">Occupations that require intense physical labour</data>
      <data key="d1">category</data>
      <data key="d2">Professions involving heavy physical work, for which fasting is contraindicated due to increased risk.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391456</data>
    </node>
    <node id="Co-morbidities">
      <data key="d0">Co-morbidities</data>
      <data key="d1">category</data>
      <data key="d2">Additional health conditions that may contraindicate fasting, such as advanced macrovascular complications, renal insufficiency, cognitive dysfunction, or uncontrolled epilepsy.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391456</data>
    </node>
    <node id="Pregnant women">
      <data key="d0">Pregnant women</data>
      <data key="d1">category</data>
      <data key="d2">A group for whom fasting is contraindicated due to potential risks to maternal and fetal health.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391456</data>
    </node>
    <node id="Dietary adjustment">
      <data key="d0">Dietary adjustment</data>
      <data key="d1">category</data>
      <data key="d2">A treatment approach for type 2 diabetes, involving modifications to food intake for fasting management.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391456</data>
    </node>
    <node id="Monotherapy with metformin">
      <data key="d0">Monotherapy with metformin</data>
      <data key="d1">category</data>
      <data key="d2">A treatment strategy for type 2 diabetes involving the use of metformin alone, which may permit fasting under certain conditions.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391456</data>
    </node>
    <node id="DPP-4 inhibitors">
      <data key="d0">DPP-4 inhibitors</data>
      <data key="d1">category</data>
      <data key="d2">A class of medications used in type 2 diabetes management, potentially compatible with fasting when combined with other strategies.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391456</data>
    </node>
    <node id="Thiazolidinediones">
      <data key="d0">Thiazolidinediones</data>
      <data key="d1">category</data>
      <data key="d2">A class of antidiabetic drugs that may be used in fasting management for type 2 diabetes under specific conditions.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391456</data>
    </node>
    <node id="Combination oral treatment">
      <data key="d0">Combination oral treatment</data>
      <data key="d1">category</data>
      <data key="d2">A treatment approach involving multiple oral antidiabetic medications, requiring careful management during fasting.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391457</data>
    </node>
    <node id="Oral plus insulin treatment">
      <data key="d0">Oral plus insulin treatment</data>
      <data key="d1">category</data>
      <data key="d2">A treatment strategy combining oral antidiabetic drugs with insulin, necessitating specific adjustments during fasting.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391457</data>
    </node>
    <node id="Short acting insulin secretogogue (glinide)">
      <data key="d0">Short acting insulin secretogogue (glinide)</data>
      <data key="d1">category</data>
      <data key="d2">A type of insulin secretagogue used in type 2 diabetes, requiring specific management during fasting.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391457</data>
    </node>
    <node id="Glinide">
      <data key="d0">Glinide</data>
      <data key="d1">category</data>
      <data key="d2">A class of short-acting insulin secretagogues, requiring specific management during fasting.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391457</data>
    </node>
    <node id="Intermediate-acting insulin">
      <data key="d0">Intermediate-acting insulin</data>
      <data key="d1">category</data>
      <data key="d2">A type of insulin used in fasting management, requiring specific administration timing.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391457</data>
    </node>
    <node id="Rapid-acting insulin">
      <data key="d0">Rapid-acting insulin</data>
      <data key="d1">category</data>
      <data key="d2">A type of insulin used in fasting management, requiring administration before meals.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391458</data>
    </node>
    <node id="Pre-mixed insulin">
      <data key="d0">Pre-mixed insulin</data>
      <data key="d1">category</data>
      <data key="d2">A type of insulin formulation requiring dose timing adjustments during fasting.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391458</data>
    </node>
    <node id="Self-monitoring blood glucose">
      <data key="d0">Self-monitoring blood glucose</data>
      <data key="d1">category</data>
      <data key="d2">A practice essential for managing diabetes during fasting, involving regular glucose level checks.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391458</data>
    </node>
    <node id="Meal planning">
      <data key="d0">Meal planning</data>
      <data key="d1">category</data>
      <data key="d2">A component of a structured education programme for diabetes management, focusing on planning meals during fasting periods.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391458</data>
    </node>
    <node id="Physical activity">
      <data key="d0">Physical activity</data>
      <data key="d1">category</data>
      <data key="d2">A component of a structured education programme for diabetes management, addressing appropriate levels of exercise during fasting.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391459</data>
    </node>
    <node id="Dosage and timing of medications">
      <data key="d0">Dosage and timing of medications</data>
      <data key="d1">category</data>
      <data key="d2">A component of a structured education programme for diabetes management, involving adjustments to medication schedules during fasting.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391459</data>
    </node>
    <node id="Glucose monitoring">
      <data key="d0">Glucose monitoring</data>
      <data key="d1">category</data>
      <data key="d2">A component of a structured education programme for diabetes management, emphasizing regular blood glucose checks during fasting.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391459</data>
    </node>
    <node id="Recognition and management of untoward events including hypoglycaemia">
      <data key="d0">Recognition and management of untoward events including hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">A component of a structured education programme for diabetes management, teaching patients to identify and handle complications like hypoglycaemia.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391459</data>
    </node>
    <node id="Health care professional">
      <data key="d0">Health care professional</data>
      <data key="d1">person</data>
      <data key="d2">A medical provider who assesses patients with type 2 diabetes before fasting and adjusts their treatment plans.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391459</data>
    </node>
    <node id="Family members/carers">
      <data key="d0">Family members/carers</data>
      <data key="d1">person</data>
      <data key="d2">Individuals involved in the care of patients with type 2 diabetes, educated on fasting-related diabetes management.</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391459</data>
    </node>
    <node id="American Diabetes Association">
      <data key="d0">American Diabetes Association</data>
      <data key="d1">organization</data>
      <data key="d2">American Diabetes Association is an organization that published clinical practice recommendations for diabetes in 2004.&lt;SEP&gt;The American Diabetes Association is referenced in the guidelines as a source for diabetes care standards.&lt;SEP&gt;The American Diabetes Association recommends the use of metformin for specific patient groups in diabetes prevention.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-e40dd1b6f667a901a4ea2e77d6f8087a&lt;SEP&gt;chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391460</data>
    </node>
    <node id="Self-Monitoring Blood Glucose (SMBG)">
      <data key="d0">Self-Monitoring Blood Glucose (SMBG)</data>
      <data key="d1">category</data>
      <data key="d2">Self-Monitoring Blood Glucose (SMBG) is a mandatory practice for people with diabetes who fast, essential for preventing hypoglycaemia and adjusting insulin doses.</data>
      <data key="d3">chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391460</data>
    </node>
    <node id="Insulin Injection">
      <data key="d0">Insulin Injection</data>
      <data key="d1">category</data>
      <data key="d2">Insulin Injection is a treatment method for diabetes that does not break the fast according to the text.</data>
      <data key="d3">chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391460</data>
    </node>
    <node id="Cataracts">
      <data key="d0">Cataracts</data>
      <data key="d1">category</data>
      <data key="d2">Cataracts are a chronic complication of diabetes that may impair vision and driving ability.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391460</data>
    </node>
    <node id="Healthcare Professionals">
      <data key="d0">Healthcare Professionals</data>
      <data key="d1">category</data>
      <data key="d2">Healthcare professionals are responsible for assessing and documenting the suitability of individuals with diabetes to drive.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391460</data>
    </node>
    <node id="Commercial Vehicles">
      <data key="d0">Commercial Vehicles</data>
      <data key="d1">category</data>
      <data key="d2">Commercial vehicles are subject to stricter licensing requirements due to the potential for severe traffic accidents involving larger vehicles.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391460</data>
    </node>
    <node id="Private Vehicles">
      <data key="d0">Private Vehicles</data>
      <data key="d1">category</data>
      <data key="d2">Private vehicles are generally subject to fewer restrictions for drivers with diabetes compared to commercial vehicles.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391460</data>
    </node>
    <node id="Severe Hypoglycaemic Events">
      <data key="d0">Severe Hypoglycaemic Events</data>
      <data key="d1">category</data>
      <data key="d2">Severe hypoglycaemic events are a significant risk factor for drivers with diabetes, increasing the likelihood of accidents.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391460</data>
    </node>
    <node id="Insulin Therapy">
      <data key="d0">Insulin Therapy</data>
      <data key="d1">category</data>
      <data key="d2">Insulin therapy is a treatment for diabetes that, in itself, has not been found to increase driving risk.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391461</data>
    </node>
    <node id="Road Traffic Act of 1996">
      <data key="d0">Road Traffic Act of 1996</data>
      <data key="d1">event</data>
      <data key="d2">The Road Traffic Act of 1996 in South Africa outlines disqualification criteria for drivers with uncontrolled diabetes.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391461</data>
    </node>
    <node id="MEC of the Province">
      <data key="d0">MEC of the Province</data>
      <data key="d1">organization</data>
      <data key="d2">The MEC of the Province is a provincial authority in South Africa responsible for receiving and processing driver's licences under the Road Traffic Act.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391461</data>
    </node>
    <node id="Attention Deficit/Hyperactivity Disorder">
      <data key="d0">Attention Deficit/Hyperactivity Disorder</data>
      <data key="d1">category</data>
      <data key="d2">Attention Deficit/Hyperactivity Disorder is a condition mentioned in the text as a situation with higher relative risks compared to diabetes-related driving risks.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391461</data>
    </node>
    <node id="Annual Assessment">
      <data key="d0">Annual Assessment</data>
      <data key="d1">event</data>
      <data key="d2">Annual assessment refers to the required periodic medical evaluations for commercial drivers with diabetes as recommended in the text.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391462</data>
    </node>
    <node id="Initial Full Medical Assessment">
      <data key="d0">Initial Full Medical Assessment</data>
      <data key="d1">event</data>
      <data key="d2">Initial full medical assessment is the process required for commercial drivers with diabetes applying for a licence.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391462</data>
    </node>
    <node id="Endocrinologist">
      <data key="d0">Endocrinologist</data>
      <data key="d1">category</data>
      <data key="d2">Endocrinologist is a specialist physician involved in the annual assessment of commercial drivers with diabetes.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391462</data>
    </node>
    <node id="Family Physician">
      <data key="d0">Family Physician</data>
      <data key="d1">category</data>
      <data key="d2">Family physician is a healthcare professional trained in diabetes management and involved in the assessment of commercial drivers with diabetes.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391462</data>
    </node>
    <node id="Blood Glucose Test Strips">
      <data key="d0">Blood Glucose Test Strips</data>
      <data key="d1">category</data>
      <data key="d2">Blood glucose test strips are tools provided to drivers with diabetes for monitoring blood glucose levels before and during driving.</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391462</data>
    </node>
    <node id="International Union Against Tuberculosis and Lung Disease">
      <data key="d0">International Union Against Tuberculosis and Lung Disease</data>
      <data key="d1">organization</data>
      <data key="d2">An organization that collaborates with the WHO to develop a framework for the care and control of tuberculosis and diabetes.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391463</data>
    </node>
    <node id="Tuberculosis (TB)">
      <data key="d0">Tuberculosis (TB)</data>
      <data key="d1">category</data>
      <data key="d2">A disease with significantly higher prevalence among people with diabetes, requiring surveillance and treatment protocols.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391463</data>
    </node>
    <node id="Blood Glucose Monitoring">
      <data key="d0">Blood Glucose Monitoring</data>
      <data key="d1">category</data>
      <data key="d2">A medical practice involving regular blood glucose testing, particularly for drivers with diabetes and those at risk of hypoglycaemia.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391463</data>
    </node>
    <node id="National TB Management Guidelines">
      <data key="d0">National TB Management Guidelines</data>
      <data key="d1">category</data>
      <data key="d2">A document outlining treatment protocols for tuberculosis, including monitoring for side effects and hyperglycaemia.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391463</data>
    </node>
    <node id="Collaborative Framework for Care and Control of Tuberculosis and Diabetes">
      <data key="d0">Collaborative Framework for Care and Control of Tuberculosis and Diabetes</data>
      <data key="d1">category</data>
      <data key="d2">A framework developed by the WHO and the International Union Against Tuberculosis and Lung Disease to guide integrated care and control of tuberculosis and diabetes.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391463</data>
    </node>
    <node id="4-symptom screening tool">
      <data key="d0">4-symptom screening tool</data>
      <data key="d1">category</data>
      <data key="d2">A standardised screening tool for tuberculosis, based on symptoms: cough lasting more than 2 weeks, loss of weight, night sweats, and fever.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391463</data>
    </node>
    <node id="Cough lasting more than 2 weeks">
      <data key="d0">Cough lasting more than 2 weeks</data>
      <data key="d1">category</data>
      <data key="d2">A symptom used in the 4-symptom screening tool for tuberculosis detection.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391463</data>
    </node>
    <node id="Loss of weight">
      <data key="d0">Loss of weight</data>
      <data key="d1">category</data>
      <data key="d2">A symptom used in the 4-symptom screening tool for tuberculosis detection.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391463</data>
    </node>
    <node id="Night sweats">
      <data key="d0">Night sweats</data>
      <data key="d1">category</data>
      <data key="d2">A symptom used in the 4-symptom screening tool for tuberculosis detection.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391463</data>
    </node>
    <node id="Fever">
      <data key="d0">Fever</data>
      <data key="d1">category</data>
      <data key="d2">A symptom used in the 4-symptom screening tool for tuberculosis detection.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391464</data>
    </node>
    <node id="Gingivitis">
      <data key="d0">Gingivitis</data>
      <data key="d1">category</data>
      <data key="d2">A reversible form of periodontal disease caused by plaque buildup, requiring timely oral hygiene practices.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391464</data>
    </node>
    <node id="Periondontitis">
      <data key="d0">Periondontitis</data>
      <data key="d1">category</data>
      <data key="d2">A severe form of periodontal disease involving destruction of the periodontal ligament, caused by plaque and calculus.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391464</data>
    </node>
    <node id="Plaque">
      <data key="d0">Plaque</data>
      <data key="d1">category</data>
      <data key="d2">A bacterial film on teeth that contributes to gingivitis and periodontitis when not properly managed.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391464</data>
    </node>
    <node id="Calculus">
      <data key="d0">Calculus</data>
      <data key="d1">category</data>
      <data key="d2">Calculus refers to hardened dental plaque that exacerbates periodontitis by promoting inflammation and bone loss.&lt;SEP&gt;Hardened plaque deposits that contribute to periodontitis and require professional dental removal.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c&lt;SEP&gt;chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391465</data>
    </node>
    <node id="Gingival sulcus">
      <data key="d0">Gingival sulcus</data>
      <data key="d1">category</data>
      <data key="d2">A natural anatomical feature around the tooth root that deepens in periodontitis, leading to pocket formation.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391465</data>
    </node>
    <node id="Pocket">
      <data key="d0">Pocket</data>
      <data key="d1">category</data>
      <data key="d2">A deepened gingival sulcus in periodontitis that collects bacteria, exacerbating inflammation and insulin resistance.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391465</data>
    </node>
    <node id="Infection control plan">
      <data key="d0">Infection control plan</data>
      <data key="d1">category</data>
      <data key="d2">A set of administrative and environmental measures to prevent TB transmission in healthcare settings.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391465</data>
    </node>
    <node id="Infection control measures">
      <data key="d0">Infection control measures</data>
      <data key="d1">category</data>
      <data key="d2">Specific actions within an infection control plan to reduce TB transmission in healthcare facilities.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391465</data>
    </node>
    <node id="National programmes">
      <data key="d0">National programmes</data>
      <data key="d1">category</data>
      <data key="d2">Refers to South African programs implementing collaborative activities for TB and diabetes care, including data collection tools.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391466</data>
    </node>
    <node id="Employers">
      <data key="d0">Employers</data>
      <data key="d1">organization</data>
      <data key="d2">Organizations responsible for informing drivers of hypoglycaemia risks and ensuring safety protocols.</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391466</data>
    </node>
    <node id="SEMDSA Steering Committee">
      <data key="d0">SEMDSA Steering Committee</data>
      <data key="d1">organization</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;The SEMDSA Steering Committee collaborated with the Advisory Committee and the Department of Health to develop a guideline for managing Type 2 Diabetes.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391466</data>
    </node>
    <node id="Advisory Committee">
      <data key="d0">Advisory Committee</data>
      <data key="d1">organization</data>
      <data key="d2">The Advisory Committee worked with the SEMDSA Steering Committee to develop a guideline for managing Type 2 Diabetes.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391466</data>
    </node>
    <node id="International Diabetes Federation">
      <data key="d0">International Diabetes Federation</data>
      <data key="d1">organization</data>
      <data key="d2">The International Diabetes Federation is an organization that published a consensus on the metabolic syndrome.&lt;SEP&gt;The International Diabetes Federation is referenced in the guidelines as a source for diabetes-related information.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950&lt;SEP&gt;chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391467</data>
    </node>
    <node id="Canadian Diabetes Association">
      <data key="d0">Canadian Diabetes Association</data>
      <data key="d1">organization</data>
      <data key="d2">The Canadian Diabetes Association is an organization that has played a significant role in publishing and issuing clinical practice guidelines related to diabetes management in Canada. It released the 2008 clinical practice guidelines for diabetes in Canada, which serve as a foundational resource for healthcare professionals. Additionally, the association issued guidelines addressing diabetes and driving, providing recommendations for individuals with diabetes regarding safe driving practices. It also published clinical practice guidelines specifically focused on diabetic neuropathy, as referenced in various texts. Furthermore, the Canadian Diabetes Association is frequently cited in diabetes-related guidelines as a credible source for evidence-based diabetes management practices. These contributions highlight the organization's ongoing commitment to advancing diabetes care through comprehensive, specialized, and widely recognized resources.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-e40dd1b6f667a901a4ea2e77d6f8087a&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023&lt;SEP&gt;chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391467</data>
    </node>
    <node id="Periodontitis">
      <data key="d0">Periodontitis</data>
      <data key="d1">category</data>
      <data key="d2">Periodontitis is a complication of diabetes caused by tooth plaque and calculus, leading to alveolar bone destruction and deeper gingival sulcus pockets that increase bacterial infection.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391467</data>
    </node>
    <node id="Tooth Plaque">
      <data key="d0">Tooth Plaque</data>
      <data key="d1">category</data>
      <data key="d2">Tooth plaque is a biofilm on teeth that contributes to periodontitis when poorly controlled diabetes increases bacterial accumulation.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391467</data>
    </node>
    <node id="Gingival Sulcus">
      <data key="d0">Gingival Sulcus</data>
      <data key="d1">category</data>
      <data key="d2">The gingival sulcus is the natural space between the tooth and gum that deepens in periodontitis, facilitating bacterial infection.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391467</data>
    </node>
    <node id="Microvascular and Macrovascular Complications">
      <data key="d0">Microvascular and Macrovascular Complications</data>
      <data key="d1">category</data>
      <data key="d2">Microvascular and macrovascular complications are diabetes-related complications that impair body functioning, such as vision loss and limb amputation.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391467</data>
    </node>
    <node id="Rehabilitation Services">
      <data key="d0">Rehabilitation Services</data>
      <data key="d1">category</data>
      <data key="d2">Rehabilitation services are multidisciplinary interventions aimed at restoring function and quality of life for patients with diabetes-related disabilities.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391468</data>
    </node>
    <node id="Multidisciplinary Approach">
      <data key="d0">Multidisciplinary Approach</data>
      <data key="d1">category</data>
      <data key="d2">A multidisciplinary approach involves collaboration among healthcare professionals, patients, and caregivers to manage diabetes rehabilitation effectively.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391468</data>
    </node>
    <node id="Technical Aids and Devices">
      <data key="d0">Technical Aids and Devices</data>
      <data key="d1">category</data>
      <data key="d2">Technical aids and devices, such as wheelchairs and low vision aids, are provided to patients requiring rehabilitation due to diabetes complications.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391468</data>
    </node>
    <node id="Home Programmes">
      <data key="d0">Home Programmes</data>
      <data key="d1">category</data>
      <data key="d2">Home programmes are components of rehabilitation plans that patients follow at home to support therapeutic interventions and prevent complications.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391468</data>
    </node>
    <node id="Early Intervention">
      <data key="d0">Early Intervention</data>
      <data key="d1">category</data>
      <data key="d2">Early intervention refers to timely therapeutic actions to prevent complications from disuse or improper use of body parts in diabetes patients.</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391468</data>
    </node>
    <node id="Endocrine Society">
      <data key="d0">Endocrine Society</data>
      <data key="d1">organization</data>
      <data key="d2">Endocrine Society is an organization that published a clinical practice guideline on the evaluation and management of adult hypoglycemic disorders.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391468</data>
    </node>
    <node id="Cryer PE">
      <data key="d0">Cryer PE</data>
      <data key="d1">person</data>
      <data key="d2">Cryer PE is an author of a clinical practice guideline on adult hypoglycemic disorders.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391468</data>
    </node>
    <node id="Axelrod L">
      <data key="d0">Axelrod L</data>
      <data key="d1">person</data>
      <data key="d2">Axelrod L is an author of a clinical practice guideline on adult hypoglycemic disorders.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391468</data>
    </node>
    <node id="Grosman AB">
      <data key="d0">Grosman AB</data>
      <data key="d1">person</data>
      <data key="d2">Grosman AB is an author of a clinical practice guideline on adult hypoglycemic disorders.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391469</data>
    </node>
    <node id="Canadian Diabetes Association Clinical Practice Guideline Expert Committee">
      <data key="d0">Canadian Diabetes Association Clinical Practice Guideline Expert Committee</data>
      <data key="d1">organization</data>
      <data key="d2">Canadian Diabetes Association Clinical Practice Guideline Expert Committee is an organization that published clinical practice guidelines on hypoglycemia.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391469</data>
    </node>
    <node id="Kitabchi AE">
      <data key="d0">Kitabchi AE</data>
      <data key="d1">person</data>
      <data key="d2">Kitabchi AE is an author of a study on hyperglycaemic crises in adult patients with diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391469</data>
    </node>
    <node id="Umpierrez GE">
      <data key="d0">Umpierrez GE</data>
      <data key="d1">person</data>
      <data key="d2">Umpierrez GE is an author of a study on hyperglycaemic crises in adult patients with diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391469</data>
    </node>
    <node id="Miles JM">
      <data key="d0">Miles JM</data>
      <data key="d1">person</data>
      <data key="d2">Miles JM is an author of a study on hyperglycaemic crises in adult patients with diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391470</data>
    </node>
    <node id="Fisher JN">
      <data key="d0">Fisher JN</data>
      <data key="d1">person</data>
      <data key="d2">Fisher JN is an author of a study on hyperglycaemic crises in adult patients with diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391470</data>
    </node>
    <node id="Hyperglycaemic crises">
      <data key="d0">Hyperglycaemic crises</data>
      <data key="d1">category</data>
      <data key="d2">Hyperglycaemic crises refers to a medical condition discussed in a 2009 study on adult patients with diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391470</data>
    </node>
    <node id="Eledrisi MS">
      <data key="d0">Eledrisi MS</data>
      <data key="d1">person</data>
      <data key="d2">Eledrisi MS is an author of a study on the diagnosis and management of diabetic ketoacidosis.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391470</data>
    </node>
    <node id="Alshanti MS">
      <data key="d0">Alshanti MS</data>
      <data key="d1">person</data>
      <data key="d2">Alshanti MS is an author of a study on the diagnosis and management of diabetic ketoacidosis.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391470</data>
    </node>
    <node id="Shah MF">
      <data key="d0">Shah MF</data>
      <data key="d1">person</data>
      <data key="d2">Shah MF is an author of a study on the diagnosis and management of diabetic ketoacidosis.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391471</data>
    </node>
    <node id="Diabetic ketoacidosis">
      <data key="d0">Diabetic ketoacidosis</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic ketoacidosis refers to a medical condition discussed in a 2006 study.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391471</data>
    </node>
    <node id="Wing RR">
      <data key="d0">Wing RR</data>
      <data key="d1">person</data>
      <data key="d2">Wing RR is an author of a study on the benefits of modest weight loss in improving cardiovascular risk factors for type 2 diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391471</data>
    </node>
    <node id="Exercise and type 2 diabetes">
      <data key="d0">Exercise and type 2 diabetes</data>
      <data key="d1">category</data>
      <data key="d2">Exercise and type 2 diabetes refers to a joint position statement on physical activity and diabetes management.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391471</data>
    </node>
    <node id="Donnelly JE">
      <data key="d0">Donnelly JE</data>
      <data key="d1">person</data>
      <data key="d2">Donnelly JE is an author of a study on appropriate physical activity interventions for weight loss in adults.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391471</data>
    </node>
    <node id="Cardiovascular disease">
      <data key="d0">Cardiovascular disease</data>
      <data key="d1">category</data>
      <data key="d2">Cardiovascular disease refers to a topic discussed in a 2008 study on type 2 diabetes mellitus.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391472</data>
    </node>
    <node id="Alberti KGMM">
      <data key="d0">Alberti KGMM</data>
      <data key="d1">person</data>
      <data key="d2">Alberti KGMM is an author of a study on harmonizing the metabolic syndrome.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391472</data>
    </node>
    <node id="Eckel RH">
      <data key="d0">Eckel RH</data>
      <data key="d1">person</data>
      <data key="d2">Eckel RH is an author of a study on harmonizing the metabolic syndrome.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391472</data>
    </node>
    <node id="Grundy SM">
      <data key="d0">Grundy SM</data>
      <data key="d1">person</data>
      <data key="d2">Grundy SM is an author of a study on harmonizing the metabolic syndrome.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391472</data>
    </node>
    <node id="Metabolic syndrome">
      <data key="d0">Metabolic syndrome</data>
      <data key="d1">category</data>
      <data key="d2">Metabolic syndrome refers to a topic discussed in a 2009 study on harmonizing definitions.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391472</data>
    </node>
    <node id="Antithrombotic Trialists' (ATT) Collaboration">
      <data key="d0">Antithrombotic Trialists' (ATT) Collaboration</data>
      <data key="d1">organization</data>
      <data key="d2">Antithrombotic Trialists' (ATT) Collaboration is an organization that published a meta-analysis on aspirin use in vascular disease prevention.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391472</data>
    </node>
    <node id="Baigent C">
      <data key="d0">Baigent C</data>
      <data key="d1">person</data>
      <data key="d2">Baigent C is an author of a meta-analysis on aspirin use in vascular disease prevention.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391472</data>
    </node>
    <node id="Blackwell L">
      <data key="d0">Blackwell L</data>
      <data key="d1">person</data>
      <data key="d2">Blackwell L is an author of a meta-analysis on aspirin use in vascular disease prevention.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391472</data>
    </node>
    <node id="Collins R">
      <data key="d0">Collins R</data>
      <data key="d1">person</data>
      <data key="d2">Collins R is an author of a meta-analysis on aspirin use in vascular disease prevention.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391473</data>
    </node>
    <node id="Pignone M">
      <data key="d0">Pignone M</data>
      <data key="d1">person</data>
      <data key="d2">Pignone M is an author of an ADA position statement on aspirin use for cardiovascular prevention in diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391473</data>
    </node>
    <node id="Alberts MJ">
      <data key="d0">Alberts MJ</data>
      <data key="d1">person</data>
      <data key="d2">Alberts MJ is an author of an ADA position statement on aspirin use for cardiovascular prevention in diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391473</data>
    </node>
    <node id="Colwell JA">
      <data key="d0">Colwell JA</data>
      <data key="d1">person</data>
      <data key="d2">Colwell JA is an author of an ADA position statement on aspirin use for cardiovascular prevention in diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391473</data>
    </node>
    <node id="Saito Y">
      <data key="d0">Saito Y</data>
      <data key="d1">person</data>
      <data key="d2">Saito Y is an author of a study on low-dose aspirin therapy in type 2 diabetes patients with reduced glomerular filtration rate.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391473</data>
    </node>
    <node id="Morimoto T">
      <data key="d0">Morimoto T</data>
      <data key="d1">person</data>
      <data key="d2">Morimoto T is an author of a study on low-dose aspirin therapy in type 2 diabetes patients with reduced glomerular filtration rate.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391474</data>
    </node>
    <node id="Ogawa H">
      <data key="d0">Ogawa H</data>
      <data key="d1">person</data>
      <data key="d2">Ogawa H is an author of a study on low-dose aspirin therapy in type 2 diabetes patients with reduced glomerular filtration rate.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391474</data>
    </node>
    <node id="JPAD trial">
      <data key="d0">JPAD trial</data>
      <data key="d1">event</data>
      <data key="d2">JPAD trial refers to a study on low-dose aspirin therapy in type 2 diabetes patients.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391474</data>
    </node>
    <node id="Curb JD">
      <data key="d0">Curb JD</data>
      <data key="d1">person</data>
      <data key="d2">Curb JD is an author of a study on diuretic-based anti-hypertensive treatment in older diabetic patients.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391474</data>
    </node>
    <node id="Pressel SL">
      <data key="d0">Pressel SL</data>
      <data key="d1">person</data>
      <data key="d2">Pressel SL is an author of a study on diuretic-based anti-hypertensive treatment in older diabetic patients.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391475</data>
    </node>
    <node id="Cutler JA">
      <data key="d0">Cutler JA</data>
      <data key="d1">person</data>
      <data key="d2">Cutler JA is an author of a study on diuretic-based anti-hypertensive treatment in older diabetic patients.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391475</data>
    </node>
    <node id="Systolic Hypertension in the Elderly Program Cooperative Research Group">
      <data key="d0">Systolic Hypertension in the Elderly Program Cooperative Research Group</data>
      <data key="d1">organization</data>
      <data key="d2">Systolic Hypertension in the Elderly Program Cooperative Research Group is an organization that published a study on anti-hypertensive treatment in older diabetic patients.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391475</data>
    </node>
    <node id="ACCORD Study Group">
      <data key="d0">ACCORD Study Group</data>
      <data key="d1">organization</data>
      <data key="d2">ACCORD Study Group is an organization that published a study on intensive blood pressure control in type 2 diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391475</data>
    </node>
    <node id="Cushman WC">
      <data key="d0">Cushman WC</data>
      <data key="d1">person</data>
      <data key="d2">Cushman WC is an author of a study on intensive blood pressure control in type 2 diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391475</data>
    </node>
    <node id="Evans GW">
      <data key="d0">Evans GW</data>
      <data key="d1">person</data>
      <data key="d2">Evans GW is an author of a study on intensive blood pressure control in type 2 diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391476</data>
    </node>
    <node id="Byington RP">
      <data key="d0">Byington RP</data>
      <data key="d1">person</data>
      <data key="d2">Byington RP is an author of a study on intensive blood pressure control in type 2 diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391476</data>
    </node>
    <node id="UK Prospective Diabetes Study Group">
      <data key="d0">UK Prospective Diabetes Study Group</data>
      <data key="d1">organization</data>
      <data key="d2">UK Prospective Diabetes Study Group is an organization that published a study on tight blood pressure control in type 2 diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391476</data>
    </node>
    <node id="Rhonda M, Cooper-DeHoff">
      <data key="d0">Rhonda M, Cooper-DeHoff</data>
      <data key="d1">person</data>
      <data key="d2">Rhonda M, Cooper-DeHoff is an author of a study on blood pressure lowering in diabetic patients.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391476</data>
    </node>
    <node id="Egelund EF">
      <data key="d0">Egelund EF</data>
      <data key="d1">person</data>
      <data key="d2">Egelund EF is an author of a study on blood pressure lowering in diabetic patients.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391476</data>
    </node>
    <node id="Pepine C">
      <data key="d0">Pepine C</data>
      <data key="d1">person</data>
      <data key="d2">Pepine C is an author of a study on blood pressure lowering in diabetic patients.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391476</data>
    </node>
    <node id="Palmer AJ">
      <data key="d0">Palmer AJ</data>
      <data key="d1">person</data>
      <data key="d2">Palmer AJ is an author of a health economic analysis on nephropathy in patients with type 2 diabetes and hypertension in the USA.&lt;SEP&gt;Palmer AJ is an author of a health economic analysis on nephropathy screening and treatment in diabetic patients.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391476</data>
    </node>
    <node id="Valentine WJ">
      <data key="d0">Valentine WJ</data>
      <data key="d1">person</data>
      <data key="d2">Valentine WJ is an author of a health economic analysis on nephropathy in patients with type 2 diabetes and hypertension in the USA.&lt;SEP&gt;Valentine WJ is an author of a health economic analysis on nephropathy screening and treatment in diabetic patients.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391476</data>
    </node>
    <node id="Chen R">
      <data key="d0">Chen R</data>
      <data key="d1">person</data>
      <data key="d2">Chen R is an author of a health economic analysis on nephropathy in patients with type 2 diabetes and hypertension in the USA.&lt;SEP&gt;Chen R is an author of a health economic analysis on nephropathy screening and treatment in diabetic patients.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391476</data>
    </node>
    <node id="J Clin Endocrinol Metab">
      <data key="d0">J Clin Endocrinol Metab</data>
      <data key="d1">organization</data>
      <data key="d2">J Clin Endocrinol Metab is a scientific journal where studies on endocrinology and metabolism are published.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391477</data>
    </node>
    <node id="Diabetes Care">
      <data key="d0">Diabetes Care</data>
      <data key="d1">organization</data>
      <data key="d2">Diabetes Care is a journal that published a study on re-evaluating the classification of the diabetic foot.&lt;SEP&gt;Diabetes Care is a journal that published a study on the Ipswich touch test for identifying diabetes foot ulceration risk.&lt;SEP&gt;Diabetes Care is a peer-reviewed medical journal focusing on diabetes research and clinical care.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391477</data>
    </node>
    <node id="Am J Med Sci">
      <data key="d0">Am J Med Sci</data>
      <data key="d1">organization</data>
      <data key="d2">Am J Med Sci is a medical journal publishing original research and reviews in clinical medicine.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391477</data>
    </node>
    <node id="Lancet">
      <data key="d0">Lancet</data>
      <data key="d1">organization</data>
      <data key="d2">Lancet is a leading international general medical journal.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391477</data>
    </node>
    <node id="Medicine and Science in Sports and Exercise">
      <data key="d0">Medicine and Science in Sports and Exercise</data>
      <data key="d1">organization</data>
      <data key="d2">Medicine and Science in Sports and Exercise is a journal covering sports medicine and exercise physiology.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391478</data>
    </node>
    <node id="Circulation">
      <data key="d0">Circulation</data>
      <data key="d1">organization</data>
      <data key="d2">Circulation is a journal published by the American Heart Association focusing on cardiovascular disease.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391478</data>
    </node>
    <node id="JAMA">
      <data key="d0">JAMA</data>
      <data key="d1">organization</data>
      <data key="d2">JAMA (Journal of the American Medical Association) is a general medical journal.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391478</data>
    </node>
    <node id="BMJ">
      <data key="d0">BMJ</data>
      <data key="d1">organization</data>
      <data key="d2">BMJ (British Medical Journal) is a peer-reviewed medical journal.&lt;SEP&gt;BMJ is a journal that published a study on adding retinal photography to screening for diabetic retinopathy in primary care.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391478</data>
    </node>
    <node id="Am J Kidney Dis">
      <data key="d0">Am J Kidney Dis</data>
      <data key="d1">organization</data>
      <data key="d2">Am J Kidney Dis is a journal focusing on kidney disease and nephrology.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391478</data>
    </node>
    <node id="Hyperglycaemic hyperosmolar state">
      <data key="d0">Hyperglycaemic hyperosmolar state</data>
      <data key="d1">category</data>
      <data key="d2">Hyperglycaemic hyperosmolar state is a medical condition characterized by extreme hyperglycemia and dehydration.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391479</data>
    </node>
    <node id="Modest weight loss">
      <data key="d0">Modest weight loss</data>
      <data key="d1">category</data>
      <data key="d2">Modest weight loss refers to a controlled reduction in body weight to improve health outcomes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391479</data>
    </node>
    <node id="Physical activity intervention strategies">
      <data key="d0">Physical activity intervention strategies</data>
      <data key="d1">category</data>
      <data key="d2">Physical activity intervention strategies are methods to promote exercise for health benefits.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391479</data>
    </node>
    <node id="Screening and treatment of diabetic nephropathy">
      <data key="d0">Screening and treatment of diabetic nephropathy</data>
      <data key="d1">category</data>
      <data key="d2">Screening and treatment of diabetic nephropathy involves early detection and management of kidney disease in diabetes.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391479</data>
    </node>
    <node id="SHEP trial">
      <data key="d0">SHEP trial</data>
      <data key="d1">event</data>
      <data key="d2">SHEP trial refers to the Systolic Hypertension in the Elderly Program clinical trial.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391480</data>
    </node>
    <node id="UKPDS study">
      <data key="d0">UKPDS study</data>
      <data key="d1">event</data>
      <data key="d2">UKPDS study refers to the UK Prospective Diabetes Study on diabetes management.</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391480</data>
    </node>
    <node id="Nephrol Dial Transplant">
      <data key="d0">Nephrol Dial Transplant</data>
      <data key="d1">organization</data>
      <data key="d2">Nephrol Dial Transplant is a journal that published a study on the health economic analysis of nephropathy in patients with type 2 diabetes and hypertension in the USA.&lt;SEP&gt;Nephrol Dial Transplant is a journal that published a study on the unrecognized prevalence of chronic kidney disease in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391480</data>
    </node>
    <node id="McFarlane P">
      <data key="d0">McFarlane P</data>
      <data key="d1">person</data>
      <data key="d2">McFarlane P is an author of the 2008 Clinical Practice Guidelines on chronic kidney disease in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391480</data>
    </node>
    <node id="Culleton B">
      <data key="d0">Culleton B</data>
      <data key="d1">person</data>
      <data key="d2">Culleton B is an author of the 2008 Clinical Practice Guidelines on chronic kidney disease in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391480</data>
    </node>
    <node id="Canadian Medical Journal">
      <data key="d0">Canadian Medical Journal</data>
      <data key="d1">organization</data>
      <data key="d2">Canadian Medical Journal is a journal that published the 2008 Clinical Practice Guidelines on chronic kidney disease in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391480</data>
    </node>
    <node id="Lewis EJ">
      <data key="d0">Lewis EJ</data>
      <data key="d1">person</data>
      <data key="d2">Lewis EJ is an author of a study on the effect of angiotensin converting enzyme inhibition on diabetic nephropathy.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391481</data>
    </node>
    <node id="Hunsicker LG">
      <data key="d0">Hunsicker LG</data>
      <data key="d1">person</data>
      <data key="d2">Hunsicker LG is an author of a study on the effect of angiotensin converting enzyme inhibition on diabetic nephropathy.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391481</data>
    </node>
    <node id="Bain RP">
      <data key="d0">Bain RP</data>
      <data key="d1">person</data>
      <data key="d2">Bain RP is an author of a study on the effect of angiotensin converting enzyme inhibition on diabetic nephropathy.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391481</data>
    </node>
    <node id="N Engl J Med">
      <data key="d0">N Engl J Med</data>
      <data key="d1">organization</data>
      <data key="d2">N Engl J Med is a journal that published a study on major congenital malformations after first-trimester exposure to ACE inhibitors.&lt;SEP&gt;N Engl J Med is a journal that published a study on the effect of angiotensin converting enzyme inhibition on diabetic nephropathy.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391481</data>
    </node>
    <node id="Cooper WO">
      <data key="d0">Cooper WO</data>
      <data key="d1">person</data>
      <data key="d2">Cooper WO is an author of a study on major congenital malformations after first-trimester exposure to ACE inhibitors.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391481</data>
    </node>
    <node id="Hernadez-Diaz S">
      <data key="d0">Hernadez-Diaz S</data>
      <data key="d1">person</data>
      <data key="d2">Hernadez-Diaz S is an author of a study on major congenital malformations after first-trimester exposure to ACE inhibitors.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391481</data>
    </node>
    <node id="Arbogast PG">
      <data key="d0">Arbogast PG</data>
      <data key="d1">person</data>
      <data key="d2">Arbogast PG is an author of a study on major congenital malformations after first-trimester exposure to ACE inhibitors.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391481</data>
    </node>
    <node id="Middleton RJ">
      <data key="d0">Middleton RJ</data>
      <data key="d1">person</data>
      <data key="d2">Middleton RJ is an author of a study on the unrecognized prevalence of chronic kidney disease in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391481</data>
    </node>
    <node id="Foley RN">
      <data key="d0">Foley RN</data>
      <data key="d1">person</data>
      <data key="d2">Foley RN is an author of a study on the unrecognized prevalence of chronic kidney disease in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391482</data>
    </node>
    <node id="Hegarty J">
      <data key="d0">Hegarty J</data>
      <data key="d1">person</data>
      <data key="d2">Hegarty J is an author of a study on the unrecognized prevalence of chronic kidney disease in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391482</data>
    </node>
    <node id="Kempen JH">
      <data key="d0">Kempen JH</data>
      <data key="d1">person</data>
      <data key="d2">Kempen JH is an author of a study on the prevalence of diabetic retinopathy in the United States.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391482</data>
    </node>
    <node id="O'Colmain BJ">
      <data key="d0">O'Colmain BJ</data>
      <data key="d1">person</data>
      <data key="d2">O'Colmain BJ is an author of a study on the prevalence of diabetic retinopathy in the United States.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391482</data>
    </node>
    <node id="Leske MC">
      <data key="d0">Leske MC</data>
      <data key="d1">person</data>
      <data key="d2">Leske MC is an author of a study on the prevalence of diabetic retinopathy in the United States.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391483</data>
    </node>
    <node id="Arch Ophthalmol">
      <data key="d0">Arch Ophthalmol</data>
      <data key="d1">organization</data>
      <data key="d2">Arch Ophthalmol is a journal that published a study on the prevalence of diabetic retinopathy in the United States.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391483</data>
    </node>
    <node id="Boyd SR">
      <data key="d0">Boyd SR</data>
      <data key="d1">person</data>
      <data key="d2">Boyd SR is an author of a section on retinopathy in the 2008 clinical practice guidelines for diabetes in Canada.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391483</data>
    </node>
    <node id="Altomere F">
      <data key="d0">Altomere F</data>
      <data key="d1">person</data>
      <data key="d2">Altomere F is an author of a section on retinopathy in the 2008 clinical practice guidelines for diabetes in Canada.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391483</data>
    </node>
    <node id="Mash B">
      <data key="d0">Mash B</data>
      <data key="d1">person</data>
      <data key="d2">Mash B is an author of a study on screening for diabetic retinopathy in primary care in South Africa.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391483</data>
    </node>
    <node id="Powell D">
      <data key="d0">Powell D</data>
      <data key="d1">person</data>
      <data key="d2">Powell D is an author of a study on screening for diabetic retinopathy in primary care in South Africa.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391484</data>
    </node>
    <node id="Du Plessis F">
      <data key="d0">Du Plessis F</data>
      <data key="d1">person</data>
      <data key="d2">Du Plessis F is an author of a study on screening for diabetic retinopathy in primary care in South Africa.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391484</data>
    </node>
    <node id="S Afr Med J">
      <data key="d0">S Afr Med J</data>
      <data key="d1">organization</data>
      <data key="d2">S Afr Med J is a journal that published a study on screening for diabetic retinopathy in primary care in South Africa.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391484</data>
    </node>
    <node id="O'Hare JP">
      <data key="d0">O'Hare JP</data>
      <data key="d1">person</data>
      <data key="d2">O'Hare JP is an author of a study on adding retinal photography to screening for diabetic retinopathy in primary care.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391484</data>
    </node>
    <node id="Hopper A">
      <data key="d0">Hopper A</data>
      <data key="d1">person</data>
      <data key="d2">Hopper A is an author of a study on adding retinal photography to screening for diabetic retinopathy in primary care.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391484</data>
    </node>
    <node id="Madhaven C">
      <data key="d0">Madhaven C</data>
      <data key="d1">person</data>
      <data key="d2">Madhaven C is an author of a study on adding retinal photography to screening for diabetic retinopathy in primary care.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391485</data>
    </node>
    <node id="Canadian Diabetes Association Clinical Practice Guidelines Expert Committee">
      <data key="d0">Canadian Diabetes Association Clinical Practice Guidelines Expert Committee</data>
      <data key="d1">organization</data>
      <data key="d2">Canadian Diabetes Association Clinical Practice Guidelines Expert Committee is an organization that published the 2008 clinical practice guidelines for diabetes in Canada.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391485</data>
    </node>
    <node id="Reiber GE">
      <data key="d0">Reiber GE</data>
      <data key="d1">person</data>
      <data key="d2">Reiber GE is an author of a study on lower extremity foot ulcers and amputations in diabetes.&lt;SEP&gt;Reiber GE is an author of a study on risk factors for amputation in patients with diabetes mellitus.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391485</data>
    </node>
    <node id="Boyko EJ">
      <data key="d0">Boyko EJ</data>
      <data key="d1">person</data>
      <data key="d2">Boyko EJ is an author of a study on lower extremity foot ulcers and amputations in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391485</data>
    </node>
    <node id="Smith DG">
      <data key="d0">Smith DG</data>
      <data key="d1">person</data>
      <data key="d2">Smith DG is an author of a study on lower extremity foot ulcers and amputations in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391485</data>
    </node>
    <node id="National Diabetes Data Group">
      <data key="d0">National Diabetes Data Group</data>
      <data key="d1">organization</data>
      <data key="d2">National Diabetes Data Group is an organization that published a study on lower extremity foot ulcers and amputations in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391485</data>
    </node>
    <node id="National Institutes of Health">
      <data key="d0">National Institutes of Health</data>
      <data key="d1">organization</data>
      <data key="d2">National Institutes of Health is an organization that published a study on lower extremity foot ulcers and amputations in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391485</data>
    </node>
    <node id="National Institute of Diabetes and Digestive and Kidney Diseases">
      <data key="d0">National Institute of Diabetes and Digestive and Kidney Diseases</data>
      <data key="d1">organization</data>
      <data key="d2">National Institute of Diabetes and Digestive and Kidney Diseases is an organization that published a study on lower extremity foot ulcers and amputations in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391485</data>
    </node>
    <node id="Pecoraro RE">
      <data key="d0">Pecoraro RE</data>
      <data key="d1">person</data>
      <data key="d2">Pecoraro RE is an author of a study on risk factors for amputation in patients with diabetes mellitus.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391486</data>
    </node>
    <node id="Koepsell TD">
      <data key="d0">Koepsell TD</data>
      <data key="d1">person</data>
      <data key="d2">Koepsell TD is an author of a study on risk factors for amputation in patients with diabetes mellitus.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391486</data>
    </node>
    <node id="Ann Intern Med">
      <data key="d0">Ann Intern Med</data>
      <data key="d1">organization</data>
      <data key="d2">Ann Intern Med is a journal that published a study on risk factors for amputation in patients with diabetes mellitus.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391486</data>
    </node>
    <node id="Rayman G">
      <data key="d0">Rayman G</data>
      <data key="d1">person</data>
      <data key="d2">Rayman G is an author of a study on the Ipswich touch test for identifying diabetes foot ulceration risk.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391486</data>
    </node>
    <node id="Vas PR">
      <data key="d0">Vas PR</data>
      <data key="d1">person</data>
      <data key="d2">Vas PR is an author of a study on the Ipswich touch test for identifying diabetes foot ulceration risk.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391486</data>
    </node>
    <node id="Baker N">
      <data key="d0">Baker N</data>
      <data key="d1">person</data>
      <data key="d2">Baker N is an author of a study on the Ipswich touch test for identifying diabetes foot ulceration risk.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391487</data>
    </node>
    <node id="Apelqvist J">
      <data key="d0">Apelqvist J</data>
      <data key="d1">person</data>
      <data key="d2">Apelqvist J is an author of practical guidelines on the management and prevention of the diabetic foot.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391487</data>
    </node>
    <node id="Bakker K">
      <data key="d0">Bakker K</data>
      <data key="d1">person</data>
      <data key="d2">Bakker K is an author of practical guidelines on the management and prevention of the diabetic foot.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391487</data>
    </node>
    <node id="Van Houtum WH">
      <data key="d0">Van Houtum WH</data>
      <data key="d1">person</data>
      <data key="d2">Van Houtum WH is an author of practical guidelines on the management and prevention of the diabetic foot.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391487</data>
    </node>
    <node id="Schaper NC">
      <data key="d0">Schaper NC</data>
      <data key="d1">person</data>
      <data key="d2">Schaper NC is an author of practical guidelines on the management and prevention of the diabetic foot.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391488</data>
    </node>
    <node id="International Working Group on the Diabetic Foot (IWGDF) Editorial Board">
      <data key="d0">International Working Group on the Diabetic Foot (IWGDF) Editorial Board</data>
      <data key="d1">organization</data>
      <data key="d2">International Working Group on the Diabetic Foot (IWGDF) Editorial Board is an organization that published practical guidelines on the management and prevention of the diabetic foot.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391488</data>
    </node>
    <node id="Lavery LA">
      <data key="d0">Lavery LA</data>
      <data key="d1">person</data>
      <data key="d2">Lavery LA is an author of a study on re-evaluating the classification of the diabetic foot.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391488</data>
    </node>
    <node id="Peters EJG">
      <data key="d0">Peters EJG</data>
      <data key="d1">person</data>
      <data key="d2">Peters EJG is an author of a study on re-evaluating the classification of the diabetic foot.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391488</data>
    </node>
    <node id="Williams JR">
      <data key="d0">Williams JR</data>
      <data key="d1">person</data>
      <data key="d2">Williams JR is an author of a study on re-evaluating the classification of the diabetic foot.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391488</data>
    </node>
    <node id="Wallace I">
      <data key="d0">Wallace I</data>
      <data key="d1">person</data>
      <data key="d2">Wallace I is an author of a study on the management of diabetes in the elderly.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391489</data>
    </node>
    <node id="Clinical Diabetes">
      <data key="d0">Clinical Diabetes</data>
      <data key="d1">organization</data>
      <data key="d2">Clinical Diabetes is a journal that published a study on clinical management of diabetes in the elderly.&lt;SEP&gt;Clinical Diabetes is a journal that published a study on the management of diabetes in the elderly.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391489</data>
    </node>
    <node id="Subramaniam I">
      <data key="d0">Subramaniam I</data>
      <data key="d1">person</data>
      <data key="d2">Subramaniam I is an author of a study on diabetes in the elderly.&lt;SEP&gt;Subramaniam I is an author who contributed to a study on diabetes in the elderly.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391489</data>
    </node>
    <node id="Danny Gold JL">
      <data key="d0">Danny Gold JL</data>
      <data key="d1">person</data>
      <data key="d2">Danny Gold JL is an author of a study on diabetes in the elderly.&lt;SEP&gt;Danny Gold JL is an author who contributed to a study on diabetes in the elderly.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391489</data>
    </node>
    <node id="Journal of Indian Academy of Geriatrics">
      <data key="d0">Journal of Indian Academy of Geriatrics</data>
      <data key="d1">organization</data>
      <data key="d2">Journal of Indian Academy of Geriatrics is a journal that published a study on diabetes in the elderly.&lt;SEP&gt;The Journal of Indian Academy of Geriatrics is a publication that featured a study on diabetes in the elderly.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b&lt;SEP&gt;chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391489</data>
    </node>
    <node id="Bethesda">
      <data key="d0">Bethesda</data>
      <data key="d1">geo</data>
      <data key="d2">Bethesda is a geographical location associated with the National Diabetes Data Group.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391490</data>
    </node>
    <node id="2008 Clinical Practice Guidelines">
      <data key="d0">2008 Clinical Practice Guidelines</data>
      <data key="d1">category</data>
      <data key="d2">2008 Clinical Practice Guidelines refers to the guidelines on chronic kidney disease in diabetes published by the Canadian Diabetes Association.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391490</data>
    </node>
    <node id="Clinical Practice Guidelines">
      <data key="d0">Clinical Practice Guidelines</data>
      <data key="d1">category</data>
      <data key="d2">Clinical Practice Guidelines refers to the guidelines on diabetes management published by various organizations.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391490</data>
    </node>
    <node id="Diabetic Foot">
      <data key="d0">Diabetic Foot</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic Foot refers to the focus of practical guidelines on the management and prevention of diabetic foot complications.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391490</data>
    </node>
    <node id="Health Economic Analysis">
      <data key="d0">Health Economic Analysis</data>
      <data key="d1">category</data>
      <data key="d2">Health Economic Analysis refers to the study on the economic analysis of nephropathy in patients with type 2 diabetes and hypertension in the USA.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391490</data>
    </node>
    <node id="Lower Extremity Foot Ulcers and Amputations">
      <data key="d0">Lower Extremity Foot Ulcers and Amputations</data>
      <data key="d1">category</data>
      <data key="d2">Lower Extremity Foot Ulcers and Amputations refers to the focus of studies on foot complications in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391490</data>
    </node>
    <node id="Ipswich Touch Test">
      <data key="d0">Ipswich Touch Test</data>
      <data key="d1">category</data>
      <data key="d2">Ipswich Touch Test refers to a method for identifying diabetes foot ulceration risk.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391490</data>
    </node>
    <node id="2004 Clinical Practice Recommendations">
      <data key="d0">2004 Clinical Practice Recommendations</data>
      <data key="d1">category</data>
      <data key="d2">2004 Clinical Practice Recommendations refers to the recommendations on diabetes management published by the American Diabetes Association.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391490</data>
    </node>
    <node id="Angiotensin Converting Enzyme Inhibition">
      <data key="d0">Angiotensin Converting Enzyme Inhibition</data>
      <data key="d1">category</data>
      <data key="d2">Angiotensin Converting Enzyme Inhibition refers to the focus of a study on its effects on diabetic nephropathy.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391491</data>
    </node>
    <node id="Major Congenital Malformations">
      <data key="d0">Major Congenital Malformations</data>
      <data key="d1">category</data>
      <data key="d2">Major Congenital Malformations refers to the focus of a study on congenital malformations after ACE inhibitor exposure.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391491</data>
    </node>
    <node id="Unrecognized Prevalence of Chronic Kidney Disease">
      <data key="d0">Unrecognized Prevalence of Chronic Kidney Disease</data>
      <data key="d1">category</data>
      <data key="d2">Unrecognized Prevalence of Chronic Kidney Disease refers to the focus of a study on the underdiagnosis of chronic kidney disease in diabetes.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391491</data>
    </node>
    <node id="Diabetic Foot Classification">
      <data key="d0">Diabetic Foot Classification</data>
      <data key="d1">category</data>
      <data key="d2">Diabetic Foot Classification refers to the focus of a study on re-evaluating the classification of the diabetic foot.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391491</data>
    </node>
    <node id="Management of Diabetes in the Elderly">
      <data key="d0">Management of Diabetes in the Elderly</data>
      <data key="d1">category</data>
      <data key="d2">Management of Diabetes in the Elderly refers to the focus of a study on diabetes care for older adults.</data>
      <data key="d3">chunk-fb086a72b59d81f32eea0b27e415d77b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391491</data>
    </node>
    <node id="Indian Academy of Geriatrics">
      <data key="d0">Indian Academy of Geriatrics</data>
      <data key="d1">organization</data>
      <data key="d2">The Indian Academy of Geriatrics is an organization associated with the journal that published a study on diabetes in the elderly.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391492</data>
    </node>
    <node id="Chau D">
      <data key="d0">Chau D</data>
      <data key="d1">person</data>
      <data key="d2">Chau D is an author who contributed to a study on clinical management of diabetes in the elderly.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391492</data>
    </node>
    <node id="Edelman SV">
      <data key="d0">Edelman SV</data>
      <data key="d1">person</data>
      <data key="d2">Edelman SV is an author who contributed to a study on clinical management of diabetes in the elderly.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391492</data>
    </node>
    <node id="Mollentze WF">
      <data key="d0">Mollentze WF</data>
      <data key="d1">person</data>
      <data key="d2">Mollentze WF is an author who contributed to a study on the management of diabetes in the elderly.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391492</data>
    </node>
    <node id="CME">
      <data key="d0">CME</data>
      <data key="d1">organization</data>
      <data key="d2">CME is a publication that featured a study on the management of diabetes in the elderly.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391493</data>
    </node>
    <node id="Statistics South Africa">
      <data key="d0">Statistics South Africa</data>
      <data key="d1">organization</data>
      <data key="d2">Statistics South Africa is an organization that released mid-year population estimates.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391493</data>
    </node>
    <node id="Bradshaw D">
      <data key="d0">Bradshaw D</data>
      <data key="d1">person</data>
      <data key="d2">Bradshaw D is an author who contributed to a study on the burden of disease attributable to diabetes in South Africa.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391493</data>
    </node>
    <node id="Norman R">
      <data key="d0">Norman R</data>
      <data key="d1">person</data>
      <data key="d2">Norman R is an author who contributed to a study on the burden of disease attributable to diabetes in South Africa.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391493</data>
    </node>
    <node id="Pieterse D">
      <data key="d0">Pieterse D</data>
      <data key="d1">person</data>
      <data key="d2">Pieterse D is an author who contributed to a study on the burden of disease attributable to diabetes in South Africa.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391493</data>
    </node>
    <node id="Levitt NS">
      <data key="d0">Levitt NS</data>
      <data key="d1">person</data>
      <data key="d2">Levitt NS is an author who contributed to a study on the burden of disease attributable to diabetes in South Africa.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391493</data>
    </node>
    <node id="South African Comparative Risk Assessment Collaborating Group">
      <data key="d0">South African Comparative Risk Assessment Collaborating Group</data>
      <data key="d1">organization</data>
      <data key="d2">The South African Comparative Risk Assessment Collaborating Group is an organization involved in a study on the burden of disease attributable to diabetes.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391494</data>
    </node>
    <node id="Puoane T">
      <data key="d0">Puoane T</data>
      <data key="d1">person</data>
      <data key="d2">Puoane T is an author who contributed to a study on obesity in South Africa.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391494</data>
    </node>
    <node id="Steyn K">
      <data key="d0">Steyn K</data>
      <data key="d1">person</data>
      <data key="d2">Steyn K is an author who contributed to a study on obesity in South Africa.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391494</data>
    </node>
    <node id="South African demographic and health survey">
      <data key="d0">South African demographic and health survey</data>
      <data key="d1">organization</data>
      <data key="d2">The South African demographic and health survey is a study on obesity in South Africa.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391494</data>
    </node>
    <node id="WHO Expert Consultation">
      <data key="d0">WHO Expert Consultation</data>
      <data key="d1">event</data>
      <data key="d2">WHO Expert Consultation is an event related to the appropriate body-mass index for Asian populations.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391494</data>
    </node>
    <node id="Salti I">
      <data key="d0">Salti I</data>
      <data key="d1">person</data>
      <data key="d2">Salti I is an author who contributed to a study on diabetes during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391494</data>
    </node>
    <node id="Bernard E">
      <data key="d0">Bernard E</data>
      <data key="d1">person</data>
      <data key="d2">Bernard E is an author who contributed to a study on diabetes during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391494</data>
    </node>
    <node id="Detournay B">
      <data key="d0">Detournay B</data>
      <data key="d1">person</data>
      <data key="d2">Detournay B is an author who contributed to a study on diabetes during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391494</data>
    </node>
    <node id="Bravis V">
      <data key="d0">Bravis V</data>
      <data key="d1">person</data>
      <data key="d2">Bravis V is an author who contributed to a study on diabetes education during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391495</data>
    </node>
    <node id="Hui E">
      <data key="d0">Hui E</data>
      <data key="d1">person</data>
      <data key="d2">Hui E is an author who contributed to a study on diabetes education during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391495</data>
    </node>
    <node id="Salin S">
      <data key="d0">Salin S</data>
      <data key="d1">person</data>
      <data key="d2">Salin S is an author who contributed to a study on diabetes education during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391495</data>
    </node>
    <node id="Al-Arouj M">
      <data key="d0">Al-Arouj M</data>
      <data key="d1">person</data>
      <data key="d2">Al-Arouj M is an author who contributed to recommendations for managing diabetes during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391495</data>
    </node>
    <node id="Assaad-Khalil S">
      <data key="d0">Assaad-Khalil S</data>
      <data key="d1">person</data>
      <data key="d2">Assaad-Khalil S is an author who contributed to recommendations for managing diabetes during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391496</data>
    </node>
    <node id="Buse J">
      <data key="d0">Buse J</data>
      <data key="d1">person</data>
      <data key="d2">Buse J is an author who contributed to recommendations for managing diabetes during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391496</data>
    </node>
    <node id="Hassanien M">
      <data key="d0">Hassanien M</data>
      <data key="d1">person</data>
      <data key="d2">Hassanien M is an author who contributed to a study on managing diabetes during Ramadan.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391496</data>
    </node>
    <node id="Venditti EM">
      <data key="d0">Venditti EM</data>
      <data key="d1">person</data>
      <data key="d2">Venditti EM is an author who contributed to a study on lifestyle intervention programs.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391496</data>
    </node>
    <node id="Bray GA">
      <data key="d0">Bray GA</data>
      <data key="d1">person</data>
      <data key="d2">Bray GA is an author who contributed to a study on lifestyle intervention programs.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391496</data>
    </node>
    <node id="Carrion-Petersen ML">
      <data key="d0">Carrion-Petersen ML</data>
      <data key="d1">person</data>
      <data key="d2">Carrion-Petersen ML is an author who contributed to a study on lifestyle intervention programs.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391497</data>
    </node>
    <node id="Pi-Sunyer X">
      <data key="d0">Pi-Sunyer X</data>
      <data key="d1">person</data>
      <data key="d2">Pi-Sunyer X is an author who contributed to the Look AHEAD trial on diabetes management.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391497</data>
    </node>
    <node id="Blackburn G">
      <data key="d0">Blackburn G</data>
      <data key="d1">person</data>
      <data key="d2">Blackburn G is an author who contributed to the Look AHEAD trial on diabetes management.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391497</data>
    </node>
    <node id="Brancati FL">
      <data key="d0">Brancati FL</data>
      <data key="d1">person</data>
      <data key="d2">Brancati FL is an author who contributed to the Look AHEAD trial on diabetes management.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391497</data>
    </node>
    <node id="Tuomilehto J">
      <data key="d0">Tuomilehto J</data>
      <data key="d1">person</data>
      <data key="d2">Tuomilehto J is an author who contributed to a study on preventing type 2 diabetes.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391497</data>
    </node>
    <node id="Lindstrom J">
      <data key="d0">Lindstrom J</data>
      <data key="d1">person</data>
      <data key="d2">Lindstrom J is an author who contributed to a study on preventing type 2 diabetes.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391498</data>
    </node>
    <node id="Eriksson JG">
      <data key="d0">Eriksson JG</data>
      <data key="d1">person</data>
      <data key="d2">Eriksson JG is an author who contributed to a study on preventing type 2 diabetes.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391498</data>
    </node>
    <node id="Pan X">
      <data key="d0">Pan X</data>
      <data key="d1">person</data>
      <data key="d2">Pan X is an author who contributed to a study on preventing NIDDM.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391498</data>
    </node>
    <node id="Li G">
      <data key="d0">Li G</data>
      <data key="d1">person</data>
      <data key="d2">Li G is an author who contributed to a study on preventing NIDDM.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391498</data>
    </node>
    <node id="Hu Y">
      <data key="d0">Hu Y</data>
      <data key="d1">person</data>
      <data key="d2">Hu Y is an author who contributed to a study on preventing NIDDM.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391498</data>
    </node>
    <node id="Pour OR">
      <data key="d0">Pour OR</data>
      <data key="d1">person</data>
      <data key="d2">Pour OR is an author who contributed to a study on prediabetes as a therapeutic target.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391499</data>
    </node>
    <node id="Dagogo-Jack S">
      <data key="d0">Dagogo-Jack S</data>
      <data key="d1">person</data>
      <data key="d2">Dagogo-Jack S is an author who contributed to a study on prediabetes as a therapeutic target.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391499</data>
    </node>
    <node id="Ramachandran A">
      <data key="d0">Ramachandran A</data>
      <data key="d1">person</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Ramachandran A is an author who contributed to the Indian Diabetes Prevention Programme (IDPP).</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391499</data>
    </node>
    <node id="Snehalatha C">
      <data key="d0">Snehalatha C</data>
      <data key="d1">person</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Snehalatha C is an author who contributed to the Indian Diabetes Prevention Programme (IDPP).</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391499</data>
    </node>
    <node id="Mary S">
      <data key="d0">Mary S</data>
      <data key="d1">person</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Mary S is an author who contributed to the Indian Diabetes Prevention Programme (IDPP).</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391499</data>
    </node>
    <node id="ADA Position Statement">
      <data key="d0">ADA Position Statement</data>
      <data key="d1">category</data>
      <data key="d2">The ADA Position Statement is a category related to guidelines on diabetes and driving.&lt;SEP&gt;The ADA Position Statement refers to a guideline on diabetes and driving published by the American Diabetes Association.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950&lt;SEP&gt;chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391499</data>
    </node>
    <node id="American Diabetes Association (ADA)">
      <data key="d0">American Diabetes Association (ADA)</data>
      <data key="d1">organization</data>
      <data key="d2">The American Diabetes Association (ADA) is an organization that issued a position statement on diabetes and driving.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391499</data>
    </node>
    <node id="Ramadaan education and awareness in diabetes (READ) programme">
      <data key="d0">Ramadaan education and awareness in diabetes (READ) programme</data>
      <data key="d1">event</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391499</data>
    </node>
    <node id="Management of people with diabetes wanting to fast during Ramadaan">
      <data key="d0">Management of people with diabetes wanting to fast during Ramadaan</data>
      <data key="d1">event</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391500</data>
    </node>
    <node id="NIDDM">
      <data key="d0">NIDDM</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391500</data>
    </node>
    <node id="metabolic syndrome">
      <data key="d0">metabolic syndrome</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391500</data>
    </node>
    <node id="Look AHEAD trial">
      <data key="d0">Look AHEAD trial</data>
      <data key="d1">event</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391500</data>
    </node>
    <node id="Indian Diabetes Prevention Programme (IDPP)">
      <data key="d0">Indian Diabetes Prevention Programme (IDPP)</data>
      <data key="d1">event</data>
      <data key="d2">The Indian Diabetes Prevention Programme (IDPP) is a study published in Diabetologia that focuses on diabetes prevention.</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391501</data>
    </node>
    <node id="National Department of Health">
      <data key="d0">National Department of Health</data>
      <data key="d1">organization</data>
      <data key="d2">The National Department of Health is the entity responsible for compiling the diabetes education guideline document.</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391501</data>
    </node>
    <node id="Patient Empowerment">
      <data key="d0">Patient Empowerment</data>
      <data key="d1">category</data>
      <data key="d2">Patient Empowerment is a core standard in diabetes education, emphasizing self-management and problem-solving skills.</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391501</data>
    </node>
    <node id="Core Standards">
      <data key="d0">Core Standards</data>
      <data key="d1">category</data>
      <data key="d2">Core Standards are the principles for diabetes education, including structured programs, accessibility, and specialized care.</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391501</data>
    </node>
    <node id="Diabetes Self-Management Education">
      <data key="d0">Diabetes Self-Management Education</data>
      <data key="d1">category</data>
      <data key="d2">Diabetes Self-Management Education includes knowledge development, behavioral intervention, and family involvement.</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391501</data>
    </node>
    <node id="Distiller LA">
      <data key="d0">Distiller LA</data>
      <data key="d1">person</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391502</data>
    </node>
    <node id="Kramer BD">
      <data key="d0">Kramer BD</data>
      <data key="d1">person</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391502</data>
    </node>
    <node id="SEMDSA Advisory Committee">
      <data key="d0">SEMDSA Advisory Committee</data>
      <data key="d1">organization</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391502</data>
    </node>
    <node id="Complication Prevention">
      <data key="d0">Complication Prevention</data>
      <data key="d1">category</data>
      <data key="d2">Complication prevention is a category focusing on preventing or delaying complications such as ulcers, gangrene, amputations, and other long-term issues through proper foot care, medical check-ups, and glucose control.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391502</data>
    </node>
    <node id="Medical Check-Ups">
      <data key="d0">Medical Check-Ups</data>
      <data key="d1">category</data>
      <data key="d2">Medical check-ups are a category highlighting the essential role of regular medical and dental evaluations in managing diabetes and detecting complications early.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391502</data>
    </node>
    <node id="Hypoglycaemic and Hyperglycaemic Emergencies">
      <data key="d0">Hypoglycaemic and Hyperglycaemic Emergencies</data>
      <data key="d1">category</data>
      <data key="d2">Hypoglycaemic and hyperglycaemic emergencies are categories of critical medical conditions requiring immediate attention, with symptoms and signs outlined for recognition and response.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391503</data>
    </node>
    <node id="Pregnancy and Glucose Control">
      <data key="d0">Pregnancy and Glucose Control</data>
      <data key="d1">category</data>
      <data key="d2">Pregnancy and glucose control is a category addressing the necessity of managing blood sugar levels before, during, and after pregnancy to prevent complications.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391503</data>
    </node>
    <node id="Family Planning and Contraception">
      <data key="d0">Family Planning and Contraception</data>
      <data key="d1">category</data>
      <data key="d2">Family planning and contraception is a category emphasizing the importance of pre-gestational counselling and planning to manage diabetes during pregnancy.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391503</data>
    </node>
    <node id="Traditional Medicine Use">
      <data key="d0">Traditional Medicine Use</data>
      <data key="d1">category</data>
      <data key="d2">Traditional medicine use is a category discussing the need for informed choices regarding the use of traditional remedies in diabetes management.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391503</data>
    </node>
    <node id="Disease Acceptance and Lifelong Therapy">
      <data key="d0">Disease Acceptance and Lifelong Therapy</data>
      <data key="d1">category</data>
      <data key="d2">Disease acceptance and lifelong therapy is a category focusing on helping patients accept their condition and commit to long-term management strategies.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391503</data>
    </node>
    <node id="Adherence to Management Plan">
      <data key="d0">Adherence to Management Plan</data>
      <data key="d1">category</data>
      <data key="d2">Adherence to management plan is a category stressing the importance of following prescribed treatment and medication regimens for effective diabetes control.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391503</data>
    </node>
    <node id="Dependence and Independence Conflict">
      <data key="d0">Dependence and Independence Conflict</data>
      <data key="d1">category</data>
      <data key="d2">Dependence and independence conflict is a category addressing the tension between relying on medical support and maintaining personal autonomy in diabetes care.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391503</data>
    </node>
    <node id="Weight Management">
      <data key="d0">Weight Management</data>
      <data key="d1">category</data>
      <data key="d2">Weight management is a category focusing on lifestyle changes, including dietary and physical activity interventions, to control obesity and waist circumference in type 2 diabetes.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391503</data>
    </node>
    <node id="Dietary Interventions">
      <data key="d0">Dietary Interventions</data>
      <data key="d1">category</data>
      <data key="d2">Dietary interventions are a category detailing healthy eating plans, food label reading, and culturally appropriate meal planning to manage blood glucose levels.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391504</data>
    </node>
    <node id="Physical Activity">
      <data key="d0">Physical Activity</data>
      <data key="d1">category</data>
      <data key="d2">Physical activity is a category recommending moderate to vigorous exercise to improve metabolic control, insulin sensitivity, and cardiovascular health in type 2 diabetes.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391504</data>
    </node>
    <node id="Caloric Restriction">
      <data key="d0">Caloric Restriction</data>
      <data key="d1">category</data>
      <data key="d2">Caloric restriction is a strategy involving reduced total food intake to achieve weight loss, emphasized as important for weight management in type 2 diabetes.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391504</data>
    </node>
    <node id="Resistance Exercise">
      <data key="d0">Resistance Exercise</data>
      <data key="d1">category</data>
      <data key="d2">Resistance exercise is a type of physical activity involving muscle-strengthening activities, recommended for people with type 2 diabetes to improve metabolic control.&lt;SEP&gt;Resistance exercise refers to activities that use muscular strength to move a weight or work against a resistance load, recommended three times per week for people with type 2 diabetes.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b&lt;SEP&gt;chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391504</data>
    </node>
    <node id="Bariatric Surgery">
      <data key="d0">Bariatric Surgery</data>
      <data key="d1">category</data>
      <data key="d2">Bariatric surgery is a tertiary care intervention for weight management, involving surgical procedures to aid in weight loss for individuals with type 2 diabetes.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391504</data>
    </node>
    <node id="Pharmacotherapy">
      <data key="d0">Pharmacotherapy</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.&lt;SEP&gt;Pharmacotherapy is a tertiary care intervention involving the use of medications to manage weight in individuals with type 2 diabetes.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b&lt;SEP&gt;chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391505</data>
    </node>
    <node id="Tertiary Care Level">
      <data key="d0">Tertiary Care Level</data>
      <data key="d1">category</data>
      <data key="d2">Tertiary care level refers to advanced medical interventions, including pharmacotherapy and bariatric surgery, provided at specialized healthcare facilities for weight management.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391505</data>
    </node>
    <node id="Culturally Acceptable Meal Planning">
      <data key="d0">Culturally Acceptable Meal Planning</data>
      <data key="d1">category</data>
      <data key="d2">Culturally acceptable meal planning is a dietary intervention strategy that ensures meal plans are culturally appropriate, affordable, and support blood glucose control in diabetes management.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391505</data>
    </node>
    <node id="Hypoglycaemia Treatment">
      <data key="d0">Hypoglycaemia Treatment</data>
      <data key="d1">category</data>
      <data key="d2">Hypoglycaemia treatment is a category involving the use of simple carbohydrates (e.g., sweets) to manage hypoglycaemic episodes in diabetes patients.</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391505</data>
    </node>
    <node id="Cardio-Respiratory Fitness">
      <data key="d0">Cardio-Respiratory Fitness</data>
      <data key="d1">category</data>
      <data key="d2">Cardio-respiratory fitness is an outcome of regular physical activity, improved through exercises like brisk walking, cycling, and swimming.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391506</data>
    </node>
    <node id="Improved Glycaemic Control">
      <data key="d0">Improved Glycaemic Control</data>
      <data key="d1">category</data>
      <data key="d2">Improved glycaemic control is a benefit of regular physical activity, particularly resistance exercise, for people with type 2 diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391506</data>
    </node>
    <node id="Decreased Insulin Resistance">
      <data key="d0">Decreased Insulin Resistance</data>
      <data key="d1">category</data>
      <data key="d2">Decreased insulin resistance is a physiological benefit of regular physical activity and resistance exercise in managing type 2 diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391506</data>
    </node>
    <node id="Improved Blood Lipid Profile">
      <data key="d0">Improved Blood Lipid Profile</data>
      <data key="d1">category</data>
      <data key="d2">Improved blood lipid profile is a health outcome associated with regular physical activity, contributing to cardiovascular benefits.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391506</data>
    </node>
    <node id="Improved Blood Pressure">
      <data key="d0">Improved Blood Pressure</data>
      <data key="d1">category</data>
      <data key="d2">Improved blood pressure is a benefit of regular physical activity, including aerobic and resistance exercises, for individuals with type 2 diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391506</data>
    </node>
    <node id="Maintenance of Weight Loss">
      <data key="d0">Maintenance of Weight Loss</data>
      <data key="d1">category</data>
      <data key="d2">Maintenance of weight loss is a key outcome of regular physical activity, supported by resistance and aerobic exercises in diabetes management.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391507</data>
    </node>
    <node id="Abdominal and Overall Fat % Reduction">
      <data key="d0">Abdominal and Overall Fat % Reduction</data>
      <data key="d1">category</data>
      <data key="d2">Abdominal and overall fat percentage reduction is a benefit of physical activity, particularly in individuals with type 2 diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391507</data>
    </node>
    <node id="Improved Well-Being">
      <data key="d0">Improved Well-Being</data>
      <data key="d1">category</data>
      <data key="d2">Improved well-being is a psychological benefit of regular physical activity, enhancing quality of life for people with type 2 diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391507</data>
    </node>
    <node id="Decreased Stress and Anxiety">
      <data key="d0">Decreased Stress and Anxiety</data>
      <data key="d1">category</data>
      <data key="d2">Decreased stress and anxiety are mental health outcomes linked to regular physical activity, including aerobic and resistance exercises.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391507</data>
    </node>
    <node id="Uncontrolled Hypertension">
      <data key="d0">Uncontrolled Hypertension</data>
      <data key="d1">category</data>
      <data key="d2">Uncontrolled hypertension is a contraindication to certain types of exercise, requiring assessment before initiating an exercise program.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391507</data>
    </node>
    <node id="Severe Autonomic Neuropathy">
      <data key="d0">Severe Autonomic Neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">Severe autonomic neuropathy is a medical condition that may predispose individuals to injury and is a contraindication to certain exercises.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391507</data>
    </node>
    <node id="Severe Peripheral Neuropathy">
      <data key="d0">Severe Peripheral Neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">Severe peripheral neuropathy is a condition that increases the risk of foot injuries and is a contraindication to certain physical activities.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391507</data>
    </node>
    <node id="Unstable Proliferative Retinopathy">
      <data key="d0">Unstable Proliferative Retinopathy</data>
      <data key="d1">category</data>
      <data key="d2">Unstable proliferative retinopathy is a contraindication to strenuous physical activity, requiring medical assessment.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391507</data>
    </node>
    <node id="Orthopaedic Injuries">
      <data key="d0">Orthopaedic Injuries</data>
      <data key="d1">category</data>
      <data key="d2">Orthopaedic injuries are conditions that may limit physical activity and require evaluation before initiating an exercise program.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391507</data>
    </node>
    <node id="Proper Footwear">
      <data key="d0">Proper Footwear</data>
      <data key="d1">category</data>
      <data key="d2">Proper footwear is a critical component of foot care, recommended to prevent injuries and complications in individuals with diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391508</data>
    </node>
    <node id="Washing Feet Daily">
      <data key="d0">Washing Feet Daily</data>
      <data key="d1">category</data>
      <data key="d2">Washing feet daily is a recommended foot care practice to maintain hygiene and prevent infections in individuals with diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391508</data>
    </node>
    <node id="Daily Feet Inspection">
      <data key="d0">Daily Feet Inspection</data>
      <data key="d1">category</data>
      <data key="d2">Daily feet inspection is a practice to detect early signs of injury, infection, or complications in individuals with diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391508</data>
    </node>
    <node id="Lubricating Oils and Creams">
      <data key="d0">Lubricating Oils and Creams</data>
      <data key="d1">category</data>
      <data key="d2">Lubricating oils and creams are used for dry skin care but should not be applied between the toes to prevent complications.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391508</data>
    </node>
    <node id="Cutting Toenails Straight">
      <data key="d0">Cutting Toenails Straight</data>
      <data key="d1">category</data>
      <data key="d2">Cutting toenails straight is a foot care recommendation to prevent ingrown toenails and related complications.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391509</data>
    </node>
    <node id="Avoiding Corn Plasters">
      <data key="d0">Avoiding Corn Plasters</data>
      <data key="d1">category</data>
      <data key="d2">Avoiding corn plasters is advised for individuals with diabetes to prevent ulcers and complications.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391509</data>
    </node>
    <node id="Avoiding Sharp Instruments">
      <data key="d0">Avoiding Sharp Instruments</data>
      <data key="d1">category</data>
      <data key="d2">Avoiding sharp instruments is a foot care practice to prevent injury, as specified in the text for individuals with diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391509</data>
    </node>
    <node id="Testing Bath Water Temperature">
      <data key="d0">Testing Bath Water Temperature</data>
      <data key="d1">category</data>
      <data key="d2">Testing bath water temperature is a safety measure recommended to prevent burns, especially for individuals with impaired sensation.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391509</data>
    </node>
    <node id="Ketonuria">
      <data key="d0">Ketonuria</data>
      <data key="d1">category</data>
      <data key="d2">Ketonuria is a medical condition (presence of ketones in urine) that is a contraindication for strenuous physical activity in people with diabetes.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391509</data>
    </node>
    <node id="Delayed Hypoglycaemia">
      <data key="d0">Delayed Hypoglycaemia</data>
      <data key="d1">category</data>
      <data key="d2">Delayed hypoglycaemia is a potential risk during strenuous physical activity, requiring monitoring before and after exercise.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391510</data>
    </node>
    <node id="Anti-Tobacco Message">
      <data key="d0">Anti-Tobacco Message</data>
      <data key="d1">category</data>
      <data key="d2">Anti-tobacco message emphasizes the importance of avoiding smoking to reduce diabetes complications and improve circulation.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391510</data>
    </node>
    <node id="Responsible Alcohol Use">
      <data key="d0">Responsible Alcohol Use</data>
      <data key="d1">category</data>
      <data key="d2">Responsible alcohol use or cessation is recommended to manage diabetes and avoid complications associated with alcohol consumption.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391510</data>
    </node>
    <node id="Smoking">
      <data key="d0">Smoking</data>
      <data key="d1">category</data>
      <data key="d2">Smoking is a risk factor for diabetes complications, and the text advises against starting or continuing smoking.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391510</data>
    </node>
    <node id="Alcohol Consumption">
      <data key="d0">Alcohol Consumption</data>
      <data key="d1">category</data>
      <data key="d2">Alcohol consumption is addressed in the text as a factor requiring responsible use or cessation in diabetes management.</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391511</data>
    </node>
    <node id="Deformity or bony prominences">
      <data key="d0">Deformity or bony prominences</data>
      <data key="d1">category</data>
      <data key="d2">A condition assessed in the foot screening form, indicating the presence of physical deformities or bony protrusions on the feet.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391511</data>
    </node>
    <node id="Skin not intact (ulcer)">
      <data key="d0">Skin not intact (ulcer)</data>
      <data key="d1">category</data>
      <data key="d2">A condition assessed in the foot screening form, indicating the presence of ulcers or breaks in the skin on the feet.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391511</data>
    </node>
    <node id="Plantar Callus">
      <data key="d0">Plantar Callus</data>
      <data key="d1">category</data>
      <data key="d2">A condition assessed in the foot screening form, indicating the presence of thickened skin on the soles of the feet.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391511</data>
    </node>
    <node id="Peripheral vascular disease">
      <data key="d0">Peripheral vascular disease</data>
      <data key="d1">category</data>
      <data key="d2">A condition assessed in the foot screening form, indicating reduced blood flow to the feet.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391511</data>
    </node>
    <node id="Previous ulcer">
      <data key="d0">Previous ulcer</data>
      <data key="d1">category</data>
      <data key="d2">A factor assessed in the foot screening form, indicating a history of foot ulcers.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391511</data>
    </node>
    <node id="Previous amputation">
      <data key="d0">Previous amputation</data>
      <data key="d1">category</data>
      <data key="d2">A factor assessed in the foot screening form, indicating a history of foot amputation.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391512</data>
    </node>
    <node id="Inappropriate footwear">
      <data key="d0">Inappropriate footwear</data>
      <data key="d1">category</data>
      <data key="d2">A factor assessed in the foot screening form, indicating the use of footwear that is unsuitable for diabetic foot care.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391512</data>
    </node>
    <node id="Monofilament neuropathy">
      <data key="d0">Monofilament neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">A test result assessed in the foot screening form, indicating loss of sensation detected via monofilament testing.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391512</data>
    </node>
    <node id="Tuning fork neuropathy">
      <data key="d0">Tuning fork neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">A test result assessed in the foot screening form, indicating loss of sensation detected via tuning fork testing.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391512</data>
    </node>
    <node id="Light touch neuropathy">
      <data key="d0">Light touch neuropathy</data>
      <data key="d1">category</data>
      <data key="d2">A test result assessed in the foot screening form, indicating loss of sensation detected via light touch testing.</data>
      <data key="d3">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391512</data>
    </node>
    <node id="SEMDSA Guideline Committee">
      <data key="d0">SEMDSA Guideline Committee</data>
      <data key="d1">organization</data>
      <data key="d2">The SEMDSA Guideline Committee adapted the Canadian Diabetes Association's guidelines for use in their 2012 guidelines.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391512</data>
    </node>
    <node id="10-g Semmes-Weinstein Monofilament">
      <data key="d0">10-g Semmes-Weinstein Monofilament</data>
      <data key="d1">category</data>
      <data key="d2">A medical screening tool used to assess sensory neuropathy by testing patients' ability to perceive touch.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391512</data>
    </node>
    <node id="128-Hz Vibration Tuning Fork">
      <data key="d0">128-Hz Vibration Tuning Fork</data>
      <data key="d1">category</data>
      <data key="d2">A medical screening tool used to assess vibration perception in diabetic neuropathy screening, employing the 'on-off' method.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391512</data>
    </node>
    <node id="Canada">
      <data key="d0">Canada</data>
      <data key="d1">geo</data>
      <data key="d2">A country referenced as the origin of the Canadian Diabetes Association's clinical practice guidelines.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391513</data>
    </node>
    <node id="Check-up Frequency Categories">
      <data key="d0">Check-up Frequency Categories</data>
      <data key="d1">category</data>
      <data key="d2">Defined intervals for medical screening (e.g., once a year, once every 6 months) based on patient risk profiles.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391513</data>
    </node>
    <node id="Profile 0">
      <data key="d0">Profile 0</data>
      <data key="d1">category</data>
      <data key="d2">A risk profile for patients without sensory neuropathy or peripheral artery disease, requiring annual check-ups.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391513</data>
    </node>
    <node id="Profile 1">
      <data key="d0">Profile 1</data>
      <data key="d1">category</data>
      <data key="d2">A risk profile for patients with sensory neuropathy but no foot deformity or PAD, requiring check-ups every 6 months.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391513</data>
    </node>
    <node id="Profile 2">
      <data key="d0">Profile 2</data>
      <data key="d1">category</data>
      <data key="d2">A risk profile for patients with sensory neuropathy and foot deformity/PAD, requiring check-ups every 3 months.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391514</data>
    </node>
    <node id="Profile 3">
      <data key="d0">Profile 3</data>
      <data key="d1">category</data>
      <data key="d2">A risk profile for patients with a history of ulceration or amputation, requiring check-ups every 1–3 months.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391514</data>
    </node>
    <node id="Integrated Chronic Disease Management (ICDM) Model">
      <data key="d0">Integrated Chronic Disease Management (ICDM) Model</data>
      <data key="d1">category</data>
      <data key="d2">A framework for managing chronic diseases, referenced as a basis for staffing and clinic structure requirements.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391514</data>
    </node>
    <node id="ANNEXURE C2">
      <data key="d0">ANNEXURE C2</data>
      <data key="d1">category</data>
      <data key="d2">ANNEXURE C2 is a section of the document outlining rapid screening methods for diabetic neuropathy, referencing the Canadian Diabetes Association's 2008 guidelines.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391514</data>
    </node>
    <node id="ANNEXURE D">
      <data key="d0">ANNEXURE D</data>
      <data key="d1">category</data>
      <data key="d2">ANNEXURE D is a section of the document detailing clinic structure requirements for chronic disease management, including staffing, equipment, and patient record management.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391514</data>
    </node>
    <node id="Screening Protocol">
      <data key="d0">Screening Protocol</data>
      <data key="d1">category</data>
      <data key="d2">A protocol for identifying and recording high-risk patients, including those with gestational diabetes or central obesity, as outlined in ANNEXURE D.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391515</data>
    </node>
    <node id="High-Risk Patients">
      <data key="d0">High-Risk Patients</data>
      <data key="d1">category</data>
      <data key="d2">A category of patients requiring targeted screening, including individuals with gestational diabetes, central obesity, or a history of diabetes.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391515</data>
    </node>
    <node id="Ventilated Space">
      <data key="d0">Ventilated Space</data>
      <data key="d1">category</data>
      <data key="d2">A requirement for clinic infrastructure, ensuring adequate and suitably ventilated areas are available for patient care.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391515</data>
    </node>
    <node id="Multisite Testing">
      <data key="d0">Multisite Testing</data>
      <data key="d1">category</data>
      <data key="d2">A method for identifying high-risk areas for ulceration in diabetic patients, distinct from general neuropathy screening.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391515</data>
    </node>
    <node id="Primary Healthcare (PHC)">
      <data key="d0">Primary Healthcare (PHC)</data>
      <data key="d1">category</data>
      <data key="d2">Refers to the foundational level of healthcare services, including equipment, staffing, and infrastructure required for chronic disease management.</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391515</data>
    </node>
    <node id="NGOs">
      <data key="d0">NGOs</data>
      <data key="d1">organization</data>
      <data key="d2">NGOs are mentioned as existing structures to be utilized for facilitating health education and peer support.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391516</data>
    </node>
    <node id="Government Departments">
      <data key="d0">Government Departments</data>
      <data key="d1">organization</data>
      <data key="d2">Government Departments are mentioned as existing structures to be utilized for facilitating health education and peer support.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391516</data>
    </node>
    <node id="Luncheon Clubs">
      <data key="d0">Luncheon Clubs</data>
      <data key="d1">category</data>
      <data key="d2">Luncheon Clubs are mentioned as existing structures to be utilized for facilitating health education and peer support.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391516</data>
    </node>
    <node id="Community Recreational Activities">
      <data key="d0">Community Recreational Activities</data>
      <data key="d1">category</data>
      <data key="d2">Community Recreational Activities are mentioned as existing structures to be utilized for facilitating health education and peer support.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391516</data>
    </node>
    <node id="Supervisors">
      <data key="d0">Supervisors</data>
      <data key="d1">person</data>
      <data key="d2">Supervisors are responsible for ensuring that down-referral protocols are completed by all health professionals.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391516</data>
    </node>
    <node id="Pharmacy personnel">
      <data key="d0">Pharmacy personnel</data>
      <data key="d1">person</data>
      <data key="d2">Pharmacy personnel are responsible for managing medication supplies based on the number of chronic patients.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391517</data>
    </node>
    <node id="Podiatrists">
      <data key="d0">Podiatrists</data>
      <data key="d1">person</data>
      <data key="d2">Podiatrists are engaged to train clinic nurses in basic foot assessments.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391517</data>
    </node>
    <node id="Clinic nurses">
      <data key="d0">Clinic nurses</data>
      <data key="d1">person</data>
      <data key="d2">Clinic nurses are trained by podiatrists to perform basic foot assessments.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391517</data>
    </node>
    <node id="Ward-based PHC outreach teams">
      <data key="d0">Ward-based PHC outreach teams</data>
      <data key="d1">organization</data>
      <data key="d2">Ward-based PHC outreach teams contribute to strengthening community-based services when deployed.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391517</data>
    </node>
    <node id="Community-based services">
      <data key="d0">Community-based services</data>
      <data key="d1">category</data>
      <data key="d2">Community-based services are supported by Ward-based PHC outreach teams and other existing structures.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391517</data>
    </node>
    <node id="Patient Adherence">
      <data key="d0">Patient Adherence</data>
      <data key="d1">category</data>
      <data key="d2">Patient Adherence refers to the extent to which a patient follows medical recommendations for managing chronic conditions.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391517</data>
    </node>
    <node id="Screening protocol">
      <data key="d0">Screening protocol</data>
      <data key="d1">category</data>
      <data key="d2">Screening protocol is a structured process to identify high-risk patients requiring specific interventions.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391517</data>
    </node>
    <node id="Group education">
      <data key="d0">Group education</data>
      <data key="d1">category</data>
      <data key="d2">Group education refers to educational activities conducted for patients in a group setting.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391517</data>
    </node>
    <node id="In-service training">
      <data key="d0">In-service training</data>
      <data key="d1">category</data>
      <data key="d2">In-service training is a program to enhance the skills and knowledge of health professionals.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391518</data>
    </node>
    <node id="Monitoring health progress">
      <data key="d0">Monitoring health progress</data>
      <data key="d1">category</data>
      <data key="d2">Monitoring health progress involves tracking the improvement or deterioration of chronic patients' health status.</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391518</data>
    </node>
    <node id="Medication Adherence">
      <data key="d0">Medication Adherence</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391518</data>
    </node>
    <node id="Barriers to Adherence">
      <data key="d0">Barriers to Adherence</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391518</data>
    </node>
    <node id="Healthcare Team">
      <data key="d0">Healthcare Team</data>
      <data key="d1">organization</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391519</data>
    </node>
    <node id="Treatment Regimen">
      <data key="d0">Treatment Regimen</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391519</data>
    </node>
    <node id="Lifestyle Factors">
      <data key="d0">Lifestyle Factors</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391519</data>
    </node>
    <node id="Social and Economic Factors">
      <data key="d0">Social and Economic Factors</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391519</data>
    </node>
    <node id="Adverse Effects">
      <data key="d0">Adverse Effects</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391519</data>
    </node>
    <node id="Healthcare Consultation">
      <data key="d0">Healthcare Consultation</data>
      <data key="d1">event</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391520</data>
    </node>
    <node id="Patient Education">
      <data key="d0">Patient Education</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391520</data>
    </node>
    <node id="Life style">
      <data key="d0">Life style</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391520</data>
    </node>
    <node id="Attitudes and beliefs">
      <data key="d0">Attitudes and beliefs</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391520</data>
    </node>
    <node id="Social and economic">
      <data key="d0">Social and economic</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391520</data>
    </node>
    <node id="Healthcare team related">
      <data key="d0">Healthcare team related</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391521</data>
    </node>
    <node id="Treatment related">
      <data key="d0">Treatment related</data>
      <data key="d1">category</data>
      <data key="d2">Description not available in text.</data>
      <data key="d3">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391521</data>
    </node>
    <node id="daily routine">
      <data key="d0">daily routine</data>
      <data key="d1">category</data>
      <data key="d2">Daily routine refers to the regular activities and habits of a patient that may need to be balanced with therapeutic alternatives.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391521</data>
    </node>
    <node id="recreational activities">
      <data key="d0">recreational activities</data>
      <data key="d1">category</data>
      <data key="d2">Recreational activities are part of a patient's lifestyle that may interact with prescribed therapies.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391521</data>
    </node>
    <node id="past experiences with other medicines">
      <data key="d0">past experiences with other medicines</data>
      <data key="d1">category</data>
      <data key="d2">This category involves a patient's history of using other medications, which can influence current treatment plans.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391521</data>
    </node>
    <node id="expectations of therapeutic outcome">
      <data key="d0">expectations of therapeutic outcome</data>
      <data key="d1">category</data>
      <data key="d2">Expectations of therapeutic outcome pertain to a patient's hopes and beliefs regarding the effectiveness of their treatment.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391522</data>
    </node>
    <node id="therapeutic alternatives">
      <data key="d0">therapeutic alternatives</data>
      <data key="d1">category</data>
      <data key="d2">Therapeutic alternatives are different treatment options identified based on clinical findings for a patient's condition.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391522</data>
    </node>
    <node id="education points">
      <data key="d0">education points</data>
      <data key="d1">category</data>
      <data key="d2">Education points include key topics to discuss with patients, such as therapy benefits, side effects, and adherence strategies.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391522</data>
    </node>
    <node id="chronic conditions">
      <data key="d0">chronic conditions</data>
      <data key="d1">category</data>
      <data key="d2">Chronic conditions are long-term health issues requiring ongoing management and adherence to prescribed therapies.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391522</data>
    </node>
    <node id="adherence">
      <data key="d0">adherence</data>
      <data key="d1">category</data>
      <data key="d2">Adherence refers to a patient's ability to follow prescribed medication regimens and treatment plans.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391522</data>
    </node>
    <node id="continuity of therapy">
      <data key="d0">continuity of therapy</data>
      <data key="d1">category</data>
      <data key="d2">Continuity of therapy involves maintaining consistent treatment plans, involving patients in care, and managing long-term conditions.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391522</data>
    </node>
    <node id="self-reporting">
      <data key="d0">self-reporting</data>
      <data key="d1">category</data>
      <data key="d2">Self-reporting includes tools and methods for patients to track their adherence, such as questionnaires and checklists.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391522</data>
    </node>
    <node id="Visual Analogue Scale (VAS)">
      <data key="d0">Visual Analogue Scale (VAS)</data>
      <data key="d1">category</data>
      <data key="d2">VAS is a tool used to assess patient-reported outcomes, often related to pain or quality of life.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391522</data>
    </node>
    <node id="Pill Identification Test (PIT)">
      <data key="d0">Pill Identification Test (PIT)</data>
      <data key="d1">category</data>
      <data key="d2">PIT is a method to evaluate a patient's knowledge of their medications, including names, dosages, and instructions.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391523</data>
    </node>
    <node id="patient">
      <data key="d0">patient</data>
      <data key="d1">person</data>
      <data key="d2">A patient is an individual receiving medical treatment, whose lifestyle, adherence to therapy, and expectations are central to the management of their condition.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391523</data>
    </node>
    <node id="prescriber">
      <data key="d0">prescriber</data>
      <data key="d1">person</data>
      <data key="d2">A prescriber is a healthcare professional responsible for prescribing medications and managing treatment plans, including addressing adherence and side effects.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391523</data>
    </node>
    <node id="side effects">
      <data key="d0">side effects</data>
      <data key="d1">category</data>
      <data key="d2">Side effects refer to unintended consequences of medication use, which must be discussed with patients to manage their impact on treatment adherence.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391523</data>
    </node>
    <node id="non-adherence">
      <data key="d0">non-adherence</data>
      <data key="d1">category</data>
      <data key="d2">Non-adherence describes a patient's failure to follow prescribed treatment regimens, which can lead to unsatisfactory clinical outcomes and requires investigation.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391524</data>
    </node>
    <node id="medication dosing errors">
      <data key="d0">medication dosing errors</data>
      <data key="d1">category</data>
      <data key="d2">Medication dosing errors involve incorrect administration of prescribed medications, which can compromise treatment efficacy and safety.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391524</data>
    </node>
    <node id="medication frequency">
      <data key="d0">medication frequency</data>
      <data key="d1">category</data>
      <data key="d2">Medication frequency refers to the number of times a medication is taken per day (e.g., once, twice, thrice), which significantly impacts adherence rates.</data>
      <data key="d3">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391524</data>
    </node>
    <node id="Pill Count">
      <data key="d0">Pill Count</data>
      <data key="d1">category</data>
      <data key="d2">Pill Count is a section or metric discussed in the context of medication adherence assessment, possibly involving a figure or visual representation.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391524</data>
    </node>
    <node id="Adherence Assessment">
      <data key="d0">Adherence Assessment</data>
      <data key="d1">category</data>
      <data key="d2">Adherence Assessment is a category that includes various metrics and self-reporting data related to medication adherence, such as VAS, PIT, and Pill Count.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391524</data>
    </node>
    <node id="VAS">
      <data key="d0">VAS</data>
      <data key="d1">category</data>
      <data key="d2">VAS (Visual Analog Scale) is a component of the Adherence Assessment, used to measure adherence levels with thresholds like &gt;95%, 75–94%, and &lt;75%.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391525</data>
    </node>
    <node id="PIT-Client knows the…">
      <data key="d0">PIT-Client knows the…</data>
      <data key="d1">category</data>
      <data key="d2">PIT-Client knows the… is a category within the Adherence Assessment, evaluating the client's knowledge of medication details such as dose, time, and instructions.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391525</data>
    </node>
    <node id="Overall Adherence">
      <data key="d0">Overall Adherence</data>
      <data key="d1">category</data>
      <data key="d2">Overall Adherence is a category that categorizes adherence levels as High, Moderate, or Low based on the integration of other assessment metrics.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391525</data>
    </node>
    <node id="Self-reporting">
      <data key="d0">Self-reporting</data>
      <data key="d1">category</data>
      <data key="d2">Self-reporting refers to a method of assessing medication adherence through patient responses to questions about their medication management.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391525</data>
    </node>
    <node id="Answered 'No' to all questions">
      <data key="d0">Answered 'No' to all questions</data>
      <data key="d1">category</data>
      <data key="d2">Answered 'No' to all questions is a self-reporting category indicating the patient did not confirm any adherence-related details.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391525</data>
    </node>
    <node id="Answered 'Yes' to 1 question">
      <data key="d0">Answered 'Yes' to 1 question</data>
      <data key="d1">category</data>
      <data key="d2">Answered 'Yes' to 1 question is a self-reporting category indicating the patient confirmed one adherence-related detail.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391526</data>
    </node>
    <node id="Answered 'Yes' to 2 or more questions">
      <data key="d0">Answered 'Yes' to 2 or more questions</data>
      <data key="d1">category</data>
      <data key="d2">Answered 'Yes' to 2 or more questions is a self-reporting category indicating the patient confirmed multiple adherence-related details.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391526</data>
    </node>
    <node id="Dose">
      <data key="d0">Dose</data>
      <data key="d1">category</data>
      <data key="d2">Dose refers to the quantity of medication taken, a component assessed in the PIT-Client knows the… category.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391526</data>
    </node>
    <node id="Time">
      <data key="d0">Time</data>
      <data key="d1">category</data>
      <data key="d2">Time refers to the specific hours medication is taken, a component assessed in the PIT-Client knows the… category.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391526</data>
    </node>
    <node id="Instructions">
      <data key="d0">Instructions</data>
      <data key="d1">category</data>
      <data key="d2">Instructions refer to additional guidance provided for medication use, a component assessed in the PIT-Client knows the… category.</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391526</data>
    </node>
    <node id="SEMDSA">
      <data key="d0">SEMDSA</data>
      <data key="d3">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d2">SEMDSA provided leadership in developing the guideline, which was compiled by the Department of Health.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391528</data>
    </node>
    <node id="SMBG">
      <data key="d0">SMBG</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d2">SMBG is a critical tool for monitoring blood glucose levels in diabetes management.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391534</data>
    </node>
    <node id="RPG">
      <data key="d0">RPG</data>
      <data key="d3">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d2">RPG is used as a diagnostic and monitoring method for diabetes management.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391534</data>
    </node>
    <node id="CKD screening">
      <data key="d0">CKD screening</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d2">Albumin/creatinine ratio is a key test used in the screening for chronic kidney disease (CKD) in diabetic patients.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391553</data>
    </node>
    <node id="CKD assessment">
      <data key="d0">CKD assessment</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d2">eGFR is calculated from serum creatinine to assess kidney function as part of CKD evaluation.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391553</data>
    </node>
    <node id="Cardiovascular Disease Risk">
      <data key="d0">Cardiovascular Disease Risk</data>
      <data key="d3">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d2">ECG is recommended for patients with ischaemic heart disease or other cardiovascular disease risk factors.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391554</data>
    </node>
    <node id="HbA1c &lt;7%">
      <data key="d0">HbA1c &lt;7%</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d2">The majority of patients have an HbA1c target of &lt;7% as per the guidelines.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391555</data>
    </node>
    <node id="HbA1c &lt;6.5%">
      <data key="d0">HbA1c &lt;6.5%</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d2">Young, low-risk, newly diagnosed patients with no cardiovascular disease have a stricter HbA1c target of &lt;6.5%.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391556</data>
    </node>
    <node id="HbA1c &lt;7.5%">
      <data key="d0">HbA1c &lt;7.5%</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d2">Older patients with high risk and poor prognosis have an adjusted HbA1c target of &lt;7.5%.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391556</data>
    </node>
    <node id="Second-line therapy">
      <data key="d0">Second-line therapy</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d2">Insulin is typically used as a second- or third-line therapy in type 2 diabetes management.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391556</data>
    </node>
    <node id="Hospital-level assessment">
      <data key="d0">Hospital-level assessment</data>
      <data key="d3">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d2">Young diabetics under 30 years are required to undergo hospital-level assessment at least once per year as per the guidelines.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391556</data>
    </node>
    <node id="Lifestyle">
      <data key="d0">Lifestyle</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d2">Insulin regimen must align with patient lifestyle to ensure adherence and effective diabetes management.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391560</data>
    </node>
    <node id="Insulin Dose Titration">
      <data key="d0">Insulin Dose Titration</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d2">Written instructions are essential for patients to safely adjust insulin doses according to titration protocols.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391560</data>
    </node>
    <node id="Multiple Daily Injections">
      <data key="d0">Multiple Daily Injections</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d2">Intensive insulin therapy involves multiple daily injections, used when standard regimens fail to achieve targets.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391561</data>
    </node>
    <node id="Unmet Glycaemic Targets">
      <data key="d0">Unmet Glycaemic Targets</data>
      <data key="d3">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d2">Specialist referral is necessary when glycaemic targets remain unmet despite standard or intensive insulin therapy.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391561</data>
    </node>
    <node id="Medical Review">
      <data key="d0">Medical Review</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d2">Hyperglycaemia requires urgent medical review as outlined in the text, establishing a direct link to clinical intervention.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391564</data>
    </node>
    <node id="Insulin Dose Adjustment">
      <data key="d0">Insulin Dose Adjustment</data>
      <data key="d3">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d2">Hyperglycaemia necessitates adjustments to insulin doses during sick days, as per the guidelines provided.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391565</data>
    </node>
    <node id="Overweight">
      <data key="d0">Overweight</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d2">The survey reported percentages of overweight adults, providing data on the prevalence of overweight in South Africa.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391571</data>
    </node>
    <node id="Weight gain">
      <data key="d0">Weight gain</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d2">Obesity is linked to weight gain in type 2 diabetic patients, especially after the introduction of sulphonylureas and insulin therapy.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391572</data>
    </node>
    <node id="Obese">
      <data key="d0">Obese</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d2">The survey reported percentages of obese adults, providing data on the prevalence of obesity in South Africa.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391572</data>
    </node>
    <node id="Hyperglycaemic hyperosmolar coma (HHS)">
      <data key="d0">Hyperglycaemic hyperosmolar coma (HHS)</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d2">Myocardial infarction is listed as a precipitant for HHS in the text.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391572</data>
    </node>
    <node id="Weight loss">
      <data key="d0">Weight loss</data>
      <data key="d3">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d2">Behavioural therapy is recommended to support weight loss in obese patients.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391573</data>
    </node>
    <node id="CVD">
      <data key="d0">CVD</data>
      <data key="d3">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d2">Cigarette smoking is a modifiable CVD risk factor in diabetes, with cessation recommended to reduce cardiovascular risk.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391575</data>
    </node>
    <node id="Diabetic Patients">
      <data key="d0">Diabetic Patients</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d2">Fasting lipid profile is a diagnostic tool used to evaluate lipid levels in diabetic patients.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391580</data>
    </node>
    <node id="Statin Therapy">
      <data key="d0">Statin Therapy</data>
      <data key="d3">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d2">Group 1 patients require statin therapy as part of their management, regardless of baseline lipid levels.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391581</data>
    </node>
    <node id="REFER">
      <data key="d0">REFER</data>
      <data key="d3">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d2">Elevated cholesterol levels above 7.5 mmol/L are a criterion for referral to further medical evaluation.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391584</data>
    </node>
    <node id="Renal Failure">
      <data key="d0">Renal Failure</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d2">ACE inhibitors can lead to renal failure, necessitating monitoring of creatinine levels and specialist referral if levels double.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391585</data>
    </node>
    <node id="CKD">
      <data key="d0">CKD</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d2">CKD management involves regular screening for early detection, including ACR and eGFR measurements.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391586</data>
    </node>
    <node id="Treatment Adherence">
      <data key="d0">Treatment Adherence</data>
      <data key="d3">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d2">Annexure F is referenced to check patient adherence to treatment protocols, ensuring effective CKD and diabetes management.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391588</data>
    </node>
    <node id="Other Causes of CKD in Diabetes">
      <data key="d0">Other Causes of CKD in Diabetes</data>
      <data key="d3">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d2">Family history of non-diabetic renal disease is a criterion for considering non-diabetic causes of CKD in diabetic patients.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391589</data>
    </node>
    <node id="20% of diabetes-related hospital admissions">
      <data key="d0">20% of diabetes-related hospital admissions</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d2">In North America, foot complications account for 20% of all diabetes-related hospital admissions.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391592</data>
    </node>
    <node id="lack of data on hospital admissions">
      <data key="d0">lack of data on hospital admissions</data>
      <data key="d3">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d2">In South Africa, data on diabetes-related hospital admissions for foot complications are not available.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391592</data>
    </node>
    <node id="Referral to Hospital">
      <data key="d0">Referral to Hospital</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d2">Charcot foot requires referral to a hospital with orthopaedic and podiatrist services for management.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391597</data>
    </node>
    <node id="Vascular Surgery">
      <data key="d0">Vascular Surgery</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d2">Peripheral artery disease requires referral to a vascular surgery center for assessment and treatment.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391597</data>
    </node>
    <node id="Secondary/Tertiary Care">
      <data key="d0">Secondary/Tertiary Care</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d2">Ulcerative foot pathology necessitates specialist management at secondary or tertiary care facilities.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391598</data>
    </node>
    <node id="Referral Hospital">
      <data key="d0">Referral Hospital</data>
      <data key="d3">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d2">Pregnant diabetic patients require referral to a hospital for evaluation and management.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391598</data>
    </node>
    <node id="Older diabetic patients">
      <data key="d0">Older diabetic patients</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d2">Aspirin is recommended for secondary prevention of cardiovascular events in older diabetic patients, particularly those with diastolic hypertension.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391604</data>
    </node>
    <node id="Elderly patients">
      <data key="d0">Elderly patients</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d2">Metformin use in elderly patients is contraindicated if serum creatinine exceeds 130 µmol/L, highlighting age-related considerations.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391604</data>
    </node>
    <node id="Coloured and African females">
      <data key="d0">Coloured and African females</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d2">Obesity is strongly correlated with diabetes in Coloured and African females, with prevalence rates of 26.3% and 31.8%, respectively.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391604</data>
    </node>
    <node id="SA burden of disease study">
      <data key="d0">SA burden of disease study</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d2">The SA burden of disease study is a research event conducted in South Africa, providing data on diabetes prevalence rates, including a 5.5% overall prevalence."+</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391605</data>
    </node>
    <node id="Diastolic hypertension">
      <data key="d0">Diastolic hypertension</data>
      <data key="d3">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d2">Diastolic hypertension is a condition for which aspirin is recommended as secondary prevention of cardiovascular events in older diabetic patients."+</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391605</data>
    </node>
    <node id="Structured education programme">
      <data key="d0">Structured education programme</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Meal planning is a core component of the structured education programme for diabetes management during fasting.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391607</data>
    </node>
    <node id="Glycaemic control">
      <data key="d0">Glycaemic control</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Assessing glycaemic control is a key part of the medical evaluation for patients planning to fast.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391608</data>
    </node>
    <node id="Medical assessment">
      <data key="d0">Medical assessment</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Assessing glycaemic control is a key part of the medical evaluation for patients planning to fast.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391608</data>
    </node>
    <node id="Diet-controlled patients">
      <data key="d0">Diet-controlled patients</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Diet-controlled patients follow specific meal planning strategies during fasting intervals.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391609</data>
    </node>
    <node id="Dosage adjustment">
      <data key="d0">Dosage adjustment</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Dosage adjustments for oral hypoglycaemic agents are necessary during fasting.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391609</data>
    </node>
    <node id="Oral hypoglycaemic agents">
      <data key="d0">Oral hypoglycaemic agents</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Dosage adjustments for oral hypoglycaemic agents are necessary during fasting.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391609</data>
    </node>
    <node id="Lipids">
      <data key="d0">Lipids</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Lipid levels are assessed as part of the medical evaluation for fasting patients.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391610</data>
    </node>
    <node id="Dose timing adjustment">
      <data key="d0">Dose timing adjustment</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Sulphonylurea dose timing is adjusted during fasting, with reduced morning doses.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391610</data>
    </node>
    <node id="Administration timing">
      <data key="d0">Administration timing</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Insulin administration timing is adjusted during fasting, with intermediate-acting insulin injected overnight and rapid-acting insulin before meals.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391610</data>
    </node>
    <node id="Renal function">
      <data key="d0">Renal function</data>
      <data key="d3">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d2">Renal function is evaluated during the medical assessment for fasting patients.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391611</data>
    </node>
    <node id="Fitness to Drive Assessment">
      <data key="d0">Fitness to Drive Assessment</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d2">Healthcare professionals are responsible for assessing the suitability of individuals with diabetes to drive.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391612</data>
    </node>
    <node id="Driving Impairment">
      <data key="d0">Driving Impairment</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d2">Hypoglycaemia may lead to transient cognitive dysfunction or loss of consciousness, impairing driving.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391613</data>
    </node>
    <node id="Driving Risk">
      <data key="d0">Driving Risk</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d2">Severe hypoglycaemic events are a significant risk factor for drivers with diabetes, increasing accident likelihood.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391613</data>
    </node>
    <node id="No Increased Driving Risk">
      <data key="d0">No Increased Driving Risk</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d2">Insulin therapy itself has not been found to be associated with increased driving risk.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391613</data>
    </node>
    <node id="Learner's Licence">
      <data key="d0">Learner's Licence</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d2">The MEC of the Province is the authority to whom individuals must submit their learner's licence if disqualified due to uncontrolled diabetes.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391614</data>
    </node>
    <node id="Persons with Diabetes">
      <data key="d0">Persons with Diabetes</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d2">Persons with diabetes are recommended to have adequate blood glucose test strips provided for monitoring during driving.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391615</data>
    </node>
    <node id="Commercial Licence">
      <data key="d0">Commercial Licence</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d2">Endocrinologists are specialists involved in the assessment and management of commercial drivers with diabetes applying for a licence.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391615</data>
    </node>
    <node id="National Programmes">
      <data key="d0">National Programmes</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d2">South Africa is referenced as a context for national programs to implement collaborative TB and diabetes activities.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391615</data>
    </node>
    <node id="Medical Evaluation">
      <data key="d0">Medical Evaluation</data>
      <data key="d3">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d2">Healthcare professionals are responsible for conducting medical evaluations to assess fitness to drive for individuals with diabetes.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391616</data>
    </node>
    <node id="World Health Organization (WHO)&quot;+">
      <data key="d0">World Health Organization (WHO)"+</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d2">The WHO collaborates on the development of the framework for integrated TB and diabetes care."+</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391616</data>
    </node>
    <node id="Healthcare Facilities">
      <data key="d0">Healthcare Facilities</data>
      <data key="d3">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d2">Healthcare facilities implement infection control plans to prevent TB transmission."+</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391619</data>
    </node>
    <node id="2012 SEMDSA Guideline">
      <data key="d0">2012 SEMDSA Guideline</data>
      <data key="d3">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d2">The 2012 SEMDSA Guideline references the International Diabetes Federation's diabetes atlas for data.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391621</data>
    </node>
    <node id="Evaluation and management of adult hypoglycemic disorders">
      <data key="d0">Evaluation and management of adult hypoglycemic disorders</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d2">Endocrine Society published a clinical practice guideline on the evaluation and management of adult hypoglycemic disorders.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391623</data>
    </node>
    <node id="Hypoglycemia">
      <data key="d0">Hypoglycemia</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d2">The Canadian Diabetes Association Clinical Practice Guideline Expert Committee published a guideline on hypoglycemia.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391624</data>
    </node>
    <node id="Intensive blood pressure control">
      <data key="d0">Intensive blood pressure control</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d2">The ACCORD Study Group conducted a study on intensive blood pressure control in type 2 diabetes.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391625</data>
    </node>
    <node id="Tight blood pressure control">
      <data key="d0">Tight blood pressure control</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d2">The UK Prospective Diabetes Study Group conducted a study on tight blood pressure control in type 2 diabetes.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391625</data>
    </node>
    <node id="Nephropathy">
      <data key="d0">Nephropathy</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d2">Palmer AJ authored a health economic analysis on nephropathy screening and treatment in diabetic patients.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391626</data>
    </node>
    <node id="Mazzone T">
      <data key="d0">Mazzone T</data>
      <data key="d3">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d2">Mazzone T authored a study published in Circulation on cardiovascular disease in type 2 diabetes." </data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391627</data>
    </node>
    <node id="prevention of NIDDM">
      <data key="d0">prevention of NIDDM</data>
      <data key="d3">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d2">NIDDM is the focus of prevention studies.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391628</data>
    </node>
    <node id="Driving and diabetics on insulin therapy">
      <data key="d0">Driving and diabetics on insulin therapy</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d2">Distiller LA is an author of the study published in S Afr Med J on driving and diabetics on insulin therapy.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391630</data>
    </node>
    <node id="Society for Endocrinology, Metabolism and Diabetes for South Africa">
      <data key="d0">Society for Endocrinology, Metabolism and Diabetes for South Africa</data>
      <data key="d3">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d2">The SEMDSA Steering Committee is part of the Society for Endocrinology, Metabolism and Diabetes for South Africa and contributed to the guideline development.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391630</data>
    </node>
    <node id="Identification Disc">
      <data key="d0">Identification Disc</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d2">Self-care includes the use of identification discs or bracelets to raise awareness of diabetes in daily life.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391632</data>
    </node>
    <node id="Family Support">
      <data key="d0">Family Support</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d2">Self-care involves involving family members for support in managing diabetes effectively.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391633</data>
    </node>
    <node id="Hypoglycaemic Emergencies">
      <data key="d0">Hypoglycaemic Emergencies</data>
      <data key="d3">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d2">Hypoglycaemia treatment is directly related to managing hypoglycaemic emergencies through the use of simple carbohydrates.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391634</data>
    </node>
    <node id="Strenuous Exercise">
      <data key="d0">Strenuous Exercise</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d2">Unstable proliferative retinopathy is a contraindication to strenuous exercise, as specified in the text.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391636</data>
    </node>
    <node id="Strenuous Physical Activity">
      <data key="d0">Strenuous Physical Activity</data>
      <data key="d3">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d2">Delayed hypoglycaemia is a risk associated with strenuous physical activity, requiring glucose monitoring.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391636</data>
    </node>
    <node id="Screening Methods">
      <data key="d0">Screening Methods</data>
      <data key="d3">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d2">ANNEXURE C2 contains detailed instructions for two screening methods: the 10-g monofilament test and the 128-Hz tuning fork test.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391640</data>
    </node>
    <node id="Health Education">
      <data key="d0">Health Education</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d2">NGOs are utilized to facilitate health education as part of existing structures.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391641</data>
    </node>
    <node id="Peer Support">
      <data key="d0">Peer Support</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d2">Support Groups are utilized to provide peer support as part of existing structures.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391641</data>
    </node>
    <node id="Diabetes Management">
      <data key="d0">Diabetes Management</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d2">HbA1c is a key tool in monitoring and managing diabetes through tracking blood glucose levels.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391641</data>
    </node>
    <node id="Health professionals">
      <data key="d0">Health professionals</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d2">Supervisors are responsible for ensuring that health professionals complete down-referral protocols.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391642</data>
    </node>
    <node id="Chronic patients">
      <data key="d0">Chronic patients</data>
      <data key="d3">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d2">Pharmacy personnel manage medication supplies based on the number of chronic patients reported by the clinic.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391642</data>
    </node>
    <node id="&gt;95%">
      <data key="d0">&gt;95%</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d2">Pill count includes the threshold '&gt;95%' indicating high adherence based on medication count.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391648</data>
    </node>
    <node id="Pill count">
      <data key="d0">Pill count</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d2">Pill count includes the threshold '&gt;95%' indicating high adherence based on medication count.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391648</data>
    </node>
    <node id="75–94%">
      <data key="d0">75–94%</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d2">Pill count includes the threshold '75–94%' indicating moderate adherence based on medication count.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391649</data>
    </node>
    <node id="High">
      <data key="d0">High</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d2">Overall Adherence categorizes adherence levels as 'High' based on integrated assessment metrics.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391649</data>
    </node>
    <node id="Less than 75%">
      <data key="d0">Less than 75%</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d2">Pill count includes the threshold 'Less than 75%' indicating low adherence based on medication count.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391650</data>
    </node>
    <node id="Moderate">
      <data key="d0">Moderate</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d2">Overall Adherence categorizes adherence levels as 'Moderate' based on integrated assessment metrics.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391650</data>
    </node>
    <node id="Low">
      <data key="d0">Low</data>
      <data key="d3">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d2">Overall Adherence categorizes adherence levels as 'Low' based on integrated assessment metrics.</data>
      <data key="d1">UNKNOWN</data>
      <data key="d4">unknown_source</data>
      <data key="d5">1754391650</data>
    </node>
    <edge source="South African managed healthcare organization" target="Type 2 Diabetes Mellitus">
      <data key="d6">10.0</data>
      <data key="d7">The study on Type 2 Diabetes Mellitus patients with comorbidities was conducted within the South African managed healthcare organization.</data>
      <data key="d8">healthcare setting,research context</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391365</data>
    </edge>
    <edge source="South African managed healthcare organization" target="Major Depressive Disorder">
      <data key="d6">9.0</data>
      <data key="d7">The study examined comorbidities between Type 2 Diabetes Mellitus and Major Depressive Disorder within the South African managed healthcare organization.</data>
      <data key="d8">comorbidity analysis,healthcare research</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391367</data>
    </edge>
    <edge source="South African managed healthcare organization" target="Annual Meeting of The Japanese Pharmacological Society">
      <data key="d6">7.0</data>
      <data key="d7">The study conducted in the South African managed healthcare organization was presented at the Annual Meeting of The Japanese Pharmacological Society.</data>
      <data key="d8">academic dissemination,international research collaboration</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391370</data>
    </edge>
    <edge source="South African managed healthcare organization" target="Healthcare Resource Utilization">
      <data key="d6">9.0</data>
      <data key="d7">Healthcare resource utilization metrics (admissions, length of stay, costs) were extracted from the South African managed healthcare organization's claims data.</data>
      <data key="d8">data extraction,healthcare metrics</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391372</data>
    </edge>
    <edge source="University of the Witwatersrand" target="Lovina Asha Naidoo">
      <data key="d6">9.0</data>
      <data key="d7">Lovina Asha Naidoo is affiliated with the University of the Witwatersrand as indicated in the study's author information.</data>
      <data key="d8">academic affiliation,institutional connection</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391362</data>
    </edge>
    <edge source="University of the Witwatersrand" target="Neil Butkow">
      <data key="d6">9.0</data>
      <data key="d7">Neil Butkow is affiliated with the University of the Witwatersrand as indicated in the study's author information.</data>
      <data key="d8">academic affiliation,institutional connection</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391365</data>
    </edge>
    <edge source="University of the Witwatersrand" target="Paula Barnard">
      <data key="d6">9.0</data>
      <data key="d7">Paula Barnard is affiliated with the University of the Witwatersrand as indicated in the study's author information.</data>
      <data key="d8">academic affiliation,institutional connection</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391366</data>
    </edge>
    <edge source="University of the Witwatersrand" target="Elena Libhaber">
      <data key="d6">9.0</data>
      <data key="d7">Elena Libhaber is affiliated with the University of the Witwatersrand as indicated in the study's author information.</data>
      <data key="d8">academic affiliation,institutional connection</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391367</data>
    </edge>
    <edge source="South Africa" target="Diabetes Mellitus">
      <data key="d6">7.0</data>
      <data key="d7">South Africa is associated with Diabetes Mellitus through the mention of a conservative estimate of diabetes prevalence among its adult population.</data>
      <data key="d8">geographic context,public health</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391529</data>
    </edge>
    <edge source="South Africa" target="Diabetic Ketoacidosis (DKA)">
      <data key="d6">8.0</data>
      <data key="d7">In South Africa, DKA is associated with a higher mortality rate compared to developed countries, according to the text.</data>
      <data key="d8">diabetes management,geographic mortality disparity</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391568</data>
    </edge>
    <edge source="South Africa" target="South African CSR Targets">
      <data key="d6">8.0</data>
      <data key="d7">South Africa is the country associated with the South African CSR targets for cataract surgery rates.</data>
      <data key="d8">geographic context,healthcare policy</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391590</data>
    </edge>
    <edge source="South Africa" target="lack of data on hospital admissions">
      <data key="d6">7.0</data>
      <data key="d7">In South Africa, data on diabetes-related hospital admissions for foot complications are not available.</data>
      <data key="d8">healthcare data gap,regional disparity</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391592</data>
    </edge>
    <edge source="South Africa" target="Gestational Diabetes Mellitus (GDM)">
      <data key="d6">8.0</data>
      <data key="d7">South Africa's guidelines for maternity care are referenced for managing GDM, indicating a connection between the country's health policies and the condition.</data>
      <data key="d8">healthcare policy,regional guidelines</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391600</data>
    </edge>
    <edge source="South Africa" target="Asian/Indian descent">
      <data key="d6">9.0</data>
      <data key="d7">South Africa is the geographic context where the Asian/Indian descent population group exhibits a 17.1% diabetes prevalence, requiring earlier screening due to increased risk at lower BMI levels.</data>
      <data key="d8">geographic context,population-specific risk</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391601</data>
    </edge>
    <edge source="South Africa" target="Urbanised Black people">
      <data key="d6">9.0</data>
      <data key="d7">South Africa is the geographic context where the Urbanised Black people population group has a 6.4% diabetes prevalence, with urbanised Black females over 60 years at particular risk.</data>
      <data key="d8">geographic context,population-specific risk</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391601</data>
    </edge>
    <edge source="South Africa" target="White and Coloured people">
      <data key="d6">9.0</data>
      <data key="d7">South Africa is the geographic context where the White and Coloured people population group has a 6.2% diabetes prevalence, with Coloured individuals over 60 years, especially females, at higher risk.</data>
      <data key="d8">geographic context,population-specific risk</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391602</data>
    </edge>
    <edge source="South Africa" target="SA burden of disease study">
      <data key="d6">9.0</data>
      <data key="d7">The SA burden of disease study is a research event conducted in South Africa, providing data on diabetes prevalence rates, including a 5.5% overall prevalence."+</data>
      <data key="d8">epidemiological study,geographic context</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391605</data>
    </edge>
    <edge source="South Africa" target="Road Traffic Act of 1996">
      <data key="d6">9.0</data>
      <data key="d7">The Road Traffic Act of 1996 in South Africa outlines disqualification criteria for drivers with uncontrolled diabetes.</data>
      <data key="d8">legal framework,legislation</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391612</data>
    </edge>
    <edge source="South Africa" target="National Programmes">
      <data key="d6">8.0</data>
      <data key="d7">South Africa is referenced as a context for national programs to implement collaborative TB and diabetes activities.</data>
      <data key="d8">geographic implementation,public health</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391615</data>
    </edge>
    <edge source="South Africa" target="National programmes">
      <data key="d6">8.0</data>
      <data key="d7">National programmes in South Africa focus on implementing TB and diabetes collaborative activities."+</data>
      <data key="d8">geographic implementation,public health</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391620</data>
    </edge>
    <edge source="South Africa" target="SEMDSA">
      <data key="d6">8.0</data>
      <data key="d7">The SEMDSA operates within South Africa and contributes to national diabetes guidelines.</data>
      <data key="d8">geographic context,organizational role</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391630</data>
    </edge>
    <edge source="Annual Meeting of The Japanese Pharmacological Society" target="Type 2 Diabetes Mellitus">
      <data key="d6">8.0</data>
      <data key="d7">The study on Type 2 Diabetes Mellitus patients with comorbidities was presented at the Annual Meeting of The Japanese Pharmacological Society.</data>
      <data key="d8">academic presentation,research dissemination</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391364</data>
    </edge>
    <edge source="Type 2 Diabetes Mellitus" target="Major Depressive Disorder">
      <data key="d6">10.0</data>
      <data key="d7">The study examines the comorbidity between Type 2 Diabetes Mellitus and Major Depressive Disorder, highlighting their bidirectional relationship and impact on healthcare outcomes.</data>
      <data key="d8">bidirectional relationship,comorbidity analysis</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391370</data>
    </edge>
    <edge source="Type 2 Diabetes Mellitus" target="Hyperglycaemic Hyperosmolar State (HHS)">
      <data key="d6">9.0</data>
      <data key="d7">Type 2 Diabetes Mellitus is linked to HHS in new-onset cases, as stated in the text.</data>
      <data key="d8">diabetes types,medical conditions</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391569</data>
    </edge>
    <edge source="Major Depressive Disorder" target="Coronary Artery Disease">
      <data key="d6">8.0</data>
      <data key="d7">Coronary artery disease is associated with Major Depressive Disorder in the context of improved patient outcomes through integrated management.</data>
      <data key="d8">cardiovascular health,comorbidity management</data>
      <data key="d9">chunk-d6b09b4b09529f8f51aa7d3eb8384af7</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391372</data>
    </edge>
    <edge source="Dr A Motsoaledi" target="Department of Health">
      <data key="d6">9.0</data>
      <data key="d7">Dr A Motsoaledi, as Minister of Health, is associated with the Department of Health through the guideline's foreword.</data>
      <data key="d8">government role,policy endorsement</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391526</data>
    </edge>
    <edge source="Dr G Ramokgopa" target="Department of Health">
      <data key="d6">9.0</data>
      <data key="d7">Dr G Ramokgopa, as Deputy Minister of Health, supports the Department of Health's diabetes guideline objectives.</data>
      <data key="d8">government collaboration,policy alignment</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391527</data>
    </edge>
    <edge source="Ms MP Matsoso" target="Department of Health">
      <data key="d6">8.0</data>
      <data key="d7">Ms MP Matsoso, as Director-General of Health, acknowledges the Department of Health's role in guideline development.</data>
      <data key="d8">leadership endorsement,organizational collaboration</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391527</data>
    </edge>
    <edge source="Department of Health" target="SEMDSA">
      <data key="d6">10.0</data>
      <data key="d7">SEMDSA provided leadership in developing the guideline, which was compiled by the Department of Health.</data>
      <data key="d8">collaboration,guideline development</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391528</data>
    </edge>
    <edge source="Department of Health" target="Non-Communicable Diseases Summit (2011)">
      <data key="d6">9.0</data>
      <data key="d7">The 2011 summit influenced the Department of Health's targets for reducing non-communicable diseases by 2020.</data>
      <data key="d8">health goals,policy influence</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391529</data>
    </edge>
    <edge source="Department of Health" target="Diabetes Implementation Strategy for South Africa">
      <data key="d6">9.0</data>
      <data key="d7">The Diabetes Implementation Strategy is an integral part of the Department of Health's approach to diabetes management.</data>
      <data key="d8">governmental implementation,health strategy</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391530</data>
    </edge>
    <edge source="Department of Health" target="Directorate: Chronic Diseases, Disabilities and Geriatrics">
      <data key="d6">9.0</data>
      <data key="d7">The Directorate is a division of the National Department of Health responsible for compiling the guideline.</data>
      <data key="d8">guideline compilation,organizational structure</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391530</data>
    </edge>
    <edge source="Department of Health" target="SEMDSA Steering Committee">
      <data key="d6">8.0</data>
      <data key="d7">The Department of Health was a member of the SEMDSA Steering Committee during guideline development.</data>
      <data key="d8">membership,policy involvement</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391621</data>
    </edge>
    <edge source="Diabetes Implementation Strategy for South Africa" target="African Diabetes Declaration and Strategy">
      <data key="d6">10.0</data>
      <data key="d7">The African Diabetes Declaration and Strategy informed the development of South Africa's Diabetes Implementation Strategy.</data>
      <data key="d8">health strategy,policy alignment</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391527</data>
    </edge>
    <edge source="Diabetes Implementation Strategy for South Africa" target="Type 2 Diabetes">
      <data key="d6">10.0</data>
      <data key="d7">The strategy focuses on managing Type 2 Diabetes at primary care level in South Africa.</data>
      <data key="d8">health condition,policy focus</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391527</data>
    </edge>
    <edge source="Diabetes Implementation Strategy for South Africa" target="Negotiated Service Delivery Agreement">
      <data key="d6">9.0</data>
      <data key="d7">The diabetes guideline supports the objectives of the Negotiated Service Delivery Agreement, aligning with its goals of improving health outcomes."|"policy alignment, health objectives</data>
      <data key="d8">9</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391528</data>
    </edge>
    <edge source="Diabetes Implementation Strategy for South Africa" target="Directorate: Chronic Diseases, Disabilities and Geriatrics">
      <data key="d6">10.0</data>
      <data key="d7">The Directorate compiled the guideline, which is an integral part of the Diabetes Implementation Strategy."|"guideline compilation, strategic integration</data>
      <data key="d8">10</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391529</data>
    </edge>
    <edge source="Healthcare Organization" target="T2DM">
      <data key="d6">9.0</data>
      <data key="d7">The healthcare organization conducted a study analyzing T2DM patients' hospitalization patterns in relation to MDD.</data>
      <data key="d8">medical research,patient study</data>
      <data key="d9">chunk-8fc89353659871857f4a2f36b706fc19</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391367</data>
    </edge>
    <edge source="Healthcare Organization" target="T2DM with MDD">
      <data key="d6">8.0</data>
      <data key="d7">The healthcare organization identified a T2DM with MDD patient group with an 18% hospital admission rate.</data>
      <data key="d8">healthcare study,patient group analysis</data>
      <data key="d9">chunk-8fc89353659871857f4a2f36b706fc19</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391370</data>
    </edge>
    <edge source="Healthcare Organization" target="T2DM without MDD">
      <data key="d6">8.0</data>
      <data key="d7">The healthcare organization analyzed a T2DM without MDD patient group with a 10% hospital admission rate.</data>
      <data key="d8">healthcare study,patient group analysis</data>
      <data key="d9">chunk-8fc89353659871857f4a2f36b706fc19</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391374</data>
    </edge>
    <edge source="T2DM without MDD" target="T2DM with MDD">
      <data key="d6">10.0</data>
      <data key="d7">The T2DM with MDD group had a significantly higher hospital admission rate (18%) compared to the T2DM without MDD group (10%).</data>
      <data key="d8">disease comorbidity,hospital utilization</data>
      <data key="d9">chunk-8fc89353659871857f4a2f36b706fc19</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391372</data>
    </edge>
    <edge source="Negotiated Service Delivery Agreement" target="Non-Communicable Diseases">
      <data key="d6">9.0</data>
      <data key="d7">The Agreement aims to reduce the burden of non-communicable diseases, including diabetes.</data>
      <data key="d8">health targets,policy framework</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391527</data>
    </edge>
    <edge source="Directorate: Chronic Diseases, Disabilities and Geriatrics" target="Screening, Diagnosis, and Management of Complications">
      <data key="d6">9.0</data>
      <data key="d7">The Directorate is responsible for implementing the screening, diagnosis, and management protocols outlined in the guideline."|"health protocol execution, organizational responsibility</data>
      <data key="d8">9</data>
      <data key="d9">chunk-76dcee1ddb22a2d709c06cd143cc277a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391528</data>
    </edge>
    <edge source="Directorate: Chronic Diseases, Disabilities and Geriatrics" target="National Department of Health">
      <data key="d6">8.0</data>
      <data key="d7">The Directorate is part of the National Department of Health responsible for compiling the guideline.</data>
      <data key="d8">document compilation,organizational hierarchy</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391630</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Diabetes Mellitus">
      <data key="d6">10.0</data>
      <data key="d7">Type 2 Diabetes is a major subset of Diabetes Mellitus, accounting for over 90% of all diabetes cases.</data>
      <data key="d8">disease classification,health condition</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391530</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Non-Communicable Diseases (NCDs)">
      <data key="d6">9.0</data>
      <data key="d7">Type 2 diabetes is a subset of non-communicable diseases, requiring targeted interventions at primary health care levels.</data>
      <data key="d8">disease classification,healthcare focus</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391534</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Macrovascular disease">
      <data key="d6">9.0</data>
      <data key="d7">Type 2 diabetes significantly increases the risk of macrovascular disease, with 2- to 5-fold higher CVD risk compared to non-diabetics.</data>
      <data key="d8">disease association,risk amplification</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391573</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Myocardial infarction">
      <data key="d6">8.0</data>
      <data key="d7">Type 2 diabetes is linked to more severe and rapidly fatal myocardial infarctions due to accelerated atherosclerosis.</data>
      <data key="d8">pathophysiological link,severity increase</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391574</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Stroke">
      <data key="d6">8.0</data>
      <data key="d7">Diabetic patients experience more extensive and rapidly fatal strokes compared to non-diabetics, driven by atherosclerosis.</data>
      <data key="d8">pathophysiological link,severity increase</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391575</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Atherosclerosis">
      <data key="d6">9.0</data>
      <data key="d7">Type 2 diabetes accelerates atherosclerosis, a major cause of diabetic mortality, influenced by hyperglycaemia and other risk factors.</data>
      <data key="d8">disease progression,pathophysiological link</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391575</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Metabolic Syndrome">
      <data key="d6">10.0</data>
      <data key="d7">The metabolic syndrome increases the risk of developing type 2 diabetes by approximately 5-fold and doubles CVD risk.</data>
      <data key="d8">etiologic relationship,risk amplification</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391576</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Lipid Disturbances">
      <data key="d6">9.0</data>
      <data key="d7">Type 2 diabetes is associated with lipid disturbances, including increased triglycerides and decreased HDL cholesterol.</data>
      <data key="d8">lipid profile,medical condition</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391578</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Ideal Lipid Profile">
      <data key="d6">9.0</data>
      <data key="d7">The ideal lipid profile is a therapeutic goal for patients with type 2 diabetes to manage lipid abnormalities.</data>
      <data key="d8">diabetes management,therapeutic target</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391579</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Diabetic Mortality">
      <data key="d6">9.0</data>
      <data key="d7">Diabetic mortality is a consequence of complications in type 2 diabetes, particularly in specific ethnic groups.</data>
      <data key="d8">diabetes complications,health outcomes</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391580</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Inheritance of Diabetes">
      <data key="d6">8.0</data>
      <data key="d7">The table in the 'Inheritance of Diabetes' section directly relates to Type 2 Diabetes risk based on parental history."|"medical genetics, risk factors</data>
      <data key="d8">8</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391599</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Gestational Diabetes Mellitus (GDM)">
      <data key="d6">7.0</data>
      <data key="d7">Type 2 Diabetes is a pre-existing condition that may coexist with GDM but is distinct in its diagnosis and management.</data>
      <data key="d8">coexisting conditions,diabetes types</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391601</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Hepatitis C">
      <data key="d6">7.0</data>
      <data key="d7">Co-infection with Hepatitis C is identified as a non-traditional risk factor for developing type 2 diabetes, primarily through liver-related insulin resistance.</data>
      <data key="d8">co-infection,metabolic risk</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391606</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Lifestyle Modification">
      <data key="d6">10.0</data>
      <data key="d7">Lifestyle modification is explicitly recommended as a primary prevention strategy for Type 2 Diabetes in high-risk individuals.</data>
      <data key="d8">chronic disease management,preventive care</data>
      <data key="d9">chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391611</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Pregnancy and Glucose Control">
      <data key="d6">8.0</data>
      <data key="d7">Pregnancy and glucose control are critical for managing type 2 diabetes to prevent complications during and after pregnancy.</data>
      <data key="d8">diabetes control,pregnancy management</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391631</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Dietary Interventions">
      <data key="d6">9.0</data>
      <data key="d7">Dietary interventions are essential for managing type 2 diabetes through culturally appropriate meal planning and blood glucose control.</data>
      <data key="d8">diabetes management,nutritional strategies</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391632</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Physical Activity">
      <data key="d6">10.0</data>
      <data key="d7">Physical activity is a cornerstone of managing type 2 diabetes by improving metabolic control and cardiovascular health.</data>
      <data key="d8">diabetes management,exercise</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391633</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Uncontrolled Hypertension">
      <data key="d6">7.0</data>
      <data key="d7">Uncontrolled hypertension is a contraindication for certain exercises in individuals with type 2 diabetes.</data>
      <data key="d8">diabetes comorbidity,medical contraindication</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391635</data>
    </edge>
    <edge source="Type 2 Diabetes" target="Severe Peripheral Neuropathy">
      <data key="d6">7.0</data>
      <data key="d7">Severe peripheral neuropathy is a contraindication to certain physical activities for individuals with type 2 diabetes.</data>
      <data key="d8">exercise restriction,neuropathy</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391635</data>
    </edge>
    <edge source="Organization of diabetes care" target="Diabetes Care in Specific Populations">
      <data key="d6">8.0</data>
      <data key="d7">The 'Organization of diabetes care' encompasses guidelines under 'Diabetes Care in Specific Populations' as part of its structured approach to diabetes management.</data>
      <data key="d8">guideline inclusion,specialized care</data>
      <data key="d9">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391528</data>
    </edge>
    <edge source="Organization of diabetes care" target="List of Algorithms, Figure and Tables">
      <data key="d6">9.0</data>
      <data key="d7">The 'Organization of diabetes care' includes a 'List of Algorithms, Figure and Tables' to provide structured references for diabetes management protocols.</data>
      <data key="d8">clinical references,resource compilation</data>
      <data key="d9">chunk-dac3bac69785ad3c5e991f2be5decaf3</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391529</data>
    </edge>
    <edge source="Glycaemic management" target="Steps 1–3">
      <data key="d6">10.0</data>
      <data key="d7">Steps 1–3 are a structured approach to glycaemic management involving lifestyle changes, metformin, and other therapies.</data>
      <data key="d8">structured care,treatment framework</data>
      <data key="d9">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391556</data>
    </edge>
    <edge source="Follow-up" target="Self-Monitoring Techniques">
      <data key="d6">8.0</data>
      <data key="d7">Follow-up involves re-evaluating self-monitoring techniques to ensure accurate blood glucose tracking and effective diabetes management.</data>
      <data key="d8">diabetes care,monitoring</data>
      <data key="d9">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391566</data>
    </edge>
    <edge source="Follow-up" target="Injection Techniques">
      <data key="d6">7.0</data>
      <data key="d7">Follow-up includes re-evaluating injection techniques to optimize insulin administration and reduce complications.</data>
      <data key="d8">injection practices,patient education</data>
      <data key="d9">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391567</data>
    </edge>
    <edge source="Hypoglycaemia" target="Diabetes Mellitus">
      <data key="d6">7.0</data>
      <data key="d7">Hypoglycaemia is an acute complication directly associated with diabetes management challenges.</data>
      <data key="d8">disease complication,therapeutic risk</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391535</data>
    </edge>
    <edge source="Hypoglycaemia" target="Sulphonylureas">
      <data key="d6">9.0</data>
      <data key="d7">Sulphonylureas are associated with hypoglycaemia as a major adverse effect.</data>
      <data key="d8">adverse effects,drug safety</data>
      <data key="d9">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391556</data>
    </edge>
    <edge source="Hypoglycaemia" target="Gliclazide">
      <data key="d6">8.0</data>
      <data key="d7">Gliclazide is associated with hypoglycaemia in &gt;11% of patients, particularly in older adults.</data>
      <data key="d8">adverse effect,drug safety</data>
      <data key="d9">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391557</data>
    </edge>
    <edge source="Hypoglycaemia" target="Glibenclamide">
      <data key="d6">9.0</data>
      <data key="d7">Glibenclamide has a high risk of hypoglycaemia, especially in older patients, due to its long duration of action.</data>
      <data key="d8">adverse effect,drug safety</data>
      <data key="d9">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391558</data>
    </edge>
    <edge source="Hypoglycaemia" target="Insulin">
      <data key="d6">9.0</data>
      <data key="d7">Hypoglycaemia is a potential risk associated with insulin therapy, requiring careful dose management.</data>
      <data key="d8">complication,insulin safety</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391559</data>
    </edge>
    <edge source="Hypoglycaemia" target="Beta-Blockers">
      <data key="d6">8.0</data>
      <data key="d7">Beta-blockers may mask symptoms of hypoglycaemia, increasing the risk of severe hypoglycaemic episodes in diabetic patients.</data>
      <data key="d8">metabolic side effect,pharmacological risk</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391588</data>
    </edge>
    <edge source="Hypoglycaemia" target="Self-Monitoring Blood Glucose (SMBG)">
      <data key="d6">9.0</data>
      <data key="d7">Regular SMBG is explicitly stated as essential to prevent hypoglycaemia in diabetic patients.</data>
      <data key="d8">diabetes management,health monitoring</data>
      <data key="d9">chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391611</data>
    </edge>
    <edge source="Hypoglycaemia" target="Diabetes">
      <data key="d6">9.0</data>
      <data key="d7">Hypoglycaemia is a complication of diabetes that may impair driving ability.</data>
      <data key="d8">complication,health risk</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391612</data>
    </edge>
    <edge source="Hypoglycaemia" target="Driving Impairment">
      <data key="d6">9.0</data>
      <data key="d7">Hypoglycaemia may lead to transient cognitive dysfunction or loss of consciousness, impairing driving.</data>
      <data key="d8">driving risk,health effect</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391613</data>
    </edge>
    <edge source="Obesity" target="Hyperglycaemia">
      <data key="d6">9.0</data>
      <data key="d7">Obesity induces insulin resistance and pancreatic beta-cell dysfunction, which over time lead to worsening hyperglycaemia, as stated in the text.</data>
      <data key="d8">metabolic impact,pathophysiology</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391570</data>
    </edge>
    <edge source="Obesity" target="Cardiovascular risk">
      <data key="d6">8.0</data>
      <data key="d7">Obesity is directly associated with an increased risk of obesity-related cardio-metabolic complications, as indicated in the text.</data>
      <data key="d8">metabolic syndrome,risk factors</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391570</data>
    </edge>
    <edge source="Obesity" target="Dyslipidaemia">
      <data key="d6">7.0</data>
      <data key="d7">Obesity is linked to dyslipidaemia, which is a major contributor to macrovascular disease in type 2 diabetes patients.</data>
      <data key="d8">lipid abnormalities,metabolic comorbidities</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391571</data>
    </edge>
    <edge source="Obesity" target="Weight gain">
      <data key="d6">8.0</data>
      <data key="d7">Obesity is linked to weight gain in type 2 diabetic patients, especially after the introduction of sulphonylureas and insulin therapy.</data>
      <data key="d8">comorbidity,metabolic impact</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391572</data>
    </edge>
    <edge source="Obesity" target="National Guideline: Prevention and Management of Overweight and Obesity in South Africa">
      <data key="d6">8.0</data>
      <data key="d7">The National Guideline provides recommendations for managing obesity in South Africa.</data>
      <data key="d8">obesity management,policy framework</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391573</data>
    </edge>
    <edge source="Obesity" target="Metabolic Syndrome">
      <data key="d6">9.0</data>
      <data key="d7">Obesity is a core component of the metabolic syndrome, characterized by abdominal obesity and elevated waist circumference.</data>
      <data key="d8">component relationship,pathophysiology</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391576</data>
    </edge>
    <edge source="Obesity" target="CVD">
      <data key="d6">9.0</data>
      <data key="d7">Obesity is a significant CVD risk factor in diabetes, associated with elevated BMI and waist circumference targets.</data>
      <data key="d8">modifiable intervention,risk factor</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391578</data>
    </edge>
    <edge source="Obesity" target="Coloured and African females">
      <data key="d6">10.0</data>
      <data key="d7">Obesity is strongly correlated with diabetes in Coloured and African females, with prevalence rates of 26.3% and 31.8%, respectively.</data>
      <data key="d8">population-specific correlation,risk factor</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391604</data>
    </edge>
    <edge source="Hypertension" target="Metabolic Syndrome">
      <data key="d6">9.0</data>
      <data key="d7">Hypertension is a key component of the metabolic syndrome, with systolic ≥130 mmHg and diastolic ≥85 mmHg as diagnostic criteria.</data>
      <data key="d8">component relationship,pathophysiology</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391577</data>
    </edge>
    <edge source="Hypertension" target="CVD">
      <data key="d6">9.0</data>
      <data key="d7">Hypertension (systolic ≥140 mmHg, diastolic ≥80 mmHg) is a critical CVD risk factor in diabetes, requiring strict control.</data>
      <data key="d8">modifiable intervention,risk factor</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391578</data>
    </edge>
    <edge source="Hypertension" target="Type 2 Diabetic Patients">
      <data key="d6">10.0</data>
      <data key="d7">Hypertension is a common comorbidity in type 2 diabetes, requiring tailored management to reduce macrovascular and microvascular complications.</data>
      <data key="d8">comorbidity,treatment guidelines</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391582</data>
    </edge>
    <edge source="Hypertension" target="ACE Inhibitors (ACEi)">
      <data key="d6">9.0</data>
      <data key="d7">ACEi is the first-line treatment for hypertension in type 2 diabetes, with specific monitoring requirements for renal function.</data>
      <data key="d8">disease management,pharmacological treatment</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391582</data>
    </edge>
    <edge source="Hypertension" target="Dihydropyridine Calcium-Channel Blockers (DHP CCB)">
      <data key="d6">8.0</data>
      <data key="d7">DHP CCB is used as an adjunct to ACEi if BP targets are not achieved in type 2 diabetes patients.</data>
      <data key="d8">pharmacological adjunct,treatment escalation</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391583</data>
    </edge>
    <edge source="Hypertension" target="Blood Pressure (BP) Targets">
      <data key="d6">10.0</data>
      <data key="d7">The revised BP targets (120/70–140/80 mmHg) are central to hypertension management in type 2 diabetes patients.</data>
      <data key="d8">clinical guidelines,therapeutic goals</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391584</data>
    </edge>
    <edge source="Hypertension" target="Microvascular Disease">
      <data key="d6">9.0</data>
      <data key="d7">Hypertension is a significant contributor to the development of microvascular disease in type 2 diabetes patients.</data>
      <data key="d8">complication pathway,disease progression</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391584</data>
    </edge>
    <edge source="Hypertension" target="Macrovascular Disease">
      <data key="d6">9.0</data>
      <data key="d7">Hypertension is a significant contributor to the development of macrovascular disease in type 2 diabetes patients.</data>
      <data key="d8">complication pathway,disease progression</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391585</data>
    </edge>
    <edge source="Chronic Kidney Disease (CKD)" target="Diabetic Nephropathy">
      <data key="d6">9.0</data>
      <data key="d7">Diabetic nephropathy is a specific type of CKD caused by diabetes mellitus, requiring targeted management strategies.</data>
      <data key="d8">disease classification,medical condition</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391587</data>
    </edge>
    <edge source="Retinopathy" target="Diabetes">
      <data key="d6">8.0</data>
      <data key="d7">Retinopathy is a chronic complication of diabetes that may affect driving performance.</data>
      <data key="d8">complication,vision impairment</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391613</data>
    </edge>
    <edge source="Pregnancy" target="Sick Days">
      <data key="d6">7.0</data>
      <data key="d7">Pregnancy is a condition that may require heightened monitoring during 'sick days' due to its impact on glycaemic stability.</data>
      <data key="d8">health condition,monitoring</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391564</data>
    </edge>
    <edge source="Pregnancy" target="Methyldopa">
      <data key="d6">9.0</data>
      <data key="d7">Methyldopa is recommended for hypertension management during pregnancy, replacing ACE inhibitors and diuretics.</data>
      <data key="d8">pregnancy safety,therapeutic use</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391586</data>
    </edge>
    <edge source="Pregnancy" target="Antenatal Unit">
      <data key="d6">8.0</data>
      <data key="d7">Pregnancy with hypertension requires referral to an antenatal unit equipped to manage high-risk pregnancies.</data>
      <data key="d8">medical facility,specialized care</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391587</data>
    </edge>
    <edge source="Pregnancy" target="Renal Medicine Physician">
      <data key="d6">7.0</data>
      <data key="d7">Pregnancy with renovascular hypertension necessitates referral to a renal medicine physician for specialized management.</data>
      <data key="d8">diagnostic care,medical specialty</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391589</data>
    </edge>
    <edge source="Older Persons" target="Diabetes Mellitus">
      <data key="d6">8.0</data>
      <data key="d7">Older Persons have a high prevalence of diabetes mellitus, requiring age-specific management strategies.</data>
      <data key="d8">age-related health,geriatric diabetes</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391599</data>
    </edge>
    <edge source="Older Persons" target="Lifestyle Interventions">
      <data key="d6">8.0</data>
      <data key="d7">Lifestyle Interventions are recommended for older persons with impaired glucose tolerance to reduce the risk of Type 2 Diabetes.</data>
      <data key="d8">diabetes prevention,health promotion</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391600</data>
    </edge>
    <edge source="HIV" target="BIOCHEMISTRY">
      <data key="d6">9.0</data>
      <data key="d7">HIV is a part of the BIOCHEMISTRY category, which includes screening for HIV infection.</data>
      <data key="d8">biochemical tests,infectious disease</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391551</data>
    </edge>
    <edge source="HIV" target="Diabetes mellitus">
      <data key="d6">10.0</data>
      <data key="d7">HIV-positive individuals on HAART are at increased risk of developing diabetes mellitus due to iatrogenic metabolic complications and accelerated atherosclerosis.</data>
      <data key="d8">comorbidity,treatment-related risk</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391602</data>
    </edge>
    <edge source="HIV" target="D5. HIV AND DIABETES">
      <data key="d6">10.0</data>
      <data key="d7">The D5 section focuses on the intersection of HIV and diabetes, emphasizing the need for regular screening and management of metabolic complications in HIV-positive patients.</data>
      <data key="d8">comorbidity management,guideline</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391603</data>
    </edge>
    <edge source="HIV" target="Diabetes Mellitus">
      <data key="d6">9.0</data>
      <data key="d7">HIV is associated with an increased incidence of diabetes mellitus in patients on antiretroviral therapy (ARVs), requiring regular screening for the condition.</data>
      <data key="d8">medical comorbidity,risk factor</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391605</data>
    </edge>
    <edge source="HIV" target="Dysglycaemia">
      <data key="d6">8.0</data>
      <data key="d7">HIV infection, particularly with fluctuating viral loads, is linked to chronic inflammation, which contributes to dysglycaemia and insulin resistance.</data>
      <data key="d8">metabolic complications,pathophysiology</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391606</data>
    </edge>
    <edge source="HIV" target="Lipodystrophy">
      <data key="d6">8.0</data>
      <data key="d7">Lipodystrophy is a recognized complication in HIV patients, often resulting from rapid weight gain post-catabolic phase and contributing to diabetes risk.</data>
      <data key="d8">HIV-related metabolic changes,disease progression</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391607</data>
    </edge>
    <edge source="Fasting" target="Structured Education Programme">
      <data key="d6">8.0</data>
      <data key="d7">A structured education programme is essential for individuals with diabetes planning to fast, providing guidance on meal planning, glucose monitoring, and medication adjustments.</data>
      <data key="d8">patient education,therapeutic planning</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391607</data>
    </edge>
    <edge source="Fasting" target="Diabetes Mellitus">
      <data key="d6">7.0</data>
      <data key="d7">Fasting is a practice that requires careful management in individuals with diabetes to avoid complications like hypoglycaemia and dehydration.</data>
      <data key="d8">dietary management,medical planning</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391608</data>
    </edge>
    <edge source="Fasting" target="Insulin Injection">
      <data key="d6">8.0</data>
      <data key="d7">The text clarifies that insulin injections do not break the fast, establishing a direct relationship between the two.</data>
      <data key="d8">fasting compliance,medical treatment</data>
      <data key="d9">chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391611</data>
    </edge>
    <edge source="Fasting" target="Self-Monitoring Blood Glucose (SMBG)">
      <data key="d6">9.0</data>
      <data key="d7">SMBG is mandated for people with diabetes who elect to fast, linking the two concepts directly.</data>
      <data key="d8">fasting protocols,glucose monitoring</data>
      <data key="d9">chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391612</data>
    </edge>
    <edge source="Tuberculosis" target="Diabetes">
      <data key="d6">10.0</data>
      <data key="d7">Diabetes is associated with a triple risk of developing tuberculosis, requiring collaborative clinical management and surveillance.</data>
      <data key="d8">disease link,medical comorbidity</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391615</data>
    </edge>
    <edge source="Tuberculosis" target="National TB Management Guidelines">
      <data key="d6">9.0</data>
      <data key="d7">TB treatment protocols are outlined in the National TB Management Guidelines, including monitoring for drug interactions and hyperglycaemia.</data>
      <data key="d8">clinical guidelines,treatment protocols</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391616</data>
    </edge>
    <edge source="Tuberculosis" target="4-symptom screening tool">
      <data key="d6">10.0</data>
      <data key="d7">The 4-symptom screening tool is used to identify TB in patients with diabetes."+</data>
      <data key="d8">disease surveillance,screening protocol</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391617</data>
    </edge>
    <edge source="Tuberculosis" target="Cough lasting more than 2 weeks">
      <data key="d6">9.0</data>
      <data key="d7">Cough lasting more than 2 weeks is a key symptom used to screen for TB in diabetic patients."+</data>
      <data key="d8">disease detection,symptom</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391617</data>
    </edge>
    <edge source="Tuberculosis" target="Loss of weight">
      <data key="d6">9.0</data>
      <data key="d7">Weight loss is a symptom used in the 4-symptom screening tool for TB detection."+</data>
      <data key="d8">disease detection,symptom</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391618</data>
    </edge>
    <edge source="Tuberculosis" target="Night sweats">
      <data key="d6">9.0</data>
      <data key="d7">Night sweats are a symptom used in the 4-symptom screening tool for TB detection."+</data>
      <data key="d8">disease detection,symptom</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391618</data>
    </edge>
    <edge source="Tuberculosis" target="Fever">
      <data key="d6">9.0</data>
      <data key="d7">Fever is a symptom used in the 4-symptom screening tool for TB detection."+</data>
      <data key="d8">disease detection,symptom</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391619</data>
    </edge>
    <edge source="Tuberculosis" target="Hyperglycaemia">
      <data key="d6">8.0</data>
      <data key="d7">Hyperglycaemia is a potential side effect of TB treatment that requires monitoring."+</data>
      <data key="d8">metabolic impact,treatment complication</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391620</data>
    </edge>
    <edge source="Monitoring of patients with diabetes and frequency of tests" target="HISTORY">
      <data key="d6">9.0</data>
      <data key="d7">HISTORY is a component of the monitoring framework for diabetes patients.</data>
      <data key="d8">monitoring framework,patient data</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391544</data>
    </edge>
    <edge source="Monitoring of patients with diabetes and frequency of tests" target="PHYSICAL EXAMINATION">
      <data key="d6">9.0</data>
      <data key="d7">PHYSICAL EXAMINATION is a component of the monitoring framework for diabetes patients.</data>
      <data key="d8">monitoring framework,physical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391545</data>
    </edge>
    <edge source="Monitoring of patients with diabetes and frequency of tests" target="BIOCHEMISTRY">
      <data key="d6">9.0</data>
      <data key="d7">BIOCHEMISTRY is a component of the monitoring framework for diabetes patients.</data>
      <data key="d8">biochemical tests,monitoring framework</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391545</data>
    </edge>
    <edge source="Monitoring of patients with diabetes and frequency of tests" target="OTHER ACTIVITIES">
      <data key="d6">9.0</data>
      <data key="d7">OTHER ACTIVITIES is a component of the monitoring framework for diabetes patients.</data>
      <data key="d8">monitoring framework,patient education</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391546</data>
    </edge>
    <edge source="Diabetes Education" target="Patient Empowerment">
      <data key="d6">10.0</data>
      <data key="d7">Diabetes Education incorporates Patient Empowerment as a core standard to promote self-management.</data>
      <data key="d8">education framework,patient autonomy</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391629</data>
    </edge>
    <edge source="Diabetes Education" target="Core Standards">
      <data key="d6">9.0</data>
      <data key="d7">Diabetes Education is structured around Core Standards such as accessibility, specialized care, and audits.</data>
      <data key="d8">program structure,quality assurance</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391629</data>
    </edge>
    <edge source="Diabetes Education" target="Diabetes Self-Management Education">
      <data key="d6">10.0</data>
      <data key="d7">Diabetes Education includes Diabetes Self-Management Education as a key component for skill development.</data>
      <data key="d8">comprehensive care,program integration</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391630</data>
    </edge>
    <edge source="Lifestyle Modification" target="Therapeutic Education">
      <data key="d6">7.0</data>
      <data key="d7">Therapeutic education supports lifestyle modification by teaching patients strategies for dietary management, physical activity, and medication adherence.</data>
      <data key="d8">lifestyle changes,patient education</data>
      <data key="d9">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391567</data>
    </edge>
    <edge source="Foot Care" target="Complication Prevention">
      <data key="d6">9.0</data>
      <data key="d7">Complication prevention is directly linked to foot care as the text emphasizes foot care to avoid ulcers, gangrene, and amputations.</data>
      <data key="d8">health management,prevention strategies</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391631</data>
    </edge>
    <edge source="Foot Care" target="Proper Footwear">
      <data key="d6">10.0</data>
      <data key="d7">Proper footwear is a critical component of foot care, essential for preventing complications in individuals with diabetes.</data>
      <data key="d8">foot care,safety measure</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391635</data>
    </edge>
    <edge source="Foot Care" target="Washing Feet Daily">
      <data key="d6">9.0</data>
      <data key="d7">Washing feet daily is a key practice in foot care to maintain hygiene and prevent infections.</data>
      <data key="d8">foot care,hygiene</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391636</data>
    </edge>
    <edge source="Foot Care" target="Daily Feet Inspection">
      <data key="d6">9.0</data>
      <data key="d7">Daily feet inspection is a vital part of foot care, ensuring early detection of injuries or complications.</data>
      <data key="d8">inspection,prevention</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391637</data>
    </edge>
    <edge source="Foot Care" target="Testing Bath Water Temperature">
      <data key="d6">9.0</data>
      <data key="d7">Testing bath water temperature is a foot care practice to prevent burns, especially in individuals with sensory impairments.</data>
      <data key="d8">foot hygiene,safety measure</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391638</data>
    </edge>
    <edge source="World Health Organization" target="Diabetes Mellitus">
      <data key="d6">4.0</data>
      <data key="d7">The World Health Organization (WHO) is referenced in the text, though no explicit relationship between WHO and Diabetes Mellitus is stated in the document.</data>
      <data key="d8">abbreviation reference,health organization</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391529</data>
    </edge>
    <edge source="World Health Organization" target="2012 SEMDSA Guideline">
      <data key="d6">8.0</data>
      <data key="d7">The 2012 SEMDSA Guideline cites the World Health Organization's definitions for diabetes diagnosis and management.</data>
      <data key="d8">citation,diagnostic criteria</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391623</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Metabolic Syndrome">
      <data key="d6">9.0</data>
      <data key="d7">Metabolic Syndrome is a risk factor for the development of Diabetes Mellitus, increasing its likelihood by approximately 5-fold.</data>
      <data key="d8">disease progression,health risk</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391530</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Impaired Fasting Glucose (IFG)">
      <data key="d6">8.0</data>
      <data key="d7">Impaired Fasting Glucose (IFG) is a precursor state to Diabetes Mellitus, considered a high-risk stage for its development.</data>
      <data key="d8">disease progression,risk factor</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391531</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Impaired Glucose Tolerance (IGT)">
      <data key="d6">8.0</data>
      <data key="d7">Impaired Glucose Tolerance (IGT) is a precursor state to Diabetes Mellitus, considered a high-risk stage for its development.</data>
      <data key="d8">disease progression,risk factor</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391531</data>
    </edge>
    <edge source="Diabetes Mellitus" target="SA Diabetes Declaration Implementation Strategy">
      <data key="d6">8.0</data>
      <data key="d7">The SA Diabetes Declaration Implementation Strategy is referenced as a tool to improve quality of diabetes care and reduce complications.</data>
      <data key="d8">disease management,healthcare framework</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391532</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Long-term care model Implementation Plan">
      <data key="d6">8.0</data>
      <data key="d7">The Long-term care model Implementation Plan is tied to structured diabetes care and complication prevention.</data>
      <data key="d8">disease management,healthcare framework</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391532</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Community Health Workers">
      <data key="d6">7.0</data>
      <data key="d7">Community Health Workers are involved in diabetes education and early detection efforts.</data>
      <data key="d8">disease awareness,healthcare delivery</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391533</data>
    </edge>
    <edge source="Diabetes Mellitus" target="SMBG">
      <data key="d6">9.0</data>
      <data key="d7">SMBG is a critical tool for monitoring blood glucose levels in diabetes management.</data>
      <data key="d8">disease monitoring,medical tool</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391534</data>
    </edge>
    <edge source="Diabetes Mellitus" target="RPG">
      <data key="d6">8.0</data>
      <data key="d7">RPG is used as a diagnostic and monitoring method for diabetes management.</data>
      <data key="d8">disease assessment,medical test</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391534</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Uncontrolled Hyperglycaemia">
      <data key="d6">7.0</data>
      <data key="d7">Uncontrolled Hyperglycaemia is a consequence of poor diabetes management and patient non-adherence.</data>
      <data key="d8">adherence issues,disease complication</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391536</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Microvascular Complications">
      <data key="d6">8.0</data>
      <data key="d7">Microvascular Complications are long-term effects of diabetes, including retinopathy, nephropathy, and neuropathy.</data>
      <data key="d8">disease progression,organ damage</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391536</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Macrovascular Complications">
      <data key="d6">8.0</data>
      <data key="d7">Macrovascular Complications are diabetes-related conditions affecting cardiovascular and peripheral systems.</data>
      <data key="d8">disease progression,systemic risk</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391537</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Antiretroviral Therapy (ART)">
      <data key="d6">9.0</data>
      <data key="d7">Antiretroviral therapy (ART) is a major risk factor for the development of diabetes mellitus in HIV-positive patients, contributing to metabolic complications like dysglycaemia.</data>
      <data key="d8">comorbidity risk,medical treatment</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391606</data>
    </edge>
    <edge source="Diabetes Mellitus" target="Oral Glucose Tolerance Test (OGTT)">
      <data key="d6">9.0</data>
      <data key="d7">The oral glucose tolerance test (OGTT) is the preferred diagnostic method for diabetes in HIV-positive patients, replacing HbA1c due to its reliability.</data>
      <data key="d8">diagnostic method,medical protocol</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391608</data>
    </edge>
    <edge source="Metabolic Syndrome" target="Dyslipidaemia">
      <data key="d6">9.0</data>
      <data key="d7">Dyslipidaemia (elevated triglycerides, low HDL) is a defining feature of the metabolic syndrome, contributing to CVD risk.</data>
      <data key="d8">component relationship,pathophysiology</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391577</data>
    </edge>
    <edge source="Metabolic Syndrome" target="Fasting glucose">
      <data key="d6">9.0</data>
      <data key="d7">Elevated fasting glucose (≥5.6 mmol/L) is a diagnostic criterion for the metabolic syndrome, linked to insulin resistance.</data>
      <data key="d8">component relationship,diagnostic criteria</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391578</data>
    </edge>
    <edge source="Metabolic Syndrome" target="Polycystic Ovarian Syndrome (PCOS)">
      <data key="d6">7.0</data>
      <data key="d7">Polycystic Ovarian Syndrome is an ancillary feature associated with the Metabolic Syndrome, contributing to its complex pathophysiology.</data>
      <data key="d8">comorbidity,metabolic dysregulation</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391579</data>
    </edge>
    <edge source="Metabolic Syndrome" target="Non-Alcoholic Fatty Liver Disease (NAFLD)">
      <data key="d6">7.0</data>
      <data key="d7">Non-Alcoholic Fatty Liver Disease is an ancillary feature of the Metabolic Syndrome, reflecting shared metabolic and inflammatory pathways.</data>
      <data key="d8">comorbidity,metabolic dysregulation</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391579</data>
    </edge>
    <edge source="Metabolic Syndrome" target="Sleep Apnoea">
      <data key="d6">7.0</data>
      <data key="d7">Sleep Apnoea is an ancillary feature linked to the Metabolic Syndrome, often co-occurring with obesity and insulin resistance.</data>
      <data key="d8">comorbidity,sleep disorders</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391580</data>
    </edge>
    <edge source="Metabolic Syndrome" target="Abdominal Obesity">
      <data key="d6">9.0</data>
      <data key="d7">Abdominal Obesity is a core characteristic of the Metabolic Syndrome, directly contributing to its diagnostic criteria and metabolic complications.</data>
      <data key="d8">central adiposity,pathophysiological link</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391581</data>
    </edge>
    <edge source="Metabolic Syndrome" target="Atherogenic Dyslipidaemia">
      <data key="d6">9.0</data>
      <data key="d7">Atherogenic Dyslipidaemia is a defining feature of the Metabolic Syndrome, characterized by dyslipidemic profiles that increase cardiovascular risk.</data>
      <data key="d8">dyslipidaemia,pathophysiological link</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391582</data>
    </edge>
    <edge source="Impaired Fasting Glucose (IFG)" target="Diabetes">
      <data key="d6">8.0</data>
      <data key="d7">Impaired Fasting Glucose is a precursor category to diabetes, identified through fasting plasma glucose testing.</data>
      <data key="d8">diagnostic criteria,disease progression</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391535</data>
    </edge>
    <edge source="Impaired Glucose Tolerance (IGT)" target="Diabetes">
      <data key="d6">8.0</data>
      <data key="d7">Impaired Glucose Tolerance is a category of intermediate hyperglycaemia that may progress to diabetes if not managed.</data>
      <data key="d8">diagnostic criteria,disease progression</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391535</data>
    </edge>
    <edge source="Non-Communicable Diseases (NCDs)" target="Health Professionals">
      <data key="d6">8.0</data>
      <data key="d7">Health professionals must know the common risk factors for NCDs and cancers, including diabetes, to implement prevention strategies.</data>
      <data key="d8">disease awareness,prevention</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391533</data>
    </edge>
    <edge source="Cardiovascular Disease (CVD)" target="Aspirin Therapy">
      <data key="d6">9.0</data>
      <data key="d7">Aspirin therapy is explicitly indicated for patients with diabetes and a history of CVD, including ischaemic heart disease, peripheral vascular disease, and thrombotic stroke.</data>
      <data key="d8">medical treatment,risk mitigation</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391581</data>
    </edge>
    <edge source="Cardiovascular Disease (CVD)" target="Ischaemic Heart Disease">
      <data key="d6">9.0</data>
      <data key="d7">Ischaemic heart disease is a specific type of cardiovascular disease that influences aspirin therapy recommendations.</data>
      <data key="d8">medical classification,treatment indication</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391582</data>
    </edge>
    <edge source="Cardiovascular Disease (CVD)" target="Peripheral Vascular Disease">
      <data key="d6">9.0</data>
      <data key="d7">Peripheral vascular disease is a specific type of cardiovascular disease that influences aspirin therapy recommendations.</data>
      <data key="d8">medical classification,treatment indication</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391584</data>
    </edge>
    <edge source="Cardiovascular Disease (CVD)" target="Previous Thrombotic Stroke">
      <data key="d6">9.0</data>
      <data key="d7">Previous thrombotic stroke is a specific type of cardiovascular disease that influences aspirin therapy recommendations.</data>
      <data key="d8">medical classification,treatment indication</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391584</data>
    </edge>
    <edge source="Peripheral Artery Disease (PAD)" target="Vascular Unit">
      <data key="d6">9.0</data>
      <data key="d7">Vascular units are involved in the assessment and management of peripheral artery disease.</data>
      <data key="d8">disease management,medical specialty</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391595</data>
    </edge>
    <edge source="Peripheral Artery Disease (PAD)" target="Intermittent Claudication">
      <data key="d6">9.0</data>
      <data key="d7">Intermittent claudication is a symptom of peripheral artery disease, indicating reduced blood flow.</data>
      <data key="d8">symptom,vascular condition</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391597</data>
    </edge>
    <edge source="Gestational Diabetes Mellitus (GDM)" target="World Health Organization (WHO)">
      <data key="d6">9.0</data>
      <data key="d7">The WHO provides the current diagnostic criteria for GDM, which are used to identify the condition.</data>
      <data key="d8">diagnostic criteria,medical guidelines</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391599</data>
    </edge>
    <edge source="Gestational Diabetes Mellitus (GDM)" target="Type 1 Diabetes">
      <data key="d6">7.0</data>
      <data key="d7">Type 1 Diabetes is a pre-existing condition that may coexist with GDM but is distinct in its diagnosis and management.</data>
      <data key="d8">coexisting conditions,diabetes types</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391600</data>
    </edge>
    <edge source="Gestational Diabetes Mellitus (GDM)" target="South Asian Descent">
      <data key="d6">9.0</data>
      <data key="d7">South Asian Descent is identified as a risk factor for GDM, linking the demographic category to increased susceptibility.</data>
      <data key="d8">population health,risk factors</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391602</data>
    </edge>
    <edge source="Gestational Diabetes Mellitus (GDM)" target="Diabetic Complications">
      <data key="d6">7.0</data>
      <data key="d7">Diabetic Complications are a concern in women with pre-existing diabetes, which can be exacerbated by GDM and require careful monitoring.</data>
      <data key="d8">complication risk,pregnancy health</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391603</data>
    </edge>
    <edge source="Chronic Conditions" target="National Guideline: Non-Communicable Diseases">
      <data key="d6">7.0</data>
      <data key="d7">The National Guideline is linked to managing chronic conditions through patient adherence and health promotion.</data>
      <data key="d8">chronic disease,health policy</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391530</data>
    </edge>
    <edge source="Chronic Conditions" target="Health Promoters">
      <data key="d6">6.0</data>
      <data key="d7">Health Promoters are tasked with promoting healthy living and addressing risk factors for non-communicable diseases.</data>
      <data key="d8">disease prevention,health education</data>
      <data key="d9">chunk-28b8f1d377e70e65ee6917c0d59e3109</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391531</data>
    </edge>
    <edge source="Annexure F" target="Treatment Adherence">
      <data key="d6">7.0</data>
      <data key="d7">Annexure F is referenced to check patient adherence to treatment protocols, ensuring effective CKD and diabetes management.</data>
      <data key="d8">documentation,medical compliance</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391588</data>
    </edge>
    <edge source="Primary Health Care Level" target="Diabetes">
      <data key="d6">10.0</data>
      <data key="d7">The primary health care level aims to educate patients, screen for diabetes, and provide appropriate treatment and management for diabetic individuals.</data>
      <data key="d8">chronic disease management,healthcare goals</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391534</data>
    </edge>
    <edge source="Health Professionals" target="Diabetes">
      <data key="d6">9.0</data>
      <data key="d7">Health professionals are responsible for promoting healthy living, recognizing diabetes symptoms, and establishing referral pathways for early detection and management.</data>
      <data key="d8">disease management,healthcare responsibilities</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391533</data>
    </edge>
    <edge source="Health Professionals" target="Health Facility">
      <data key="d6">7.0</data>
      <data key="d7">Health professionals operate within health facilities to provide care and services to patients.</data>
      <data key="d8">healthcare setting,professional roles</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391535</data>
    </edge>
    <edge source="Patients" target="Health System">
      <data key="d6">7.0</data>
      <data key="d7">Patients have obligations to the health system, including lifestyle modifications and adherence to chronic illness management plans.</data>
      <data key="d8">healthcare coordination,patient responsibility</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391534</data>
    </edge>
    <edge source="Patients" target="Health care professional">
      <data key="d6">9.0</data>
      <data key="d7">Health care professionals assess and adjust treatment plans for patients with type 2 diabetes before fasting.</data>
      <data key="d8">medical assessment,treatment adjustment</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391608</data>
    </edge>
    <edge source="Patients" target="Family members/carers">
      <data key="d6">8.0</data>
      <data key="d7">Family members/carers are educated alongside patients on fasting-related diabetes management.</data>
      <data key="d8">caregiver education,diabetes management</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391609</data>
    </edge>
    <edge source="Oral Health Promotion" target="Dentists">
      <data key="d6">6.0</data>
      <data key="d7">Oral health promotion involves collaboration with dentists for periodontal treatment.</data>
      <data key="d8">dental care,preventive treatment</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391535</data>
    </edge>
    <edge source="Oral Health Promotion" target="Oral Hygienists">
      <data key="d6">6.0</data>
      <data key="d7">Oral health promotion includes referrals to oral hygienists for preventive treatment.</data>
      <data key="d8">dental professionals,preventive care</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391536</data>
    </edge>
    <edge source="Oral Health Promotion" target="Diabetes">
      <data key="d6">7.0</data>
      <data key="d7">Oral health promotion is integrated into diabetes management to prevent complications and ensure regular dental referrals.</data>
      <data key="d8">complication prevention,comprehensive care</data>
      <data key="d9">chunk-48019451fb64599a32100497e8728c0d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391537</data>
    </edge>
    <edge source="National Glycohemoglobin Standardization Program (NGSP)" target="Diabetes Control and Complications Trial (DCCT)">
      <data key="d6">9.0</data>
      <data key="d7">NGSP and DCCT are connected through the standardization of HbA1c assays, ensuring alignment with international reference values for diabetes diagnosis.</data>
      <data key="d8">medical testing,standardization</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391536</data>
    </edge>
    <edge source="Diabetes" target="Glycated Haemoglobin A1c (HbA1c)">
      <data key="d6">10.0</data>
      <data key="d7">HbA1c is a diagnostic tool used to confirm diabetes when standardized criteria are met, as outlined in the text.</data>
      <data key="d8">diagnostic method,medical condition</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391538</data>
    </edge>
    <edge source="Diabetes" target="Fasting Plasma Glucose (FPG)">
      <data key="d6">8.0</data>
      <data key="d7">FPG is a diagnostic test used to identify diabetes, with a threshold of ≥7.0 mmol/L for diagnosis.</data>
      <data key="d8">diagnostic test,medical condition</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391539</data>
    </edge>
    <edge source="Diabetes" target="Two-hour Plasma Glucose (2-h PG) during Oral Glucose Tolerance Test (OGTT)">
      <data key="d6">8.0</data>
      <data key="d7">2-h PG is a diagnostic test used to identify diabetes, with a threshold of ≥11.1 mmol/L for diagnosis.</data>
      <data key="d8">diagnostic test,medical condition</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391540</data>
    </edge>
    <edge source="Diabetes" target="Symptomatic individuals">
      <data key="d6">9.0</data>
      <data key="d7">Symptomatic individuals are directly linked to diabetes diagnosis, as symptoms like polyuria and weight loss are key indicators.</data>
      <data key="d8">clinical presentation,disease diagnosis</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391540</data>
    </edge>
    <edge source="Diabetes" target="Asymptomatic individuals">
      <data key="d6">8.0</data>
      <data key="d7">Asymptomatic individuals require additional testing for diabetes diagnosis due to the absence of clear symptoms.</data>
      <data key="d8">asymptomatic screening,diagnostic challenges</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391541</data>
    </edge>
    <edge source="Diabetes" target="Family Planning">
      <data key="d6">8.0</data>
      <data key="d7">Family Planning is emphasized for women with diabetes to manage reproductive health risks and optimize pre-conception care.</data>
      <data key="d8">diabetes management,reproductive health</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391600</data>
    </edge>
    <edge source="Diabetes" target="Pre-Conception Care">
      <data key="d6">9.0</data>
      <data key="d7">Pre-Conception Care is critical for women with diabetes to ensure optimal health before pregnancy and reduce complications.</data>
      <data key="d8">diabetes care,pregnancy preparation</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391601</data>
    </edge>
    <edge source="Diabetes" target="Cataracts">
      <data key="d6">8.0</data>
      <data key="d7">Cataracts are a chronic complication of diabetes that may impact driving ability.</data>
      <data key="d8">complication,vision impairment</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391614</data>
    </edge>
    <edge source="Diabetes" target="Periodontal Disease">
      <data key="d6">9.0</data>
      <data key="d7">Diabetes increases the risk and severity of periodontal disease, with poor glycemic control exacerbating inflammation and insulin resistance.</data>
      <data key="d8">disease comorbidity,inflammation</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391616</data>
    </edge>
    <edge source="Diabetes" target="Blood Glucose Monitoring">
      <data key="d6">10.0</data>
      <data key="d7">Diabetes management requires frequent blood glucose monitoring to prevent hypoglycaemia and ensure safe driving.</data>
      <data key="d8">medical monitoring,safety protocols</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391617</data>
    </edge>
    <edge source="Diabetes" target="HbA1c">
      <data key="d6">9.0</data>
      <data key="d7">HbA1c is a critical metric for monitoring long-term blood glucose control in diabetes management."+</data>
      <data key="d8">diagnostic tool,medical monitoring</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391618</data>
    </edge>
    <edge source="Diabetes" target="Employers">
      <data key="d6">8.0</data>
      <data key="d7">Employers are informed of the risks associated with hypoglycaemia in drivers with diabetes."+</data>
      <data key="d8">occupational safety,risk management</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391620</data>
    </edge>
    <edge source="Diabetes" target="Periodontitis">
      <data key="d6">9.0</data>
      <data key="d7">Periodontitis is exacerbated by poorly controlled diabetes, creating a bidirectional relationship between oral health and systemic disease.</data>
      <data key="d8">bidirectional relationship,disease interaction</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391621</data>
    </edge>
    <edge source="Fasting Plasma Glucose (FPG)" target="Two-hour Plasma Glucose (2-h PG) during Oral Glucose Tolerance Test (OGTT)">
      <data key="d6">7.0</data>
      <data key="d7">FPG and 2-h PG are alternative diagnostic tests for diabetes, differing in the method of glucose measurement and thresholds.</data>
      <data key="d8">diagnostic alternatives,medical testing</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391537</data>
    </edge>
    <edge source="Two-hour Plasma Glucose (2-h PG) during Oral Glucose Tolerance Test (OGTT)" target="World Health Organization (WHO)">
      <data key="d6">9.0</data>
      <data key="d7">The WHO is referenced as the authority recommending the 75g glucose load for the OGTT, which is used to measure 2-h PG levels.</data>
      <data key="d8">diagnostic standards,medical guidelines</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391537</data>
    </edge>
    <edge source="Two-hour Plasma Glucose (2-h PG) during Oral Glucose Tolerance Test (OGTT)" target="High-risk individuals">
      <data key="d6">10.0</data>
      <data key="d7">High-risk individuals are explicitly indicated to undergo a 75g OGTT for diabetes diagnosis.</data>
      <data key="d8">diagnostic testing,targeted screening</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391538</data>
    </edge>
    <edge source="Glycated Haemoglobin A1c (HbA1c)" target="Malaria">
      <data key="d6">8.0</data>
      <data key="d7">Malaria is mentioned as a population characteristic that may influence the use of HbA1c in diabetes diagnosis.</data>
      <data key="d8">diagnostic limitations,population factors</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391537</data>
    </edge>
    <edge source="Glycated Haemoglobin A1c (HbA1c)" target="Haemoglobinopathies">
      <data key="d6">8.0</data>
      <data key="d7">Haemoglobinopathies are listed as factors affecting the accuracy of HbA1c measurements in certain populations.</data>
      <data key="d8">diagnostic constraints,health conditions</data>
      <data key="d9">chunk-9b3360eaab1fbda0f4be34916f26a0c1</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391539</data>
    </edge>
    <edge source="World Health Organization (WHO)" target="International Union Against Tuberculosis and Lung Disease">
      <data key="d6">9.0</data>
      <data key="d7">The WHO collaborates with the International Union Against Tuberculosis and Lung Disease to develop a framework for integrated TB and diabetes care.</data>
      <data key="d8">collaborative framework,health policy</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391615</data>
    </edge>
    <edge source="High-risk individuals" target="Lifestyle modification">
      <data key="d6">8.0</data>
      <data key="d7">High-risk individuals are advised to undergo lifestyle modification as a primary prevention strategy for type 2 diabetes.</data>
      <data key="d8">diabetes prevention,health intervention</data>
      <data key="d9">chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391611</data>
    </edge>
    <edge source="High-risk individuals" target="Metformin">
      <data key="d6">7.0</data>
      <data key="d7">High-risk individuals who fail to control diabetes with lifestyle modifications may benefit from metformin as an additional therapy.</data>
      <data key="d8">diabetes management,pharmacological intervention</data>
      <data key="d9">chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391612</data>
    </edge>
    <edge source="High-Risk Individuals" target="Screening for Early Detection of Type 2 Diabetes in Adults">
      <data key="d6">8.0</data>
      <data key="d7">High-Risk Individuals are the primary target group for targeted screening in the context of early detection of Type 2 Diabetes.</data>
      <data key="d8">risk factors,targeted screening</data>
      <data key="d9">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391539</data>
    </edge>
    <edge source="Low-Risk Individuals" target="Screening for Early Detection of Type 2 Diabetes in Adults">
      <data key="d6">7.0</data>
      <data key="d7">Low-Risk Individuals are subject to screening only after the age of 45 years, as per the guidelines for early detection of Type 2 Diabetes.</data>
      <data key="d8">age-based screening,risk stratification</data>
      <data key="d9">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391539</data>
    </edge>
    <edge source="Screening for Early Detection of Type 2 Diabetes in Adults" target="Health Care Setting">
      <data key="d6">9.0</data>
      <data key="d7">Screening for Early Detection of Type 2 Diabetes in Adults is explicitly required to be conducted within a Health Care Setting to ensure proper follow-up and care.</data>
      <data key="d8">healthcare environment,medical protocol</data>
      <data key="d9">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391538</data>
    </edge>
    <edge source="Health Care Setting" target="Community Screening">
      <data key="d6">7.0</data>
      <data key="d7">Community Screening is explicitly conducted outside a Health Care Setting, which is discouraged due to challenges in follow-up and care accessibility.</data>
      <data key="d8">healthcare accessibility,screening environment</data>
      <data key="d9">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391540</data>
    </edge>
    <edge source="Organization of Diabetes Care" target="Regular Audit">
      <data key="d6">9.0</data>
      <data key="d7">The Organization of Diabetes Care mandates the implementation of a Regular Audit to evaluate care quality and improve service delivery standards.</data>
      <data key="d8">healthcare management,quality assurance</data>
      <data key="d9">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391539</data>
    </edge>
    <edge source="Organization of Diabetes Care" target="Requirements at Clinic Level for a Diabetes Service">
      <data key="d6">8.0</data>
      <data key="d7">The Requirements at Clinic Level for a Diabetes Service are integral to the Organization of Diabetes Care, ensuring structured and sustainable diabetes management.</data>
      <data key="d8">healthcare infrastructure,service protocols</data>
      <data key="d9">chunk-1427a4f3a37a8bc9105d9dc8f4a4b755</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391540</data>
    </edge>
    <edge source="Diabetes Service" target="Protocols and Guidelines">
      <data key="d6">9.0</data>
      <data key="d7">The Diabetes Service relies on Protocols and Guidelines to ensure standardized care and referrals for patients.</data>
      <data key="d8">care procedures,healthcare standards</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391540</data>
    </edge>
    <edge source="Diabetes Service" target="Basic PHC Equipment">
      <data key="d6">9.0</data>
      <data key="d7">The Diabetes Service requires Basic PHC Equipment to perform essential diagnostics and patient monitoring.</data>
      <data key="d8">diagnostic tools,medical equipment</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391541</data>
    </edge>
    <edge source="Diabetes Service" target="Patient Recall System">
      <data key="d6">8.0</data>
      <data key="d7">The Diabetes Service utilizes a Patient Recall System to manage non-attendance and ensure continuity of care.</data>
      <data key="d8">patient tracking,service delivery</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391541</data>
    </edge>
    <edge source="Diabetes Service" target="Annual Audit">
      <data key="d6">9.0</data>
      <data key="d7">The Annual Audit evaluates the effectiveness of the Diabetes Service in meeting care targets and guidelines.</data>
      <data key="d8">performance review,quality assurance</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391541</data>
    </edge>
    <edge source="Diabetes Service" target="Education Material">
      <data key="d6">7.0</data>
      <data key="d7">The Diabetes Service incorporates Education Material to inform patients about disease management and prevention.</data>
      <data key="d8">health literacy,patient education</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391542</data>
    </edge>
    <edge source="Diabetes Service" target="Support Groups">
      <data key="d6">6.0</data>
      <data key="d7">The Diabetes Service includes Support Groups to provide social and psychological support for patients.</data>
      <data key="d8">community support,patient engagement</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391543</data>
    </edge>
    <edge source="Diabetes Service" target="Register of All Patients">
      <data key="d6">8.0</data>
      <data key="d7">The Diabetes Service requires a Register of All Patients to manage recall and ensure continuity of care.</data>
      <data key="d8">patient tracking,service delivery</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391543</data>
    </edge>
    <edge source="Diabetes Service" target="Legible Patient Records">
      <data key="d6">7.0</data>
      <data key="d7">The Diabetes Service mandates Legible Patient Records for accurate and clear documentation of patient information.</data>
      <data key="d8">care standards,record clarity</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391544</data>
    </edge>
    <edge source="Diabetes Service" target="Flow Charts and Annual Review Charts">
      <data key="d6">7.0</data>
      <data key="d7">The Diabetes Service utilizes Flow Charts and Annual Review Charts to monitor patient progress and ensure regular care.</data>
      <data key="d8">care monitoring,visual tools</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391544</data>
    </edge>
    <edge source="Diabetes Service" target="Adequate Space">
      <data key="d6">8.0</data>
      <data key="d7">The Diabetes Service depends on Adequate Space to provide individual consultations and group education sessions.</data>
      <data key="d8">clinic infrastructure,spatial requirements</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391545</data>
    </edge>
    <edge source="Diabetes Service" target="Trained Personnel for Chronic Disease Management">
      <data key="d6">9.0</data>
      <data key="d7">The Diabetes Service requires Trained Personnel to effectively manage chronic diseases and deliver quality care.</data>
      <data key="d8">specialized care,staff training</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391545</data>
    </edge>
    <edge source="Diabetes Service" target="Annexure D - Clinic Structure">
      <data key="d6">7.0</data>
      <data key="d7">The Diabetes Service incorporates Annexure D - Clinic Structure to define the physical and operational layout of the clinic.</data>
      <data key="d8">clinic design,structural guidelines</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391546</data>
    </edge>
    <edge source="Diabetes Service" target="Schedule of Visits to a Diabetes Clinic">
      <data key="d6">8.0</data>
      <data key="d7">The Diabetes Service follows the Schedule of Visits to ensure regular examinations and tests for patients.</data>
      <data key="d8">care scheduling,visit frequency</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391547</data>
    </edge>
    <edge source="Protocols and Guidelines" target="Annual Audit">
      <data key="d6">8.0</data>
      <data key="d7">The Annual Audit assesses compliance with Protocols and Guidelines to ensure adherence to care standards.</data>
      <data key="d8">compliance check,guideline validation</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391542</data>
    </edge>
    <edge source="Basic PHC Equipment" target="Integrated Chronic Disease Management (ICDM) Model">
      <data key="d6">9.0</data>
      <data key="d7">The ICDM Model mandates the availability of basic PHC equipment to support chronic disease management in clinics.</data>
      <data key="d8">healthcare infrastructure,resource allocation</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391639</data>
    </edge>
    <edge source="Basic PHC Equipment" target="Primary Healthcare (PHC)">
      <data key="d6">9.0</data>
      <data key="d7">Primary healthcare requires the availability of basic PHC equipment to support chronic disease management.</data>
      <data key="d8">healthcare infrastructure,resource allocation</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391640</data>
    </edge>
    <edge source="Annual Audit" target="Controlled Glycaemia, Blood Pressure and Lipids">
      <data key="d6">9.0</data>
      <data key="d7">The Annual Audit evaluates patients' achievement of targets related to Controlled Glycaemia, Blood Pressure, and Lipids.</data>
      <data key="d8">audit criteria,health indicators</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391543</data>
    </edge>
    <edge source="Annual Audit" target="Specific Procedures: BP Checked, HbA1c Done, Foot Exam, Retinopathy Assessed">
      <data key="d6">8.0</data>
      <data key="d7">The Annual Audit tracks adherence to Specific Procedures like BP checks, HbA1c testing, foot exams, and retinopathy assessments.</data>
      <data key="d8">audit procedures,compliance checks</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391544</data>
    </edge>
    <edge source="Patient Recall System" target="Follow-Up Appointments">
      <data key="d6">8.0</data>
      <data key="d7">A patient recall system is integral to achieving regular follow-up and meeting therapeutic objectives, emphasizing its role in diabetes management.</data>
      <data key="d8">medical adherence,system efficiency</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391564</data>
    </edge>
    <edge source="Support Groups" target="Peer Support">
      <data key="d6">7.0</data>
      <data key="d7">Support Groups are utilized to provide peer support as part of existing structures.</data>
      <data key="d8">community engagement,peer support</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391641</data>
    </edge>
    <edge source="Initial Visit" target="History, Physical Examination, Biochemistry">
      <data key="d6">9.0</data>
      <data key="d7">The Initial Visit includes components such as History, Physical Examination, and Biochemistry assessments.</data>
      <data key="d8">diagnostic procedures,visit components</data>
      <data key="d9">chunk-7817b9988673b530a82175902d6ef212</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391543</data>
    </edge>
    <edge source="HISTORY" target="Symptoms of hyperglycaemia">
      <data key="d6">9.0</data>
      <data key="d7">Symptoms of hyperglycaemia is a part of the HISTORY category, which includes patient symptoms and medical history.</data>
      <data key="d8">health monitoring,patient symptoms</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391545</data>
    </edge>
    <edge source="HISTORY" target="Medication">
      <data key="d6">9.0</data>
      <data key="d7">Medication is a part of the HISTORY category, which includes assessment of medication adherence and side effects.</data>
      <data key="d8">health monitoring,medication review</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391546</data>
    </edge>
    <edge source="HISTORY" target="Symptoms of hypoglycaemia">
      <data key="d6">9.0</data>
      <data key="d7">Symptoms of hypoglycaemia is a part of the HISTORY category, which includes patient symptoms related to low blood sugar levels.</data>
      <data key="d8">health monitoring,hypoglycaemia assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391546</data>
    </edge>
    <edge source="HISTORY" target="Depression">
      <data key="d6">9.0</data>
      <data key="d7">Depression is a part of the HISTORY category, which includes assessment of mental health in diabetes patients.</data>
      <data key="d8">health monitoring,mental health</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391547</data>
    </edge>
    <edge source="HISTORY" target="Review home monitoring chart">
      <data key="d6">9.0</data>
      <data key="d7">Review home monitoring chart is a part of the HISTORY category, which includes review of patient home glucose monitoring data.</data>
      <data key="d8">data review,health monitoring</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391548</data>
    </edge>
    <edge source="HISTORY" target="PHYSICAL EXAMINATION">
      <data key="d6">8.0</data>
      <data key="d7">HISTORY and PHYSICAL EXAMINATION are both categories within the monitoring framework, focusing on different aspects of patient assessment.</data>
      <data key="d8">medical assessment,patient monitoring</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391551</data>
    </edge>
    <edge source="HISTORY" target="OTHER ACTIVITIES">
      <data key="d6">8.0</data>
      <data key="d7">HISTORY and OTHER ACTIVITIES are both categories within the monitoring framework, focusing on different aspects of patient assessment.</data>
      <data key="d8">medical assessment,patient monitoring</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391552</data>
    </edge>
    <edge source="HISTORY" target="BIOCHEMISTRY">
      <data key="d6">8.0</data>
      <data key="d7">HISTORY and BIOCHEMISTRY are both categories within the monitoring framework, focusing on different aspects of patient assessment.</data>
      <data key="d8">medical assessment,patient monitoring</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391552</data>
    </edge>
    <edge source="PHYSICAL EXAMINATION" target="Weight &amp; BMI">
      <data key="d6">9.0</data>
      <data key="d7">Weight &amp; BMI is a part of the PHYSICAL EXAMINATION category, which includes measurement of weight and body mass index.</data>
      <data key="d8">body metrics,physical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391546</data>
    </edge>
    <edge source="PHYSICAL EXAMINATION" target="Waist circumference">
      <data key="d6">9.0</data>
      <data key="d7">Waist circumference is a part of the PHYSICAL EXAMINATION category, which includes measurement of waist circumference.</data>
      <data key="d8">body metrics,physical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391547</data>
    </edge>
    <edge source="PHYSICAL EXAMINATION" target="Blood pressure">
      <data key="d6">9.0</data>
      <data key="d7">Blood pressure is a part of the PHYSICAL EXAMINATION category, which includes measurement of blood pressure.</data>
      <data key="d8">cardiovascular health,physical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391548</data>
    </edge>
    <edge source="PHYSICAL EXAMINATION" target="Feet inspection">
      <data key="d6">9.0</data>
      <data key="d7">Feet inspection is a part of the PHYSICAL EXAMINATION category, which includes assessment of foot health.</data>
      <data key="d8">foot care,physical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391548</data>
    </edge>
    <edge source="PHYSICAL EXAMINATION" target="Injection sites">
      <data key="d6">9.0</data>
      <data key="d7">Injection sites is a part of the PHYSICAL EXAMINATION category, which includes inspection of injection sites for complications.</data>
      <data key="d8">injection sites,physical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391549</data>
    </edge>
    <edge source="PHYSICAL EXAMINATION" target="OTHER ACTIVITIES">
      <data key="d6">8.0</data>
      <data key="d7">PHYSICAL EXAMINATION and OTHER ACTIVITIES are both categories within the monitoring framework, focusing on different aspects of patient assessment.</data>
      <data key="d8">medical assessment,patient monitoring</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391552</data>
    </edge>
    <edge source="PHYSICAL EXAMINATION" target="BIOCHEMISTRY">
      <data key="d6">8.0</data>
      <data key="d7">PHYSICAL EXAMINATION and BIOCHEMISTRY are both categories within the monitoring framework, focusing on different aspects of patient assessment.</data>
      <data key="d8">medical assessment,patient monitoring</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391553</data>
    </edge>
    <edge source="BIOCHEMISTRY" target="Blood glucose">
      <data key="d6">9.0</data>
      <data key="d7">Blood glucose is a part of the BIOCHEMISTRY category, which includes measurement of blood glucose levels.</data>
      <data key="d8">biochemical tests,glucose monitoring</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391547</data>
    </edge>
    <edge source="BIOCHEMISTRY" target="HbA1c">
      <data key="d6">9.0</data>
      <data key="d7">HbA1c is a part of the BIOCHEMISTRY category, which includes measurement of glycated hemoglobin levels.</data>
      <data key="d8">biochemical tests,hemoglobin</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391548</data>
    </edge>
    <edge source="BIOCHEMISTRY" target="Lipids (TC, HDLC, LDLC, TG)">
      <data key="d6">9.0</data>
      <data key="d7">Lipids (TC, HDLC, LDLC, TG) is a part of the BIOCHEMISTRY category, which includes measurement of lipid profile parameters.</data>
      <data key="d8">biochemical tests,lipid profile</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391548</data>
    </edge>
    <edge source="BIOCHEMISTRY" target="Creatinine; calculate eGFR">
      <data key="d6">9.0</data>
      <data key="d7">Creatinine; calculate eGFR is a part of the BIOCHEMISTRY category, which includes measurement of kidney function.</data>
      <data key="d8">biochemical tests,kidney function</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391549</data>
    </edge>
    <edge source="BIOCHEMISTRY" target="Potassium">
      <data key="d6">9.0</data>
      <data key="d7">Potassium is a part of the BIOCHEMISTRY category, which includes measurement of potassium levels.</data>
      <data key="d8">biochemical tests,electrolytes</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391550</data>
    </edge>
    <edge source="BIOCHEMISTRY" target="Urine protein: (albumin/creatinine ratio)">
      <data key="d6">9.0</data>
      <data key="d7">Urine protein: (albumin/creatinine ratio) is a part of the BIOCHEMISTRY category, which includes measurement of urine protein and albumin/creatinine ratio.</data>
      <data key="d8">biochemical tests,kidney function</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391551</data>
    </edge>
    <edge source="BIOCHEMISTRY" target="OTHER ACTIVITIES">
      <data key="d6">8.0</data>
      <data key="d7">BIOCHEMISTRY and OTHER ACTIVITIES are both categories within the monitoring framework, focusing on different aspects of patient assessment.</data>
      <data key="d8">medical assessment,patient monitoring</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391554</data>
    </edge>
    <edge source="OTHER ACTIVITIES" target="Education">
      <data key="d6">9.0</data>
      <data key="d7">Education is a part of the OTHER ACTIVITIES category, which includes patient education on lifestyle and disease management.</data>
      <data key="d8">lifestyle management,patient education</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391548</data>
    </edge>
    <edge source="OTHER ACTIVITIES" target="Goal setting">
      <data key="d6">9.0</data>
      <data key="d7">Goal setting is a part of the OTHER ACTIVITIES category, which includes setting medical and lifestyle goals for patients.</data>
      <data key="d8">goal planning,patient education</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391549</data>
    </edge>
    <edge source="OTHER ACTIVITIES" target="Pre-conception counselling/family planning">
      <data key="d6">9.0</data>
      <data key="d7">Pre-conception counselling/family planning is a part of the OTHER ACTIVITIES category, which includes guidance for patients planning pregnancy.</data>
      <data key="d8">patient education,reproductive health</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391550</data>
    </edge>
    <edge source="OTHER ACTIVITIES" target="Medication revision/adjustment">
      <data key="d6">9.0</data>
      <data key="d7">Medication revision/adjustment is a part of the OTHER ACTIVITIES category, which includes adjustment of medication regimens.</data>
      <data key="d8">medication management,patient education</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391550</data>
    </edge>
    <edge source="OTHER ACTIVITIES" target="Immunisations">
      <data key="d6">9.0</data>
      <data key="d7">Immunisations is a part of the OTHER ACTIVITIES category, which includes administration of vaccines.</data>
      <data key="d8">patient education,preventive care</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391551</data>
    </edge>
    <edge source="ANNUAL VISIT" target="Screening for retinopathy">
      <data key="d6">9.0</data>
      <data key="d7">Screening for retinopathy is a part of the ANNUAL VISIT category, which includes assessment of eye health for diabetic retinopathy.</data>
      <data key="d8">annual check-up,eye health</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391550</data>
    </edge>
    <edge source="Waist circumference" target="Asian/Indian descent">
      <data key="d6">10.0</data>
      <data key="d7">Asian/Indian descent individuals require lower waist circumference thresholds (women ≥ 80 cm, men ≥ 90 cm) for diabetes risk assessment due to their increased susceptibility at lower values.</data>
      <data key="d8">medical screening criteria,population-specific risk</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391602</data>
    </edge>
    <edge source="Blood pressure" target="Medical assessment">
      <data key="d6">8.0</data>
      <data key="d7">Blood pressure evaluation is conducted during the medical assessment for fasting patients.</data>
      <data key="d8">cardiovascular health,health assessment</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391609</data>
    </edge>
    <edge source="Feet inspection" target="monofilament assessment">
      <data key="d6">9.0</data>
      <data key="d7">monofilament assessment is a specific test included in the Feet inspection category.</data>
      <data key="d8">foot health,medical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391552</data>
    </edge>
    <edge source="Feet inspection" target="vibration sense using tuning fork">
      <data key="d6">9.0</data>
      <data key="d7">vibration sense using tuning fork is a specific test included in the Feet inspection category.</data>
      <data key="d8">foot health,medical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391553</data>
    </edge>
    <edge source="Feet inspection" target="Ankle jerk">
      <data key="d6">9.0</data>
      <data key="d7">Ankle jerk is a specific test included in the Feet inspection category.</data>
      <data key="d8">foot health,medical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391554</data>
    </edge>
    <edge source="Feet inspection" target="peripheral neuropathy">
      <data key="d6">9.0</data>
      <data key="d7">peripheral neuropathy is a specific test included in the Feet inspection category.</data>
      <data key="d8">foot health,medical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391555</data>
    </edge>
    <edge source="Feet inspection" target="foot pulses">
      <data key="d6">9.0</data>
      <data key="d7">foot pulses is a specific test included in the Feet inspection category.</data>
      <data key="d8">foot health,medical assessment</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391556</data>
    </edge>
    <edge source="HbA1c" target="Glycaemic Control Targets">
      <data key="d6">10.0</data>
      <data key="d7">HbA1c is a critical parameter in determining glycaemic control targets for diabetic patients.</data>
      <data key="d8">blood glucose management,medical targets</data>
      <data key="d9">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391554</data>
    </edge>
    <edge source="HbA1c" target="Metformin">
      <data key="d6">9.0</data>
      <data key="d7">Metformin is prescribed to achieve HbA1c targets of &lt;7% in step 1 and &lt;8.5% in step 2.</data>
      <data key="d8">glucose control,therapeutic target</data>
      <data key="d9">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391557</data>
    </edge>
    <edge source="HbA1c" target="FPG">
      <data key="d6">8.0</data>
      <data key="d7">Both HbA1c and FPG are used to monitor blood glucose control, with HbA1c reflecting long-term trends and FPG indicating fasting levels.</data>
      <data key="d8">diabetes monitoring metrics</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391559</data>
    </edge>
    <edge source="HbA1c" target="Zidovudine">
      <data key="d6">8.0</data>
      <data key="d7">Zidovudine suppresses bone marrow and affects the accuracy of HbA1c testing in HIV-positive patients, making it an unreliable diagnostic tool.</data>
      <data key="d8">diagnostic limitation,drug interaction</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391607</data>
    </edge>
    <edge source="HbA1c" target="Diabetes Management">
      <data key="d6">9.0</data>
      <data key="d7">HbA1c is a key tool in monitoring and managing diabetes through tracking blood glucose levels.</data>
      <data key="d8">diabetes care,medical monitoring</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391641</data>
    </edge>
    <edge source="Education" target="Lifestyle and behavioural changes including smoking cessation">
      <data key="d6">9.0</data>
      <data key="d7">Lifestyle and behavioural changes including smoking cessation is a part of the Education category, which includes lifestyle modifications for diabetes management.</data>
      <data key="d8">behaviour change,patient education</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391550</data>
    </edge>
    <edge source="Education" target="Self-management">
      <data key="d6">9.0</data>
      <data key="d7">Self-management is a part of the Education category, which includes patient strategies for self-care.</data>
      <data key="d8">patient education,self-care</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391551</data>
    </edge>
    <edge source="Education" target="Nutrition advice, eating habits and meal planning">
      <data key="d6">9.0</data>
      <data key="d7">Nutrition advice, eating habits and meal planning is a part of the Education category, which includes dietary recommendations for diabetes patients.</data>
      <data key="d8">nutrition,patient education</data>
      <data key="d9">chunk-98786d9fc0c669ea92f47d22f68e9730</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391551</data>
    </edge>
    <edge source="Foot examination" target="Foot and shoe inspection">
      <data key="d6">7.0</data>
      <data key="d7">Foot examination is a component of foot and shoe inspection protocols for diabetic patients.</data>
      <data key="d8">diabetic foot care,preventive measures</data>
      <data key="d9">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391554</data>
    </edge>
    <edge source="Albumin/creatinine ratio" target="CKD screening">
      <data key="d6">9.0</data>
      <data key="d7">Albumin/creatinine ratio is a key test used in the screening for chronic kidney disease (CKD) in diabetic patients.</data>
      <data key="d8">disease screening,medical testing</data>
      <data key="d9">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391553</data>
    </edge>
    <edge source="eGFR" target="CKD assessment">
      <data key="d6">8.0</data>
      <data key="d7">eGFR is calculated from serum creatinine to assess kidney function as part of CKD evaluation.</data>
      <data key="d8">diagnostic tool,kidney function</data>
      <data key="d9">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391553</data>
    </edge>
    <edge source="Glycosuria" target="Glycaemic Control">
      <data key="d6">6.0</data>
      <data key="d7">Glycosuria is mentioned as an alternative, albeit less reliable, measure of glycaemic control.</data>
      <data key="d8">alternative testing,diabetes monitoring</data>
      <data key="d9">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391554</data>
    </edge>
    <edge source="Glycosuria" target="Self-monitoring technique">
      <data key="d6">7.0</data>
      <data key="d7">Glycosuria is mentioned as a poor measure of glycaemic control, but the text specifies a self-monitoring technique (testing the second voided specimen) if glycosuria is the only tool available.</data>
      <data key="d8">alternative testing methods,diabetes monitoring</data>
      <data key="d9">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391555</data>
    </edge>
    <edge source="ECG" target="Cardiovascular Disease Risk">
      <data key="d6">8.0</data>
      <data key="d7">ECG is recommended for patients with ischaemic heart disease or other cardiovascular disease risk factors.</data>
      <data key="d8">heart health,risk assessment</data>
      <data key="d9">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391554</data>
    </edge>
    <edge source="Glycaemic Control Targets" target="Eye examination for retinopathy">
      <data key="d6">9.0</data>
      <data key="d7">Eye examination for retinopathy is part of the broader glycaemic control management, as complications like retinopathy are linked to poor glycaemic control.</data>
      <data key="d8">complication monitoring,diabetes management</data>
      <data key="d9">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391555</data>
    </edge>
    <edge source="Weight and waist" target="Referral to health educator and/or dietician">
      <data key="d6">8.0</data>
      <data key="d7">Referral to health educators or dieticians is more frequent for patients who are overweight or obese, as indicated in the text.</data>
      <data key="d8">health management,obesity intervention</data>
      <data key="d9">chunk-ede226b3a0ceacb1cf58a1a70ebfe39d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391555</data>
    </edge>
    <edge source="BMI" target="Asian/Indian descent">
      <data key="d6">10.0</data>
      <data key="d7">Asian/Indian descent individuals require lower BMI thresholds (22–25 kg/m²) for diabetes risk assessment due to their increased susceptibility at lower BMI levels.</data>
      <data key="d8">medical screening criteria,population-specific risk</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391601</data>
    </edge>
    <edge source="Majority of patients" target="HbA1c &lt;7%">
      <data key="d6">9.0</data>
      <data key="d7">The majority of patients have an HbA1c target of &lt;7% as per the guidelines.</data>
      <data key="d8">medical guidelines,target management</data>
      <data key="d9">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391555</data>
    </edge>
    <edge source="Young, Low risk, Newly diagnosed, No cardiovascular disease" target="HbA1c &lt;6.5%">
      <data key="d6">8.0</data>
      <data key="d7">Young, low-risk, newly diagnosed patients with no cardiovascular disease have a stricter HbA1c target of &lt;6.5%.</data>
      <data key="d8">patient stratification,target specificity</data>
      <data key="d9">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391556</data>
    </edge>
    <edge source="Older persons, High risk, Hypoglycaemic unaware, Poor short-term prognosis" target="HbA1c &lt;7.5%">
      <data key="d6">7.0</data>
      <data key="d7">Older patients with high risk and poor prognosis have an adjusted HbA1c target of &lt;7.5%.</data>
      <data key="d8">risk adaptation,target flexibility</data>
      <data key="d9">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391556</data>
    </edge>
    <edge source="Biguanides" target="Metformin">
      <data key="d6">10.0</data>
      <data key="d7">Biguanides are represented by metformin, the only available product in this category.</data>
      <data key="d8">drug classification,monotherapy</data>
      <data key="d9">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391556</data>
    </edge>
    <edge source="Biguanides" target="Sulphonylurea">
      <data key="d6">9.0</data>
      <data key="d7">Biguanides (e.g., metformin) are often used in combination with sulphonylurea drugs (e.g., gliclazide, glibenclamide) as part of combination therapy for type 2 diabetes management.</data>
      <data key="d8">combination therapy,drug interaction</data>
      <data key="d9">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391557</data>
    </edge>
    <edge source="Sulphonylureas" target="Weight gain">
      <data key="d6">7.0</data>
      <data key="d7">Sulphonylureas are associated with weight gain in type 2 diabetic patients.</data>
      <data key="d8">metabolic impact,pharmacological effect</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391572</data>
    </edge>
    <edge source="Sulphonylureas" target="Elderly patients">
      <data key="d6">9.0</data>
      <data key="d7">Sulphonylureas like glibenclamide are contraindicated in elderly patients due to increased hypoglycaemia risk, while gliclazide and glimepiride are preferred.</data>
      <data key="d8">age-related risk,medication contraindication</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391605</data>
    </edge>
    <edge source="Sulphonylureas" target="Dose timing adjustment">
      <data key="d6">9.0</data>
      <data key="d7">Sulphonylurea dose timing is adjusted during fasting, with reduced morning doses.</data>
      <data key="d8">medication management,treatment adaptation</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391610</data>
    </edge>
    <edge source="Insulin" target="Second-line therapy">
      <data key="d6">8.0</data>
      <data key="d7">Insulin is typically used as a second- or third-line therapy in type 2 diabetes management.</data>
      <data key="d8">therapy sequence,treatment escalation</data>
      <data key="d9">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391556</data>
    </edge>
    <edge source="Insulin" target="Metformin">
      <data key="d6">9.0</data>
      <data key="d7">Insulin is combined with metformin in step 3 to reduce insulin resistance and lower required doses.</data>
      <data key="d8">combination therapy,metabolic synergy</data>
      <data key="d9">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391558</data>
    </edge>
    <edge source="Insulin" target="SMBG">
      <data key="d6">10.0</data>
      <data key="d7">SMBG is critical for monitoring blood glucose levels during insulin therapy to prevent complications like hypoglycaemia.</data>
      <data key="d8">diabetes management tool</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391560</data>
    </edge>
    <edge source="Insulin" target="Elderly patients">
      <data key="d6">8.0</data>
      <data key="d7">Insulin dosing for elderly patients is recommended at moderate doses (0.25–0.35 units/kg/day) after assessing physical and cognitive capability.</data>
      <data key="d8">age-related dosing,medication use</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391607</data>
    </edge>
    <edge source="Insulin" target="Administration timing">
      <data key="d6">10.0</data>
      <data key="d7">Insulin administration timing is adjusted during fasting, with intermediate-acting insulin injected overnight and rapid-acting insulin before meals.</data>
      <data key="d8">medication management,treatment adaptation</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391610</data>
    </edge>
    <edge source="Insulin" target="Periodontal Disease">
      <data key="d6">10.0</data>
      <data key="d7">Periodontal disease reduces insulin effectiveness due to systemic inflammation."+</data>
      <data key="d8">disease interaction,metabolic impact</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391622</data>
    </edge>
    <edge source="Insulin" target="Periodontitis">
      <data key="d6">8.0</data>
      <data key="d7">Periodontitis reduces the effectiveness of insulin produced in the body, linking oral inflammation to metabolic dysfunction.</data>
      <data key="d8">inflammation,metabolic impact</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391624</data>
    </edge>
    <edge source="Metformin" target="Severe Renal Impairment">
      <data key="d6">10.0</data>
      <data key="d7">Severe renal impairment is a contraindication for metformin use due to lactic acidosis risk.</data>
      <data key="d8">contraindication,drug safety</data>
      <data key="d9">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391559</data>
    </edge>
    <edge source="Metformin" target="Elderly patients">
      <data key="d6">7.0</data>
      <data key="d7">Metformin use in elderly patients is contraindicated if serum creatinine exceeds 130 µmol/L, highlighting age-related considerations.</data>
      <data key="d8">age-related risk,medication contraindication</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391604</data>
    </edge>
    <edge source="Metformin" target="American Diabetes Association">
      <data key="d6">9.0</data>
      <data key="d7">The American Diabetes Association recommends metformin for specific patient groups in diabetes prevention.</data>
      <data key="d8">diabetes treatment,medical recommendation</data>
      <data key="d9">chunk-13c6d53292dee777497019b48adc774c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391610</data>
    </edge>
    <edge source="Metformin" target="Dosage adjustment">
      <data key="d6">10.0</data>
      <data key="d7">Metformin dosage is modified during fasting, with two-thirds taken at dusk and one-third at dawn.</data>
      <data key="d8">medication management,treatment adaptation</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391611</data>
    </edge>
    <edge source="Lifestyle modification" target="HbA1c &lt;7%">
      <data key="d6">9.0</data>
      <data key="d7">Lifestyle modification is a key component of achieving the HbA1c target of &lt;7%.</data>
      <data key="d8">non-pharmacological intervention,target achievement</data>
      <data key="d9">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391556</data>
    </edge>
    <edge source="Lifestyle modification" target="Weight loss">
      <data key="d6">9.0</data>
      <data key="d7">Lifestyle modification is emphasized as a method to achieve and maintain weight loss in obese patients.</data>
      <data key="d8">intervention strategy,weight management</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391573</data>
    </edge>
    <edge source="Young diabetics &lt;30 years" target="Hospital-level assessment">
      <data key="d6">9.0</data>
      <data key="d7">Young diabetics under 30 years are required to undergo hospital-level assessment at least once per year as per the guidelines.</data>
      <data key="d8">age-specific care,medical referral</data>
      <data key="d9">chunk-3b872e8f4507f0b517d813175b50e40d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391556</data>
    </edge>
    <edge source="Sulphonylurea" target="Severe Renal Impairment">
      <data key="d6">10.0</data>
      <data key="d7">Severe renal impairment is a contraindication for sulphonylurea use (eGFR &lt;60 ml/minute).</data>
      <data key="d8">contraindication,drug safety</data>
      <data key="d9">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391558</data>
    </edge>
    <edge source="Step 1" target="Step 2">
      <data key="d6">10.0</data>
      <data key="d7">Failure in Step 1 (HbA1c &gt;7% and &lt;8.5%) triggers progression to Step 2 with sulphonylurea addition.</data>
      <data key="d8">clinical pathway,treatment escalation</data>
      <data key="d9">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391558</data>
    </edge>
    <edge source="Step 2" target="Step 3">
      <data key="d6">10.0</data>
      <data key="d7">Failure in Step 2 (HbA1c &gt;7% and &lt;8.5%) leads to Step 3 insulin initiation.</data>
      <data key="d8">clinical pathway,treatment escalation</data>
      <data key="d9">chunk-2d53ce416d979deb26807ffd3d639467</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391559</data>
    </edge>
    <edge source="Intermediate-acting Insulin" target="Long-acting Insulin">
      <data key="d6">7.0</data>
      <data key="d7">Both are types of insulin regimens used in diabetes management, differing in duration and administration timing.</data>
      <data key="d8">insulin types,treatment regimens</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391558</data>
    </edge>
    <edge source="Intermediate-acting Insulin" target="Biphasic Insulin">
      <data key="d6">6.0</data>
      <data key="d7">Biphasic insulin may be used as an alternative to intermediate-acting insulin in certain treatment scenarios.</data>
      <data key="d8">insulin regimen alternatives</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391560</data>
    </edge>
    <edge source="Biphasic Insulin" target="SMBG">
      <data key="d6">9.0</data>
      <data key="d7">SMBG is mandated for patients on biphasic insulin, with specific pre-meal glucose testing requirements.</data>
      <data key="d8">insulin type,monitoring protocol</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391565</data>
    </edge>
    <edge source="Self-Monitoring of Blood Glucose (SMBG)" target="Glucometer Strips">
      <data key="d6">10.0</data>
      <data key="d7">Glucometer strips are required for SMBG to enable accurate and frequent blood glucose monitoring.</data>
      <data key="d8">diabetes tools,monitoring essentials</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391561</data>
    </edge>
    <edge source="Fasting Glucose" target="Insulin Therapy">
      <data key="d6">9.0</data>
      <data key="d7">Fasting glucose is a target metric monitored during insulin therapy to ensure effective blood sugar control.</data>
      <data key="d8">diabetes monitoring,target metrics</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391559</data>
    </edge>
    <edge source="Fasting Glucose" target="Intermediate- or Long-Acting Insulin">
      <data key="d6">9.0</data>
      <data key="d7">Fasting glucose monitoring is required for patients on intermediate- or long-acting insulin, as specified in the text.</data>
      <data key="d8">insulin type,monitoring protocol</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391565</data>
    </edge>
    <edge source="Polyuria" target="Severe Decompensation">
      <data key="d6">8.0</data>
      <data key="d7">Polyuria is a symptom associated with severe diabetes decompensation, indicating uncontrolled hyperglycaemia.</data>
      <data key="d8">diabetes symptoms,severe conditions</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391560</data>
    </edge>
    <edge source="Polydipsia" target="Severe Decompensation">
      <data key="d6">8.0</data>
      <data key="d7">Polydipsia is a symptom linked to severe diabetes decompensation, reflecting excessive thirst due to hyperglycaemia.</data>
      <data key="d8">diabetes symptoms,severe conditions</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391561</data>
    </edge>
    <edge source="Weight Loss" target="Severe Decompensation">
      <data key="d6">7.0</data>
      <data key="d7">Weight loss is a criterion for severe diabetes decompensation, signaling significant metabolic imbalance.</data>
      <data key="d8">diabetes indicators,metabolic health</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391562</data>
    </edge>
    <edge source="Diabetic Ketoacidosis (DKA)" target="Hyperglycaemic Hyperosmolar State (HHS)">
      <data key="d6">16.0</data>
      <data key="d7">Both DKA and HHS are hyperglycaemic emergencies requiring urgent intravenous treatment, as outlined in the text.&lt;SEP&gt;Both DKA and HHS are severe hyperglycaemic conditions with significant morbidity and mortality, requiring emergency treatment with intravenous fluids and insulin.</data>
      <data key="d8">emergency treatment,hyperglycaemia,medical conditions</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb&lt;SEP&gt;chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391567</data>
    </edge>
    <edge source="Diabetic Ketoacidosis (DKA)" target="Myocardial Infarction (MI)">
      <data key="d6">8.0</data>
      <data key="d7">Myocardial Infarction is a precipitating factor for DKA, as stated in the text.</data>
      <data key="d8">medical conditions,precipitating factors</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391569</data>
    </edge>
    <edge source="Diabetic Ketoacidosis (DKA)" target="Cerebrovascular Accident (CVA)">
      <data key="d6">8.0</data>
      <data key="d7">Cerebrovascular Accident is a precipitating factor for DKA, as noted in the text.</data>
      <data key="d8">medical conditions,precipitating factors</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391570</data>
    </edge>
    <edge source="Diabetic Ketoacidosis (DKA)" target="Type 1 Diabetes">
      <data key="d6">9.0</data>
      <data key="d7">Type 1 Diabetes is associated with DKA in new-onset cases, according to the text.</data>
      <data key="d8">diabetes types,medical conditions</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391571</data>
    </edge>
    <edge source="Diabetic Ketoacidosis (DKA)" target="Hyperglycaemic Coma">
      <data key="d6">9.0</data>
      <data key="d7">Hyperglycaemic Coma is differentiated into DKA and HHS, with DKA being one of the two main categories.</data>
      <data key="d8">clinical diagnosis,medical differentiation</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391572</data>
    </edge>
    <edge source="Diabetic Ketoacidosis (DKA)" target="Hyperglycaemia">
      <data key="d6">9.0</data>
      <data key="d7">Hyperglycaemia is a key feature of diabetic ketoacidosis, as both are characterized by elevated blood glucose levels and metabolic acidosis.</data>
      <data key="d8">metabolic syndrome,pathophysiological overlap</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391573</data>
    </edge>
    <edge source="Diabetic Ketoacidosis (DKA)" target="Hyperglycaemic Hyperosmolar Coma (HHS)">
      <data key="d6">8.0</data>
      <data key="d7">Both DKA and HHS are distinct but related types of hyperglycaemic coma, differentiated by factors such as ketone presence, age demographics, and clinical presentation.</data>
      <data key="d8">medical differentiation,metabolic disorders</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391574</data>
    </edge>
    <edge source="Structured Education" target="Insulin Therapy">
      <data key="d6">10.0</data>
      <data key="d7">Structured education is a critical component of initiating and managing insulin therapy, ensuring patient understanding.</data>
      <data key="d8">patient education,treatment protocols</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391560</data>
    </edge>
    <edge source="Insulin Regimen" target="Lifestyle">
      <data key="d6">9.0</data>
      <data key="d7">Insulin regimen must align with patient lifestyle to ensure adherence and effective diabetes management.</data>
      <data key="d8">lifestyle adaptation,personalized treatment</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391560</data>
    </edge>
    <edge source="Insulin Regimen" target="SMBG">
      <data key="d6">9.0</data>
      <data key="d7">The frequency of SMBG depends on the insulin regimen being used, establishing a direct connection between the two.</data>
      <data key="d8">monitoring frequency,regimen dependency</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391562</data>
    </edge>
    <edge source="Written Instructions" target="Insulin Dose Titration">
      <data key="d6">9.0</data>
      <data key="d7">Written instructions are essential for patients to safely adjust insulin doses according to titration protocols.</data>
      <data key="d8">dose management,patient compliance</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391560</data>
    </edge>
    <edge source="Acute Complications" target="Insulin Therapy">
      <data key="d6">9.0</data>
      <data key="d7">Acute complications like hypoglycaemia are risks associated with insulin therapy, requiring patient education.</data>
      <data key="d8">complication management,safety protocols</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391561</data>
    </edge>
    <edge source="Intensive Insulin Therapy" target="Multiple Daily Injections">
      <data key="d6">8.0</data>
      <data key="d7">Intensive insulin therapy involves multiple daily injections, used when standard regimens fail to achieve targets.</data>
      <data key="d8">injection protocols,treatment escalation</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391561</data>
    </edge>
    <edge source="Intensive Insulin Therapy" target="Glycaemic Targets">
      <data key="d6">9.0</data>
      <data key="d7">Intensive insulin therapy is recommended when glycaemic targets are not met, indicating a direct relationship between unmet targets and the need for escalated therapy.</data>
      <data key="d8">medical intervention,treatment escalation</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391562</data>
    </edge>
    <edge source="Intensive Insulin Therapy" target="Doctor">
      <data key="d6">9.0</data>
      <data key="d7">The Doctor is responsible for considering intensive insulin therapy when glycaemic targets are not met.</data>
      <data key="d8">medical decision-making,treatment escalation</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391564</data>
    </edge>
    <edge source="Specialist Referral" target="Unmet Glycaemic Targets">
      <data key="d6">8.0</data>
      <data key="d7">Specialist referral is necessary when glycaemic targets remain unmet despite standard or intensive insulin therapy.</data>
      <data key="d8">medical evaluation,treatment adjustment</data>
      <data key="d9">chunk-9bbcd566de8858c4d6aa03975c27d5ed</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391561</data>
    </edge>
    <edge source="Specialist Referral" target="Glycaemic Targets">
      <data key="d6">8.0</data>
      <data key="d7">Specialist referral is appropriate when glycaemic targets remain unmet, showing a clear link to the need for expert medical evaluation.</data>
      <data key="d8">medical consultation,target unmet</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391563</data>
    </edge>
    <edge source="Specialist Referral" target="Doctor">
      <data key="d6">8.0</data>
      <data key="d7">The Doctor is the professional who may initiate specialist referral if glycaemic targets remain unmet.</data>
      <data key="d8">clinical judgment,referral authority</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391565</data>
    </edge>
    <edge source="Acute Illness" target="Sick Days">
      <data key="d6">8.0</data>
      <data key="d7">Acute illness is a key factor during 'sick days,' requiring adjustments to insulin therapy and urgent medical attention if glycaemic control is compromised.</data>
      <data key="d8">illness impact,medical urgency</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391562</data>
    </edge>
    <edge source="Poor Glycaemic Control" target="Sick Days">
      <data key="d6">9.0</data>
      <data key="d7">Poor glycaemic control is a critical concern during 'sick days,' necessitating additional insulin or therapy adjustments.</data>
      <data key="d8">health risk,management escalation</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391563</data>
    </edge>
    <edge source="Hypoglycaemic Episodes" target="Sick Days">
      <data key="d6">7.0</data>
      <data key="d7">Hypoglycaemic episodes are a potential complication during 'sick days,' requiring careful monitoring and therapy modifications.</data>
      <data key="d8">complication management,safety</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391563</data>
    </edge>
    <edge source="Adjustments to Therapy" target="Sick Days">
      <data key="d6">9.0</data>
      <data key="d7">Adjustments to therapy are necessary during 'sick days' to manage hyperglycaemia and ensure patient safety.</data>
      <data key="d8">health crisis,treatment modification</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391565</data>
    </edge>
    <edge source="Oral Agents" target="SMBG">
      <data key="d6">6.0</data>
      <data key="d7">SMBG is not supported by evidence for patients on oral agents, highlighting a distinction in monitoring practices between insulin and non-insulin therapies.</data>
      <data key="d8">monitoring limitations,therapy type</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391563</data>
    </edge>
    <edge source="Intermediate- or Long-Acting Insulin" target="SMBG">
      <data key="d6">9.0</data>
      <data key="d7">SMBG is required for patients on intermediate- or long-acting insulin, involving daily fasting glucose monitoring.</data>
      <data key="d8">insulin type,monitoring protocol</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391564</data>
    </edge>
    <edge source="Intermediate- or Long-Acting Insulin" target="Average Fasting Glucose">
      <data key="d6">9.0</data>
      <data key="d7">Average fasting glucose calculation is mandated for patients on intermediate- or long-acting insulin to assess glycaemic trends.</data>
      <data key="d8">insulin management,trend analysis</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391566</data>
    </edge>
    <edge source="Sick Days" target="Clinic">
      <data key="d6">8.0</data>
      <data key="d7">Clinic is a destination for urgent assistance during 'sick days,' as recommended in the text for patients with hyperglycaemia.</data>
      <data key="d8">health facility,urgent care access</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391566</data>
    </edge>
    <edge source="Sick Days" target="Hospital">
      <data key="d6">9.0</data>
      <data key="d7">Hospital is a critical resource for urgent medical intervention during 'sick days,' as outlined in the text.</data>
      <data key="d8">emergency care,health facility</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391568</data>
    </edge>
    <edge source="Follow-Up Appointments" target="Therapeutic Education">
      <data key="d6">8.0</data>
      <data key="d7">Follow-up appointments are essential for providing therapeutic education and re-education to patients, ensuring adherence to management protocols.</data>
      <data key="d8">education,medical follow-up</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391563</data>
    </edge>
    <edge source="Clinic" target="Screening protocol">
      <data key="d6">7.0</data>
      <data key="d7">The clinic develops and implements a screening protocol to identify high-risk patients.</data>
      <data key="d8">patient identification,protocol development</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391642</data>
    </edge>
    <edge source="Clinic" target="Group education">
      <data key="d6">7.0</data>
      <data key="d7">The clinic identifies areas where group education may be given to patients.</data>
      <data key="d8">education provision,group activities</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391643</data>
    </edge>
    <edge source="Clinic" target="In-service training">
      <data key="d6">8.0</data>
      <data key="d7">The clinic facilitates regular in-service training for health professionals.</data>
      <data key="d8">professional development,training programs</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391644</data>
    </edge>
    <edge source="Clinic" target="Monitoring health progress">
      <data key="d6">9.0</data>
      <data key="d7">The clinic monitors the health progress of chronic patients on a quarterly basis.</data>
      <data key="d8">health tracking,patient monitoring</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391645</data>
    </edge>
    <edge source="Hospital" target="Severe Hypoglycaemia">
      <data key="d6">9.0</data>
      <data key="d7">Severe Hypoglycaemia requires hospital admission for observation and treatment, as per the protocol.</data>
      <data key="d8">hospital referral,medical treatment</data>
      <data key="d9">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391568</data>
    </edge>
    <edge source="Hyperglycaemia" target="Medical Review">
      <data key="d6">10.0</data>
      <data key="d7">Hyperglycaemia requires urgent medical review as outlined in the text, establishing a direct link to clinical intervention.</data>
      <data key="d8">health monitoring,urgent care</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391564</data>
    </edge>
    <edge source="Hyperglycaemia" target="Insulin Dose Adjustment">
      <data key="d6">9.0</data>
      <data key="d7">Hyperglycaemia necessitates adjustments to insulin doses during sick days, as per the guidelines provided.</data>
      <data key="d8">dose modification,health crisis</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391565</data>
    </edge>
    <edge source="Hyperglycaemia" target="Hyperglycaemic Hyperosmolar Coma (HHS)">
      <data key="d6">9.0</data>
      <data key="d7">Hyperglycaemia is a defining characteristic of hyperglycaemic hyperosmolar coma, marked by markedly raised blood glucose levels and severe dehydration.</data>
      <data key="d8">metabolic syndrome,pathophysiological overlap</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391571</data>
    </edge>
    <edge source="Hyperglycaemia" target="Strenuous Exercise">
      <data key="d6">8.0</data>
      <data key="d7">Hyperglycaemia (&gt;14 mmol/L) is a contraindication for strenuous exercise, as outlined in the text.</data>
      <data key="d8">diabetes management,medical contraindication</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391637</data>
    </edge>
    <edge source="Diet" target="Glycaemic Control">
      <data key="d6">8.0</data>
      <data key="d7">Diet is emphasized as a critical component of glycaemic control during illness or stress, as outlined in the text.</data>
      <data key="d8">health stability,nutritional management</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391565</data>
    </edge>
    <edge source="Diet" target="SMBG">
      <data key="d6">7.0</data>
      <data key="d7">Diet guidelines are integrated with SMBG practices to ensure glycaemic stability during illness or sick days.</data>
      <data key="d8">health strategy,integrated management</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391566</data>
    </edge>
    <edge source="Urgent Referrals" target="Sodium Chloride 0.9% Infusion">
      <data key="d6">9.0</data>
      <data key="d7">Sodium chloride 0.9% infusion is recommended during urgent referrals to manage dehydration and prevent hypoglycaemia in critical patients.</data>
      <data key="d8">emergency care,hydration</data>
      <data key="d9">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391566</data>
    </edge>
    <edge source="Back-referrals" target="Primary Care">
      <data key="d6">8.0</data>
      <data key="d7">Back-referrals ensure patients are returned to primary care for continuous follow-up and management after specialist interventions.</data>
      <data key="d8">continuity of care,referral systems</data>
      <data key="d9">chunk-a7f14fa25c0f0f6b50f4346d68fa7305</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391567</data>
    </edge>
    <edge source="Glycaemic Control" target="SMBG">
      <data key="d6">10.0</data>
      <data key="d7">SMBG is essential for improving glycaemic control, as it empowers patients to take responsibility for managing their blood glucose levels.</data>
      <data key="d8">monitoring,self-management</data>
      <data key="d9">chunk-cc794a96abc6fea4b99860aedd47da8b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391562</data>
    </edge>
    <edge source="Self-Care" target="Identification Disc">
      <data key="d6">6.0</data>
      <data key="d7">Self-care includes the use of identification discs or bracelets to raise awareness of diabetes in daily life.</data>
      <data key="d8">awareness tools,personal care</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391632</data>
    </edge>
    <edge source="Self-Care" target="Family Support">
      <data key="d6">7.0</data>
      <data key="d7">Self-care involves involving family members for support in managing diabetes effectively.</data>
      <data key="d8">care support,family involvement</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391633</data>
    </edge>
    <edge source="Severe Hypoglycaemia" target="Dextrose Solution">
      <data key="d6">9.0</data>
      <data key="d7">Dextrose Solution is used in intravenous treatment for severe hypoglycaemia, as outlined in the protocol.</data>
      <data key="d8">drug administration,medical treatment</data>
      <data key="d9">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391569</data>
    </edge>
    <edge source="Hyperglycaemic Hyperosmolar State (HHS)" target="Myocardial Infarction (MI)">
      <data key="d6">8.0</data>
      <data key="d7">Myocardial Infarction is also a precipitating factor for HHS, according to the text.</data>
      <data key="d8">medical conditions,precipitating factors</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391569</data>
    </edge>
    <edge source="Hyperglycaemic Hyperosmolar State (HHS)" target="Hyperglycaemic Coma">
      <data key="d6">9.0</data>
      <data key="d7">Hyperglycaemic Coma is differentiated into DKA and HHS, with HHS being one of the two main categories.</data>
      <data key="d8">clinical diagnosis,medical differentiation</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391570</data>
    </edge>
    <edge source="Hyperglycaemic Hyperosmolar State (HHS)" target="Cerebrovascular Accident (CVA)">
      <data key="d6">8.0</data>
      <data key="d7">Cerebrovascular Accident is a precipitating factor for HHS, as stated in the text.</data>
      <data key="d8">medical conditions,precipitating factors</data>
      <data key="d9">chunk-8a3fa9809e33f235ebfe9c0204d7fbfb</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391571</data>
    </edge>
    <edge source="Recurrent Hypoglycaemia" target="Hypoglycaemic Unawareness">
      <data key="d6">8.0</data>
      <data key="d7">Recurrent Hypoglycaemia may be the cause or consequence of hypoglycaemic unawareness, as stated in the text.</data>
      <data key="d8">causation,medical condition link</data>
      <data key="d9">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391567</data>
    </edge>
    <edge source="Recurrent Hypoglycaemia" target="Diabetic Patient Education">
      <data key="d6">8.0</data>
      <data key="d7">Diabetic Patient Education is essential to prevent recurrent hypoglycaemia by identifying underlying causes and improving adherence.</data>
      <data key="d8">medical education,prevention</data>
      <data key="d9">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391568</data>
    </edge>
    <edge source="Recurrent Hypoglycaemia" target="Alcohol Abuse">
      <data key="d6">8.0</data>
      <data key="d7">Alcohol Abuse is identified as a cause of recurrent hypoglycaemia in the text.</data>
      <data key="d8">causation,medical risk factor</data>
      <data key="d9">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391568</data>
    </edge>
    <edge source="Recurrent Hypoglycaemia" target="Self-induced Hypoglycaemia">
      <data key="d6">7.0</data>
      <data key="d7">Self-induced Hypoglycaemia is listed as a cause of recurrent hypoglycaemic episodes.</data>
      <data key="d8">causation,patient behavior</data>
      <data key="d9">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391569</data>
    </edge>
    <edge source="Hypoglycaemic Unawareness" target="Hypoglycaemic Awareness">
      <data key="d6">7.0</data>
      <data key="d7">Hypoglycaemic Awareness is the opposite of hypoglycaemic unawareness, a complication linked to long-term diabetes.</data>
      <data key="d8">awareness,medical condition contrast</data>
      <data key="d9">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391568</data>
    </edge>
    <edge source="Thiamine 100mg IMI" target="Alcohol Abuse">
      <data key="d6">8.0</data>
      <data key="d7">Thiamine 100mg IMI is administered to patients with alcohol abuse as part of IV infusion protocols.</data>
      <data key="d8">medical treatment,patient condition</data>
      <data key="d9">chunk-75e013bb28ba01bfbc374edd67be9709</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391569</data>
    </edge>
    <edge source="Alcohol Abuse" target="Diabetic Dyslipidaemia">
      <data key="d6">7.0</data>
      <data key="d7">Alcohol abuse is a secondary cause of hyperlipidaemia that must be excluded in diabetic dyslipidaemia management.</data>
      <data key="d8">medical evaluation,secondary causes</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391583</data>
    </edge>
    <edge source="Type 1 Diabetes" target="Inheritance of Diabetes">
      <data key="d6">8.0</data>
      <data key="d7">The table in the 'Inheritance of Diabetes' section directly relates to Type 1 Diabetes risk based on parental history."|"medical genetics, risk factors</data>
      <data key="d8">8</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391598</data>
    </edge>
    <edge source="Dyslipidaemia" target="CVD">
      <data key="d6">9.0</data>
      <data key="d7">Dyslipidaemia (elevated triglycerides, low HDL) is a major CVD risk factor in diabetes, requiring management to reduce vascular disease.</data>
      <data key="d8">modifiable intervention,risk factor</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391577</data>
    </edge>
    <edge source="Dyslipidaemia" target="Diuretics">
      <data key="d6">7.0</data>
      <data key="d7">Diuretics may worsen dyslipidaemia, necessitating monitoring of lipid levels in patients.</data>
      <data key="d8">cardiovascular risk,pharmacological effect</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391586</data>
    </edge>
    <edge source="Dyslipidaemia" target="Beta-Blockers">
      <data key="d6">7.0</data>
      <data key="d7">Beta-blockers may exacerbate dyslipidaemia, requiring careful monitoring of lipid profiles.</data>
      <data key="d8">cardiovascular risk,pharmacological effect</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391586</data>
    </edge>
    <edge source="Dyslipidaemia" target="HAART">
      <data key="d6">9.0</data>
      <data key="d7">HAART contributes to dyslipidaemia, a metabolic complication involving abnormal lipid levels in HIV-positive patients.</data>
      <data key="d8">metabolic disorder,treatment-related complication</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391602</data>
    </edge>
    <edge source="Dyslipidaemia" target="Lipodystrophy">
      <data key="d6">7.0</data>
      <data key="d7">Dyslipidaemia and lipodystrophy are interconnected metabolic complications in HIV patients, both contributing to insulin resistance and diabetes risk.</data>
      <data key="d8">HIV complications,metabolic syndrome</data>
      <data key="d9">chunk-868ccb5351320321cda28e935f38e86b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391606</data>
    </edge>
    <edge source="Neuropathy" target="Loss of Protective Sensation">
      <data key="d6">9.0</data>
      <data key="d7">Neuropathy is a condition that leads to loss of protective sensation in the feet.</data>
      <data key="d8">medical condition,sensory impairment</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391596</data>
    </edge>
    <edge source="Neuropathy" target="Category 1">
      <data key="d6">10.0</data>
      <data key="d7">Neuropathy is a defining factor in Category 1, which includes sensory neuropathy but no deformity or PAD.</data>
      <data key="d8">medical condition,risk categorization</data>
      <data key="d9">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391637</data>
    </edge>
    <edge source="Neuropathy" target="Category 2">
      <data key="d6">10.0</data>
      <data key="d7">Neuropathy is a defining factor in Category 2, which includes sensory neuropathy and PAD or deformity.</data>
      <data key="d8">medical condition,risk categorization</data>
      <data key="d9">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391638</data>
    </edge>
    <edge source="South Africa Demographic and Health Survey, 2003" target="Overweight">
      <data key="d6">9.0</data>
      <data key="d7">The survey reported percentages of overweight adults, providing data on the prevalence of overweight in South Africa.</data>
      <data key="d8">data source,epidemiology</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391571</data>
    </edge>
    <edge source="South Africa Demographic and Health Survey, 2003" target="Obese">
      <data key="d6">9.0</data>
      <data key="d7">The survey reported percentages of obese adults, providing data on the prevalence of obesity in South Africa.</data>
      <data key="d8">data source,epidemiology</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391572</data>
    </edge>
    <edge source="Myocardial infarction" target="Hyperglycaemic hyperosmolar coma (HHS)">
      <data key="d6">8.0</data>
      <data key="d7">Myocardial infarction is listed as a precipitant for HHS in the text.</data>
      <data key="d8">pathophysiology,precipitant</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391572</data>
    </edge>
    <edge source="Cerebrovascular accident" target="Hyperglycaemic hyperosmolar coma (HHS)">
      <data key="d6">8.0</data>
      <data key="d7">Cerebrovascular accident is listed as a precipitant for HHS in the text.</data>
      <data key="d8">pathophysiology,precipitant</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391573</data>
    </edge>
    <edge source="Insulin therapy" target="Weight gain">
      <data key="d6">7.0</data>
      <data key="d7">Insulin therapy is associated with weight gain in type 2 diabetic patients.</data>
      <data key="d8">metabolic impact,pharmacological effect</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391574</data>
    </edge>
    <edge source="Behavioural therapy" target="Weight loss">
      <data key="d6">9.0</data>
      <data key="d7">Behavioural therapy is recommended to support weight loss in obese patients.</data>
      <data key="d8">intervention strategy,weight management</data>
      <data key="d9">chunk-358680bfd64f7682f010caf1db56168e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391573</data>
    </edge>
    <edge source="Atherosclerosis" target="Diabetic dyslipidaemia">
      <data key="d6">9.0</data>
      <data key="d7">Diabetic dyslipidaemia (elevated triglycerides, low HDL) contributes to atherosclerosis, a major cause of diabetic mortality.</data>
      <data key="d8">disease progression,pathophysiological link</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391576</data>
    </edge>
    <edge source="Cigarette smoking" target="CVD">
      <data key="d6">8.0</data>
      <data key="d7">Cigarette smoking is a modifiable CVD risk factor in diabetes, with cessation recommended to reduce cardiovascular risk.</data>
      <data key="d8">modifiable intervention,risk factor</data>
      <data key="d9">chunk-72284fe3e2da042b4841a91a96c6513d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391575</data>
    </edge>
    <edge source="Triglycerides" target="Ideal Lipid Profile">
      <data key="d6">7.0</data>
      <data key="d7">The ideal lipid profile specifies that triglycerides should be kept below 1.7 mmol/L in diabetic patients.</data>
      <data key="d8">lipid levels,therapeutic target</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391580</data>
    </edge>
    <edge source="Sleep Apnoea" target="Attention Deficit/Hyperactivity Disorder">
      <data key="d6">6.0</data>
      <data key="d7">Both sleep apnoea and attention deficit/hyperactivity disorder are mentioned as conditions with higher relative risks compared to diabetes-related driving risks.</data>
      <data key="d8">comparative risk analysis,health conditions</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391614</data>
    </edge>
    <edge source="Lipid Disturbances" target="Vascular Disease">
      <data key="d6">8.0</data>
      <data key="d7">Lipid disturbances are a contributing factor to the high incidence of vascular disease in diabetic patients.</data>
      <data key="d8">cardiovascular risk,pathophysiology</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391579</data>
    </edge>
    <edge source="HDL Cholesterol" target="Ideal Lipid Profile">
      <data key="d6">7.0</data>
      <data key="d7">The ideal lipid profile sets minimum thresholds for HDL cholesterol (1.0 mmol/L for men, 1.2 mmol/L for women) in diabetic patients.</data>
      <data key="d8">lipid levels,therapeutic target</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391581</data>
    </edge>
    <edge source="LDL Cholesterol" target="Statins">
      <data key="d6">10.0</data>
      <data key="d7">Statins are first-line agents for lowering LDL cholesterol in diabetic patients.</data>
      <data key="d8">lipid management,pharmacological therapy</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391579</data>
    </edge>
    <edge source="Fasting Lipid Profile" target="Diabetic Patients">
      <data key="d6">8.0</data>
      <data key="d7">Fasting lipid profile is a diagnostic tool used to evaluate lipid levels in diabetic patients.</data>
      <data key="d8">diabetes management,diagnostic testing</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391580</data>
    </edge>
    <edge source="Metabolic Control" target="Diabetic Dyslipidaemia">
      <data key="d6">9.0</data>
      <data key="d7">Effective metabolic control is essential to managing diabetic dyslipidaemia and preventing vascular disease.</data>
      <data key="d8">disease management,metabolic regulation</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391580</data>
    </edge>
    <edge source="Diabetic Dyslipidaemia" target="Hypothyroidism">
      <data key="d6">7.0</data>
      <data key="d7">Hypothyroidism is a secondary cause of hyperlipidaemia that must be excluded in diabetic dyslipidaemia management.</data>
      <data key="d8">medical evaluation,secondary causes</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391581</data>
    </edge>
    <edge source="Diabetic Dyslipidaemia" target="Renal Disease">
      <data key="d6">7.0</data>
      <data key="d7">Renal disease is a secondary cause of hyperlipidaemia that must be excluded in diabetic dyslipidaemia management.</data>
      <data key="d8">medical evaluation,secondary causes</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391582</data>
    </edge>
    <edge source="Group 1" target="Statin Therapy">
      <data key="d6">10.0</data>
      <data key="d7">Group 1 patients require statin therapy as part of their management, regardless of baseline lipid levels.</data>
      <data key="d8">pharmacological treatment,risk stratification</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391581</data>
    </edge>
    <edge source="Group 2" target="Statin Therapy">
      <data key="d6">8.0</data>
      <data key="d7">Group 2 patients may require statin therapy after assessing their risk of cardiovascular disease.</data>
      <data key="d8">pharmacological treatment,risk stratification</data>
      <data key="d9">chunk-79bcdf813ecc9a1a30cad14ddfd21884</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391582</data>
    </edge>
    <edge source="ACE Inhibitors (ACEi)" target="Estimated Glomerular Filtration Rate (eGFR)">
      <data key="d6">10.0</data>
      <data key="d7">eGFR is monitored during ACE inhibitor therapy to assess kidney function and adjust treatment.</data>
      <data key="d8">pharmacological monitoring,renal function assessment</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391583</data>
    </edge>
    <edge source="Random Cholesterol &gt; 7.5 mmol/L" target="REFER">
      <data key="d6">8.0</data>
      <data key="d7">Elevated cholesterol levels above 7.5 mmol/L are a criterion for referral to further medical evaluation.</data>
      <data key="d8">diagnostic threshold,medical referral</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391584</data>
    </edge>
    <edge source="Fasting Triglycerides &gt; 10 mmol/L" target="REFER">
      <data key="d6">8.0</data>
      <data key="d7">Severely elevated triglycerides above 10 mmol/L are a criterion for referral to further medical evaluation.</data>
      <data key="d8">diagnostic threshold,medical referral</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391585</data>
    </edge>
    <edge source="White-Coat Hypertension" target="Ambulatory BP Measurement (ABPM)">
      <data key="d6">8.0</data>
      <data key="d7">Ambulatory BP measurement is used to diagnose white-coat hypertension accurately.</data>
      <data key="d8">blood pressure monitoring,diagnostic method</data>
      <data key="d9">chunk-bb7f04e1dd6acb6d198b1c58406f9ead</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391583</data>
    </edge>
    <edge source="Peripheral Vascular Disease" target="Vascular Unit">
      <data key="d6">9.0</data>
      <data key="d7">Vascular units manage complications related to peripheral vascular disease in diabetic patients.</data>
      <data key="d8">disease management,vascular care</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391593</data>
    </edge>
    <edge source="ACE Inhibitors" target="Hyperkalemia">
      <data key="d6">9.0</data>
      <data key="d7">ACE inhibitors may induce hyperkalemia, a condition requiring immediate medical attention and possible discontinuation of the medication.</data>
      <data key="d8">medical risk,side effect</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391584</data>
    </edge>
    <edge source="ACE Inhibitors" target="Renal Failure">
      <data key="d6">9.0</data>
      <data key="d7">ACE inhibitors can lead to renal failure, necessitating monitoring of creatinine levels and specialist referral if levels double.</data>
      <data key="d8">renal complication,side effect</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391585</data>
    </edge>
    <edge source="ACE Inhibitors" target="Persistent Cough">
      <data key="d6">8.0</data>
      <data key="d7">Persistent cough is a common side effect of ACE inhibitors, often resolving with dose reduction or discontinuation.</data>
      <data key="d8">respiratory issue,side effect</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391586</data>
    </edge>
    <edge source="ACE Inhibitors" target="Lower Glucose Levels">
      <data key="d6">7.0</data>
      <data key="d7">ACE inhibitors may cause lower glucose levels, requiring caution in diabetic patients.</data>
      <data key="d8">metabolic impact,side effect</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391586</data>
    </edge>
    <edge source="ACE Inhibitors" target="Angioedema">
      <data key="d6">9.0</data>
      <data key="d7">ACE inhibitors are associated with angioedema, a life-threatening condition requiring patient education on symptoms and immediate medical intervention.</data>
      <data key="d8">allergic reaction,side effect</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391587</data>
    </edge>
    <edge source="ACE Inhibitors" target="CKD">
      <data key="d6">10.0</data>
      <data key="d7">ACE inhibitors are prescribed for CKD management to delay progression, even in the absence of hypertension.</data>
      <data key="d8">disease management,therapeutic use</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391590</data>
    </edge>
    <edge source="Diuretics" target="Insulin Release Inhibition">
      <data key="d6">8.0</data>
      <data key="d7">Diuretics, when used in large doses, may inhibit insulin release, affecting glucose regulation.</data>
      <data key="d8">metabolic impact,pharmacological effect</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391585</data>
    </edge>
    <edge source="Beta-Blockers" target="Hypoglycaemia Masking">
      <data key="d6">8.0</data>
      <data key="d7">Beta-blockers can mask the symptoms of hypoglycaemia, increasing the risk of undetected low blood sugar in diabetic patients.</data>
      <data key="d8">pharmacological effect,risk management</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391585</data>
    </edge>
    <edge source="Diabetic Nephropathy" target="Screening">
      <data key="d6">9.0</data>
      <data key="d7">Screening for CKD, including ACR and eGFR, is critical for early detection of diabetic nephropathy.</data>
      <data key="d8">diagnostic procedure,disease monitoring</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391588</data>
    </edge>
    <edge source="Diabetic Nephropathy" target="CKD">
      <data key="d6">10.0</data>
      <data key="d7">Diabetic nephropathy is a progressive complication of diabetes that contributes to the development and progression of CKD.</data>
      <data key="d8">diabetes complication,disease progression</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391589</data>
    </edge>
    <edge source="Hyperkalemia" target="Renal Care">
      <data key="d6">7.0</data>
      <data key="d7">Hyperkalemia is a contraindication for ACE-inhibitors, influencing referral criteria for specialized renal care.</data>
      <data key="d8">medical contraindication,treatment adjustment</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391589</data>
    </edge>
    <edge source="Renal Medicine Physician" target="Renovascular Hypertension">
      <data key="d6">9.0</data>
      <data key="d7">Patients with suspected renovascular hypertension require referral to a renal medicine physician for specialized care.</data>
      <data key="d8">medical referral,specialist consultation</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391587</data>
    </edge>
    <edge source="Screening" target="CKD">
      <data key="d6">9.0</data>
      <data key="d7">CKD management involves regular screening for early detection, including ACR and eGFR measurements.</data>
      <data key="d8">diagnostic tool,medical procedure</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391586</data>
    </edge>
    <edge source="Monitoring" target="CKD">
      <data key="d6">9.0</data>
      <data key="d7">CKD requires ongoing monitoring of kidney function through eGFR and serum creatinine levels.</data>
      <data key="d8">disease management,medical procedure</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391587</data>
    </edge>
    <edge source="Treatment Adjustment" target="CKD">
      <data key="d6">8.0</data>
      <data key="d7">Treatment adjustment is crucial in CKD management to achieve target blood pressure and prevent disease progression.</data>
      <data key="d8">medical intervention,therapeutic strategy</data>
      <data key="d9">chunk-2747f5a8e50f80ecb003d82a6236b5de</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391587</data>
    </edge>
    <edge source="Diabetic Retinopathy" target="Fundus Examination">
      <data key="d6">9.0</data>
      <data key="d7">Fundus examination is a critical screening method for identifying diabetic retinopathy and its severity.</data>
      <data key="d8">diagnostic procedure,screening</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391589</data>
    </edge>
    <edge source="Diabetic Retinopathy" target="South African CSR Targets">
      <data key="d6">6.0</data>
      <data key="d7">South African CSR targets relate to cataract surgery rates, which are indirectly connected to diabetic retinopathy management through eye complications.</data>
      <data key="d8">healthcare policy,visual impairment</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391589</data>
    </edge>
    <edge source="Diabetic Retinopathy" target="HIV Population on ARVs">
      <data key="d6">8.0</data>
      <data key="d7">HIV population on ARVs requires regular screening for diabetic retinopathy due to increased diabetes prevalence and associated complications.</data>
      <data key="d8">diabetes comorbidity,screening necessity</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391590</data>
    </edge>
    <edge source="Diabetic Retinopathy" target="Pregnant Women with Pre-Existing Diabetes">
      <data key="d6">9.0</data>
      <data key="d7">Pregnant women with pre-existing diabetes are at higher risk for diabetic retinopathy, necessitating frequent monitoring.</data>
      <data key="d8">high-risk group,monitoring requirement</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391591</data>
    </edge>
    <edge source="Diabetic Retinopathy" target="Fundus Photography">
      <data key="d6">9.0</data>
      <data key="d7">Fundus photography is a critical screening method for detecting and monitoring diabetic retinopathy.</data>
      <data key="d8">diagnostic imaging,screening method</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391592</data>
    </edge>
    <edge source="Fundus Examination" target="District Level">
      <data key="d6">7.0</data>
      <data key="d7">Fundus examination services should be available at the district level to ensure accessibility for diabetic patients.</data>
      <data key="d8">healthcare infrastructure,service availability</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391590</data>
    </edge>
    <edge source="Mobile Fundus Camera" target="Retinal Photography">
      <data key="d6">9.0</data>
      <data key="d7">Retinal photography is facilitated by the use of a mobile fundus camera, which enables feasible screening in primary care settings.</data>
      <data key="d8">medical equipment,screening technology</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391593</data>
    </edge>
    <edge source="Family History of Non-Diabetic Renal Disease" target="Other Causes of CKD in Diabetes">
      <data key="d6">7.0</data>
      <data key="d7">Family history of non-diabetic renal disease is a criterion for considering non-diabetic causes of CKD in diabetic patients.</data>
      <data key="d8">differential diagnosis,genetic factors</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391589</data>
    </edge>
    <edge source="Systemic Disease" target="Other Causes of CKD in Diabetes">
      <data key="d6">6.0</data>
      <data key="d7">Systemic disease is a potential underlying cause of CKD in diabetic patients, necessitating further investigation.</data>
      <data key="d8">comorbid conditions,differential diagnosis</data>
      <data key="d9">chunk-3d51f582eadeb6057c2d495ca70b761b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391590</data>
    </edge>
    <edge source="Diabetic Retinopathy (DR)" target="Retinal Photography">
      <data key="d6">9.0</data>
      <data key="d7">Retinal photography is a recommended method for screening and monitoring diabetic retinopathy in primary care settings.</data>
      <data key="d8">medical technology,screening</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391590</data>
    </edge>
    <edge source="Diabetic Retinopathy (DR)" target="Laser Therapy">
      <data key="d6">8.0</data>
      <data key="d7">Laser therapy is a treatment option for proliferative retinopathy and macula oedema associated with diabetic retinopathy.</data>
      <data key="d8">disease management,medical treatment</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391591</data>
    </edge>
    <edge source="Diabetic Retinopathy (DR)" target="Vitrectomy Surgery">
      <data key="d6">7.0</data>
      <data key="d7">Vitrectomy surgery is used for advanced cases of diabetic retinopathy requiring intervention.</data>
      <data key="d8">disease progression,surgical intervention</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391592</data>
    </edge>
    <edge source="Foot Problems in Diabetes" target="Ulceration">
      <data key="d6">10.0</data>
      <data key="d7">Foot problems in diabetes are a major cause of ulceration, which can lead to amputation if untreated.</data>
      <data key="d8">complication,disease progression</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391591</data>
    </edge>
    <edge source="Foot Problems in Diabetes" target="Amputation">
      <data key="d6">9.0</data>
      <data key="d7">Foot problems in diabetes contribute to the risk of amputation, a severe complication of the disease.</data>
      <data key="d8">complication,disease progression</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391591</data>
    </edge>
    <edge source="Foot Problems in Diabetes" target="Orthotist">
      <data key="d6">8.0</data>
      <data key="d7">Orthotists provide orthotic support to address structural deformities and mobility issues in diabetic foot problems.</data>
      <data key="d8">foot care,orthotic intervention</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391593</data>
    </edge>
    <edge source="Peripheral Sensory Diabetic Neuropathy" target="Ulceration">
      <data key="d6">10.0</data>
      <data key="d7">Peripheral sensory diabetic neuropathy increases the risk of foot ulceration due to loss of protective sensation.</data>
      <data key="d8">medical condition,risk factor</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391591</data>
    </edge>
    <edge source="Ulceration" target="Peripheral Arterial Disease (PAD)">
      <data key="d6">9.0</data>
      <data key="d7">Peripheral arterial disease (PAD) is a significant risk factor for foot ulceration in diabetic patients.</data>
      <data key="d8">risk factor,vascular disease</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391593</data>
    </edge>
    <edge source="Ulceration" target="Multisite Testing">
      <data key="d6">7.0</data>
      <data key="d7">Multisite testing is used to identify specific foot sites at risk of ulceration, distinct from general neuropathy screening.</data>
      <data key="d8">localized risk assessment,ulceration prevention</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391640</data>
    </edge>
    <edge source="Amputation" target="Surgeon">
      <data key="d6">9.0</data>
      <data key="d7">Surgeons perform amputations as a last resort for severe foot complications in diabetic patients.</data>
      <data key="d8">complication management,surgical procedure</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391594</data>
    </edge>
    <edge source="Laser Therapy" target="Ophthalmologist">
      <data key="d6">9.0</data>
      <data key="d7">Ophthalmologists perform laser therapy as a treatment for proliferative retinopathy and macula oedema.</data>
      <data key="d8">medical intervention,specialist role</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391593</data>
    </edge>
    <edge source="Vitrectomy Surgery" target="Ophthalmologist">
      <data key="d6">8.0</data>
      <data key="d7">Ophthalmologists conduct vitrectomy surgery for advanced retinopathy cases requiring surgical intervention.</data>
      <data key="d8">specialist role,surgical treatment</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391594</data>
    </edge>
    <edge source="Pharmacological Intervention" target="Ophthalmologist">
      <data key="d6">7.0</data>
      <data key="d7">Ophthalmologists may prescribe pharmacological interventions for sight-threatening diabetic retinopathy.</data>
      <data key="d8">medical treatment,specialist role</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391595</data>
    </edge>
    <edge source="Peripheral Arterial Disease (PAD)" target="Ischaemia">
      <data key="d6">8.0</data>
      <data key="d7">Peripheral arterial disease (PAD) is associated with ischaemia, a critical factor in delayed ulcer healing.</data>
      <data key="d8">complication,vascular disease</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391593</data>
    </edge>
    <edge source="Risk Categorisation System for Diabetic Feet" target="Foot Assessment Forms">
      <data key="d6">8.0</data>
      <data key="d7">Foot assessment forms are used in conjunction with the risk categorisation system to document and manage diabetic foot risks.</data>
      <data key="d8">diagnostic tools,risk management</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391594</data>
    </edge>
    <edge source="Foot Care Management" target="Annexure C1">
      <data key="d6">7.0</data>
      <data key="d7">Annexure C1 provides guidelines for foot care management as referenced in the text.</data>
      <data key="d8">care protocol,document reference</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391594</data>
    </edge>
    <edge source="North America" target="20% of diabetes-related hospital admissions">
      <data key="d6">8.0</data>
      <data key="d7">In North America, foot complications account for 20% of all diabetes-related hospital admissions.</data>
      <data key="d8">epidemiology,healthcare statistics</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391592</data>
    </edge>
    <edge source="Podiatrist" target="Foot Ulceration">
      <data key="d6">10.0</data>
      <data key="d7">Podiatrists play a critical role in preventing and managing foot ulceration in diabetic patients.</data>
      <data key="d8">specialist care,ulcer prevention</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391593</data>
    </edge>
    <edge source="Podiatrist" target="Patient">
      <data key="d6">7.0</data>
      <data key="d7">Podiatrists are referred to for the treatment of non-ulcerative and ulcerative foot pathology.</data>
      <data key="d8">medical treatment,specialist referral</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391596</data>
    </edge>
    <edge source="Podiatrist" target="Non-Ulcerative Foot Pathology">
      <data key="d6">8.0</data>
      <data key="d7">Severe non-ulcerative foot pathology requires consultation with a podiatrist.</data>
      <data key="d8">foot care,specialist consultation</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391597</data>
    </edge>
    <edge source="Orthotist" target="Patient">
      <data key="d6">7.0</data>
      <data key="d7">Orthotists provide orthotic interventions to support foot care and mobility for patients.</data>
      <data key="d8">mobility support,specialist referral</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391597</data>
    </edge>
    <edge source="Surgeon" target="Patient">
      <data key="d6">7.0</data>
      <data key="d7">Surgeons may be involved in surgical interventions for foot pathology.</data>
      <data key="d8">specialist referral,surgical treatment</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391598</data>
    </edge>
    <edge source="Wound Care Unit" target="Foot Ulceration">
      <data key="d6">10.0</data>
      <data key="d7">Wound care units specialize in treating foot ulcers and promoting healing in diabetic patients.</data>
      <data key="d8">specialized care,ulcer treatment</data>
      <data key="d9">chunk-95a37fdd4e75602e7ee73f9697d76aa6</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391594</data>
    </edge>
    <edge source="Wound Care Unit" target="Patient">
      <data key="d6">7.0</data>
      <data key="d7">Wound care units manage and treat foot ulcers in patients.</data>
      <data key="d8">specialist referral,wound care</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391599</data>
    </edge>
    <edge source="risk categorisation system for diabetic feet" target="Category 0">
      <data key="d6">9.0</data>
      <data key="d7">The risk categorisation system includes Category 0 as one of its defined risk levels for diabetic feet.</data>
      <data key="d8">classification,risk stratification</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391594</data>
    </edge>
    <edge source="risk categorisation system for diabetic feet" target="Category 1">
      <data key="d6">9.0</data>
      <data key="d7">The risk categorisation system includes Category 1 as one of its defined risk levels for diabetic feet.</data>
      <data key="d8">classification,risk stratification</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391595</data>
    </edge>
    <edge source="risk categorisation system for diabetic feet" target="Category 2">
      <data key="d6">9.0</data>
      <data key="d7">The risk categorisation system includes Category 2 as one of its defined risk levels for diabetic feet.</data>
      <data key="d8">classification,risk stratification</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391596</data>
    </edge>
    <edge source="risk categorisation system for diabetic feet" target="Category 3">
      <data key="d6">9.0</data>
      <data key="d7">The risk categorisation system includes Category 3 as one of its defined risk levels for diabetic feet.</data>
      <data key="d8">classification,risk stratification</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391597</data>
    </edge>
    <edge source="Category 0" target="Skin not intact (ulcer)">
      <data key="d6">9.0</data>
      <data key="d7">The presence of skin ulcers would disqualify an individual from Category 0 (no neuropathy or PAD).</data>
      <data key="d8">exclusion criteria,risk categorization</data>
      <data key="d9">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391638</data>
    </edge>
    <edge source="Category 0" target="Previous ulcer">
      <data key="d6">9.0</data>
      <data key="d7">A history of ulcers would disqualify an individual from Category 0 (no neuropathy or PAD).</data>
      <data key="d8">exclusion criteria,risk categorization</data>
      <data key="d9">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391638</data>
    </edge>
    <edge source="Category 0" target="Previous amputation">
      <data key="d6">9.0</data>
      <data key="d7">A history of amputation would disqualify an individual from Category 0 (no neuropathy or PAD).</data>
      <data key="d8">exclusion criteria,risk categorization</data>
      <data key="d9">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391639</data>
    </edge>
    <edge source="Category 0" target="Inappropriate footwear">
      <data key="d6">9.0</data>
      <data key="d7">Use of inappropriate footwear would disqualify an individual from Category 0 (no neuropathy or PAD).</data>
      <data key="d8">exclusion criteria,risk categorization</data>
      <data key="d9">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391640</data>
    </edge>
    <edge source="Category 2" target="Peripheral vascular disease">
      <data key="d6">10.0</data>
      <data key="d7">Peripheral vascular disease is a defining factor in Category 2, which includes sensory neuropathy and PAD or deformity.</data>
      <data key="d8">medical condition,risk categorization</data>
      <data key="d9">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391639</data>
    </edge>
    <edge source="Category 2" target="Deformity or bony prominences">
      <data key="d6">10.0</data>
      <data key="d7">Deformity or bony prominences is a defining factor in Category 2, which includes sensory neuropathy and PAD or deformity.</data>
      <data key="d8">medical condition,risk categorization</data>
      <data key="d9">chunk-64e5a3cde95aa21d4710ea279f09b919</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391640</data>
    </edge>
    <edge source="Health Care Personnel" target="Patient">
      <data key="d6">9.0</data>
      <data key="d7">Health care personnel collaborate with patients in foot care management decisions and education.</data>
      <data key="d8">collaboration,medical partnership</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391595</data>
    </edge>
    <edge source="Health Care Personnel" target="Care Giver">
      <data key="d6">8.0</data>
      <data key="d7">Health care personnel work with care givers to ensure proper foot care education and management.</data>
      <data key="d8">care coordination,patient support</data>
      <data key="d9">chunk-d4dbac77be4a61fb0b4f8ee844d03453</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391596</data>
    </edge>
    <edge source="Patient" target="Barriers to Adherence">
      <data key="d6">6.0</data>
      <data key="d7">The text discusses how patients face various barriers to medication adherence, which are categorized and analyzed.</data>
      <data key="d8">health challenges,patient behavior</data>
      <data key="d9">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391643</data>
    </edge>
    <edge source="Charcot Foot" target="Referral to Hospital">
      <data key="d6">9.0</data>
      <data key="d7">Charcot foot requires referral to a hospital with orthopaedic and podiatrist services for management.</data>
      <data key="d8">medical referral,specialist care</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391597</data>
    </edge>
    <edge source="Foot Ulceration" target="Annexure B: General Principles for Foot Care">
      <data key="d6">7.0</data>
      <data key="d7">Annexure B provides general principles for foot care, which is critical for preventing foot ulceration."|"medical guidelines, prevention</data>
      <data key="d8">7</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391598</data>
    </edge>
    <edge source="Painful Peripheral Neuropathy" target="Annexure C2: Rapid Screening for Diabetic Neuropathy">
      <data key="d6">7.0</data>
      <data key="d7">Annexure C2's rapid screening method is designed to identify painful peripheral neuropathy in diabetic patients."|"diagnostic tools, neuropathy</data>
      <data key="d8">7</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391599</data>
    </edge>
    <edge source="Peripheral Artery Disease" target="Vascular Surgery">
      <data key="d6">9.0</data>
      <data key="d7">Peripheral artery disease requires referral to a vascular surgery center for assessment and treatment.</data>
      <data key="d8">referral,vascular care</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391597</data>
    </edge>
    <edge source="Peripheral Artery Disease" target="Annexure C1: Foot Screening Assessment Form">
      <data key="d6">7.0</data>
      <data key="d7">Annexure C1's screening form is relevant to diagnosing peripheral artery disease through foot assessment."|"diagnostic tools, vascular health</data>
      <data key="d8">7</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391599</data>
    </edge>
    <edge source="Ulcerative Foot Pathology" target="Secondary/Tertiary Care">
      <data key="d6">10.0</data>
      <data key="d7">Ulcerative foot pathology necessitates specialist management at secondary or tertiary care facilities.</data>
      <data key="d8">medical referral,specialist care</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391598</data>
    </edge>
    <edge source="Diabetes in Pregnancy" target="Referral Hospital">
      <data key="d6">9.0</data>
      <data key="d7">Pregnant diabetic patients require referral to a hospital for evaluation and management.</data>
      <data key="d8">medical referral,pregnancy care</data>
      <data key="d9">chunk-87e7e545e69a570dc134ec02d336fb1d</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391598</data>
    </edge>
    <edge source="Periodontal Disease" target="Gingivitis">
      <data key="d6">10.0</data>
      <data key="d7">Gingivitis is a reversible form of periodontal disease caused by plaque buildup."+</data>
      <data key="d8">disease classification,oral health</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391617</data>
    </edge>
    <edge source="Periodontal Disease" target="Periondontitis">
      <data key="d6">10.0</data>
      <data key="d7">Periondontitis is a severe form of periodontal disease involving destruction of the periodontal ligament."+</data>
      <data key="d8">disease classification,oral health</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391618</data>
    </edge>
    <edge source="Periodontal Disease" target="Plaque">
      <data key="d6">10.0</data>
      <data key="d7">Plaque is a primary cause of both gingivitis and periodontitis."+</data>
      <data key="d8">etiology,oral health</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391619</data>
    </edge>
    <edge source="Periodontal Disease" target="Calculus">
      <data key="d6">9.0</data>
      <data key="d7">Calculus contributes to the progression of periodontitis by promoting bacterial accumulation."+</data>
      <data key="d8">etiology,oral health</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391619</data>
    </edge>
    <edge source="Periodontal Disease" target="Gingival sulcus">
      <data key="d6">9.0</data>
      <data key="d7">The gingival sulcus deepens in periodontitis, leading to pocket formation and bacterial infection."+</data>
      <data key="d8">anatomy,disease progression</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391620</data>
    </edge>
    <edge source="Periodontal Disease" target="Pocket">
      <data key="d6">9.0</data>
      <data key="d7">Pockets formed in periodontitis collect bacteria, worsening inflammation and insulin resistance."+</data>
      <data key="d8">anatomy,disease progression</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391621</data>
    </edge>
    <edge source="Pre-Conception Care" target="Diabetic Complications">
      <data key="d6">8.0</data>
      <data key="d7">Diabetic Complications are a focus of pre-conception care, as screening for complications is emphasized to optimize maternal health before pregnancy.</data>
      <data key="d8">diabetes management,health screening</data>
      <data key="d9">chunk-75ca22fbc387195da8d2321ec5c32e2e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391600</data>
    </edge>
    <edge source="Asian/Indian descent" target="D4. HIGH-RISK ETHNIC GROUPS AND DIABETES">
      <data key="d6">10.0</data>
      <data key="d7">The D4 section discusses targeted screening and management strategies for the Asian/Indian descent population group, who are at higher diabetes risk at lower BMI levels.</data>
      <data key="d8">guideline,population-specific intervention</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391604</data>
    </edge>
    <edge source="Urbanised Black people" target="D4. HIGH-RISK ETHNIC GROUPS AND DIABETES">
      <data key="d6">10.0</data>
      <data key="d7">The D4 section discusses targeted screening and management strategies for the Urbanised Black people population group, who have a 6.4% diabetes prevalence.</data>
      <data key="d8">guideline,population-specific intervention</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391603</data>
    </edge>
    <edge source="White and Coloured people" target="D4. HIGH-RISK ETHNIC GROUPS AND DIABETES">
      <data key="d6">10.0</data>
      <data key="d7">The D4 section discusses targeted screening and management strategies for the White and Coloured people population group, who have a 6.2% diabetes prevalence.</data>
      <data key="d8">guideline,population-specific intervention</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391605</data>
    </edge>
    <edge source="HAART" target="Dysglycaemia">
      <data key="d6">9.0</data>
      <data key="d7">HAART contributes to dysglycaemia, a metabolic complication characterized by impaired glucose regulation in HIV-positive patients.</data>
      <data key="d8">metabolic disorder,treatment-related complication</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391602</data>
    </edge>
    <edge source="HAART" target="Lipodystrophy">
      <data key="d6">9.0</data>
      <data key="d7">HAART contributes to lipodystrophy, a metabolic complication involving abnormal fat distribution in HIV-positive patients.</data>
      <data key="d8">metabolic disorder,treatment-related complication</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391603</data>
    </edge>
    <edge source="HAART" target="Accelerated atherosclerosis">
      <data key="d6">9.0</data>
      <data key="d7">HAART contributes to accelerated atherosclerosis, a cardiovascular complication in HIV-positive patients with diabetes.</data>
      <data key="d8">cardiovascular risk,treatment-related complication</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391604</data>
    </edge>
    <edge source="HAART" target="CD4 cut off point">
      <data key="d6">9.0</data>
      <data key="d7">The CD4 cut off point (350 cells/mm³) is a parameter that influences the initiation of HAART, which is associated with metabolic complications like dysglycaemia and dyslipidaemia in HIV-positive individuals."+</data>
      <data key="d8">comorbidity risk,treatment guideline</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391605</data>
    </edge>
    <edge source="Type 2 diabetes" target="Micro- and macrovascular complications">
      <data key="d6">8.0</data>
      <data key="d7">Type 2 diabetes is associated with micro- and macrovascular complications, requiring vigilance by healthcare providers in high-risk populations.</data>
      <data key="d8">chronic disease complications,healthcare management</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391602</data>
    </edge>
    <edge source="Aspirin" target="Older diabetic patients">
      <data key="d6">8.0</data>
      <data key="d7">Aspirin is recommended for secondary prevention of cardiovascular events in older diabetic patients, particularly those with diastolic hypertension.</data>
      <data key="d8">cardiovascular prevention,medication use</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391604</data>
    </edge>
    <edge source="Aspirin" target="Diastolic hypertension">
      <data key="d6">8.0</data>
      <data key="d7">Diastolic hypertension is a condition for which aspirin is recommended as secondary prevention of cardiovascular events in older diabetic patients."+</data>
      <data key="d8">cardiovascular prevention,medication use</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391605</data>
    </edge>
    <edge source="Aspirin" target="Antithrombotic Trialists' (ATT) Collaboration">
      <data key="d6">10.0</data>
      <data key="d7">The Antithrombotic Trialists' (ATT) Collaboration conducted a meta-analysis on aspirin use in vascular disease prevention.</data>
      <data key="d8">medication,research collaboration</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391624</data>
    </edge>
    <edge source="Aspirin" target="Pignone M">
      <data key="d6">9.0</data>
      <data key="d7">Pignone M authored an ADA position statement on aspirin use for cardiovascular prevention in diabetes.</data>
      <data key="d8">authorship,medication</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391626</data>
    </edge>
    <edge source="Glitazones" target="Elderly patients">
      <data key="d6">9.0</data>
      <data key="d7">Glitazones are avoided in elderly patients due to risks of fluid retention, cardiac failure, and osteoporotic fractures.</data>
      <data key="d8">age-related risk,medication contraindication</data>
      <data key="d9">chunk-0d231d8a45d08ffe4e73e7ef3d703442</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391606</data>
    </edge>
    <edge source="Meal planning" target="Structured education programme">
      <data key="d6">10.0</data>
      <data key="d7">Meal planning is a core component of the structured education programme for diabetes management during fasting.</data>
      <data key="d8">diabetes management,education</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391607</data>
    </edge>
    <edge source="Meal planning" target="Diet-controlled patients">
      <data key="d6">9.0</data>
      <data key="d7">Diet-controlled patients follow specific meal planning strategies during fasting intervals.</data>
      <data key="d8">diet management,fasting protocols</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391609</data>
    </edge>
    <edge source="Physical activity" target="Structured education programme">
      <data key="d6">10.0</data>
      <data key="d7">Physical activity guidelines are part of the structured education programme for managing diabetes during fasting.</data>
      <data key="d8">education,health guidelines</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391608</data>
    </edge>
    <edge source="Dosage and timing of medications" target="Structured education programme">
      <data key="d6">10.0</data>
      <data key="d7">Adjusting medication schedules is a critical aspect of the structured education programme for fasting.</data>
      <data key="d8">education,treatment protocols</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391609</data>
    </edge>
    <edge source="Glucose monitoring" target="Structured education programme">
      <data key="d6">10.0</data>
      <data key="d7">Regular blood glucose monitoring is emphasized in the structured education programme for fasting.</data>
      <data key="d8">education,health monitoring</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391609</data>
    </edge>
    <edge source="Recognition and management of untoward events including hypoglycaemia" target="Structured education programme">
      <data key="d6">10.0</data>
      <data key="d7">Training on recognizing and managing complications like hypoglycaemia is included in the structured education programme.</data>
      <data key="d8">education,emergency response</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391610</data>
    </edge>
    <edge source="American Diabetes Association" target="2012 SEMDSA Guideline">
      <data key="d6">7.0</data>
      <data key="d7">The 2012 SEMDSA Guideline references the American Diabetes Association's 2011 standards of medical care.</data>
      <data key="d8">care protocols,citation</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391622</data>
    </edge>
    <edge source="Healthcare Professionals" target="Fitness to Drive Assessment">
      <data key="d6">7.0</data>
      <data key="d7">Healthcare professionals are responsible for assessing the suitability of individuals with diabetes to drive.</data>
      <data key="d8">driver fitness,medical evaluation</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391612</data>
    </edge>
    <edge source="Healthcare Professionals" target="Severe Hypoglycaemic Events">
      <data key="d6">7.0</data>
      <data key="d7">Healthcare professionals are tasked with educating patients on managing severe hypoglycaemic events to ensure driving safety.</data>
      <data key="d8">medical guidance,risk management</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391614</data>
    </edge>
    <edge source="Healthcare Professionals" target="Annual Assessment">
      <data key="d6">8.0</data>
      <data key="d7">Healthcare professionals are responsible for conducting annual assessments for commercial drivers with diabetes.</data>
      <data key="d8">medical evaluation,regulatory compliance</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391615</data>
    </edge>
    <edge source="Healthcare Professionals" target="Medical Evaluation">
      <data key="d6">8.0</data>
      <data key="d7">Healthcare professionals are responsible for conducting medical evaluations to assess fitness to drive for individuals with diabetes.</data>
      <data key="d8">driver suitability,medical assessment</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391616</data>
    </edge>
    <edge source="Commercial Vehicles" target="Annual Assessment">
      <data key="d6">8.0</data>
      <data key="d7">Commercial vehicle drivers require annual medical assessments to maintain their licences.</data>
      <data key="d8">medical evaluation,regulatory requirement</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391613</data>
    </edge>
    <edge source="Commercial Vehicles" target="Road Traffic Act of 1996">
      <data key="d6">8.0</data>
      <data key="d7">The Road Traffic Act of 1996 lacks specific legislation for commercial vehicle drivers with diabetes, which is a gap in the current framework.</data>
      <data key="d8">legislative gap,transportation safety</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391615</data>
    </edge>
    <edge source="Private Vehicles" target="Road Traffic Act of 1996">
      <data key="d6">7.0</data>
      <data key="d7">The Road Traffic Act of 1996 imposes fewer restrictions on private vehicle drivers with diabetes compared to commercial drivers.</data>
      <data key="d8">driver classification,legal framework</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391614</data>
    </edge>
    <edge source="Severe Hypoglycaemic Events" target="Driving Risk">
      <data key="d6">9.0</data>
      <data key="d7">Severe hypoglycaemic events are a significant risk factor for drivers with diabetes, increasing accident likelihood.</data>
      <data key="d8">accident risk,health risk</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391613</data>
    </edge>
    <edge source="Insulin Therapy" target="No Increased Driving Risk">
      <data key="d6">7.0</data>
      <data key="d7">Insulin therapy itself has not been found to be associated with increased driving risk.</data>
      <data key="d8">safety,treatment</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391613</data>
    </edge>
    <edge source="MEC of the Province" target="Learner's Licence">
      <data key="d6">7.0</data>
      <data key="d7">The MEC of the Province is the authority to whom individuals must submit their learner's licence if disqualified due to uncontrolled diabetes.</data>
      <data key="d8">administrative process,legal authority</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391614</data>
    </edge>
    <edge source="Endocrinologist" target="Commercial Licence">
      <data key="d6">9.0</data>
      <data key="d7">Endocrinologists are specialists involved in the assessment and management of commercial drivers with diabetes applying for a licence.</data>
      <data key="d8">licensing process,specialist involvement</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391615</data>
    </edge>
    <edge source="Blood Glucose Test Strips" target="Persons with Diabetes">
      <data key="d6">8.0</data>
      <data key="d7">Persons with diabetes are recommended to have adequate blood glucose test strips provided for monitoring during driving.</data>
      <data key="d8">medical equipment,safety measure</data>
      <data key="d9">chunk-ca3d853e7f6e836a5bb3c9d9f2ad1b78</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391615</data>
    </edge>
    <edge source="Collaborative Framework for Care and Control of Tuberculosis and Diabetes" target="World Health Organization (WHO)&quot;+">
      <data key="d6">10.0</data>
      <data key="d7">The WHO collaborates on the development of the framework for integrated TB and diabetes care."+</data>
      <data key="d8">collaborative effort,health policy</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391616</data>
    </edge>
    <edge source="Calculus" target="Periodontitis">
      <data key="d6">9.0</data>
      <data key="d7">Calculus exacerbates periodontitis by promoting bacterial accumulation and inflammation in the gingival sulcus.</data>
      <data key="d8">bacterial infection,dental pathology</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391623</data>
    </edge>
    <edge source="Infection control plan" target="Healthcare Facilities">
      <data key="d6">8.0</data>
      <data key="d7">Healthcare facilities implement infection control plans to prevent TB transmission."+</data>
      <data key="d8">health policy,infection prevention</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391619</data>
    </edge>
    <edge source="Infection control plan" target="Infection control measures">
      <data key="d6">9.0</data>
      <data key="d7">Infection control measures are components of an infection control plan for TB prevention."+</data>
      <data key="d8">health policy,infection prevention</data>
      <data key="d9">chunk-b752ce36b859046d9641b5096d445e7c</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391620</data>
    </edge>
    <edge source="SEMDSA Steering Committee" target="Advisory Committee">
      <data key="d6">9.0</data>
      <data key="d7">The SEMDSA Steering Committee and Advisory Committee collaborated on developing the 2012 SEMDSA Guideline for Type 2 Diabetes management.</data>
      <data key="d8">collaboration,guideline development</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391620</data>
    </edge>
    <edge source="SEMDSA Steering Committee" target="Society for Endocrinology, Metabolism and Diabetes for South Africa">
      <data key="d6">8.0</data>
      <data key="d7">The SEMDSA Steering Committee is part of the Society for Endocrinology, Metabolism and Diabetes for South Africa and contributed to the guideline development.</data>
      <data key="d8">collaboration,organizational structure</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391630</data>
    </edge>
    <edge source="International Diabetes Federation" target="2012 SEMDSA Guideline">
      <data key="d6">7.0</data>
      <data key="d7">The 2012 SEMDSA Guideline references the International Diabetes Federation's diabetes atlas for data.</data>
      <data key="d8">citation,data source</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391621</data>
    </edge>
    <edge source="International Diabetes Federation" target="metabolic syndrome">
      <data key="d6">9.0</data>
      <data key="d7">The International Diabetes Federation is associated with the metabolic syndrome consensus.</data>
      <data key="d8">diabetes classification,global health</data>
      <data key="d9">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391628</data>
    </edge>
    <edge source="Canadian Diabetes Association" target="2012 SEMDSA Guideline">
      <data key="d6">7.0</data>
      <data key="d7">The 2012 SEMDSA Guideline cites the Canadian Diabetes Association's 2008 clinical practice guidelines.</data>
      <data key="d8">citation,clinical standards</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391621</data>
    </edge>
    <edge source="Canadian Diabetes Association" target="SEMDSA Guideline Committee">
      <data key="d6">9.0</data>
      <data key="d7">The Canadian Diabetes Association's guidelines were adapted by the SEMDSA Guideline Committee for use in their 2012 document.</data>
      <data key="d8">guideline adaptation,medical collaboration</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391638</data>
    </edge>
    <edge source="Periodontitis" target="Tooth Plaque">
      <data key="d6">10.0</data>
      <data key="d7">Tooth plaque is a direct cause of periodontitis, contributing to alveolar bone destruction and pocket formation.</data>
      <data key="d8">causation,dental health</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391622</data>
    </edge>
    <edge source="Microvascular and Macrovascular Complications" target="Rehabilitation Services">
      <data key="d6">8.0</data>
      <data key="d7">Rehabilitation services address the functional impairments caused by microvascular and macrovascular complications of diabetes.</data>
      <data key="d8">complication management,rehabilitation focus</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391622</data>
    </edge>
    <edge source="Microvascular and Macrovascular Complications" target="Early Intervention">
      <data key="d6">9.0</data>
      <data key="d7">Early intervention prevents complications from disuse or improper body part usage in diabetes patients, reducing long-term disability.</data>
      <data key="d8">complication mitigation,prevention strategy</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391623</data>
    </edge>
    <edge source="Rehabilitation Services" target="Multidisciplinary Approach">
      <data key="d6">9.0</data>
      <data key="d7">A multidisciplinary approach is essential for effective rehabilitation services, involving patients, caregivers, and diverse healthcare professionals.</data>
      <data key="d8">comprehensive care,team collaboration</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391622</data>
    </edge>
    <edge source="Rehabilitation Services" target="Technical Aids and Devices">
      <data key="d6">8.0</data>
      <data key="d7">Technical aids and devices are integral components of rehabilitation services, enabling mobility and independence for disabled patients.</data>
      <data key="d8">assistive technology,rehabilitation support</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391623</data>
    </edge>
    <edge source="Rehabilitation Services" target="Home Programmes">
      <data key="d6">7.0</data>
      <data key="d7">Home programmes are a critical extension of rehabilitation services, ensuring continuity of care outside clinical settings.</data>
      <data key="d8">patient autonomy,therapeutic adherence</data>
      <data key="d9">chunk-e40dd1b6f667a901a4ea2e77d6f8087a</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391624</data>
    </edge>
    <edge source="Endocrine Society" target="Evaluation and management of adult hypoglycemic disorders">
      <data key="d6">9.0</data>
      <data key="d7">Endocrine Society published a clinical practice guideline on the evaluation and management of adult hypoglycemic disorders.</data>
      <data key="d8">guideline publication,medical condition</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391623</data>
    </edge>
    <edge source="Endocrine Society" target="Cryer PE">
      <data key="d6">8.0</data>
      <data key="d7">Cryer PE is an author affiliated with the Endocrine Society's clinical practice guideline.</data>
      <data key="d8">author affiliation,medical guideline</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391624</data>
    </edge>
    <edge source="Canadian Diabetes Association Clinical Practice Guideline Expert Committee" target="Hypoglycemia">
      <data key="d6">9.0</data>
      <data key="d7">The Canadian Diabetes Association Clinical Practice Guideline Expert Committee published a guideline on hypoglycemia.</data>
      <data key="d8">guideline publication,medical condition</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391624</data>
    </edge>
    <edge source="Kitabchi AE" target="Hyperglycaemic crises">
      <data key="d6">9.0</data>
      <data key="d7">Kitabchi AE authored a study on hyperglycaemic crises in adult patients with diabetes.</data>
      <data key="d8">authorship,medical condition</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391624</data>
    </edge>
    <edge source="Kitabchi AE" target="J Clin Endocrinol Metab">
      <data key="d6">9.0</data>
      <data key="d7">Kitabchi AE authored a study published in J Clin Endocrinol Metab on hyperglycaemic crises." </data>
      <data key="d8">authorship,journal publication</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391626</data>
    </edge>
    <edge source="Kitabchi AE" target="Lancet">
      <data key="d6">8.0</data>
      <data key="d7">Kitabchi AE contributed to a study published in Lancet on hyperglycaemic crises." </data>
      <data key="d8">authorship,journal publication</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391627</data>
    </edge>
    <edge source="Eledrisi MS" target="Diabetic ketoacidosis">
      <data key="d6">9.0</data>
      <data key="d7">Eledrisi MS authored a study on the diagnosis and management of diabetic ketoacidosis.</data>
      <data key="d8">authorship,medical condition</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391624</data>
    </edge>
    <edge source="Eledrisi MS" target="Am J Med Sci">
      <data key="d6">9.0</data>
      <data key="d7">Eledrisi MS authored a study published in Am J Med Sci on diabetic ketoacidosis." </data>
      <data key="d8">authorship,journal publication</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391626</data>
    </edge>
    <edge source="Wing RR" target="Weight loss">
      <data key="d6">8.0</data>
      <data key="d7">Wing RR authored a study on the benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.</data>
      <data key="d8">authorship,health intervention</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391624</data>
    </edge>
    <edge source="Wing RR" target="Diabetes Care">
      <data key="d6">9.0</data>
      <data key="d7">Wing RR authored a study published in Diabetes Care on modest weight loss." </data>
      <data key="d8">authorship,journal publication</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391626</data>
    </edge>
    <edge source="Alberti KGMM" target="Metabolic syndrome">
      <data key="d6">9.0</data>
      <data key="d7">Alberti KGMM contributed to a study on harmonizing the metabolic syndrome.</data>
      <data key="d8">authorship,medical condition</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391624</data>
    </edge>
    <edge source="Saito Y" target="JPAD trial">
      <data key="d6">8.0</data>
      <data key="d7">Saito Y participated in the JPAD trial on low-dose aspirin therapy in type 2 diabetes patients.</data>
      <data key="d8">clinical trial,research participation</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391625</data>
    </edge>
    <edge source="Saito Y" target="Circulation">
      <data key="d6">8.0</data>
      <data key="d7">Saito Y participated in a study published in Circulation on low-dose aspirin therapy." </data>
      <data key="d8">authorship,journal publication</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391628</data>
    </edge>
    <edge source="Curb JD" target="JAMA">
      <data key="d6">9.0</data>
      <data key="d7">Curb JD authored a study published in JAMA on diuretic-based anti-hypertensive treatment." </data>
      <data key="d8">authorship,journal publication</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391627</data>
    </edge>
    <edge source="ACCORD Study Group" target="Intensive blood pressure control">
      <data key="d6">10.0</data>
      <data key="d7">The ACCORD Study Group conducted a study on intensive blood pressure control in type 2 diabetes.</data>
      <data key="d8">medical intervention,research collaboration</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391625</data>
    </edge>
    <edge source="ACCORD Study Group" target="JAMA">
      <data key="d6">10.0</data>
      <data key="d7">ACCORD Study Group published a study in JAMA on intensive blood pressure control." </data>
      <data key="d8">journal publication,research collaboration</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391628</data>
    </edge>
    <edge source="UK Prospective Diabetes Study Group" target="Tight blood pressure control">
      <data key="d6">10.0</data>
      <data key="d7">The UK Prospective Diabetes Study Group conducted a study on tight blood pressure control in type 2 diabetes.</data>
      <data key="d8">medical intervention,research collaboration</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391625</data>
    </edge>
    <edge source="UK Prospective Diabetes Study Group" target="BMJ">
      <data key="d6">10.0</data>
      <data key="d7">UK Prospective Diabetes Study Group published a study in BMJ on tight blood pressure control." </data>
      <data key="d8">journal publication,research collaboration</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391627</data>
    </edge>
    <edge source="Palmer AJ" target="Nephropathy">
      <data key="d6">8.0</data>
      <data key="d7">Palmer AJ authored a health economic analysis on nephropathy screening and treatment in diabetic patients.</data>
      <data key="d8">authorship,medical condition</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391626</data>
    </edge>
    <edge source="Palmer AJ" target="Am J Kidney Dis">
      <data key="d6">8.0</data>
      <data key="d7">Palmer AJ authored a study published in Am J Kidney Dis on diabetic nephropathy screening." </data>
      <data key="d8">authorship,journal publication</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391627</data>
    </edge>
    <edge source="Circulation" target="Mazzone T">
      <data key="d6">9.0</data>
      <data key="d7">Mazzone T authored a study published in Circulation on cardiovascular disease in type 2 diabetes." </data>
      <data key="d8">authorship,journal publication</data>
      <data key="d9">chunk-6987f72c1a80b0b088e76986e2825547</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391627</data>
    </edge>
    <edge source="Bravis V" target="Ramadaan education and awareness in diabetes (READ) programme">
      <data key="d6">8.0</data>
      <data key="d7">Bravis V is associated with the Ramadaan education and awareness in diabetes (READ) programme.</data>
      <data key="d8">diabetes management,health education</data>
      <data key="d9">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391627</data>
    </edge>
    <edge source="Hassanien M" target="Management of people with diabetes wanting to fast during Ramadaan">
      <data key="d6">8.0</data>
      <data key="d7">Hassanien M is associated with the Management of people with diabetes wanting to fast during Ramadaan.</data>
      <data key="d8">diabetes care,religious practices</data>
      <data key="d9">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391628</data>
    </edge>
    <edge source="Pi-Sunyer X" target="Look AHEAD trial">
      <data key="d6">9.0</data>
      <data key="d7">Pi-Sunyer X is associated with the Look AHEAD trial.</data>
      <data key="d8">clinical trials,diabetes intervention</data>
      <data key="d9">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391629</data>
    </edge>
    <edge source="Ramachandran A" target="Indian Diabetes Prevention Programme (IDPP)">
      <data key="d6">9.0</data>
      <data key="d7">Ramachandran A is an author of the study published in Diabetologia on the Indian Diabetes Prevention Programme (IDPP).</data>
      <data key="d8">authorship,research contribution</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391629</data>
    </edge>
    <edge source="Snehalatha C" target="Indian Diabetes Prevention Programme (IDPP)">
      <data key="d6">9.0</data>
      <data key="d7">Snehalatha C is an author of the study published in Diabetologia on the Indian Diabetes Prevention Programme (IDPP).</data>
      <data key="d8">authorship,research contribution</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391630</data>
    </edge>
    <edge source="Mary S" target="Indian Diabetes Prevention Programme (IDPP)">
      <data key="d6">9.0</data>
      <data key="d7">Mary S is an author of the study published in Diabetologia on the Indian Diabetes Prevention Programme (IDPP).</data>
      <data key="d8">authorship,research contribution</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391631</data>
    </edge>
    <edge source="NIDDM" target="prevention of NIDDM">
      <data key="d6">7.0</data>
      <data key="d7">NIDDM is the focus of prevention studies.</data>
      <data key="d8">diabetes prevention,public health</data>
      <data key="d9">chunk-22ea9604ec397a3a7efc9e587557e950</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391628</data>
    </edge>
    <edge source="National Department of Health" target="SEMDSA">
      <data key="d6">9.0</data>
      <data key="d7">The National Department of Health acknowledges the SEMDSA Steering Committee and Advisory Committee for their input on the guideline.</data>
      <data key="d8">collaboration,guideline development</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391629</data>
    </edge>
    <edge source="Distiller LA" target="Driving and diabetics on insulin therapy">
      <data key="d6">9.0</data>
      <data key="d7">Distiller LA is an author of the study published in S Afr Med J on driving and diabetics on insulin therapy.</data>
      <data key="d8">authorship,research contribution</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391630</data>
    </edge>
    <edge source="Kramer BD" target="Driving and diabetics on insulin therapy">
      <data key="d6">9.0</data>
      <data key="d7">Kramer BD is an author of the study published in S Afr Med J on driving and diabetics on insulin therapy.</data>
      <data key="d8">authorship,research contribution</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391631</data>
    </edge>
    <edge source="SEMDSA Advisory Committee" target="Society for Endocrinology, Metabolism and Diabetes for South Africa">
      <data key="d6">8.0</data>
      <data key="d7">The SEMDSA Advisory Committee is part of the Society for Endocrinology, Metabolism and Diabetes for South Africa and contributed to the guideline development.</data>
      <data key="d8">collaboration,organizational structure</data>
      <data key="d9">chunk-29bddf5b5dad63a794a84d0ff0adf023</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391631</data>
    </edge>
    <edge source="Complication Prevention" target="Medical Check-Ups">
      <data key="d6">8.0</data>
      <data key="d7">Complication prevention requires regular medical check-ups to detect and address chronic complications early.</data>
      <data key="d8">early detection,preventive care</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391632</data>
    </edge>
    <edge source="Complication Prevention" target="Hypoglycaemic and Hyperglycaemic Emergencies">
      <data key="d6">7.0</data>
      <data key="d7">Complication prevention involves recognizing symptoms of hypoglycaemic and hyperglycaemic emergencies to avoid severe outcomes.</data>
      <data key="d8">complication prevention,emergency response</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391633</data>
    </edge>
    <edge source="Weight Management" target="Dietary Interventions">
      <data key="d6">9.0</data>
      <data key="d7">Weight management relies on dietary interventions such as healthy eating plans and food label reading to achieve and maintain optimal weight.</data>
      <data key="d8">dietary strategies,weight control</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391631</data>
    </edge>
    <edge source="Weight Management" target="Physical Activity">
      <data key="d6">10.0</data>
      <data key="d7">Weight management is closely tied to physical activity recommendations, including moderate to vigorous exercise for weight loss and maintenance.</data>
      <data key="d8">exercise,weight regulation</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391632</data>
    </edge>
    <edge source="Weight Management" target="Caloric Restriction">
      <data key="d6">9.0</data>
      <data key="d7">Caloric restriction is a key component of weight management strategies, as reducing food intake is essential for achieving weight loss goals.</data>
      <data key="d8">dietary strategy,weight loss</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391633</data>
    </edge>
    <edge source="Dietary Interventions" target="Culturally Acceptable Meal Planning">
      <data key="d6">9.0</data>
      <data key="d7">Culturally acceptable meal planning is a subset of dietary interventions, ensuring meal plans are culturally appropriate and support diabetes management.</data>
      <data key="d8">cultural adaptation,dietary strategies</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391633</data>
    </edge>
    <edge source="Physical Activity" target="Resistance Exercise">
      <data key="d6">8.0</data>
      <data key="d7">Resistance exercise is a form of physical activity recommended for type 2 diabetes patients to improve metabolic control and insulin sensitivity.</data>
      <data key="d8">exercise type,metabolic health</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391635</data>
    </edge>
    <edge source="Resistance Exercise" target="Improved Glycaemic Control">
      <data key="d6">10.0</data>
      <data key="d7">Resistance exercise is directly linked to improved glycaemic control, as recommended for managing type 2 diabetes.</data>
      <data key="d8">diabetes management,health benefit</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391634</data>
    </edge>
    <edge source="Resistance Exercise" target="Decreased Insulin Resistance">
      <data key="d6">9.0</data>
      <data key="d7">Resistance exercise contributes to decreased insulin resistance, a key benefit for individuals with type 2 diabetes.</data>
      <data key="d8">exercise impact,metabolic improvement</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391635</data>
    </edge>
    <edge source="Resistance Exercise" target="Maintenance of Weight Loss">
      <data key="d6">8.0</data>
      <data key="d7">Resistance exercise supports the maintenance of weight loss, which is crucial for diabetes management.</data>
      <data key="d8">physical activity,weight management</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391636</data>
    </edge>
    <edge source="Resistance Exercise" target="Abdominal and Overall Fat % Reduction">
      <data key="d6">9.0</data>
      <data key="d7">Resistance exercise aids in reducing abdominal and overall fat percentages, enhancing metabolic health.</data>
      <data key="d8">exercise benefit,fat reduction</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391637</data>
    </edge>
    <edge source="Bariatric Surgery" target="Tertiary Care Level">
      <data key="d6">9.0</data>
      <data key="d7">Bariatric surgery is a tertiary care-level intervention used for weight management in individuals with type 2 diabetes.</data>
      <data key="d8">specialized care,weight loss</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391633</data>
    </edge>
    <edge source="Pharmacotherapy" target="Tertiary Care Level">
      <data key="d6">8.0</data>
      <data key="d7">Pharmacotherapy is a tertiary care-level intervention for weight management, involving medication use in type 2 diabetes patients.</data>
      <data key="d8">medication use,specialized treatment</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391634</data>
    </edge>
    <edge source="Pharmacotherapy" target="Treatment related">
      <data key="d6">9.0</data>
      <data key="d7">Treatment-related barriers are directly tied to pharmacotherapy challenges, such as complex regimens and adverse effects.</data>
      <data key="d8">medication complexity,therapeutic management</data>
      <data key="d9">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391644</data>
    </edge>
    <edge source="Hypoglycaemia Treatment" target="Hypoglycaemic Emergencies">
      <data key="d6">10.0</data>
      <data key="d7">Hypoglycaemia treatment is directly related to managing hypoglycaemic emergencies through the use of simple carbohydrates.</data>
      <data key="d8">emergency response,glucose management</data>
      <data key="d9">chunk-03650d0126e6b49e45077884bfc6007b</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391634</data>
    </edge>
    <edge source="Cardio-Respiratory Fitness" target="Improved Blood Lipid Profile">
      <data key="d6">8.0</data>
      <data key="d7">Cardio-respiratory fitness is associated with improved blood lipid profiles through regular aerobic activity.</data>
      <data key="d8">cardiovascular health,lipid improvement</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391634</data>
    </edge>
    <edge source="Cardio-Respiratory Fitness" target="Improved Blood Pressure">
      <data key="d6">8.0</data>
      <data key="d7">Cardio-respiratory fitness contributes to improved blood pressure, a benefit of regular physical activity.</data>
      <data key="d8">blood pressure,exercise outcome</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391635</data>
    </edge>
    <edge source="Unstable Proliferative Retinopathy" target="Strenuous Exercise">
      <data key="d6">7.0</data>
      <data key="d7">Unstable proliferative retinopathy is a contraindication to strenuous exercise, as specified in the text.</data>
      <data key="d8">diabetes complication,medical contraindication</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391636</data>
    </edge>
    <edge source="Ketonuria" target="Strenuous Exercise">
      <data key="d6">7.0</data>
      <data key="d7">Ketonuria is a contraindication for strenuous physical activity, as highlighted in the text.</data>
      <data key="d8">exercise restriction,health risk</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391636</data>
    </edge>
    <edge source="Delayed Hypoglycaemia" target="Strenuous Physical Activity">
      <data key="d6">9.0</data>
      <data key="d7">Delayed hypoglycaemia is a risk associated with strenuous physical activity, requiring glucose monitoring.</data>
      <data key="d8">exercise safety,health risk</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391636</data>
    </edge>
    <edge source="Anti-Tobacco Message" target="Smoking">
      <data key="d6">10.0</data>
      <data key="d7">The anti-tobacco message directly addresses the importance of avoiding smoking to prevent diabetes complications.</data>
      <data key="d8">health advocacy,smoking cessation</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391636</data>
    </edge>
    <edge source="Responsible Alcohol Use" target="Alcohol Consumption">
      <data key="d6">8.0</data>
      <data key="d7">Responsible alcohol use is a guideline for managing alcohol consumption in diabetes patients.</data>
      <data key="d8">diabetes management,health behavior</data>
      <data key="d9">chunk-7328f1285f97b5e01ee98cc53f8391b9</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391637</data>
    </edge>
    <edge source="10-g Semmes-Weinstein Monofilament" target="Check-up Frequency Categories">
      <data key="d6">8.0</data>
      <data key="d7">The 10-g Semmes-Weinstein Monofilament is a method used to determine check-up frequencies based on patient risk profiles.</data>
      <data key="d8">medical testing,screening methodology</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391638</data>
    </edge>
    <edge source="128-Hz Vibration Tuning Fork" target="Check-up Frequency Categories">
      <data key="d6">8.0</data>
      <data key="d7">The 128-Hz Vibration Tuning Fork is another method used to assess risk profiles and determine check-up intervals.</data>
      <data key="d8">medical testing,screening methodology</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391640</data>
    </edge>
    <edge source="Profile 0" target="Profile 3">
      <data key="d6">7.0</data>
      <data key="d7">All profiles represent risk categories for diabetic neuropathy, differentiated by the presence of neuropathy, deformity, PAD, and prior ulcers/amputations.</data>
      <data key="d8">medical categorization,risk stratification</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391639</data>
    </edge>
    <edge source="ANNEXURE C2" target="Screening Methods">
      <data key="d6">9.0</data>
      <data key="d7">ANNEXURE C2 contains detailed instructions for two screening methods: the 10-g monofilament test and the 128-Hz tuning fork test.</data>
      <data key="d8">document structure,medical procedures</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391640</data>
    </edge>
    <edge source="ANNEXURE D" target="Ventilated Space">
      <data key="d6">8.0</data>
      <data key="d7">ANNEXURE D specifies the requirement for adequately ventilated space as part of clinic infrastructure.</data>
      <data key="d8">clinic infrastructure,environmental standards</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391640</data>
    </edge>
    <edge source="Screening Protocol" target="High-Risk Patients">
      <data key="d6">9.0</data>
      <data key="d7">The screening protocol is designed to identify high-risk patients, such as those with gestational diabetes or central obesity.</data>
      <data key="d8">patient categorization,risk identification</data>
      <data key="d9">chunk-b1a4a348ba034ff661690123ff0f6743</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391640</data>
    </edge>
    <edge source="NGOs" target="Health Education">
      <data key="d6">7.0</data>
      <data key="d7">NGOs are utilized to facilitate health education as part of existing structures.</data>
      <data key="d8">health support,resource utilization</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391641</data>
    </edge>
    <edge source="Government Departments" target="Health Education">
      <data key="d6">7.0</data>
      <data key="d7">Government Departments are utilized to facilitate health education as part of existing structures.</data>
      <data key="d8">health support,resource utilization</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391642</data>
    </edge>
    <edge source="Community Recreational Activities" target="Health Education">
      <data key="d6">7.0</data>
      <data key="d7">Community Recreational Activities are utilized to facilitate health education as part of existing structures.</data>
      <data key="d8">health promotion,resource utilization</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391643</data>
    </edge>
    <edge source="Supervisors" target="Health professionals">
      <data key="d6">8.0</data>
      <data key="d7">Supervisors are responsible for ensuring that health professionals complete down-referral protocols.</data>
      <data key="d8">protocol compliance,responsibility</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391642</data>
    </edge>
    <edge source="Pharmacy personnel" target="Chronic patients">
      <data key="d6">7.0</data>
      <data key="d7">Pharmacy personnel manage medication supplies based on the number of chronic patients reported by the clinic.</data>
      <data key="d8">chronic disease monitoring,medication management</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391642</data>
    </edge>
    <edge source="Podiatrists" target="Clinic nurses">
      <data key="d6">9.0</data>
      <data key="d7">Podiatrists train clinic nurses to perform basic foot assessments.</data>
      <data key="d8">healthcare education,training</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391642</data>
    </edge>
    <edge source="Ward-based PHC outreach teams" target="Community-based services">
      <data key="d6">8.0</data>
      <data key="d7">Ward-based PHC outreach teams contribute to strengthening community-based services.</data>
      <data key="d8">public health,service enhancement</data>
      <data key="d9">chunk-1ad658d71c2cfb7b36bed8ed79dcb30e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391642</data>
    </edge>
    <edge source="Healthcare Team" target="Patient Education">
      <data key="d6">7.0</data>
      <data key="d7">The healthcare team is recommended to provide patient education to improve adherence through better understanding and support.</data>
      <data key="d8">education,healthcare support</data>
      <data key="d9">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391643</data>
    </edge>
    <edge source="Healthcare Team" target="Healthcare Consultation">
      <data key="d6">8.0</data>
      <data key="d7">The healthcare team's role is central to healthcare consultations, where patient education and support are discussed.</data>
      <data key="d8">healthcare interaction,patient support</data>
      <data key="d9">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391644</data>
    </edge>
    <edge source="Treatment Regimen" target="Lifestyle Factors">
      <data key="d6">8.0</data>
      <data key="d7">The text emphasizes that treatment regimens must be adapted to patients' lifestyles to improve adherence.</data>
      <data key="d8">lifestyle integration,regimen adaptation</data>
      <data key="d9">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391643</data>
    </edge>
    <edge source="Treatment Regimen" target="Life style">
      <data key="d6">8.0</data>
      <data key="d7">Lifestyle factors influence the adaptation of treatment regimens to align with patients' daily routines.</data>
      <data key="d8">lifestyle compatibility,regimen flexibility</data>
      <data key="d9">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391644</data>
    </edge>
    <edge source="Social and Economic Factors" target="Healthcare Consultation">
      <data key="d6">7.0</data>
      <data key="d7">Social and economic factors are addressed during healthcare consultations to identify and mitigate barriers to adherence.</data>
      <data key="d8">consultation,socioeconomic impact</data>
      <data key="d9">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391643</data>
    </edge>
    <edge source="Healthcare Consultation" target="Social and economic">
      <data key="d6">7.0</data>
      <data key="d7">Social and economic factors are addressed during healthcare consultations to mitigate adherence barriers.</data>
      <data key="d8">consultation strategies,socioeconomic impact</data>
      <data key="d9">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391645</data>
    </edge>
    <edge source="Healthcare Consultation" target="Patient Education">
      <data key="d6">9.0</data>
      <data key="d7">Healthcare consultations are a critical setting for patient education to improve adherence.</data>
      <data key="d8">clinical communication,education delivery</data>
      <data key="d9">chunk-0618ebe32404f4b8d6f32d748ff424d5</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391646</data>
    </edge>
    <edge source="daily routine" target="therapeutic alternatives">
      <data key="d6">8.0</data>
      <data key="d7">The text emphasizes balancing daily routines with therapeutic alternatives, indicating a direct relationship between these categories.</data>
      <data key="d8">lifestyle management,treatment integration</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391644</data>
    </edge>
    <edge source="expectations of therapeutic outcome" target="education points">
      <data key="d6">9.0</data>
      <data key="d7">Education points focus on aligning patient expectations with realistic therapeutic outcomes, creating a strong connection between these categories.</data>
      <data key="d8">outcome alignment,patient education</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391645</data>
    </edge>
    <edge source="education points" target="patient">
      <data key="d6">9.0</data>
      <data key="d7">Education points are tailored to the patient's specific needs, aiming to improve adherence and address concerns about side effects or therapeutic outcomes.</data>
      <data key="d8">individualized care,patient education</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391646</data>
    </edge>
    <edge source="education points" target="adherence">
      <data key="d6">9.0</data>
      <data key="d7">Education points aim to enhance adherence by addressing patient concerns and providing realistic expectations about treatment.</data>
      <data key="d8">adherence promotion,educational strategies</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391647</data>
    </edge>
    <edge source="chronic conditions" target="adherence">
      <data key="d6">10.0</data>
      <data key="d7">Adherence is critical in managing chronic conditions, as the text highlights the importance of addressing adherence challenges in long-term care.</data>
      <data key="d8">chronic disease management,medication compliance</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391645</data>
    </edge>
    <edge source="adherence" target="continuity of therapy">
      <data key="d6">8.0</data>
      <data key="d7">Continuity of therapy involves strategies to improve adherence, such as involving patients in care plans and minimizing medication complexity.</data>
      <data key="d8">patient involvement,therapy persistence</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391646</data>
    </edge>
    <edge source="adherence" target="patient">
      <data key="d6">10.0</data>
      <data key="d7">A patient's adherence to prescribed medication regimens is critical for therapeutic success and must be supported through education and lifestyle adjustments.</data>
      <data key="d8">patient behavior,treatment compliance</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391648</data>
    </edge>
    <edge source="adherence" target="prescriber">
      <data key="d6">9.0</data>
      <data key="d7">A prescriber plays a key role in addressing adherence challenges by investigating causes, adjusting regimens, and providing patient education.</data>
      <data key="d8">adherence strategies,clinical management</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391649</data>
    </edge>
    <edge source="adherence" target="side effects">
      <data key="d6">8.0</data>
      <data key="d7">Side effects can impact adherence, as patients may discontinue medication if adverse effects are perceived as intolerable or unmanageable.</data>
      <data key="d8">adverse reactions,treatment discontinuation</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391649</data>
    </edge>
    <edge source="adherence" target="medication frequency">
      <data key="d6">10.0</data>
      <data key="d7">Higher medication frequency (e.g., three or four times daily) is associated with poorer adherence, highlighting the importance of simplifying regimens.</data>
      <data key="d8">compliance challenges,dosage complexity</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391650</data>
    </edge>
    <edge source="continuity of therapy" target="self-reporting">
      <data key="d6">7.0</data>
      <data key="d7">Self-reporting tools like VAS and PIT support continuity of therapy by enabling patients to monitor and report adherence issues.</data>
      <data key="d8">monitoring tools,therapeutic tracking</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391645</data>
    </edge>
    <edge source="continuity of therapy" target="medication dosing errors">
      <data key="d6">8.0</data>
      <data key="d7">Medication dosing errors can disrupt continuity of therapy, emphasizing the need for clear records and patient involvement in care planning.</data>
      <data key="d8">error prevention,therapy interruption</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391647</data>
    </edge>
    <edge source="patient" target="prescriber">
      <data key="d6">8.0</data>
      <data key="d7">The prescriber's responsibilities include managing the patient's treatment plan, addressing non-adherence, and ensuring therapeutic goals are aligned with the patient's lifestyle.</data>
      <data key="d8">doctor-patient interaction,treatment planning</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391646</data>
    </edge>
    <edge source="prescriber" target="non-adherence">
      <data key="d6">7.0</data>
      <data key="d7">Non-adherence necessitates the prescriber's intervention to investigate underlying causes, such as side effects or lifestyle conflicts, and adjust the treatment plan accordingly.</data>
      <data key="d8">clinical investigation,regimen modification</data>
      <data key="d9">chunk-e8553409de2918effb9c98baee2c387e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391646</data>
    </edge>
    <edge source="PIT-Client knows the…" target="Dose">
      <data key="d6">8.0</data>
      <data key="d7">The PIT-Client knows the… category evaluates the patient's knowledge of the medication dose.</data>
      <data key="d8">knowledge assessment,medication details</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391647</data>
    </edge>
    <edge source="PIT-Client knows the…" target="Time">
      <data key="d6">8.0</data>
      <data key="d7">The PIT-Client knows the… category evaluates the patient's knowledge of the medication timing.</data>
      <data key="d8">knowledge assessment,medication details</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391648</data>
    </edge>
    <edge source="PIT-Client knows the…" target="Instructions">
      <data key="d6">8.0</data>
      <data key="d7">The PIT-Client knows the… category evaluates the patient's knowledge of additional medication instructions.</data>
      <data key="d8">knowledge assessment,medication details</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391649</data>
    </edge>
    <edge source="Overall Adherence" target="High">
      <data key="d6">9.0</data>
      <data key="d7">Overall Adherence categorizes adherence levels as 'High' based on integrated assessment metrics.</data>
      <data key="d8">adherence classification,performance</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391649</data>
    </edge>
    <edge source="Overall Adherence" target="Moderate">
      <data key="d6">9.0</data>
      <data key="d7">Overall Adherence categorizes adherence levels as 'Moderate' based on integrated assessment metrics.</data>
      <data key="d8">adherence classification,performance</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391650</data>
    </edge>
    <edge source="Overall Adherence" target="Low">
      <data key="d6">9.0</data>
      <data key="d7">Overall Adherence categorizes adherence levels as 'Low' based on integrated assessment metrics.</data>
      <data key="d8">adherence classification,performance</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391650</data>
    </edge>
    <edge source="Self-reporting" target="Answered 'No' to all questions">
      <data key="d6">9.0</data>
      <data key="d7">Self-reporting includes the category where the patient answers 'No' to all adherence-related questions.</data>
      <data key="d8">assessment method,response category</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391647</data>
    </edge>
    <edge source="Self-reporting" target="Answered 'Yes' to 1 question">
      <data key="d6">9.0</data>
      <data key="d7">Self-reporting includes the category where the patient answers 'Yes' to one adherence-related question.</data>
      <data key="d8">assessment method,response category</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391647</data>
    </edge>
    <edge source="Self-reporting" target="Answered 'Yes' to 2 or more questions">
      <data key="d6">9.0</data>
      <data key="d7">Self-reporting includes the category where the patient answers 'Yes' to two or more adherence-related questions.</data>
      <data key="d8">assessment method,response category</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391648</data>
    </edge>
    <edge source="Glycaemic control" target="Medical assessment">
      <data key="d6">9.0</data>
      <data key="d7">Assessing glycaemic control is a key part of the medical evaluation for patients planning to fast.</data>
      <data key="d8">diabetes monitoring,health assessment</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391608</data>
    </edge>
    <edge source="Medical assessment" target="Lipids">
      <data key="d6">8.0</data>
      <data key="d7">Lipid levels are assessed as part of the medical evaluation for fasting patients.</data>
      <data key="d8">health assessment,metabolic health</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391610</data>
    </edge>
    <edge source="Medical assessment" target="Renal function">
      <data key="d6">8.0</data>
      <data key="d7">Renal function is evaluated during the medical assessment for fasting patients.</data>
      <data key="d8">health assessment,kidney health</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391611</data>
    </edge>
    <edge source="Dosage adjustment" target="Oral hypoglycaemic agents">
      <data key="d6">9.0</data>
      <data key="d7">Dosage adjustments for oral hypoglycaemic agents are necessary during fasting.</data>
      <data key="d8">medication management,treatment adaptation</data>
      <data key="d9">chunk-ebdd9159e939274d247a78b6acac88a4</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391609</data>
    </edge>
    <edge source="&gt;95%" target="Pill count">
      <data key="d6">9.0</data>
      <data key="d7">Pill count includes the threshold '&gt;95%' indicating high adherence based on medication count.</data>
      <data key="d8">adherence metric,threshold</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391648</data>
    </edge>
    <edge source="Pill count" target="75–94%">
      <data key="d6">9.0</data>
      <data key="d7">Pill count includes the threshold '75–94%' indicating moderate adherence based on medication count.</data>
      <data key="d8">adherence metric,threshold</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391649</data>
    </edge>
    <edge source="Pill count" target="Less than 75%">
      <data key="d6">9.0</data>
      <data key="d7">Pill count includes the threshold 'Less than 75%' indicating low adherence based on medication count.</data>
      <data key="d8">adherence metric,threshold</data>
      <data key="d9">chunk-f480f72b48dd45386afd9bcad167646e</data>
      <data key="d10">unknown_source</data>
      <data key="d11">1754391650</data>
    </edge>
  </graph>
</graphml>
